1/0//7
‫התשס"ז‬/'‫ז‬
‫רשומות‬
ISRAEL STATE RECORDS
‫כ"ז באייר התשס"ז‬
May 15, 2007
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Patents expired
Notices
Changes in particulars entered
in register
Corrigenda
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
‫עמוד‬
Page
4
791
404
404
401
404
409
470
‫פטנטים‬
479
420
i
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫פטנטים שפג תוקפם‬
‫הודעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫תיקוני טעויות‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
422
434
434
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
474
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,4 ‫ רח' הסדנא‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה לציבור בימי חול‬,‫ תלפיות‬,4 ‫לשכת הפטנטים נמצאת ברח' הסדנא‬
.10::/ -‫ ו‬0::/ ‫שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬0../ ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. /-0414.-0
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on
weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 99.
.₪ 69 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 75742.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
.₪ 1,1.0 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,06 '‫מס‬
2
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
Particulars of the applications are
given in the following order:
Number and date of application
And the first four symbols of the
International Classification
Title of invention
(as proposed by applicant)
Applicant
Priority right: Convention country –
Number and date of
Foreign application
3
‫ לחוק הפטנטים‬19 ‫הודעה לפי סעיף‬
1697 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬:0 ‫בתקנה‬
:1690–‫תשכ"ח‬
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2022121661
172638
PILOT BACK-UP SYSTEM AND
METHOD
MENAHEM HAR-EVEN
6026221660
‫מערכת ושיטה לגיבוי טייס‬
‫מנחם הר אבן‬
173026
174520
174521
174609
SEISMIC ISOLATION DEVICE FOR
BUILDING STRUCTURE
VLADIMIR BRIMAN
/626/21660
PROTECTING CHILDREN AND
PASSENGERS WITH RESPECT TO A
VEHICLE
ASHER S. SABAN
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
F41A
‫טוען מחסניות‬
‫אלי פישביין‬
MAGAZINE LOADER
ELI FISCHBEIN
1026/21660
H04B
‫ התקן ומערכת לאפנון אותות‬,‫שיטה‬
‫תקשורת‬
‫אלביט מערכות בע"מ‬
DUAL PHYSICAL LAYER FOR
COMMUNICATION SYSTEMS
ELBIT SYSTEMS LTD.
1/26/21660
E04H
‫חיש גדר‬
‫יואב קדוש‬
QUICK HEDGEROW
JOAV KADOSH
1/26/21660
B64D
E04H
‫מתקן של בידוד סיסמי למבני בניה‬
‫ולדימיר ברימן‬
174634
B60R
‫הגנה של ילדים ונוסעים ביחס לכלי רכב‬
‫ סבן‬.‫אשר ש‬
4
/626/21660
174669
METHOD FOR REGULATING OSNR
IN A FIBER OPTIC COMMUNICATION
LINE USING RAMAN
AMPLIFICATION
ECI TELECOM LTD
/226/21660
H04B
‫ בקו תקשורת בעל‬OSNR ‫שיטה לוויסות‬
‫סיב אופטי תוך שימוש בהגבר מסוג‬
RAMAN
174706
CERTIFICATE IMPLEMENTATION
SYSTEM
NDS LIMITED
6126/21660
174709
174710
A SYSTEM AND A METHOD FOR
RELIABLE SYMMETRIC DATA
SYNCHRONIZATION
EMOZE LTD
6126/21660
SYSTEM AND METHOD FOR
OPTICAL SENSING OF SURFACE
MOTIONS
ABRAHAM AHARONI
5
H04L
‫מערכת ליישום של אישור‬
METHOD, DEVICE AND SYSTEM FOR
USE IN A VIDEOCONFERENCE
SESSION
ERAN DARIEL
6126/21660
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
H04N
‫ התקן ומערכת לשימוש בשיחת‬,‫שיטה‬
‫ועידה מסוג וידיאו‬
‫ערן דריאל‬
H04L
‫שיטה ומערכת לתיאום בו–זמני אמין של‬
‫מידע‬
‫אמוז בע"מ‬
174713
G01N
‫מערכת ושיטה לחישה אופטית של‬
‫תנועות משטח‬
‫אברהם אהרוני‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6126/21660
174717
METHOD OF INDICATING THE
PRESENCE OF A HAZARDOUS
SUBSTANCE AND STICKER
THEREFOR
RAANAN NOVIK
6126/21660
‫שיטה לציון נוכחות חומר מסוכן ומדבקה‬
‫עבורה‬
‫רענן נוביק‬
174723
RESTRICTING UNSUPERVISED
ACTIVITY OF UNMANNED VESSELS
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
6/26/21660
PROPULSION KIT
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
6/26/21660
KEY MANAGEMENT SYSTEM
NDS LIMITED
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B63B
‫הגבלת פעולה התקפית של כלי שיט‬
‫בלתי מאויש‬
‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפאל‬
174731
SYSTEM AND METHOD FOR
OPTIMIZING DATA TRANSMISSION
OVER AN AIRLINK
GAMESTREAM LTD.
6/26/21660
B65C
H04B
‫שיטה ומערכת ליעול העברת מידע דרך‬
‫קישור אוויר‬
‫גיימסטרים בע"מ‬
174733
F42B
‫ערכת דחיפה‬
‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפאל‬
174755
H04L
‫מערכת לניהול מפתחות‬
6
6/26/21660
174779
OPTICAL REMOTE CONTROL
SYSTEM
ELIYAHU DARDARI
6/26/21660
‫מערכת שלט רחוק אופטית‬
‫אליהו דרדרי‬
174780
174881
174882
174883
MORPHING FLIGHT SURFACES
ZAMIR TRIBELSKY
7
B65C
‫כלי טיס מופעל מבחוץ באמצעות מדחף‬
‫כפול מונגד סיבוב‬
‫זמיר טריבלסקי‬
CONTRAPUNTALLY
INTEROPERATED AIR VEHICLE
ZAMIR TRIBELSKY
2626/21660
B64C
‫עילוי אווירי מערבולתי‬
‫זמיר טריבלסקי‬
AIR VORTICES PROPELLING
ZAMIR TRIBELSKY
2626/21660
B64C
‫מטריצת טיסה נתמכת‬
‫זמיר טריבלסקי‬
FLIGHT SUSTAINING MATRIX
ZAMIR TRIBELSKY
2626/21660
G08B
‫מערכת השגחה לכלי נשק‬
‫דוד כהן‬
WEAPON MONITORING SYSTEM
DAVID COHEN
2626/21660
G08C
174884
B64C
‫עיצוב משטחי טיסה‬
‫זמיר טריבלסקי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2626/21660
174885
‫זנב מנתב‬
‫זמיר טריבלסקי‬
STEERING TAIL
ZAMIR TRIBELSKY
2626/21660
174886
174887
174888
SECURITY FENCE CONSTRUCTION
EL-FAR ELECTRONICS SYSTEMS
2000 LTD.
1/26/21660
174921
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G08B
‫מבנה גדר בטחון‬
‫ בע"מ‬0/// ‫פר אלקטרוניקה מערכות‬-‫אל‬
175121
H04Q
‫רשת קוגניטיבית‬
‫ציון חדד‬
COGNITIVE NETWORK
ZION HADAD
1/26/21660
F41H
‫מערכת שיבוש מבוזרת‬
‫אלתא מערכות בע"מ‬
DISTRIBUTED JAMMER SYSTEM
OPTIGO SYSTEMS LTD
2226/21660
B64C
‫מערך כנף דינמי‬
‫זמיר טריבלסקי‬
DYNAMIC WING ARRAY
ZAMIR TRIBELSKY
2626/21660
B23P
‫מחולל משטח אוויר‬
‫זמיר טריבלסקי‬
AIRFOIL GENERATOR
ZAMIR TRIBELSKY
2626/21660
B64C
175144
H04L
8
‫רשת נתונים אלחוטית‬
‫אלביט מערכות בע"מ‬
WIRELESS DATA NETWORK
ELBIT SYSTEMS LTD.
1126/21660
175162
THE METHOD FOR DETERMINING
THE VERTICAL ON MOVING
OBJECTS AND THE DEVICE FOR ITS
IMPLEMENTATION
NAUMOV, MICHAEL
1026/21660
A METHOD OF COMPACTING
OPTICAL SYSTEMS COMPRISING
MULTIPLE OPTICAL CHANNELS
INTO CONFINED SPACES
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
/626/21660
DEPLOYMENT CONTROL SYSTEM
9
‫נאומוב מיכאל‬
F41C
‫אקדח רוס"ר‬
‫סילבר שדו מערכות בטחוניות מתקדמות‬
‫בע"מ‬
175276
ON-GIMBALS CRYOGENIC COOLING
SYSTEM
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
1/26/21660
‫השיטה לקביעת האנך על עצמים ניידים‬
‫ומכשיר להוצאה לפועל של השיטה‬
175232
ASSAULT PISTOL RIFLE
SILVER SHADOW ADVANCED
SECURITY SYSTEMS LTD.
1/26/21660
G01C
F25B
‫מערכת קירור קריאוגנית המותקנת על‬
‫גימבלים‬
‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפאל‬
175277
G02B
‫שיטה לדחיסת מערכות אופטיות המכילות‬
‫ערוצים אופטיים מרובים למרחבים‬
‫מוגבלים‬
‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפאל‬
175329
F41A
‫מערכת לבקרה על פריסת כוחות‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫דוד כהן‬
DAVID COHEN
6026121660
175526
A METHOD FOR MEASURING
STRUCTURE PARAMETERS USING
SPECTRAL IMAGING SYSTEMS
NOVA MEASURING INSTRUMENTS
LTD.
2026121660
‫שיטת מדידה של פרמטרי מבנה תוך‬
‫שימוש במערכת הדמיה ספקטראלית‬
‫נובה מכשירי מדידה בע"מ‬
175682
176055
176274
WEB CONTENT DISTRIBUTION TO
PERSONAL CELLULAR
TELECOMMUNICATIONS DEVICES
CELLTICK TECHNOLOGIES LTD.
2/26021660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G06F
‫הפצת תוכן וובי למכשירים סלולריים‬
‫אישיים‬
‫סלטיק טכנולוגיות בע"מ‬
176275
CELLULAR EMERGENCY
NOTIFICATION SERVICE
CELLTICK TECHNOLOGIES LTD.
2126/21660
G02B
‫סורק אופטי לינארי‬
‫מרק שכטרמן‬
LINEAR OPTICAL SCANNER
MARK SHECHTERMAN
2/26021660
F41A
‫מערכת לבקרה על פריסת כוחות‬
‫דוד כהן‬
DEPLOYMENT CONTROL SYSTEM
DAVID COHEN
/226121660
H01L
H04M
‫שרות סלולרי להודעות חירום‬
‫סלטיק טכנולוגיות בע"מ‬
176811
A61K
10
METHODS AND KITS FOR
DIAGNOSING AND TREATING
MENTAL RETARDATION
RAMOT AT TEL AVIV UNIVERSITY
LTD.
US
60/698039
12/07/2005
2026/21660
‫שיטות וערכות לאבחון וטיפול בפיגור שכלי‬
176867
A . ALLWEIL ARCH
176906
177237
FILM COMPOSITIONS
WARNER-LAMBERT COMPANY LLC.
US
10/792066
03/03/2004
771037023
0110712004
US
PCT/IB/2005/000449
WO/2005/092271
1226121661
11
B32B
‫גילוי דטרמיניסטי של אותות במערך של‬
‫גלאים‬
‫דורון קויאט‬
DETERMINISTIC DETECTION OF
SIGNALS IN A DETECTOR ARRAY
DORON KWIAT
1226121661
H01R
‫מיתקן הארקה מיבני עבור מיכשור‬
‫אלקטרוני – דיגיטלי להשגת רזולוציה‬
‫גבוהה מאוד‬
‫אדריכל אברהם אלואיל‬
STRUCTURAL GROUNDING PLANT
FOR DIGITAL ELECTRONICS TO
ATTAIN VERY HIGH RESOLUTION
2/26/21660
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
177266
A61K
‫הרכבי משטחים‬
A61K
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
FILM PRODUCTS HAVING
CONTROLLED DISINTEGRATION
PROPERTIES
WARNER-LAMBERT COMPANY LLC
US
10/792362
03/03/2004
771030449
0110712004
US
PCT/IB/2005/000451
WO/2005/092272
6/26/21660
‫תוצרי פילם בעלי תכונות התפוררות‬
‫מבוקרות‬
177347
DESIMFEATION WATER WITH
LOIZER
SARAH MOGRABI
6/26/21661
‫חיטוי מים על ידי לייזר‬
‫שרה מוגרבי‬
177399
METHODS AND SYSTEMS FOR
CONTROLLING THE PITCH OF A
PROPELLER
THE INSITU GROUP, INC.
US
60/549684
03/03/2004
771017490
0210312004
US
PCT/US/2005/007035
WO/2005/084373
2026/21660
MINIATURE MISSILE
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
6/26/21661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C02F
B64D
‫שיטות והתקנים לבקרת הפסיעה של‬
‫מדחף‬
177527
F42B
‫טילון‬
‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפאל‬
177720
B65C
12
METHOD AND APPARATUS FOR
APPLYING VARIABLE CODED
LABELS TO ITEMS OF PRODUCE
SINCLAIR SYSTEMS
INTERNATIONAL, LLC
US
60/549778
03/03/2004
PCT/US/2005/007167
WO/2005/084383
6/26021660
177930
177995
MECHANISM FOR OPENING AND
CLOSING A VEHICLE DOOR
ALEX ORIGINAL LTD
2/26021660
‫אלכס אוריגינל בע"מ‬
178060
13
B60G
‫מתלה רכב אנכי ללא מוביל‬
‫יחזקאל דודוביץ‬
178139
MODULAR ATTACHMENT
ASSEMBLY FOR VEHICLE ANTITHEFT DEVICE
RAV BARIACH SECURITY
PRODUCTS LTD.
2/26021660
B62D
‫מנגנון לפתיחת ולסגירת דלת של רכב‬
VERTICAL NON- GUIDED VEHICLE
SUSPENSION
JECHESKEL DAVIDOVITCH
2/26021660
B65F
‫פח סל‬
‫פירמט וינדיש‬
BASKET GARBAGE
FRIMET VINDISH
2226021660
‫שיטה ומתקן להנפקת תוויות מקודדות‬
‫משתנות עבור פריטים לייצור‬
B60R
‫מכלול חיבור מודולרי להתקן נגד גניבת‬
‫רכב‬
‫רב בריח מוצרי בטחון בע"מ‬
178170
B65D
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫ תחתוניות‬,‫מנפק קומפקטי לתחבושות‬
‫וחיתולים‬
‫לינה קרקוז‬
A COMPACT SANITARY NAPKIN,
PEDS AND DIAPER DISPENSER
VITALY KARAKUZ
1626021660
178225
‫מכלול משטח מודולרי‬
MODULAR PALLET ASSEMBLY
POLYMER LOGISTICS BV
1226021660
178234
‫וורטקס טכנולוגיות אקולוגיות בע"מ‬
178270
178293
CYCLONE SEPARATOR WITH DRY
FOG NOZZLES
MORDECHAY EYAL
1026021660
THERMAL BATTERY WITH LONG
LIFE TIME AND LONG SHELF LIFE
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
1/26021660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B60R
‫רהיט לרכב‬
‫רפאל דורסט‬
CAR FURNITURE
RAPHAEL DURST
1026021660
B01D
‫מפריד מערבולת ציקלון‬
VORTEX CYCLONE SEPARATOR
VORTEX ECOLOGICAL
TECHNOLOGIES LTD.
1126021660
B65D
B01D
‫מפריד ציקלוני עם מערפלי מים יבשים‬
‫מרדכי איל‬
178314
H01M
‫סוללה תרמית בעלת זמן חיים וחיי מדף‬
‫ארוכים‬
‫רשות לפיתוח אמצעי לחימה בע"מ‬-‫רפאל‬
178370
B65D
14
FOLDING CONTAINER WITH
ELASTICALLY SUSPENDED BASE
POLYMER LOGISTICS BV
6/26/21661
‫מיכל מתקפל עם בסיס תלוי באופן גמיש‬
178431
LIFT AUGMENTATION SYSTEM
JOHN R. LEE
US
60/559970
07/04/2004
901449917
0110412004
US
901449912
0110412004
US
901490992
7210412004
US
901414024
2410412004
US
901979404
0117012004
US
PCT/US/2005/011541
WO/2005/099380
6122621660
178454
REFILLABLE DEVICE AND A
FILLING ARRANGEMENT THEREFOR
ADORAM LESHEM
6122621660
178455
REFILLABLE CONTAINER AND A
FILLING ARRANGEMENT THEREFOR
ADORAM LESHEM
6122621660
178466
PASSENGER TRANSPORTATION
SYSTEM, ESPECIALLY AN
ESCALATOR OR MOVING WALK
INVENTIO AG
EP
05109858.0 21/10/2005
2122621660
15
178577
B64D
‫מערכת לתוספת תנופה‬
B65D
‫מתקן למילוי חוזר והתקן למילויו‬
‫אדורם לשם‬
B65D
‫מיכל למילוי חוזר והתקן למילויו‬
‫אדורם לשם‬
B65G
‫מערכת הסעה לנוסעים במיוחד מדרגות‬
‫נעות או מסוע‬
B62B
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫נושא רשימת קניות‬
‫תמנון הופ בע"מ‬
SHOPPING LIST SUPPORT
TAMNUN HOP LTD.
2/26/21661
178592
B64D
‫כלי תעופה בעל כנף מסתובבת‬
ROTARY WING VEHICLE
PAUL E. ARLTON
US
60/562081
14/04/2004
PCT/US/2005/012560
WO/2005/099415
1026/21661
178598
C07C
SKIN-PROTECTING ALKALINITYCONTROLLING COMPOSITION AND
THE USE THEREOF
CP KELCO APS
PA
DK
26/04/2004
200400649
PCT/DK/2005/000285
WO/2005/102262
2/22621660
‫הרכב הגנה על העור ולבקרה על‬
‫ ושימוש בו‬,‫בסיסיותו‬
178699
B62K
VEHICLE SPEED CONTROL
ASSEMBLY
GAVRIEL OR-GIL
1126/21661
‫מכלול שליטה במהירות כלי רכב‬
‫גבריאל אורגיל‬
178728
DPI FORMULATION CONTAINING
SULFOALKYL ETHER
CYCLODEXTRIN
CYDEX, INC.
US
60/564892
23/04/2004
PCT/US/2005/014010
WO/2005/104712
2022621660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C08B
‫ המכילה סולפואלקיל‬DPI ‫פורמולציית‬
‫אתר ציקלודקסטרין‬
178729
C07D
16
A PROCESS FOR THE PREPARATION OF
ANGIOTENSIN II ANTAGONISTIC
COMPOUNDS
DIPHARMA S.P.A.
IT
MI2005A001989 20/10/2005
2026/21661
‫תהליך להכנת תרכובות אנטיגוניסטיות‬
II ‫לאנגיאוטנסין‬
178732
?-AMINOAMIDE DERIVATIVES
USEFUL IN THE TREATMENT OF
RESTLESS LEGS SYNDROME AND
ADDICTIVE DISORDERS
NEWRON PHARMACEUTICALS S.P.A.
EP
04009532.5 22/04/2004
PCT/EP/2005/004166
WO/2005/102300
1126/21661
1122621660
‫תולדות אלפא–אמינואמיד המשמשות‬
‫לטיפול בתסמונת רגליים חסרות מנוחה‬
‫ואי סדרים ממכרים‬
178750
ANTIFUNGAL DRUG DELIVERY
MARCEL NIMNI
US
10/832933
27/04/2004
PCT/US/2005/014246
WO/2005/105072
17
C07C
‫תכשירים למתן תרופות אנטי–פטרייתיות‬
178778
TOBACCO HOLDER FOR A HOOKAH
ROEE SHAY ZION
1126/21661
C07C
178779
A24D
‫מחזיק טבק עבור נרגילה‬
‫רועי שי ציון‬
C07H
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN ANTHRACYCLINE
AGENT AND A CYTIDINE ANALOG
IN A LIPOSOMAL CARRIER
CELATOR PHARMACEUTICALS, INC.
US
60/565210
22/04/2004
PCT/CA/2005/000625
WO/2005/102359
1/26/21661
‫תכשירי רוקחות המכילים גורם‬
‫אנתרצקלין ואנאלוג ציטידין בנשא‬
‫ליפוסומי‬
178781
STEROID COMPOSITIONS AND
TRANSDERMAL FORMULATIONS
AND PATCHES CONTAINING THE
SAME
HUNTER-FLEMING LIMITED
GB
0409498.3
28/04/2004
PCT/GB/2005/001596
WO/2005/105104
1122621660
‫תכשירים סטרואידיים ועצובים וטלאים‬
‫המכילים אותם‬
178783
178785
METHODS OF USING AND
COMPOSITIONS COMPRISING
THALIDOMIDE FOR THE
TREATMENT AND MANAGEMENT
OF PULMONARY HYPERTENSION
CELGENE CORPORATION
US
60/565169
23/04/2004
PCT/US/2005/013596
WO/2005/102333
1226/21661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B60J
‫כיסוי חכם לרכב‬
‫ליבושר דודי‬
SMART CAR COVER DEVICE
LEIBUSHER DAVID
1226/21661
C07J
A61K
‫שיטות לשימוש ותרכובות המכילות‬
‫תלידומיד לטיפול וניהול יתר לחץ דם ריאתי‬
178786
A61K
18
METHODS OF USING AND
COMPOSITIONS COMPRISING
IMMUNOMODULATORY
COMPOUNDS FOR THE TREATMENT
AND MANAGEMENT OF
PULMONARY HYPERTENSION
CELGENE CORPORATION
US
60/565172
23/04/2004
PCT/US/2005/013598
WO/2005/105088
1226/21661
178788
METHODS OF USING AND
COMPOSITIONS COMPRISING PDE4
MODULATORS FOR THE
TREATMENT AND MANAGEMENT
OF PULMONARY HYPERTENSION
CELGENE CORPORATION
US
60/565174
23/04/2004
PCT/US/2005/013597
WO/2005/102317
2626121661
‫שיטות לטיפול ותרכובות המכילות‬
‫תרכובות אימונומודולטוריות לטיפול וניהול‬
‫יתר לחץ דם ריאתי‬
‫שיטות לשימוש ותרכובות הכוללות‬
‫ לטיפול וניהול יתר‬PDE4 ‫מודולטורים של‬
‫לחץ דם ריאתי‬
178815
THE TREATMENT OF RESPIRATORY
DISEASE
SOSEI R&D LTD
GB
0410398.2
10/05/2004
PCT/GB/2005/001776
WO/2005/107872
2626121661
THE TREATMENT OF CHILDHOOD
ASTHMA
19
A61K
178816
C07D
‫הטיפול במחלה נשימתית‬
C07D
‫הטיפול במחלת אסטמה של גיל הילדות‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
SOSEI R&D LTD
GB
0410399.0
PCT/GB/2005/001791
WO/2005/107873
10/05/2004
6026121661
178846
SOLID DOSAGE FORM OF WETTED
HEPARIN
EMISPHERE TECHNOLOGIES, INC.
US
60/569475
06/05/2004
901412919
7910412004
US
901494914
0410412004
US
PCT/US/2005/016012
WO/2005/107773
1122621660
178853
TAR COMPOSITION FOR THE
TREATMENT OF SKIN DISEASES
DR. M. BURSTEIN LTD.
1122621660
A61K
‫ בורשטיין בע"מ‬.‫דר' מ‬
178856
B60R
‫מערכת בקרה לפליטת חומר נדיף‬
‫בן דוד ג'ייקוב‬
178899
[3.2.0] HETEROCYCLIC COMPOUNDS
AND METHODS OF USING THE SAME
NEREUS PHARMACEUTICALS, INC.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫צורה של מנה מוצקה של הפרין רטוב‬
‫הרכב המכיל זפת לטיפול במחלות עור‬
VOLATILE BLOWING CONTROL
SYSTEM
BEN-DAVID JACOB
1026/21661
C08B
C07D
‫] ושיטות‬:. 0. /[ ‫תרכובות הטרוציקליות‬
‫לשימוש בהן‬
20
US
60/567336
901440434
US
901497790
US
901921492
US
901944732
US
901949344
US
PCT/US/2005/014846
WO/2006/028525
1022621660
30/04/2004
7410912004
2910112004
7217712004
7310712004
0410312004
178927
‫בורג חליץ‬
‫דני הולנדר‬
EXTRICABLE FASTENER
DANI HOLANDER
/622621660
178932
CONCENTRATE LIQUID AND SYRUP
INSTALLATION
YESHAYA GERAFI
/622621660
21
‫ישעיה ג'רפי‬
A01M
‫מכשיר ושיטה למניעת טפילות בתוך נפח‬
‫מוגדר‬
‫אבי קליימן‬
178984
USE OF PPAR AGONISTS TO TREAT
RUMINANTS
PFIZER PRODUCTS INC.
US
60/574136
25/05/2004
B65D
‫מתקן לנוזל מרוכז ותרכיז‬
178936
APPARATUS AND METHOD FOR THE
PREVENTION OF INFESTATION
INSIDE A VOLUME OF INTEREST
KLAYMAN AVI
2/26121661
F16B
A61K
‫ לטיפול במעלי‬PPAR ‫שימוש באגוניסטים‬
‫גירה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PCT/IB/2005/001501
WO/2005/115369
6026121661
178985
TOPICAL CYPRESS ESSENTIAL OIL
COMPOSITION FOR STRETCH
MARKS
LELEE MEHREGANI
AU
2004902458 11/05/2004
PCT/AU/2005/000655
WO/2005/107694
2026121661
2/26121661
C07D
‫צירופים של אגוניסטים של אדרנו–קולטן‬
‫גליקופירולט‬
0‫וביתא‬
18/05/2004
6022221660
VEHICLE AND GUIDE-WAY FOR
EXTREME RIDING CONDITIONS
HECHT ERAN
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61K
‫שיטות ותכשירים קשורים להפחתת שומן‬
179013
COMBINATIONS OF
GLYCOPYRROLATE AND
BETA2 ADRENOCEPTOR AGONISTS
NOVARTIS AG
GB
0411056.5
PCT/EP/2005/005354
WO/2005/110402
‫תרכובת שמן יסודי מעצי ברוש מקומיים‬
‫עבור סימני מתיחה‬
179008
METHODS AND RELATED
COMPOSITIONS FOR REDUCTION OF
FAT
LOS ANGELES BIOMEDICAL
RESEARCH INSTITUTE AT HARBOR
UCLA MEDICAL CENTER
US
60/572879
19/05/2004
PCT/US/2005/017957
WO/2005/112942
A61K
179079
B61B
‫כלי רכב ומסילה לנסיעה בתנאים קיצוניים‬
‫הכט ערן‬
22
6/22221660
179119
CAR ENGINE PARTS AND DEARINGS
LUBRICATION SYSTEM
LESHCHINSKY ALEXANDER
6/22221660
179120
A SPONGE WHICH CONTAINS SOLID
OR VISCOUS SOAP AND METHOD
AND APPARATUS FOR
MANUFACTURING SAME
ISRAEL TSABARI
2026121661
179177
ACYCLOVIR FORMULATIONS
EMISPHERE TECHNOLOGIES, INC.
US
60/573003
19/05/2004
PCT/US/2005/017815
WO/2005/112937
2122221660
179185
179187
FOB HAVING A CLIP AND METHOD
FOR MANUFACTURE THEREOF
ON TRACK INNOVATIONS LTD.
23
‫מערכת הסיכה של חלקי מכונה קטנים‬
‫ומסבים של מנוע המכוניות‬
‫לשצ'רשנסקי אלכסנדר‬
A47C
‫ספוג המכיל סבון מוצק ושיטה ומערכת‬
‫של הייצור‬
‫ישראל צברי‬
C07D
‫פורמולציות של אסיקלוביר‬
A45D
‫מסכה אסתטית‬
‫כהן כוכבה‬
AESTHETIC MASK
COHEN COHAVA
2122221660
F16N
A44B
‫שרשרת בעלת אטב ושיטה ליצורה‬
‫און טרק אינובישנס בע"מ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2126121661
179189
ANTIMICROBIAL SOLUTIONS
CONTAINING SILVER NANO
PARTICLES
KISHORE MADHUKAR PAKNIKAR
IN
548/MUM/2004 12/05/2004
PCT/IN/2005/000155
WO/2005/120173
2226121661
179190
STABILIZING SOLUTIONS FOR
SUBMICRONIC PARTICLES, METHODS
FOR MAKING THE SAME AND
METHODS FOR STABILIZING
SUBMICRONIC PARTICLES
KISHORE MADHUKAR PAKNIKAR
IN
550/MUM/2004 12/05/2004
PCT/IN/2005/000153
WO/2006/001033
2/22221660
179274
179277
AEROSOLIZED
FOSFOMYCIN/AMINOGLYCOSIDE
COMBINATION FOR THE
TREATMENT OF BACTERIAL
RESPIRATORY INFECTIONS
Corus Pharma, Inc.
US
60/571739
17/05/2004
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫תמיסות אנטי חיידקיות המכילות‬
‫חלקיקי ננו של כסף‬
A61K
–‫תמיסות מייצבות עבור חלקיקים תת‬
‫ שיטות להכנתן ושיטות‬,‫מיקרוניים‬
‫לייצוב חלקיקים תת–מיקרוניים‬
F25B
‫מערכת קירור‬
‫עמיר קליין‬
COOLING SYSTEM
AMIR KLEIN
6126121661
A61K
C07F
‫ אמינוגליקוזיד‬/‫קומבינציית פוספומיצין‬
‫בצורת תרסיס לטיפול בזיהומים‬
‫בקטריאליים של דרכי הנשימה‬
24
901949004
US
PCT/US/2005/014690
WO/2005/110022
6/26021661
0310312004
179323
‫שיטה לטיפול בסרטן‬
CANCER TREATMENT METHOD
SMITHKLINE BEECHAM (CORK)
LIMITED
US
60/577337
04/06/2004
PCT/US/2005/019568
WO/2005/120512
1/26121661
179330
COMBINATION THERAPY WITH
GLATIRAMER ACETATE AND
MINOCYCLINE FOR THE
TREATMENT OF MULTIPLE
SCLEROSIS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/575114
28/05/2004
PCT/US/2005/018938
WO/2005/117902
2022221660
25
C07C
‫טיפול קומבינציה בטרשת נפוצה עם‬
‫גלאטירמר אצטאט ומינוציקלין‬
‫טבע תעשיות פרמצבטיות בע"מ‬
179341
A TURBINE ENGINE HAVING A
THERMAL BARRIER COATING AND
A METHOD FOR PROVIDING A
COMPONENT WITH PROTECTION
AGAINST SAND
UNITED TECHNOLOGIES
CORPORATION
US
11/336437
20/01/2006
C07D
F01D
‫מנוע טורבינה עם צפוי חוסם חום ושיטה‬
‫להענקת הגנה נגד חול לפריט‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179398
IV – DPP ‫מעכבי‬
DPP-IB INHIBITORS
SANTHERA PHARMACEUTICALS
(SCHWEIZ) AG
EP
04013512.1 08/06/2004
PCT/EP/2005/006162
WO/2005/121131
2/26121661
179399
179400
PURINE DERIVATIVES AS
ADENOSINE A1 RECEPTOR
AGONISTS AND METHODS OF USE
THEREOF
INOTEK PHARMACEUTICALS
CORPORATION
US
60/574805
26/05/2004
901444293
7410112004
US
PCT/US/2005/018381
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61L
‫תכשיר לסגירת רקמה‬
TISSUE CLOSING PREPARATION
JURIDICAL FOUNDATION THE
CHEMO-SERO- THERAPEUTIC
RESEARCH INSTITUTE
2004JP
21/05/2004
152474
PCT/JP/2005/009065
WO/2005/113030
1126121661
C07D
C07H
‫תולדות פיורין כאגוניסטים לקולטן אדנוסין‬
‫ ושיטות לשימוש בהן‬A1
26
WO/2005/117910
2126021661
179401
THERAPY OF PLATINUM-RESISTANT
CANCER
GENENTECH, INC.
US
60/580333
16/06/2004
PCT/US/2005/021286
WO/2006/007398
6226021661
1/26121661
H04B
‫שיטה והתקן להקצאה פעילה של תהליכי‬
ARQ– H–
179403
SYSTEM, APPARATUS AND METHOD
FOR GENERATING FORCE BY
INTRODUCING A CONTROLLED
PLASMA ENVIRONMENT INTO AN
ASYMMETRIC CAPACITOR
ROBERT CHRYSLER BRENNAN
US
60/573884
24/05/2004
771734499
2310412004
US
PCT/US/2005/019246
WO/2006/115507
27
‫טיפול בסרטן עמיד לתרכובות פלטינה‬
179402
METHOD AND APPARATUS FOR
DYNAMICALLY ALLOCATING HARQ PROCESSES
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/578712
10/06/2004
PCT/US/2005/019237
WO/2005/125226
A61K
H02J
‫ התקן ושיטה לייצור כוח על ידי‬,‫מערכת‬
‫הכנסת סביבת פלזמה מבוקרת לתוך קבל‬
‫אסימטרי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1622221660
179404
METHOD AND SYSTEM FOR
REDUCING DISTRACTION DURING
DRIVING
SHMUEL SADOVSKY
1/26121661
‫שיטה ומערכת להקטנת הסחת דעת בזמן‬
‫נהיגה‬
‫שמואל סדובסקי‬
179405
HETEROCYCLIC COMPOUNDS AND
THEIR USE AS ALDOSTERONE
SYNTHASE INHIBITORS
SPEEDEL EXPERIMENTA AG
CH
00916/04
28/05/2004
PCT/EP/2005/052417
WO/2005/118557
1/26121661
179406
TETRAHYDRO-IMIDAZO[1,5-A]
PYRIDIN DERIVATIVES AS
ALDOSTERONE SYNTHASE
INHIBITORS
SPEEDEL EXPERIMENTA AG
CH
915/04
28/05/2004
PCT/EP/2005/052419
WO/2005/118581
6226021661
179407
DIAMETER MEASURING DEVICE
ASTRAZENECA AB
SE
0401408-0
02/06/2004
PCT/SE/2005/000825
WO/2005/118428
1/26121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B60R
179408
C07D
‫תרכובות הטרוציקליות ושימוש בהן‬
‫כמעכבי אלדוסטרון סינטאז‬
C07D
A– 5, [‫נגזרות של טטרהידרו–אימידזו‬
‫]פירידין כמעכבי אלדוסטרונ–סינתז‬1
B65D
‫מתקן למדידת קוטר‬
C07D
28
BICYCLIC, NITROGEN-CONTAINING
HETEROCYCLES AS AROMATASE
INHIBITORS
SPEEDEL EXPERIMENTA AG
CH
915/04
28/05/2004
PCT/EP/2005/052416
WO/2005/118540
1/26121661
179409
HETEROCYCLIC COMPOUNDS AND
THEIR USE AS ALDOSTERONE
SYNTHASE INHIBITORS
SPEEDEL EXPERIMENTA AG
CH
0916/04
28/05/2004
7741104
0910112004
CH
PCT/EP/2005/052418
WO/2005/118541
1/26021662
179410
MICROSCOPIC NETWORKS OF
CONTAINERS AND NANOTUBES
NANOXIS AB
SE
0003506-3
28/09/2000
PCT/SE/2001/002116
WO/2002/026616
1/26121661
179411
PARTICULATE COMPRISING A
CALCIUM-CONTAINING COMPOUND
AND A SUGAR ALCOHOL
NYCOMED PHARMA AS
PA 2004
DK
24/05/2004
00813
PCT/DK/2005/000338
WO/2005/115342
29
‫הטרוציקליים ביציקליים המכילים חנקן‬
‫כמעכבים לארומאטאז‬
C07D
‫תרכובות הטרוציקליות ושימוש בהן‬
‫כמעכבי אלדוסטרון סינטאז‬
B82B
–‫רשתות מיקרוסקופיות של מיכלים וננו‬
‫צינורות‬
A61K
‫חומר חלקיקי הכולל תרכובת המכילה‬
‫סידן ואלכוהול סוכר‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
SPLICING SYSTEM
NDS LIMITED
GB
0413723.8
901447443
US
PCT/IL/2005/000608
WO/2005/122688
6226021661
179412
‫מערכת שזירה‬
18/06/2004
2710912004
179413
IN VITRO TECHNIQUES FOR USE
WITH STEM CELLS
IN MOTION INVESTMENT, LTD.
US
60/576266
01/06/2004
901444420
7410112004
US
PCT/IL/2005/000571
WO/2005/120090
6226021661
179414
1026121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫תרכובות הטרוציקליות מאוחות‬
179415
METHOD AND APPARATUS FOR
DETECTING ZERO RATE FRAMES IN
A COMMUNICATIONS SYSTEM
QUALCOMM INCORPORATED
US
09/388029
01/09/1999
PCT/US/2000/023926
WO/2001/017158
H04Q
‫ לשימוש עם תאי גזע‬VITRO IN ‫טכניקות‬
FUSED HETEROCYCLIC COMPOUND
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2004JP
02/06/2004
165050
2004-044237 0210312004
JP
PCT/JP/2005/010451
WO/2005/118588
/226/21666
H04N
H04L
‫שיטה והתקן לגילוי קצב אפס של מסגרות‬
‫במערכת תקשורת‬
179416
G11C
30
METHOD AND SYSTEM FOR
PROVIDING DIRECTED BANK
REFRESH FOR VOLATILE MEMORIES
QUALCOMM INCORPORATED
US
60/575334
27/05/2004
701942034
0417712004
US
PCT/US/2005/018903
WO/2005/119691
1026121661
179417
IMPROVED DATA MESSAGING
EFFICIENCY FOR AN ASSISTED
WIRELESS POSITION
DETERMINATION SYSTEM
QUALCOMM INCORPORATED
US
10/854981
26/05/2004
PCT/US/2005/018916
WO/2005/119287
1626121661
179418
SYSTEM AND METHOD FOR
DISSEMINATING COLOR INK AND
COLORANT FORMULAS
SUN CHEMICAL CORPORATION
US
10/709659
20/05/2004
PCT/US/2005/017662
WO/2005/114482
6/26021661
179419
HETEROARYL SULFONES AND
SULFONAMIDES AND THERAPEUTIC
USES THEREOF
31
‫שיטה ומערכת עבור מתן ריענון שקע‬
‫זיכרון של זכרון נדיף‬
G01S
‫יעילות משופרת של העברת מידע‬
‫בהודעות עבור מערכת איתור מיקום‬
‫אלחוטית נתמכת‬
G06F
‫מערכת ושיטה לפיזור דיו צבע ונוסחאות‬
‫פיגמנטים‬
C07D
‫סלפונים וסלפונאמידיים הטרואריליים‬
‫ושימושים רפואיים שלהם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
TEMPLE UNIVERSITY-OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION
US
60/578162
08/06/2004
PCT/US/2005/020023
WO/2005/123077
2026121661
179420
COMPOSITIONS OF NDV AND
METHODS OF USE THEREOF FOR
TREATMENT OF CANCER
THERAVIR MANAGEMENT L.P.
US
60/572475
20/05/2004
PCT/IL/2005/000518
WO/2005/113013
1026121661
‫ ושיטות לשימוש בהם‬NDV ‫תכשירים של‬
‫לטיפול בסרטן‬
.‫פ‬.‫תרוויר מנג'מנט ל‬
179421
179422
RECOMBINANT VACCINES AGAINST
INFECTIOUS BURSAL DISEASE
VIRUS
RAHAN MERISTEM
1126121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A01H
IBDV ‫חיסון רקומביננטי נגד‬
‫רחן מריסטם‬
179423
DEVICE, SYSTEM AND METHOD FOR
IN VIVO ANALYSIS
C12P
‫שיטות להערכת רצפים של‬
‫ריבונוקליאוטידים‬
‫אנימה סל מטרולוג'י‬
METHODS FOR EVALUATING
RIBONUCLEOTIDE SEQUENCES
ANIMA CELL METROLOGY
US
60/574210
26/05/2004
PCT/IL/2005/000540
WO/2005/116252
1622221660
A61K
A61K
‫ מערכת ושיטה לאנליזה תוך גופית‬,‫מכשיר‬
32
GIVEN IMAGING LTD.
US
60/572777
PCT/IL/2005/000525
WO/2005/113021
‫גיוון אימג'ינג בע"מ‬
21/05/2004
2/26121661
179424
SUBSTITUTED OXAZOLE BENZOISOTHIAZOLE DIOXIDE
DERIVATIVES, PROCESS FOR THEIR
PREPARATION AND THEIR USE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102004026532.1 29/05/2004
PCT/EP/2005/005321
WO/2005/116003
1/26121661
‫נגזרות אוקסזול–בנזואיזותיאזול‬
‫ תהליך לייצורן‬,‫דיאוקסיד מותמרים‬
‫ושימוש שלהן‬
179425
179426
179427
ANTIBODIES AS T CELL RECEPTOR
MIMICS, METHODS OF PRODUCTION
AND USES THEREOF
33
C08B
‫ייצור של אתילצלולוז בעל משקל‬
‫מולקולרי נמוך‬
PRODUCTION OF LOW MOLECULAR
WEIGHT ETHYLCELLULOSE
DOW GLOBAL TECHNOLOGIES INC.
US
60/574599
26/05/2004
PCT/US/2005/007396
WO/2005/118649
1/26121661
G01S
‫מערכת קוהרנטית למיקום גיאוגרפי‬
COHERENT GEOLOCATION SYSTEM
BAE SYSTEMS INFORMATION AND
ELECTRONIC SYSTEMS
INTEGRATION INC.
US
10/853693
25/05/2004
PCT/US/2005/018049
WO/2006/073473
6/26/21661
C07D
C12N
‫ שיטות‬,‫נוגדנים כחקיינים לקולטי טי–תאים‬
‫ ושימושיהם‬,‫לייצורם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
VAUGHAN P. WITTMAN
US
60/574857
901940020
US
901949334
US
901913299
US
PCT/US/2005/018789
WO/2005/116072
2026121661
27/05/2004
2417212004
2410712004
2010412004
179428
STENT WITH CONTOURED
BRIDGING ELEMENTS
CONOR MEDSYSTEMS, INC.
US
60/573085
21/05/2004
PCT/US/2005/017068
WO/2005/115277
1/26121661
1/26121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫סטנט עם מרכיבי גישור מעוצבים‬
179429
IMMEDIATE RELEASE
PHARMACEUTICAL TABLETS WITH
HEIGHT GREATER THAN WIDTH
ACCU-BREAK TECHNOLOGIES, INC.
US
60/573042
21/05/2004
901413734
2710412004
US
PCT/US/2005/018633
WO/2005/112897
A61F
A61K
‫תכשיר לשחרור מידי בצורת טבליות אשר‬
‫גובהן גדול מרוחבן‬
179430
A61K
34
PHARMACEUTICAL TABLETS
HAVING A SEPARATION MARK
POSITIONED ON THE SIDE OF SAID
TABLETS
ACCU-BREAK TECHNOLOGIES, INC.
US
60/573042
21/05/2004
901413734
2710412004
US
PCT/US/2005/018638
WO/2005/112870
1/26121661
‫תכשיר בטבליות עם סימן הפרדה בצדי‬
‫הטבליות‬
179431
PHARMACEUTICAL TABLETS
HAVING A RELATIVELY INACTIVE
SEGMENT
ACCU-BREAK TECHNOLOGIES, INC.
US
60/573042
21/05/2004
901413734
2710412004
US
PCT/US/2005/018639
WO/2005/112898
1/26121661
1/26121661
35
‫תכשיר בטבליות עם מקטע לא פעיל‬
‫באופן יחסי‬
179432
PHARMACEUTICAL TABLETS
COMPRISING TWO OR MORE
UNITARY SEGMENTS
ACCU-BREAK TECHNOLOGIES, INC.
US
60/573042
21/05/2004
901413734
2710412004
US
PCT/US/2005/018631
WO/2005/112900
A61K
A61K
‫תכשיר בטבליות הכוללות שני מקטעים או‬
‫יותר המשמשים כיחידות נפרדות‬
179433
A61K
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
SCORED PHARMACEUTICAL
TABLETS COMPRISING A
PLURALITY OF SEGMENTS
ACCU-BREAK TECHNOLOGIES, INC.
US
60/573042
21/05/2004
901413734
2710412004
US
PCT/US/2005/018632
WO/2006/038916
2026121661
179434
INGESTIBLE DEVICE PLATFORM
FOR THE COLON
SPECTRUM DYNAMICS LLC
US
60/572466
20/05/2004
PCT/IL/2005/000517
WO/2005/112895
1222221660
‫תכשיר בטבליות מחורצות הכוללות‬
‫מקטעים מרובים‬
‫ עבור בדיקות המעי‬,‫גלולה מכנית לבליעה‬
‫הגס‬
179436
TANK FOR SIMULTANEOUS
STORAGE OF BOTH PRESSURED GAS
AND LIQUID FUEL
RADEL LLC
6126021661
179437
PROPANE-1,3-DIONE DERIVATIVE
OR ITS SALT
ASTELLAS PHARMA INC.
2004JP
04/06/2004
166486
2004-099474 3010312004
JP
PCT/JP/2005/010184
WO/2005/118556
6/26021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61K
179438
B65B
‫המיכל המשולב לאייחסון גז ודלק נוזלי‬
‫רדאל ללס‬
C07D
‫– פרופאן דיאון או מלח שלו‬: ,1 ‫תולדות‬
C07C
36
LEVODOPA PRODRUGS, AND
COMPOSITIONS AND USES THEREOF
XENOPORT, INC.
US
60/577087
04/06/2004
PCT/US/2005/019492
WO/2005/121069
6226021661
179439
NETHOD AND SYSTEM FOR
PROVIDING THE STATUS OF USER
EQUIPMENT IN A WIRELESS LOCAL
NETWORK INTERWORKING WITH
3GPP SYSTEMS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/576753
02/06/2004
PCT/US/2005/019238
WO/2005/122476
1126121661
179440
REPORTING TERMINAL
CAPABILITIES FOR SUPPORTING
SHORT MESSAGE SERVICE
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/576700
02/06/2004
771772403
2210412004
US
PCT/US/2005/018386
WO/2005/122604
1026121661
37
179441
‫מטרימי תרופות של לבודופה ותכשירים‬
‫והשימוש בהם‬
H04Q
‫שיטה ומערכת למתן המעמד של ציוד‬
‫משתמש במערכת תקשורת אלחוטית‬
GPP3 ‫מקומית משותפת עם מערכות‬
H04Q
‫דיווח על יכולות מסוף עבור תמיכה‬
‫בשירות הודעות קצרות‬
C12Q
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫ פרוליל‬HIF ‫בדיקת פעילות של‬
‫הידרוקסילאז‬
HIF PROLYL HYDROXYLASE
ACTIVITY ASSAY
FIBROGEN, INC.
US
60/575324
28/05/2004
PCT/US/2005/018577
WO/2005/118836
1626121661
179442
C12N
CARTILAGE AND BONE REPAIR
COMPOSITION
UNIVERSIDAD DE MALAGA
ES
P200401227 21/05/2004
PCT/ES/2005/000287
WO/2005/112542
6/26021661
‫תכשיר לתיקון סחוס ועצמות‬
179443
‫תולדות ליפופיליות מונואמידים שעברו‬
‫קילציה‬
LIPOPHILIC DERIVATIVES OF
CHELATE MONOAMIDES
KEREOS, INC.
US
60/578474
09/06/2004
901904740
2110412004
US
PCT/US/2005/019966
WO/2005/122891
6026021661
179444
4-PHENYL-PYRIMIDINE-2CARBONITRILE DERIVATIVES
N.V. ORGANON
EP
04253491.7 11/06/2004
0470994943
2317212004
EP
PCT/EP/2005/006266
WO/2005/121106
2226021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61B
C07D
‫–קרבוניטריל‬0–‫–פניל–פירימידין‬4 ‫תולדות‬
179445
C07D
38
1-METHYL-3-TRIFLUOROMETHYLPYRAZOLE-4-CARBOXYLIC ACID
(ORTHO-PHENYL)-ANILIDES AND USE
THEREOF AS FUNGICIDE
BASF AKTIENGESELLSCHAFT
DE
102004029468.2 18/06/2004
PCT/EP/2005/006278
WO/2005/123689
2/26021661
–‫–טריפלואורומתיל–פריאוזול‬:–‫–מתיל‬1
–)‫–חומצה קרבוקסילית (אורתו–פניל‬4
‫אנילידים ושימוש בהם כקוטלי פטריות‬
179446
2,4,5,6-SUBSTITUTED PYRIMIDINES,
METHOD FOR THE PRODUCTION AND
USE THEREOF FOR COMBATING
PARASITIC FUNGI
BASF AKTIENGESELLSCHAFT
DE
102004030927.2 25/06/2004
PCT/EP/2005/006598
WO/2006/000358
2126021661
2026021661
39
,‫– פירימידינים מותמרים‬9 , . , 4 ,0
‫שיטה לייצורם ושימוש בהם למלחמה‬
‫בפטריות טפילות‬
179447
METHODS OF USING APO2L
RECEPTOR AGONISTS AND NK CELL
ACTIVATORS
GENENTECH, INC.
US
60/581129
18/06/2004
PCT/US/2005/021117
WO/2006/009731
C07D
C12N
‫שיטות לשימוש באגוניסטים של קולטן‬
NK ‫ ומשפעלים שלך תאי‬APO2L
179448
C07D
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1-METHYL-3-DIFLUOROMETHYLPYRAZOL-4-CARBONIC ACID-(ORTHOPHENYL)-ANILIDES, AND USE
THEREOF AS A FUNGICIDE
–4–‫–דיפלואורומתיל–פיראזול‬:–‫–מתיל‬1
–‫חומצה קרבונית‬
‫ והשימוש בהם‬,‫(אורתו–פניל)–אנילידים‬
‫כקוטלי פטריות‬
BASF AKTIENGESELLSCHAFT
DE
102004029469.0 18/06/2004
PCT/EP/2005/006479
WO/2005/123690
2/26021661
179449
6-(2-FLUOROPHENYL)TRIAZOLOPYRIMIDINES, METHOD FOR
THE PRODUCTION THEREOF, USE
THEREOF FOR CONTROLLING
HARMFUL FUNGI, AND AGENTS
CONTAINING THE SAME
BASF AKTIENGESELLSCHAFT
DE
102004030166.2 22/06/2004
PCT/EP/2005/006342
WO/2005/123739
1/26121661
–)‫–פלואורופניל‬0(–9
‫ שיטה לייצורם‬,‫טריאזולופירימידינים‬
‫ושימוש בהם לשליטה בפטריות מזיקות‬
‫וגורמים המכילים אותם‬
179450
RELEASABLE COUPLING AND
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412050.7
28/05/2004
PCT/GB/2005/002105
WO/2005/115506
2/26121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
A61M
‫התקן הזרקה ומצמד הניתן לשחרור‬
179451
B01D
40
METHOD FOR THE PRODUCTION OF
CHEMICAL AND PHARMACEUTICAL
PRODUCTS WITH INTEGRATED
MULTICOLUMN CHROMATOGRAPHY
BAYER TECHNOLOGY SERVICES
GMBH
DE
102004025000.6 21/05/2004
PCT/EP/2005/005313
WO/2005/113101
1026121661
‫שיטה לייצור מוצרים כימיים ורוקחים‬
‫בשילוב כרומטוגרפיה רבת קולונות‬
179454
COATED TABLET FORMULATION
AND METHOD
BRISTOL-MYERS SQUIBB COMPANY
US
60/575319
28/05/2004
PCT/US/2005/018692
WO/2005/117841
2126121661
1626121661
‫פורמולציה של טבליה מצופה ושיטה‬
179455
BICYCLIC HETEROCYCLES AS HIV
INTEGRASE INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
60/575513
28/05/2004
901903317
2010412004
US
771729497
7710412004
US
PCT/US/2005/016473
WO/2005/118593
41
C07D
‫תרכובות ביציקליות הטרוציקליות כמעכבי‬
‫ אינטגרז‬HIV
179456
DOSAGE FORM FOR DELIVERY OF
MULTIPLE DRUG FORMS
ALZA CORPORATION
US
60/573312
21/05/2004
PCT/US/2005/017678
WO/2005/112896
1026121661
A61K
179457
A61K
‫צורת מינון למתן צורות תרופה מרובות‬
A23K
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
ANIMAL FEED COMPOSITIONS WITH
EHHANCED HISTIDINE CONTENT
CARGILL INC.
US
60/575628
28/05/2004
901411393
0410912004
US
PCT/US/2005/018625
WO/2006/001968
6126021661
179458
SUBSTITUTED ARYL AND
HETEROARYL DERIVATIVES AS
MODULATORS OF METABOLISM
AND THE PROPHYLAXIS AND
TREATMENT OF DISORDERS
RELATED THERETO
ARENA PHARMACEUTICALS, INC.
US
60/577354
04/06/2004
PCT/US/2005/019318
WO/2005/121121
1026121661
179459
SYSTEM FOR DYNAMIC
ARBITRATION OF A SHARED
RESOURCE ON A DEVICE
QUALCOMM INCORPORATED
US
10/854984
26/05/2004
PCT/US/2005/018673
WO/2005/119446
1026121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179460
‫תרכובות מספוא לחיות עם תכולת‬
‫היסטידין מוגברת‬
C07D
‫תולדות של ניגזרות אריל והטרואריל‬
‫כמווסתי מטבוליזם ומניעה וטיפול‬
‫בהפרעות הקשורות בו‬
G06F
‫מערכת לתיווך דינמי של משאבים‬
‫משותפים בהתקן‬
G11C
42
METHOD AND SYSTEM FOR
PROVIDING SEAMLESS SELFREFRESH FOR DIRECTED BANK
REFRESH IN VOLATILE MEMORIES
QUALCOMM INCORPORATED
US
60/575335
27/05/2004
701942211
0417712004
US
PCT/US/2005/018917
WO/2005/119692
2026021661
179461
METHOD FOR PREPARING 5-[4-(2HYDROXY-PROPYL)-3,5-DIOXO-4,5,DIHYDRO-3H] 2,4-[TRIAZIN-2-YL]BENZAMIDE DERIVATIVES BY
DEPROTECTING THE HYDROXYLPROTECTED PRECURSERS
PFIZER PRODUCTS INC.
US
60/583851
29/06/2004
PCT/IB/2005/002036
WO/2006/003500
6226/21661
‫שיטה ומערכת למתן ריענון עצמי שקוף‬
‫עבור רענון זיכרון ייזום בזיכרונות נדיפים‬
–0(–4[ – . ‫שיטה להכנת נגזרות של‬
–4 ,.–‫–דיאוקסו‬: ,.–)‫הידרוקסי–פרופיל‬
–]‫ איל‬0–]‫–[טריאזין‬H3 2], 1–‫דיהידרו‬
‫בנזאמיד על ידי הסרת הגנה מפרקורסורים‬
‫מוגני הידרוקסיל‬
179462
USE OF THE RECEPTOR GPR86
PARADIGM THERAPEUTICS LIMITED
GB
0414798.9
01/07/2004
901449473
0910112004
US
047024344
7910412004
GB
901943417
2010412004
US
PCT/GB/2005/002601
WO/2006/003422
/226121661
43
C07D
179463
G01N
GPR86 ‫שימוש ברצפטור‬
A01N
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫ בפוריות‬IL – 17
IL-17 IN FERTILITY
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V.
US
60/575326
28/05/2004
PCT/US/2005/018952
WO/2005/117979
6/26121661
179464
PIPING BAG, BLANK FOR
MANUFACTURING A PIPING BAG
AND METHOD OF MANUFACTURING
A PIPING BAG
KEE PLASTICS AB
SE
0401356-1
26/05/2004
901414232
2910412004
US
PCT/SE/2005/000148
WO/2005/115162
1/26121661
,‫ חלל המשמש לייצור השקית‬,‫שקית זילוף‬
‫ושיטה לייצורה‬
179465
CAPNOGRAPHY APPARATUS
ORIDION MEDICAL LTD.
US
60/575174
27/05/2004
PCT/IL/2005/000547
WO/2005/115087
2/26/21661
179466
A METHOD OF ENCRYPTING AND
TRANSFERRING DATA BETWEEN A
SENDER AND A RECEIVER USING A
NETWORK
GCRYPT LIMITED
GB
0411560.6
24/05/2004
PCT/GB/2005/001479
WO/2005/117331
1626121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A23G
179467
A61B
‫מכשיר לקפנוגרפיה‬
‫אורידיון מדיקל בע"מ‬
H04L
‫שיטה להצפנת והעברת מידע בין שולח‬
‫ומקבל המשתמשים ברשת‬
C07C
44
TETRACYCLINE DERIVATIVES AND
ANALOGS AND PROCESSES FOR THE
PREPARATION THEREOF
THE PRESIDENT AND FELLOWS OF
HARVARD COLLEGE
US
60/573623
21/05/2004
901990941
7710312004
US
PCT/US/2005/017831
WO/2005/112945
1222221660
179468
METHOD OF ASSEMBLING AN INVIVO IMAGING DEVICE
GIVEN IMAGING LTD.
US
60/738972
23/11/2005
1222221660
179471
GEMSTONE CONSTRUCTION
PARTICULARLY USEFUL FOR
DIAMONDS
JACKOB TSROR
1/26121661
45
A61B
‫שיטה להרכבת התקן הדמיה תוך–גופי‬
‫גיוון אימג'ינג בע"מ‬
B24B
‫בניית אבני חן–שימושי במיוחד ליהלומים‬
‫יעקב צרור‬
179472
METHODS AND KITS FOR
DIAGNOSING AND/OR ASSESSING
SEVERITY AND TREATING
GAUCHER DISEASE
RAMOT AT TEL AVIV UNIVERSITY
LTD.
US
60/573335
24/05/2004
PCT/IL/2005/000530
WO/2005/115429
1/26121661
‫תולדות ואנאלוגים של טטראציקלין‬
‫ותהליכים להכנתם‬
179474
A23L
‫שיטות וערכות לאבחון וטיפול במחלת‬
‫גושה‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
A23L
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
FUNCTIONAL FOODS COMPRISING
FLAVONOIDS AND TOCOTRIENOLS
AND METHODS THEREOF
KGK SYNERGIZE INC.
US
60/574655
26/05/2004
PCT/IB/2005/001424
WO/2005/115377
6026021661
179475
MULTI-JET WATER METER WITH
FLOW COMPENSATING BASKET
ARAD LTD.
US
60/578602
10/06/2004
901929417
7917712004
US
771749909
0110912004
US
PCT/IL/2005/000619
WO/2005/121714
6026021661
‫דברי מאכל המכילים פלבונואידים‬
‫וטוקוטריאנולים ושיטות להכנתם‬
‫מד מים רב–סילוני עם סל בעל פיצוי–זרם‬
179476
ANTIBODIES AGAINST HUMAN
INTERLEUKIN-13 AND USES
THEREFOR
WYETH
US
60/578473
09/06/2004
901414139
0910912004
US
901447314
2210912004
US
PCT/US/2005/020160
WO/2005/123126
/226/21660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G01F
179477
‫ארד בע"מ‬
A61K
‫ אנושי‬1:–‫נוגדנים נגד אינטרלוקין‬
‫ושימושים בהם‬
H04Q
46
‫שיטה ומערכת לקישור שכבה בסיוע‬
‫טכניקת הנדאופ‬
METHOD AND APPARATUS FOR
LINK LAYER ASSISTED HANDOFF
MOTOROLA, INC.
US
60/676064
29/04/2005
771343179
7310212009
US
PCT/US/2006/012409
WO/2006/118732
1122221660
179478
TUBULAR RADIATION ABSORBING
DEVICE FOR A SOLAR POWER PLANT
WITH IMPROVED EFFICIENCY
SCHOTT AG
DE
102005057276.6 25/11/2005
6/2602166/
179479
ENZYMATIC TREATMENT OF
RETINITIS PIGMENTOSA AND
RELEVANT PHARMACEUTICAL
COMPOSITION THEREFOR IN FORM
OF A KIT
ROBERTO GIORDANI
F24J
‫התקן צינורי סופג קרינה עבור מפעל‬
‫כח סולרי עם יעילות משופרת‬
A61K
‫טיפול אנזימטי של רטיניטיס פיגמנטוזה‬
‫ותכשירי רוקחות רלבנטים בצורת קיט‬
PCT/IT/2004/000331
WO/2005/120544
6026021661
INHALER USING PODS
MEDERIO AG
SE
0401612-7
PCT/SE/2005/000875
WO/2005/123002
179480
‫משאף המשתמש בתרמילים‬
18/06/2004
1/26121661
MINIMIZING POWDER RETENTION
ON SURFACES
MEDERIO AG
47
A61J
179481
A61J
‫הקטנת אחיזת אבקה על גבי משטחים‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
SE
0401612-7
PCT/SE/2005/000795
WO/2005/123004
2/26121661
18/06/2004
179482
A CHECK VALVE WITH A SPIRAL
COIL SEAL
HUSKY INJECTION MOLDING
SYSTEMS LTD.
US
10/876584
28/06/2004
PCT/CA/2005/000743
WO/2006/000077
1226/21661
‫שסתום בדיקה עם אטום סליל ספיראלי‬
179483
179484
NEW 4-BENZYLIDENE-PIPERIDIN
DERIVATIVES
RICHTER GEDEON VEGYESZETI
GYAR RT.
HU
P0401522
29/07/2004
PCT/HU/2005/000077
WO/2006/010964
1226/21661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫–בנזילאידן–פיפרידין‬4 ‫תולדות חדשות של‬
179485
INDOLE-2 CARBOXAMIDINE
DERIVATIVES AS NMDA RECEPTOR
ANTAGONISTS
C07D
‫תולדות אמיד חדשות של הטרוציקליים‬
‫חומצה קרבוקסילית‬
NEW HETEROCYCLIC CARBOXYLIC
ACID AMIDE DERIVATIVES
RICHTER GEDEON VEGYESZETI
GYAR RT.
HU
P0401527
29/07/2004
PCT/HU/2005/000082
WO/2006/010969
1226/21661
B22D
C07D
‫–קרבוקסאמיד‬0 ‫תולדות אינדול‬
NMDA ‫כאנטגוניסטים של קולטן‬
48
RICHTER GEDEON VEGYESZETI
GYAR RT.
HU
P0401523
29/07/2004
PCT/HU/2005/000078
WO/2006/010965
1226/21661
179486
NEW BENZOYL UREA DERIVATIVES
RICHTER GEDEON VEGYESZETI
GYAR RT.
HU
P0401524
29/07/2004
PCT/HU/2005/000079
WO/2006/010966
1226/21661
179487
KYNURENIC ACID AMIDE
DERIVATIVES AS NR2B RECEPTOR
ANTAGONISTS
RICHTER GEDEON VEGYESZETI
GYAR RT.
HU
P041525
29/07/2004
PCT/HU/2005/000080
WO/2006/010967
1/26121661
DRY POWDER INHALER
MEDERIO AG
SE
0401453-6
PCT/SE/2005/000779
WO/2005/120615
6/26021661
179488
‫תולדות חדשות של בנזואיל אוריאה‬
C07D
‫תולדות אמיד של חומצה קינורינית‬
NR2B ‫כאנטגוניסטים של קולטן‬
A61M
‫משאף לאבקה יבשה‬
07/06/2004
179489
SECURING DOSE QUALITY OF
INHALABLE DRUG
MEDERIO AG
SE
0401453-6
07/06/2004
0407972-1
7410912004
SE
49
C07D
A61M
‫איכות מינון בטוח של תרופה הניתנת‬
‫לשאיפה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PCT/SE/2005/000843
WO/2005/120616
6126021661
179490
SYSTEM AND METHOD FOR
CREATING GRAPHICS ON GLASS
SURFACES
VISUAL ICE, INC.
US
60/577141
04/06/2004
771037474
0910712004
US
PCT/US/2005/019716
WO/2005/118161
1/22222000
‫מערכת ושיטה ליצירת גרפיקה על זכוכית‬
179491
PRESSURISED METERED DOSE
INHALERS
CHIESI FARMACEUTICI S.P.A.
IT
MI98A002559 25/11/1998
IT
MI99A001712 3010117999
PCT/EP/1999/009002
WO/2000/030608
1/26121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61K
‫משאפים בעלי מנה קצובה בלחץ‬
179494
COMPOUNDS FOR USE AS A
MEDICAMENT WHICH INHIBIT
PROCESSING OF THE VIRAL Gag p25
PROTEIN (CA-SP1) TO P24(CA) AND
USE THEREOF
THE GOVERNMENT OF THE UNITED
STATES OF AMERICA AS
REPRESENTED BY THE SECRETARY
OF THE DEPARTMENT OF HEALTH
AND HUMAN SERVICES
US
10/851637
24/05/2004
901943997
7110212004
US
PCT/US/2005/018331
WO/2005/113059
B05D
A61M
‫תרכובות לשימוש כתרופה אשר מעקבות‬
‫עיבוד של חלבון‬
) P (CA04 ‫ ) ל‬p Gag ( CA–SP10. ‫הוירלי‬
‫ושימושן‬
50
6/26121661
179495
METHOD AND INSTALLATION FOR
EXTRACTING CONSTITUENTS FROM
SUGAR BEETS
SUDZUCKER AKTIENGESELLSCHAFT
DE
102004028782.1 16/06/2004
PCT/EP/2005/004769
WO/2005/123967
1/26121661
‫שיטה ומערכת למצוי מרכיבים מסלק‬
‫סוכר‬
179496
TRIAZOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
METABOLEX, INC.
US
60/574426
25/05/2004
PCT/US/2005/018318
WO/2005/115383
1026121661
1126/21661
51
C07D
‫תולדות טריאזול ותכשירי רוקחות‬
‫המכילים אותן‬
179498
ORALLY-ADMINISTRABLE
COMPOSITIONS COMPRISING
STABLE AMORPHOUS CALCIUM
CARBONATE
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
60/574208
26/05/2004
PCT/IL/2005/000545
WO/2005/115414
A23N
A61K
‫הרכבים הניתנים דרך הפה הכוללים סידן‬
‫פחמתי אמורפי יציב‬
179499
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
A01N
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
MIXTURES OF ANTHRANILAMIDE
INVERTEBRATE PEST CONTROL
AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/591239
26/07/2004
901990001
7310912004
US
PCT/US/2005/026116
WO/2006/068669
1026121661
179500
USER INTERFACE ACTION
PROCESSING USING A FRESHNESS
STATUS
QUALCOMM INCORPORATED
US
10/854977
26/05/2004
PCT/US/2005/018674
WO/2005/119414
1/26121661
SYSTEM AND METHOD FOR
AUTOMATED SEARCH BY
DISTRIBUTED ELEMENTS
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G06F
‫עיבוד פעולת ממשק של משתמש על ידי‬
‫רעננות סטטוס‬
179501
METHOD AND SYSTEM FOR
PROVIDING INDEPENDENT BANK
REFRESH FOR VOLATILE MEMORIES
QUALCOMM INCORPORATED
US
60/575333
27/05/2004
701942997
0417712004
US
PCT/US/2005/018580
WO/2005/119690
2126/21661
‫חומרים להדברת מזיקים חסרי חוליות‬
‫שהם תערובות של אנתרנילאמידים‬
G11C
‫שיטה ומערכת לאספקת רענון שקע זיכרון‬
‫בלתי יציב בצורה עצמאית‬/‫משתנה‬
179502
G05D
‫שיטה ומערכת לחיפוש ממוכן על ידי‬
‫יסודות מבוזרים‬
52
RAYTHEON COMPANY
US
10/892747
PCT/US/2005/025332
WO/2006/020154
2/26021661
15/07/2004
179503
ABLATION APPARATUS AND
SYSTEM TO LIMIT NERVE
CONDUCTION
JNJ TECHNOLOGY HOLDINGS, L.L.C.
US
10/870202
17/06/2004
PCT/US/2005/021023
WO/2006/009705
1026/21661
‫מתקן הסרה ומערכת להגביל מוליכות של‬
‫עצב‬
179504
179505
179506
STENT HAVING STRUTS WITH
REVERSE DIRECTION CURVATURE
MEDINOL LTD.
53
C07D
–:–‫–פאניל‬1–‫–אוקסו‬0 ‫תהליך עבור ייצור‬
‫אוקסאביסיקלו‬
‫] הקסאן‬: .1 . /[
PROCESS FOR PRODUCING 2-OXO-1PHENYL-3OXABICYCLO[3.1.0]HEXANE
SUMITOMO CHEMICAL COMPANY,
LIMITED.
2004JP
16/06/2004
178957
PCT/JP/2005/011221
WO/2005/123709
6/26021661
C07D
‫קארבוקסימילים אינדוליזינים‬
DIAZA –‫ ו‬AZA ‫ונגזרותיהם‬
INDOLIZINE CARBOXIMIDES AND
THEIR AZA AND DIAZA DERIVATIVES
SCHWARZ PHARMA AG
DE
102004037445.7 02/08/2004
04070424747
0210412004
EP
PCT/EP/2005/008240
WO/2006/015737
2/26021661
A61B
A61F
‫סטנט בעל יתדות עם עקמומיות מהופכת‬
‫מדינול בע"מ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
US
10/864685
PCT/IB/2005/001569
WO/2005/120394
08/06/2004
1026121661
179508
‫ על ידי‬0 ‫פירימידינים מותמרים בעמדה‬
4 ‫הטרואריל המכיל הטרואטום בעמדה‬
‫לשימוש בטיפול בהפרעת התרבות של‬
‫תאים‬
2-SUBSTITUTED-4- HETEROARYLPYRIMIDINES USEFUL FOR THE
TREATMENT OF PROLIFERATIVE
DISORDERS
CYCLACEL LIMITED
GB
0411791.7
PCT/GB/2005/002134
WO/2005/116025
26/05/2004
1126121661
179509
METHOD FOR SELECTING OR
OBTAINING PLANTS WHICH ARE
RESISTANT TO PVMV
GENOPLANTE-VALOR
FR
0405616
25/05/2004
PCT/FR/2005/001296
WO/2005/118850
1222121661
6/26021661
METHODS OF USING IL-1
ANTAGONISTS TO TREAT
AUTOINFLAMMATORY DISEASE
C12Q
‫שיטה לבחירה או להשגה של צמחים‬
PVMV –‫עמידים ל‬
179510
DENDRITIC POLYMERS WITH ENHANCED
AMPLIFICATION AND INTERIOR
FUNCTIONALITY
DENDRITIC NANOTECHNOLOGIES, INC
US
PCT/US2005/138643 20/04/2005
PCT/US/2005/047635
WO/2006/115547
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
179512
A61K
‫פולימרים דנדריטיים עם הגברה‬
‫משופרת ופונקצינליות פנימית‬
A61K
IL– 1 ‫שיטות לשימוש באנטגוניסטים של‬
‫לטיפול במחלות דלקתיות עצמיות‬
54
REGENERON PHARMACEUTICALS,
INC.
US
60/577023
04/06/2004
PCT/US/2005/019674
WO/2005/117945
1026/21661
179513
METHODS OF TREATING TYPE I
DIABETES BY BLOCKING VEGF MEDIATED ACTIVITY
REGENERON PHARMACEUTICALS,
INC.
US
60/592628
30/07/2004
PCT/US/2005/027180
WO/2006/015297
2/26021661
1 ‫שיטות לטיפול בסכרת מטיפוס‬
‫באמצעות חסימת פעילות מתווכת על ידי‬
VEGF
179514
METHOD OF ADMINISTERING AND
USING VEGF INHIBITORS FOR THE
TREATMENT OF MALIGNANT
PLEURAL EFFUSION
REGENERON PHARMACEUTICALS,
INC.
US
60/580893
18/06/2004
PCT/US/2005/021391
WO/2006/009809
2626021661
METHOD OF ADMINISTERING AND
USING VEGF INHIBITORS FOR THE
TREATMENT OF HUMAN CANCER
55
C07K
179515
C07K
VEGF ‫שיטה למתן ושימוש במעכבי‬
‫לטיפול בתפליט צדר ממאיר‬
A61K
VEGF ‫שיטה למתן ושימוש במעכבי‬
‫לטיפול בסרטן בבני אדם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
REGENERON PHARMACEUTICALS,
INC.
US
60/578499
10/06/2004
PCT/US/2005/020762
WO/2005/123104
1/22221660
179516
TYMPANIC THERMOMETER PROBE
COVER WITH FILM SUPPORT
MECHANISM
SHERWOOD SERVICES AG
US
11/286620
23/11/2005
1/22221660
‫כיסוי לבוחן מדחם תפי עם מנגנון תמיכה‬
‫פילמי‬
179517
SINGLE LUMEN ADAPTER FOR
AUTOMATIC VALVE
SHERWOOD SERVICES AG
US
11/286094
23/11/2005
1/26121661
179518
179519
AMIDO COMPOUNDS AND THEIR
USE AS PHARMACEUTICALS
INCYTE CORPORATION
US
60/582556
24/06/2004
901939719
2217212004
US
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
F16K
‫מתאם לחלל בודד עבור שסתום אוטומטי‬
MERCAPTOIMIDAZOLES AS CCR2
RECEPTOR ANTAGONISTS
JANSSEN PHARMACEUTICA N.V.
EP
PCT/EP2004/50933 26/05/2004
PCT/EP/2005/052369
WO/2005/118578
1/26021661
A61B
C07D
‫מרקפטואימידאזולים כאנטאגוניסטים‬
CCR2 ‫לקולטן‬
C07D
‫תרכובות אמידו ושימושן כתכשיר של‬
‫רוקחות‬
56
PCT/US/2005/022411
WO/2006/002349
1/26021661
179520
N - SUBSTITUTED PIPERIDINES AND
THEIR USE AS PHARMACEUTICALS
INCYTE CORPORATION
US
60/582557
24/06/2004
901974410
3010912004
US
901949440
0210912004
US
PCT/US/2005/022307
WO/2006/012226
1/22221660
‫ – פיפרידינס מומרים ושימושם כתכשיר‬N
‫של רוקחות‬
179522
PTICAL SCANNING SYSTEM BASED
ON ROTATING POLYGON AND
CYLINDERIC LENSES
ZVI NEZER
1/22221660
C07D
G02B
‫מערכת סריקה אופטית בעלת פוליגון‬
‫סובב ומערכת עדשות גליליות‬
‫צבי נזר‬
179523
A62B
‫תיק הצלה‬
‫צחי טופלברג‬
RESCUE BAG
TZACHI TOPELBERG
1/26121661
179524
PYRIDIN- 4 - YL - ETHYNYL IMIDAZOLES AND PYRAZOLES AS
MGLU5 RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
PCT/EP2004/05881 01/06/2004
0402727949
0110912004
EP
PCT/EP/2005/005559
WO/2005/118568
57
C07D
‫ –יל – אתיניל – אימידזולים‬4 – ‫פירידיו‬
‫ופירזולים כאנטגוניסטים של קולטן‬
MGLU5
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1/26121661
179527
VARIABLE FOCAL LENGTH LENS
STEREO DISPLAY. INC.
US
10/855287
27/05/2004
PCT/US/2005/018527
WO/2005/119331
6/2602166/
179529
3 -? - D - RIBOFURANOSYLTHIAZOLO
[4-5-d] PYRIMIDINE NUCLEOSIDES
AND USES THEREOF
G02B
‫עדשות עם מרחק מיקוד משתנה‬
C07H
– D – ? –: ‫נוקלאוסידים של‬
‫] פירימידין‬d – 5, 4[ ‫ריבופורנוזילתיאזולו‬
‫ושימושם‬
ANADYS PHARMACEUTICALS, INC.
PCT/US/2004/018011
WO/2005/121162
1126121661
179530
NOVEL COMPOUNDS,
PHARMACEUTICAL COMPOSITIONS
CONTAINING SAME AND METHODS
OF USE FOR SAME
THE JOHNS HOPKINS UNIVERSITY
US
60/574639
26/05/2004
PCT/US/2005/018443
WO/2005/117590
/626121661
179531
A REUSABLE MINIATURE CAMERA
HEAD
MEDIGUS LTD.
IL
162251
31/05/2004
PCT/IL/2005/000555
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫ תכשירי רוקחות‬,‫תרכובות חדשות‬
‫ ושיטות לשימושן‬,‫המכילים אותן‬
A61B
‫ראש מצלמה מיניאטורי הניתן לשימוש‬
‫חוזר‬
‫מדיגוס בע"מ‬
58
WO/2005/115221
6/26021661
179532
QUINAZOLINE DERIVATIVES
USEFUL AS VANILLOID
ANTAGONISTS
NOVARTIS AG
GB
0412769.2
08/06/2004
PCT/EP/2005/006253
WO/2005/120510
1/26121661
179533
TREATMENT WITH CISPLATIN AND
AN EGFR-INHIBITOR
F. HOFFMANN-LA ROCHE AG
US
60/576790
03/06/2004
PCT/EP/2005/005737
WO/2005/117916
6226021661
179534
HETEROCYCLIC ANTIVIRAL
COMPOUNDS
F. HOFFMANN-LA ROCHE AG
US
60/578759
09/06/2004
PCT/EP/2005/005895
WO/2005/121145
6026021661
179536
METHODS OF REDUCING
NEMATODE DAMAGE
SYNGENTA PARTICIPATIONS AG
EP
04013338.1 07/06/2004
PCT/EP/2005/006057
WO/2005/120232
59
C07D
‫נגזרות של קוינאזולין השימושיות‬
‫כאנטגוניסטים של ונילואיד‬
A61K
EGFR –‫טיפול עם ציספלטין ומעכב‬
C07D
‫תרכובות אנטי –ויראליות הטרוציקליות‬
A01N
‫שיטה להפחתת נזק מנמטודים‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179537
SUGAR COATINGS AND METHODS
THEREFOR
WYETH
US
60/577668
07/06/2004
PCT/US/2005/019972
WO/2005/120466
1/26121661
179538
SYNTHESIS OF AMINO-ALKOXYHEPTANOIC ALKYL ESTER
F. HOFFMANN-LA ROCHE AG
EP
04102458.9 02/06/2004
PCT/EP/2005/005736
WO/2005/118525
1/22221660
179539
179541
ARRAY OF MICROMIRROR ARRAY
LENSES
STEREO DISPLAY. INC.
US
10/857714
28/05/2004
PCT/US/2005/018529
WO/2005/119332
6126021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫ציפויי סוכר ושיטות לשימושם‬
C07C
– ‫סינטזה של אסטר של אלקיל אמינו‬
‫אלקוקסי – הפטנואי‬
A61C
‫מתקן דנטלי לשטיפה‬
‫נובה בע"מ‬-‫רידנט‬
DENTAL IRRIGATOR
REDENT-NOVA LTD.
1/26121661
A61K
179542
G03B
‫מערך של מיקרו–מראות למערך עדשות‬
A61M
60
INFUSION BAG WITH INTEGRATED
RINSING SYSTEM
LABORATOIRE AGUETTANT
FR
0405919
02/06/2004
PCT/FR/2005/050414
WO/2006/018555
1026121661
‫שקית עירוי עם מערכת שטיפה משולבת‬
179545
VIRAL AND VIRAL ASSOCIATED
MIRNAS AND USES THEREOF
ROSETTA GENOMICS LTD.
US
10/709739
26/05/2004
901422440
0317012004
US
901422447
0317012004
US
901422449
0417012004
US
901994094
2410312004
US
PCT/IB/2005/002352
WO/2005/116250
1226021661
179546
USES OF GPR100 RECEPTOR IN
DIABETES AND OBESITY
REGULATION
PARADIGM THERAPEUTICS LIMITED
GB
0413872.3
21/06/2004
901449974
0910112004
US
042332149
2017012004
GB
901920444
2717012004
US
PCT/GB/2005/002434
WO/2005/124361
1126/22000
OPTICAL INSPECTION SYSTEM
ORBOTECH LTD.
61
179547
C12Q
‫ וכאלה‬,‫ ויראליות‬MIRNA ‫מולקולות‬
‫ ושימושיהם‬,‫הקשורות לוירוסים‬
‫רוזטה ג'נומיקס בע"מ‬
G01N
‫ בוויסות‬GPR100 ‫שימושים ברצפטור‬
‫סכרת ושמנות‬
G01N
‫מערכת בדיקה אופטית‬
‫אורבוטק בע"מ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179548
METHOD AND APPARATUS FOR
DYNAMICALLY ADJUSTING DATA
TRANSMISSION PARAMETERS AND
CONTROLLING H-ARQ PROCESSES
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/578728
10/06/2004
PCT/US/2005/019651
WO/2005/125109
1/26121661
‫שיטה ומכשיר לכיוונון דינאמי של‬
‫פרמטרים של שידור נתונים ושליטה‬
H–ARQ ‫בתהליכי‬
179549
179550
179551
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61M
‫התקן הזרקה‬
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412053.1
28/05/2004
PCT/GB/2005/002108
WO/2005/115507
/226121661
A61M
‫התקן הזרקה‬
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412055.6
28/05/2004
PCT/GB/2005/002126
WO/2005/115510
1/26121661
A61M
‫התקן הזרקה‬
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412061.4
28/05/2004
PCT/GB/2005/002137
WO/2005/115513
1/26121661
H04B
179552
C10B
62
PLANT AND METHOD FOR PRODUCING
COMBUSTIBLE SUBSTANCES BY
DEPOLYMERIZATION OF GUM
PRODUCTS
ROMANA MACERI CENTRO ITALIA
S.R.I.
IT
FI2004A000127 09/06/2004
PCT/IT/2005/000309
WO/2005/121278
1626121661
‫מפעל ושיטה לייצור חומרים הניתנים‬
‫לבעירה באמצעות דה–פולימריזציה של‬
‫מוצרי גומי‬
179553
‫להבים צבעוניים לסכיני גילוח‬
COLORED RAZOR BLADES
THE GILLETTE COMPANY
US
10/860928
03/06/2004
PCT/US/2005/017718
WO/2005/120783
1/26121661
179554
TABLE USED TO RECEIVE A
WORKPIECE AND METHOD FOR
TREATING A WORKPIECE ON SAID
TYPE OF TABLE
OC OERLIKON BALZERS AG
CH
935/04
03/06/2004
PCT/CH/2005/000300
WO/2005/118440
1/26121661
63
B65G
‫שולחן לקבלת אביזר לעיבוד ושיטה לעיבוד‬
‫האביזר על שולחן שכזה‬
179555
INDENTIFICATION OF
ERGOTHIONEINE TRANSPORTER
AND THERAPEUTIC USES THEREOF
UNIVERSITAT ZU KOLN
EP
04012250.9 24/05/2004
PCT/EP/2005/005613
WO/2005/116657
B26B
G01N
‫זיהוי של ארגותיאוניין מוביל ושימושים‬
‫רפואיים שלו‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2/26121661
179556
DEVICE FOR FEEDING PROPELLING
CHARGES TO A HEAVY WEAPON
KRAUSS-MAFFEI WEGMANN GMBH &
CO. KG
DE
102004025742.6 26/05/2004
PCT/DE/2005/000888
WO/2005/116564
6/26021661
179557
METHOD OF TREATING
GRANULOMA ANNULARE OR
SARCOID
GENENTECH, INC.
US
60/578768
09/06/2004
901419099
7010912004
US
PCT/US/2005/020342
WO/2005/123777
1/26121661
179559
THERAMUTEIN MODULATORS
HOUSEY, GERARD, M
US
60/573962
23/05/2004
901930434
2217712004
US
901933073
0317212004
US
PCT/US/2005/018412
WO/2005/115992
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
F41A
‫התקן להזנת מטען חומר הודף לכלי‬
‫נשק כבד‬
C07K
‫שיטה לטיפול בגרגירומת טבעתית או‬
‫סרקואידית‬
C07D
‫מאפננים של תרמאוטין‬
64
2/26021661
179560
NOVEL OXABISPIDINE COMPOUNDS
AND THEIR USE IN THE TREATMENT
OF CARDIAC ARRHYTHMIAS
ASTRAZENECA AB
SE
0401539-2
15/06/2004
PCT/SE/2005/000891
WO/2005/123748
2/26021661
‫תרכובות אוקסאביספידין חדשות והשימוש‬
‫בהן בטיפול בהפרעות בקצב הלב‬
179561
NOVEL OXABISPIDINE COMPOUNDS
AND THEIR USE IN THE TREATMENT
OF CARDIAC ARRHYTHMIAS
ASTRAZENECA AB
SE
0401540-0
15/06/2004
PCT/SE/2005/000890
WO/2005/123747
6126121661
C07D
‫תרכובות אוקסאביספידין חדשות והשימוש‬
‫בהן בטיפול בהפרעות בקצב הלב‬
179562
SYSTEM AND DEVICE FOR
CHARACTERIZING GRINDING STOCK
IN A CYLINDER MILL
BUHLER AG
DE
102004031052.1 25/06/2004
PCT/CH/2005/000242
WO/2006/000112
65
C07D
G01N
‫מערכת ושיטה לאפיון טחינה של מלאי‬
‫במטחנה גלילית‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1126121661
179563
APPARATUS AND METHOD FOR
MONITORING STRAIN AND/OR LOAD
APPLIED TO A MAMMAL
DANIEL M. RONCHI
AU
20044902785 25/05/2004
PCT/AU/2005/000743
WO/2005/115228
1/26121661
‫או מטען‬/‫מתקן ושיטה לניטור עומס ו‬
‫המופעל על יונק‬
179564
NUTRITIONAL FOOD AND FEED,
COMPOSITION, PROCESSING AND
METHOD OF USE
NUTRINIA LTD
US
60/573376
24/05/2004
901903410
2410412004
US
901921744
7417712004
US
PCT/IL/2005/000529
WO/2005/115473
1126121661
A23K
‫תרכובות מזון מזינות תהליכים ליצורן‬
‫ושיטות לשימוש בהן‬
‫נוטריניה בע"מ‬
179565
LIGANDS BINDING THE COMPLEX
OF UROKINASE-TYPE
PLASMINOGEN ACTIVATOR (uPA)
AND ITS RECEPTOR (uPAR) THAT
INHIBIT DOWNSTREAM uPAR
INTERACTIONS: IDENTIFICATION
AND USE IN DIAGNOSIS OR
THERAPY
ATTENUON, LLC
US
60/573896
25/05/2004
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61B
A61K
‫ליגנדים הקושרים את הקומפלקס של‬
)uPA( ‫משפעל פלסמינוגן מסוג יורוקינז‬
‫) אשר מעכבים‬uPAR( ‫עם הרצפטורים שלו‬
‫ זיהוי ושימוש‬:uPAR ‫אינטראקציות עוקבות‬
‫באבחון או ריפוי‬
66
PCT/US/2005/018322
WO/2005/116077
1226121661
179566
CONCENTRATED AQUEOUS
FORMULATIONS FOR CROP
PROTECTION
BAYER CROPSCIENCE GMBH
DE
102004026937.8 01/06/2004
PCT/EP/2005/005524
WO/2005/117583
1/22221660
‫תכשירים מימיים מרוכזים להגנה על‬
‫יבול‬
179567
A61B
DEVICE AND METHOD FOR IN-VIVO
ILLUMINATION
GIVEN IMAGING LTD.
US
11/319771
29/12/2005
1226121661
‫התקן ושיטה לתאורה תוך–גופית‬
‫גיוון אימג'ינג בע"מ‬
179568
LOW-FOAMING AQUEOUS
FORMULATIONS USED FOR CROP
PROTECTION
BAYER CROPSCIENCE GMBH
DE
102004026938.6 01/06/2004
PCT/EP/2005/005525
WO/2005/117580
1626021662
SEMICONDUCTOR DEVICE AND
METHOD OF FORMING A
SEMICONDUCTOR DEVICE
67
A01N
A01N
‫תכשירים מימיים מרוכזים עם שיעור‬
‫נמוך של היווצרות קצף להגנה על יבול‬
179569
H01L
‫התקן חצי מוליך ושיטה ליצירת התקן חצי‬
‫מוליך‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
CAMBRIDGE SEMICONDUCTOR
LIMITED
US
60/234219
21/09/2000
PCT/GB/2001/004211
WO/2002/025700
2626021661
179570
CMP COMPOSITION FOR IMPROVED
OXIDE REMOVAL RATE
CABOT MICROELECTRONICS
CORPORATION
US
10/871774
18/06/2004
PCT/US/2005/020614
WO/2006/009640
2626021661
179571
METHOD OF POLISHING A
TUNGSTEN-CONTAINING
SUBSTRATE
CABOT MICROELECTRONICS
CORPORATION
US
10/869397
16/06/2004
PCT/US/2005/020615
WO/2006/009641
2626021661
179572
REAL TIME POLISHING PROCESS
MONITORING
CABOT MICROELECTRONICS
CORPORATION
US
10/867087
14/06/2004
PCT/US/2005/020612
WO/2005/123337
1/26121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179575
C09G
‫הרכב ליטוש כימי – מכני לקצב משופר‬
‫של הסרת תחמוצות‬
C09G
‫שיטה לליטוש מצע המכיל טונגסטן‬
B24B
‫פיקוח על תהליך ליטוש בזמן אמת‬
B65D
68
SELF-HEATING OR COOLING
CONTAINER
UNIQ PLC
GB
0411919.4
27/05/2004
PCT/GB/2005/002112
WO/2005/115872
2626/21666
179576
A METHOD AND A DEVICE FOR
PROCESSING A DATA PACKET
STREAM IN A COMMUNICATION
SYSTEM
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
EP
99113820.7 15/07/1999
PCT/EP/2000/006526
WO/2001/006714
1/26121661
‫מיכל לחימום או קירור עצמי‬
‫שיטה והתקן לעיבוד זרימת יחידת נתונים‬
‫במערכת תיקשורת‬
179578
CARBON - CONTAINING PUMICE
STONE AND PROCESS FOR THE
PRODUCTION THEREOF
SERGE BENSAID
FR
0405786
28/05/2004
PCT/FR/2005/001313
WO/2005/118483
1022221660
69
H04L
179579
C02F
‫אבן ספגית המכיל פחמן ושיטה להכנתו‬
H05B
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫התקן המאפשר לדימרים חכמים מבוססי‬
‫ לפועל היטב ללא‬,‫תקשורת על קוי חשמל‬
‫צרוך בהשחלת חוטים חדשים‬
‫טריטוניקס טכנולוגיות בע"מ‬
A DEVICE THAT ENABLES PLC
BASED SMART DIMMERS TO
FUNCTION WITH NO NEW WIRES
TRITONICS TECHNOLOGIES LTD
2/26021661
179580
SUBSTITUTED QUINAZOLINES AS
ANTI-CANCER AGENTS
ASTRAZENECA AB
US
60/579265
15/06/2004
PCT/GB/2005/002327
WO/2005/123696
1022221660
179581
179582
179583
FUEL CONDITIONING APPARATUS
WAYNE KENNETH GLEW
AU
2004902733 24/05/2004
PCT/AU/2005/000731
WO/2005/116439
1/2612166/
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61B
A61N
‫אוטומציה של תהליך השוואתי על ידי‬
‫רג'יסטרציה‬
‫אלגוטק מערכות בע"מ‬
COMPARISON WORKFLOW
AUTOMATION BY REGISTRATION
ALGOTEC SYSTEMS LTD.
1626121661
–‫קווינאזולינים מותמרים כגורמים אנטי‬
‫סרטניים‬
‫תיוג עמוד שדרה‬
‫אלגוטק מערכות בע"מ‬
SPINE LABELING
ALGOTEC SYSTEMS LTD.
1022221660
C07D
179584
F02M
‫מתקן להתאמת דלק‬
C08L
70
FLAME RETARDANT
POLYURETHANES AND ADDITIVES
THEREFOR
ALBEMARLE CORPORATION
‫פוליאורתנים מעכבי בערה ותוספים עבורם‬
PCT/US/2004/016814
WO/2005/118720
1026121661
179585
AEROSOL CONTAINER WITH
ACTUATOR SECURED TO
VALVESTEM
NARDONE PETER
AU
2004902793 26/05/2004
PCT/AU/2005/000739
WO/2005/115876
1026121661
‫מיכל אירוסולים בעל מפעיל המחובר‬
‫לקנה השסתום‬
179586
BINDING MOLECULES CAPABLE OF
NEUTRALIZING RABIES VIRUS AND USES
THEREOF
CRUCELL HOLLAND B.V.
EP
PCT/EP2004/050943
901414023
US
EP
PCT/EP2004/051661
EP
PCT/EP2004/052286
EP
PCT/EP2004/052772
EP
PCT/EP2005/050310
EP
PCT/EP2005/050953
PCT/EP/2005/052410
WO/2005/118644
71
B65D
C07K
‫מולקולות בעלות יכולת קישור‬
,‫היכולות לנטרל נגיף כלבת‬
‫ושימושים בהן‬
27/05/2004
2110412004
2910112004
2310912004
0317712004
2410712004
0310312004
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1022221660
179588
INJECTION MOLDING METHOD AND
SYSTEM, AND MOLDED PRODUCTS
MANUFACTURED THEREBY
KETER PLASTIC LTD.
1026121661
‫ ומוצרים‬,‫מערכת ושיטה ליציקה בהזרקה‬
‫מיוצקים המיוצרים דרכן‬
179589
INJECTION PORT AND METHOD OF
MAKING THE SAME
WEST PHARMACEUTICAL
SERVICES, INC.
US
60/575020
27/05/2004
PCT/US/2005/018583
WO/2005/118251
1126121661
179591
DIGITAL WIPES AND METHOD OF
HANDLING
DR PRODUCTS, LLC
US
60/574515
26/05/2004
PCT/US/2005/018518
WO/2005/117740
6/2602166/
ULTRASOUND CONTRAST AGENT
DOSAGE FORMULATION
ACUSPHERE, INC.
PCT/US/2004/017813
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B29C
179594
‫כתר פלסטיק בע"מ‬
B29C
‫פתח הזרקה ושיטה לייצורו‬
A46B
‫ממחטות דיגיטליות ושיטה לטיפול‬
A61K
‫חומר ניגוד על קולי לפורמולציות מינון‬
72
WO/2005/120587
6226021661
179595
SUBSTITUTED INDAZOLES,
COMPOSITIONS CONTAINING
SAME, PREPARATION AND USE
Aventis Pharma S.A
FR
0406042
04/06/2004
PCT/FR/2005/001335
WO/2006/003276
2/26121661
‫ תכשירים המכילים‬,‫נגזרות של אינדאזולים‬
‫ הכנתם והשימוש בהם‬,‫אותם‬
179596
179597
SMART CARD DATA TRANSACTION
SYSTEM AND METHODS FOR
PROVIDING STORAGE AND
TRANSMISSION SECURITY
IBM CORPORATION
H04L
‫מערכת אלחוטית מבוססת חיישנים‬
WIRELESS SENSOR NETWORK
IBM CORPORATION
US
10/856684
28/05/2004
PCT/EP/2005/052282
WO/2005/119981
1/2612166/
C07D
G07F
‫שיטות ומערכת טרנזקציית כרטיס נתונים‬
‫חכם לאספקת אחסון והעברה מאובטחת‬
PCT/EP/2004/050880
WO/2005/119606
6/26021661
179599
GLUCAGON RECEPTOR
ANTAGONISTS, PREPARATION AND
THERAPEUTIC USES
ELI LILLY AND COMPANY
US
60/579362
14/06/2004
73
C07C
‫ הכנתם‬,‫אנטגוניסטים של רצפטור גלוקגון‬
‫ושימושם הריפויי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PCT/US/2005/019901
WO/2005/123668
1226021661
179600
ENANTIOSELECTIVE PREPARATION
OF QUINOLINE DERIVATIVE
NOVARTIS AG
GB
0413960.6
22/06/2004
PCT/EP/2005/006686
WO/2005/123684
1/26121661
179601
CHEWABLE, SUCKABLE AND
SWALLOWABLE TABLET
CONTAINING A CALCIUMCONTAINING COMPOUND AS AN
ACTIVE SUSBTANCE
NYCOMED PHARMA AS
PA 2004
DK
01/06/2004
00860
PCT/DK/2005/000337
WO/2005/117829
1/26121661
179602
CERBERUS/COCO DERIVATIVES
AND USES THEREOF
ACCELERON PHARMA INC
US
60/575062
27/05/2004
PCT/US/2005/018928
WO/2005/115439
6/26021661
179603
PYRROLOPYRIDINE DERIVATIVES
GLAXO GROUP LIMITED
GB
0412908.6
09/06/2004
042494044
7717712004
GB
PCT/EP/2005/006182
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫הכנה אנאנטיוסלקטיבית של נגזרת של‬
‫קוינולין‬
A61K
,‫ מציצה ובליעה‬,‫גלולה ניתנה ללעיסה‬
‫המכילה תרכובת שמכילה סידן כחומר‬
‫פעיל‬
A61K
‫קוקוס ושימושן‬/‫נגזרות של צרברוס‬
C07D
‫נגזרות של פירולופירידין‬
74
WO/2005/121140
2026021661
179604
PYRROLOPYRIDINE DERIVATIVES
AND THEIR USE AS CRTH2
ANTAGONISTS
NOVARTIS AG
GB
0413619.8
17/06/2004
040199340
7410412004
GB
PCT/EP/2005/006493
WO/2005/123731
1/26021661
179605
PYRROLOPYRIMIDINE AND
PYRROLOPYRIDINE DERIVATIVES
SUBSTITUTED WITH
TETRAHYDROPYRIDINE AS CRF
ANTAGONISTS
TAISHO PHARMACEUTICAL CO.,
LTD.
2004JP
25/06/2004
188129
PCT/JP/2005/012141
WO/2006/001501
1/26021661
179606
PYRROLOPYRIMIDINE AND
PYRROLOPYRIDINE DERIVATIVES
SUBSTITUTED WITH A CYCLIC
AMINO GROUP AS CRF
ANTAGONISTS
TAISHO PHARMACEUTICAL CO.,
LTD.
2004JP
25/06/2004
188128
PCT/JP/2005/012152
WO/2006/001511
75
C07D
‫נגזרות של פירולופירידין ושימושן‬
CRTH2 ‫כאנטגוניסטים של‬
C07D
‫נגזרות פירולפירימידין ופירולפירידין‬
‫מותמרות בטטרההידרופירידין‬
CRF ‫כאנטגוניסטים של‬
C07D
‫נגזרות פירולפירימידין ופירולפירידין‬
‫מותמרות בקבוצת אמינו טבעתית‬
CRF ‫כאנטגוניסטים של‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2/26021661
179607
INDOLES USEFUL IN THE
TREATMENT OF INFLAMMATION
BIOLIPOX AB
US
60/580402
18/06/2004
PCT/GB/2005/002396
WO/2005/123674
1126121661
‫אינדולים השימושיים לטיפול בדלקת‬
179608
179609
IMIDAZOLE VARIANTS AS
MODULATORS OF GABA RECEPTOR
FOR THE TREATMENT OF GI
DISORDERS
ASTRAZENECA AB
SE
0401653.1
24/06/2004
PCT/SE/2005/000951
WO/2006/001750
1026121661
C07D
‫ואריאנטים של אימידאזול כמודולטורים של‬
GI ‫רצפטור גאבא לטיפול בהפרעות‬
179610
LOCALIZED CONTROLLED
ABSORPTION OF STATINS IN THE
GASTROINTESTINAL TRACT FOR
ACHIEVING HIGH BLOOD LEVELS
OF STATINS
DEXCEL PHARMA TECHNOLOGIES
LTD.
US
60/574561
27/05/2004
901490979
2910112004
US
PCT/IL/2005/000539
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61M
‫) מלאכותי‬AIRWAY( ‫מכשיר נתיב אויר‬
ARTIFICIAL AIRWAY APPARATUS
YOUNG PETER JEFFREY
GB
0411858.4
27/05/2004
PCT/EP/2005/005754
WO/2005/118039
1626021661
C07D
A61K
‫ספיגה מקומית מבוקרת של סטטינים‬
‫במערכת העיכול להשגת רמות דם גבוהות‬
‫של סטטינים‬
‫דקסל פארמה טכנולוגיות בע"מ‬
76
WO/2005/115380
2/26021661
179611
1 - AZA - BICYCLO [3.3.1] NONANES
NOVARTIS AG
US
60/581020
18/06/2004
PCT/EP/2005/006566
WO/2005/123732
6226021661
179612
BENZIMIDAZOLONE CARBOXYLIC
ACID DERIVATIVES
PFIZER INC.
2004JP
15/06/2004
177488
901901004
0210912004
US
901901034
0210912004
US
901901044
0210912004
US
PCT/IB/2005/001825
WO/2005/123718
6026021661
179613
COMPOUNDS AND COMPOSITIONS
AS PROTEIN KINASE INHIBITORS
IRM LLC
US
60/578491
10/06/2004
PCT/US/2005/020371
WO/2005/123719
6026021661
179614
PREPARATION OF PREGABALIN
AND RELATED COMPOUNDS
WARNER-LAMBERT COMPANY LLC
US
60/581671
21/06/2004
901929034
7417712004
US
PCT/IB/2005/001924
77
C07D
‫] נונאנים‬:.:.1[ ‫ – אזא – ביציקלו‬1
C07D
‫נגזרות של חומצה קרבוקסילית של‬
‫בנזימידאזולון‬
C07D
‫תרכובות ותכשירים כמעכבי קינז של‬
‫חלבון‬
C07C
‫הכנת פרגבלין ותרכובות קשורות‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
WO/2006/000904
6026021661
179615
PARTICLES EMBEDDED IN A
POROUS SUBSTRATE FOR
REMOVING TARGET ANALYTE
FROM A SAMPLE
PATHOGEN REMOVAL AND
DIAGNOSTIC TECHNOLOGIES INC.
US
60/578061
09/06/2004
901979774
0917012004
US
901971999
7317012004
US
PCT/US/2005/020036
WO/2005/123952
2/26021661
1/26121661
‫חלקיקים מקובעים במצע נקבובי להסרת‬
‫אנליטים מסומנים מדוגמא‬
179616
TREATMENT OR PREVENTION OF
SKIN CONDITIONS OR TISSUE
CONDITIONS IN ANIMALS USING
BORYLOXYPYRIDYLMETHANONES
ANACOR PHARMACEUTICALS, INC
US
60/579,421
14/06/2004
PCT/US/2005/021165
WO/2005/123094
C07F
‫טיפול בהפרעות עור או הפרעות רקמה או‬
‫מניעתן בחיות על–ידי שימוש‬
‫בבורילאוקסיפירידילמתנונים‬
179617
METHOD OF STABILIZING PROTEINS
ARES TRADING S.A.
EP
04076627.1 01/06/2004
PCT/EP/2005/052413
WO/2005/117948
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C12M
A61K
‫שיטה לייצוב של חלבונים‬
78
1/26121661
179620
STABILIZED INTERFERON LIQUID
FORMULATIONS
ARES TRADING S.A.
EP
04076626.3 01/06/2004
901979314
0917012004
US
PCT/EP/2005/052414
WO/2005/117949
2126121661
‫פורמולציות אינטרפרון נוזליות מיוצבות‬
179621
FILTER CARTRIDGE AND DEVICE FOR
FILTERING LIQUIDS
BRITA GMBH
DE
102004026188.1 28/05/2004
PCT/EP/2005/005161
WO/2005/118482
1/26121661
FISHING LURE
ABACUS (C.I.) LIMITED
AU
2004902847
PCT/AU/2005/000746
WO/2005/115137
1/26121661
79
A61K
179622
C02F
‫מילוי לסינון והתקן לסינון נוזלים‬
A01K
‫פיתיון דייג‬
28/05/2004
179623
H01Q
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
ANTENNA HOUSING AND ANTENNA
COMPRISING SUCH AN ANTENNA
HOUSING
HUBER + SUHNER AG
EP
04012693.0 28/05/2004
PCT/EP/2005/005756
WO/2005/117206
1/26/21661
‫מבנה לאנטנה ואנטנה הכולל מבנה‬
‫לאנטנה‬
179624
APPARATUS FOR FILTERING LIQUIDS
BRITA GMBH
DE
102004026167.9 28/05/2004
PCT/EP/2005/004484
WO/2005/118104
6226021661
179625
PRESERVATION BY VAPORIZATION
BRONSHTEIN VICTOR
US
60/576394
02/06/2004
PCT/US/2005/019285
WO/2005/117962
1/26121661
179627
PARTICULATE-STABILIZED
INJECTABLE PHARMACEUTICAL
COMPOSITIONS OF POSACONASOLE
SCHERING CORPORATION
US
60/575126
28/05/2004
PCT/US/2005/018945
WO/2005/117831
2/26121661
OPTICAL FIBRE CONNECTOR
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179629
B01D
‫התקן לסינון נוזלים‬
A61K
‫שימור על ידי אידוי‬
A61K
‫תרכובות רוקחיות הניתנות להזרקה של‬
‫פוסאקונזול בעלות חלקיקים מיוצבים‬
G02B
‫מחבר לסיב אופטי‬
80
TYCO ELECTRONICS RAYCHEM N.V.
GB
0412003.6
28/05/2004
PCT/GB/2005/001886
WO/2005/119318
6126021661
179631
DIAMINE B2 ADRENERGIC
RECEPTOR AGONISTS
THERAVANCE, INC.
US
60/576560
03/06/2004
PCT/US/2005/019549
WO/2005/121065
1626021661
/226121661
‫ אדרנרגי‬B2 ‫אגוניסטים לקולטן דיאמין‬
179632
BIS (THIO-HYDRAZIDE AMIDE)
SALTS FOR TREATMENT OF
CANCERS
SYNTA PHARMACEUTICALS, CORP.
US
60/582596
23/06/2004
901947394
7910412004
US
PCT/US/2005/021642
WO/2006/009940
81
C07C
‫מלחי ביס (תיאו–הידרואזיד אמיד) לטיפול‬
‫בסרטן‬
179633
DRUG COMPOSITIONS, FUSIONS
AND CONJUGATES
DOMANTIS LIMITED
US
60/576271
01/06/2004
901932397
0217212004
US
PCT/GB/2005/002163
WO/2005/118642
1026/21661
C07C
179634
C07K
‫ מיזוגים ותצמידים‬,‫תכשירים תרופתיים‬
C07D
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
5-SUBSTITUTED-2-PHENYLAMINOBENZAMIDES AS MEK INHIBITOR
CHUGAI SEIYAKU KABUSHIKI
KAISHA
2004JP
26/07/2004
218004
2004-012093 7410312004
JP
PCT/JP/2005/013620
WO/2006/011466
‫–פנילאמינו–בנזאמידים מותמרים בעמדה‬0
MEK ‫ כמעכבי‬.
6226/21661
179635
HUMAN ANTI-KIR ANTIBODIES
UNIVERSITY OF GENOA
DK
PCT/DK2004/00470 01/07/2004
0710112004
IB
PCT/IB2004/02464
0910712004
DK
PA2005 00025
PCT/EP/2005/053122
WO/2006/003179
6/26/21661
179636
COMBINATION THERAPY WITH
RADIOLABELED ANTI-CD20
ANTIBODY IN THE TREATMENT OF
B-CELL LYMPHOMA
SCHERING AKTIENGESELLSCHAFT
US
60/586414
09/07/2004
PCT/EP/2005/007213
WO/2006/005477
1/22221660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫ ממקור אנושי‬KIR ‫נוגדנים נוגדי‬
A61K
‫ מסומן‬CD20 ‫טיפול רפואי משולב עם נוגדן‬
‫רדיואקטיבית בטיפול בלימפומה של תאי‬
B
179637
ULTRA LOW POWER WAKE-UP
CIRCUIT
SHERWOOD SERVICES AG
US
11/291249
01/12/2005
C07K
H02M
‫מעגל הדורש מתח נמוך מאוד להפעלתו‬
‫מחדש‬
82
/226121661
179638
METHOD OF FORMING ADHESIVES
MIXTURES AND BALLISTIC
COMPOSITES UTILIZING THE SAME
ADDISON CLOSSON ADHESIVE
TEXTIES, INC
US
60/575093
28/05/2004
PCT/US/2005/019061
WO/2006/049651
1/22221660
‫שיטה ליצירת תערובות דבק ותכשירים‬
‫בליסטים באמצעות שימוש בתערובות אלו‬
179639
A METHOD AND SYSTEM FOR
DIAGNOSING AND TREATING A
PEST INFESTED BODY
AMIT TECHNOLOGY SCIENCE &
MEDICINE LTD
1/26021661
‫עמית טכנולוגיה למדע ולרפואה בע"מ‬
179640
C07K
‫תולדות מטסטין ושימושיהן‬
179642
POLYSACCHARIDE DERIVATIVES
AND USES IN INDUCTION OF AN
IMMUNE RESPONSE
CHILDRENS HOSPITAL &
RESEARCH CENTER AT OAKLAND
US
60/582672
23/06/2004
PCT/US/2005/022590
WO/2006/002402
83
A61K
‫שיטה ומערכת דיאגנוסטית וטיפול של‬
‫מזיקים מתוך גוף‬
METASTIN DERIVATIVES AND USE
THEREOF
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2004JP
25/06/2004
187671
2004-393377 7417212004
JP
PCT/JP/2005/012021
WO/2006/001499
1/26021661
B32B
C08B
‫תולדות של פוליסכרידים ושימושים כגורמי‬
‫תגובות חיסון‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1/2612166/
179643
MEDICAL ADHESIVE AND METHODS
OF TISSUE ADHESION
THE UNIVERSITY OF PITTSBURGH
A61L
‫אגד מדבק רפואי ושיטה להדבקות של‬
‫רקמה‬
PCT/US/2004/016767
WO/2005/118011
1/22221660
179644
C.L.C ‫מאגד חוטים‬
‫חזן גבי‬
CLUSTER COMPUTER
GABI HAZAN
1/22221660
179645
METHOD AND DEVICE FOR
TAILORING DIETS OF PATIENTS
ILANA DARIEL
2626021661
VENTILATION SYSTEM FOR PET
LITTER BOX
YONATAN BEN-AMI
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A23L
‫שיטה והתקן להתאמת דיאטות לחולים‬
‫אילנה דריאל‬
179646
CONSTRUCTION SYSTEM FOR
CONSTRUCTING PLANE
STRUCTURES
PRESS BRICK SYSTEM B.V.
NL
1026397
11/06/2004
7029947
7410112004
NL
7021092
7110912004
NL
PCT/NL/2005/000429
WO/2005/121475
1/22221660
H01B
179647
E04F
‫מערכת בניה לבניית סטרוקטורות‬
‫שטוחות‬
A01K
‫מערכת איוורור לארגז חול לצרכים של‬
‫חיות מחמד‬
‫יונתן בן עמי‬
84
1/22221660
179648
‫מערכת לחימום מים‬
‫זלמן שורצמן‬
WATER HEATING SYSTEM
ZALMAN SCHWARTZMAN
/226121661
179649
A SYSTEM AND METHOD FOR
MANAGING DETRIMENTAL
CARDIAC REMODELING
MORTON M. MOWER
US
60/575121
28/05/2004
PCT/US/2005/019089
WO/2005/118062
1026121661
6226021661
179650
C07D
–1–‫–אוקסו‬0 ‫תהליך להכנת תולדות‬
–‫פירולידין באמצעות אלילציה תוך‬
‫מולקולרית‬
11/06/2004
179651
WASTE WATER DISTRIBUTION
SYSTEM
PETER SHEPHERD WILSON
AU
2004902930 02/06/2004
PCT/AU/2005/000774
WO/2005/118969
85
A61N
‫מערכת ושיטה לניהול עיצוב מחדש מזיק‬
‫של הלב‬
PROCESS FOR PREPARING 2-OXO-1PYRROLIDINE DERIVATIVES BY
INTRAMOLECULAR ALLYLATION
UCB, S.A.
EP
04013715.0
PCT/EP/2005/005689
WO/2005/121082
F24H
E03C
‫מערכת לחלוקת מי שופכין‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1/26121661
179652
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412057.2
28/05/2004
PCT/GB/2005/002128
WO/2005/115511
1/26121661
179653
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412049.9
28/05/2004
PCT/GB/2005/002131
WO/2005/115512
1/26121661
179654
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412056.4
28/05/2004
PCT/GB/2005/002117
WO/2005/115516
1/26121661
179655
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412054.9
28/05/2004
PCT/GB/2005/002120
WO/2005/115509
1/26121661
179656
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412050.7
28/05/2004
047204449
2410412004
GB
047204347
2410412004
GB
047204949
2410412004
GB
047209744
2410412004
GB
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61M
‫התקן הזרקה‬
A61M
‫התקן הזרקה‬
A61M
‫התקן הזרקה‬
A61M
‫התקן הזרקה‬
A61M
‫התקן הזרקה‬
86
047204449
GB
047204142
GB
047204944
GB
047204447
GB
047204744
GB
040107041
GB
PCT/GB/2005/002135
WO/2005/115514
1/26121661
2410412004
2410412004
2410412004
2410412004
2410412004
0910412004
179657
‫התקן הזרקה‬
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0412051.5
28/05/2004
PCT/GB/2005/002116
WO/2005/115508
2/26/21661
179658
ANTI-RHESUS D RECOMBINANT
POLYCLONAL ANTIBODY AND
METHODS OF MANUFACTURE
SYMPHOGEN A/S
DK
PA200401133 20/07/2004
DK
PA200401992 2217212004
PCT/DK/2005/000501
WO/2006/007850
2/26021661
C07K
D ‫נוגדן רב–שבטי רקומביננטי נוגד רהזוס‬
‫ושיטות ליצורו‬
179659
USE OF 6-(2-TOLYL)TRIAZOLOPYRIMIDINES AS
FUNGICIDES, NOVEL 6-(2-TOLYL)TRIAZOLOPYRIMIDINES, METHOD FOR
THE PRODUCTION THEREOF, USE
THEREOF FOR CONTROLLING
HARMFUL FUNGI, AND AGENTS
CONTAINING THE SAME
BASF AKTIENGESELLSCHAFT
DE
102004030165.4 22/06/2004
PCT/EP/2005/006343
WO/2005/123740
87
A61M
C07D
–)‫–טולואיל‬0(–9‫שימוש ב‬
,‫טריאזולופירימידינים כקוטלי פטריות‬
‫–טולואיל)–טריאזולופירימידינים‬0(–9
‫ השימוש בהם‬,‫ שיטה ליצרם‬,‫חדשים‬
‫לבקרה על פטריות מזיקות וגורמים‬
‫המכילים אותם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2/26021661
THYMIDINE KINASE
MOLMED SPA
GB
0413702.2
PCT/IB/2005/002358
WO/2005/123912
179660
‫תימידין קינאז‬
18/06/2004
2/26021661
IL-13 BINDING AGENTS
WYETH
US
60/581078
771749024
US
PCT/US/2005/021454
WO/2006/085938
179661
A61K
IL–1: ‫גורמים קושרים‬
17/06/2004
0910912004
2/26121661
179662
LASER INTERFEROMETER MIRROR
ASSEMBLY
NANOBEAM LIMITED
GB
0412429.3
03/06/2004
PCT/GB/2005/050065
WO/2005/119362
2/26121661
2/26121661
CHARGED PARTICLE GUN
NANOBEAM LIMITED
G03F
‫הרכב מראת לייזר אינטרפרומטרית‬
179663
APPARATUS FOR BLANKING A
CHARGED PARTICLE BEAM
NANOBEAM LIMITED
GB
0412428.5
03/06/2004
PCT/GB/2005/050064
WO/2005/119361
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C12N
H01J
‫מערכת לאטימת קרן של חלקיקים טעונים‬
179664
H01J
‫כלי ירי לחלקיקים טעונים‬
88
GB
0412426.9
PCT/GB/2005/050063
WO/2005/119723
03/06/2004
1126021661
179665
METHOD FOR THE PURIFICATION OF
DIMETHYLACETAMIDE (DMAC)
BASF AKTIENGESELLSCHAFT
DE
102004030616.8 24/06/2004
PCT/EP/2005/006732
WO/2006/000392
1/22221660
179666
TORQUE-BALANCING
DIFFERENTIAL MECHANISM
YEFIM KERETH
262602166/
C07C
‫שיטה לטיהור דימתילאצטאמיד‬
) DMAC(
F16H
‫מנגנון דיפרנציאל מאזן מומנט–סיבוב‬
‫יפים קרת‬
179667
B22F
‫שיטה לגיבוש אבקות חזקות מצופות‬
‫וקשות‬
METHOD FOR CONSOLIDATING
TOUGH COATED HARD POWDERS
ALLOMET CORPORATION
PCT/US/2004/018445
WO/2006/001791
6126021661
BENZOIMIDAZOLE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
PHARMACYCLICS, INC.
89
179669
C07D
‫תולדות בנזואימידאזול ותכשירי רוקחות‬
‫המכילים אותן‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
US
60/576330
PCT/US/2005/019420
WO/2005/121102
6126021661
02/06/2004
179670
HETEROCYCLIC COMPOUNDS AND
PROCESSES FOR THE PREPARATION
THEREOF
PHARMACYCLICS, INC.
US
60/576382
02/06/2004
PCT/US/2005/019394
WO/2005/118554
2626021661
6/26021661
ANTI-CD3 ANTIBODIES
NOVIMMUNE S.A.
US
60/576483
901909743
US
PCT/US/2005/019922
WO/2005/118635
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫תרכובות הטרוציקליות ותהליכים להכנתן‬
179671
5-AMINO-2,4,7-TRIOXO-3,4,7,8TETRAHYDRO-2H-PYRIDO[2,3D]PYRIMIDINE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
JAPAN TOBACCO INC.
2004JP
11/06/2004
174770
2004-321777 7017712004
JP
PCT/JP/2005/011082
WO/2005/121142
C07D
C07D
–0,7,4,:–‫–טריאוקסו‬7,4,0–‫–אמינו‬. ‫תולדות‬
‫) פירימידין‬D–:,0( ‫–פירידו‬H2–‫טטראהידרו‬
‫ותכשירי רוקחות המכילים אותן‬
179672
C07K
CD : ‫נוגדנים נגד‬
03/06/2004
7010912004
90
6226021661
179673
A SYSTEM OF UNDERWATER
POWER GENERATION
ATLANTIS RESOURCES
CORPORATION PTE.
AU
2004902885 01/06/2004
2004904902
7217012004
AU
PCT/AU/2005/000779
WO/2005/119052
6226021661
/626/2200/
‫מערכת תת–ימית ליצור אנרגיה‬
179674
CHEMICAL COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM FOR THE
TREATMENT OF INFLAMMATORY
DISORDERS
SCHERING CORPORATION
US
60/576153
02/06/2004
PCT/US/2005/019131
WO/2005/121130
WEARING PART CONSISTING OF A
DIAMANTIFEROUS COMPOSITE
91
C07D
‫תרכובות כימיות והרכבים רוקחיים‬
‫המכילים אותן לטיפול בהפרעות דלקתיות‬
179676
BIFURCATED STENT AND METHOD
OF MAKING SAME
MEDINOL LTD.
US
08/642297
03/05/1996
/626121661
F03B
A61M
‫סטנט מפולג ושיטה לייצורו‬
‫מדינול בע"מ‬
179677
C22C
‫חלק הניתן להתבלות המכיל חומר מרוכב‬
‫הכולל חלקיקי יהלום‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
CERATIZIT AUSTRIA GESELLSCHAFT
M.B.H
AT
GM386/2004 01/06/2004
PCT/AT/2005/000184
WO/2005/118901
/626121661
179679
FLUID PERMEABLE COMPOSITE
MATERIAL AND PROCESS FOR
SAME
JOHN ARTHUR CUMMINS
AU
2004902827 28/05/2004
PCT/AU/2005/000751
WO/2005/116135
1/22221660
‫תרכובות חדירות לנוזלים ושיטה להכנתן‬
179680
‫קנדי חשמל ונכסים בע"מ‬
179681
ELECTRIC KETTLE WITH LOCKING
BASE
KENNEDY ELECTRICAL & ASSETS
LTD.
/226121661
A47B
‫קומקום חשמלי עם בסיס ננעל‬
‫קנדי חשמל ונכסים בע"מ‬
179684
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND
CORTICOSTEROIDS
ALMIRALL PRODESFARMA S.A.
EP
P200401312 31/05/2004
PCT/EP/2005/005840
WO/2005/115466
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A47B
‫קומקום חשמלי המשמש גם להכנת מזון‬
‫תינוקות‬
ELECTRIC KETTLE FOR ALSO
PREPARING INFANT FORMULA
KENNEDY ELECTRICAL & ASSETS
LTD.
1/22221660
C08L
A61K
‫צירופים המכילים גורמים אנטי–מוסקרינים‬
‫וקורטיקוסטירואידים‬
92
/226121661
179685
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND
CORTICOSTEROIDS
ALMIRALL PRODESFARMA S.A.
ES
P200401312
31/05/2004
EP
PCT/EP05/01969 2410212004
GB
PCT/GB05/00740 2410212004
GB
PCT/GB05/00722 2410212004
PCT/EP/2005/005838
WO/2005/115464
/226121661
‫תצריפים המכילים גורמים נוגדי‬
‫מוסקרין וקורטיקוסטרואידים‬
179686
COMBINATIONS COMPRISING
ANTIMUSCARINIG AGENTS AND PDE4
INHIBITORS
ALMIRALL PRODESFARMA S.A.
ES
P200401312
31/05/2004
EP
PCT/GB05/01969 2410212004
GB
PCT/GB05/00740 2410212004
GB
PCT/GB05/00722 2410212004
PCT/EP/2005/005839
WO/2005/115465
/226121661
93
A61K
–‫צירופים המכילים גורמים אנטי‬
PDE4 ‫מוסקרינים ןמעכבי‬
179687
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND
BETA-ADRENERGIC AGONISTS
ALMIRALL PRODESFARMA S.A.
ES
P200401312 31/05/2004
PCT/EP/2005/005841
WO/2005/115467
A61K
A61K
‫צירופים המכילים גורמים אנטי מוסקרינים‬
‫ואגוניסטים בתא–אדרנרגים‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
/226121661
179689
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND
PDE4 INHIBITORS
ALMIRALL PRODESFARMA S.A.
ES
P200401312 31/05/2004
PCT/EP/2005/005836
WO/2005/115462
/226121661
A61K
‫צירופים המכילים גורמים אנטי מוסקרינים‬
PDE4 ‫ומעכבי‬
179690
A61K
‫צירופים המכילים גורמים אנטי‬
–‫מוסקרינים ואגוניסטים בתא‬
‫אדרנרגים‬
COMBINATIONS COMPRISING
ANTIMUSCARINIC AGENTS AND BETAADRENERGIC AGONISTS
ALMIRALL PRODESFARMA S.A.
ES
P200401312
31/05/2004
EP
PCT/EP05/01969 2410212004
GB
PCT/GB05/00740 2410212004
GB
PCT/GB05/00722 2410212004
PCT/EP/2005/005837
WO/2005/115463
2126/21661
179691
METHOD AND SYSTEM FOR
DETERMINING RESIDENCE WITHIN
SERVICE AREA IN MOBILE
COMMUNICATION NETWORK
NEC CORPORATION
2004JP
07/06/2004
168825
PCT/JP/2005/007064
WO/2005/122615
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04Q
‫מערכת ושיטה לקביעת משכן בתוך איזור‬
‫שירות ברשת תקשורת ניידת‬
94
2/26021661
179692
ALKYNYL DERIVATIVES AS
MODULATORS OF METABOTROPIC
GLUTAMATE RECEPTORS
ADDEX PHARMACEUTICALS SA
GB
0413605.7
17/06/2004
PCT/IB/2005/002390
WO/2005/123703
/626121661
‫תולדות אלקיניליות כמאפננות של קולטני‬
‫גלוטאמאט מתאבוטרופי‬
179693
SUBSTITUTED THIAZOLEACETIC AS
CRTH2 LIGANDS
7TM PHARMA A/S
GB
0412198.4
29/05/2004
047479447
2410912004
GB
042407944
2917012004
GB
PCT/EP/2005/005882
WO/2005/116001
1/26121661
179695
METHOD FOR PLASMA STRIPPING
USING PERIODIC MODULATION OF
GAS CHEMISTRY AND
HYDROCARBON ADDITION
LAM RESEARCH CORPORATION
US
10/860833
03/06/2004
PCT/US/2005/018784
WO/2005/122226
6026021661
179696
DOMAIN-INFLUENCED PREFIX
ASSIGNMENT METHOD AND
APPARATUS
UTSTARCOM, INC.
US
10/861577
04/06/2004
PCT/US/2005/019609
WO/2005/119997
95
C07D
C07D
CRTH2 ‫תיאזולאצטי מותמר כליגנד של‬
H01L
‫הליך לקילוף בפלזמה באמצעות‬
‫מודולציה מחזורית של כימיה של גזים‬
‫והוספת פחמימן‬
H04L
‫שיטה ומערכת להקצאת קידומת‬
‫המושפעת ע"י דומיין‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179697
VARIANTS OF UNC5H2, THEIR
PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V.
EP
04102511.5 04/06/2004
PCT/EP/2005/052573
WO/2005/118641
1026121661
‫ הכנתם ותכשירי‬,H5UNC0 ‫וריאנטים של‬
‫רוקחות המכילים אותם‬
179699
MULTISPECTRAL IMAGING
BIOMETRICS
LUMIDIGM, INC.
US
60/576364
01/06/2004
901900491
7710412004
US
901970402
7110912004
US
901944344
7410212004
US
771774014
2410412004
US
771774700
2410412004
US
771774707
2410412004
US
PCT/US/2005/018874
WO/2006/093508
1/26121661
179700
OCULAR IMPLANT AND METHODS
FOR MAKING AND USING SAME
BECTON DICKINSON AND
COMPANY
US
10/857452
01/06/2004
PCT/US/2005/018242
WO/2005/117780
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07K
G06K
‫מדידות ביומטריות באמצעות הדמייה‬
‫מולטיספקטרלית‬
A61F
‫שתל עייני שיטות להכנתו ושימוש בו‬
96
2626021661
179701
COMPOUND FOR PREPARING
THIAZOLE BY
AMINOMETHYLATION
SUMITOMO CHEMICAL COMPANY,
LIMITED.
2004JP
17/06/2004
179472
2004-770107 0110412004
JP
PCT/JP/2005/011095
WO/2005/123704
2/26021661
179702
CLAMPING DEVICE FOR A TOOL ON
A MACHINE TOOL, ESPECIALLY A
PLUNGE ELECTRICAL DISCHARGE
MACHINE
SYSTEM 3R INTERNATIONAL AB
EP
04020227.7 26/08/2004
PCT/EP/2005/006306
WO/2006/021248
/626021661
179703
METHOD FOR PRODUCING
OPTICALLY ACTIVE
CYCLOPROPANECARBOXYLATE
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED.
2004JP
01/07/2004
195253
PCT/JP/2005/012533
WO/2006/004180
97
C07D
‫תרכובת עבור הכנת ת'יאזול ע"י‬
‫אמינומת'ילאיישן‬
B23H
,‫מתקן הידוק עבור כלי על מכונת כלי‬
‫במיוחד מכונת שחרור זריקה חשמלית‬
C07C
‫שיטה עבור ייצור תרכובת‬
‫ציקלופרופאנקרבוקסילאט פעילה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
/626021661
179704
METHOD FOR PRODUCING
OPTICALLY ACTIVE
CYCLOPROPANECARBOXYLATE
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED.
2004JP
01/07/2004
195254
PCT/JP/2005/012530
WO/2006/004178
1022121661
‫שיטה עבור ייצור תרכובת‬
‫ציקלופרופאנקרבוקסילאט פעילה‬
179705
COATED CUTTING TOOL AND
MANUFACTURING METHOD THEREOF
SUMITOMO ELECTRIC HARDMETAL
CORP.
JP
2004-381262
28/12/2004
JP
PCT/JP2005/015869 3710412004
PCT/JP/2005/023761
WO/2006/070730
6022121661
179706
SURFACE-COATED CUTTING TOOL
SUMITOMO ELECTRIC HARDMETAL
CORP.
2004JP
22/12/2004
371920
2004-314434 2417212004
JP
PCT/JP/2005/022343
WO/2006/067956
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07F
B23B
‫כלי שיבוב מצופה ושיטה לייצורו‬
B23B
‫כלי שיבוב עם ציפוי פני שטח‬
98
6226021661
179707
SYSTEM AND METHOD FOR
CONTROLLING METAMERISM
SUN CHEMICAL CORPORATION
US
10/709827
01/06/2004
PCT/US/2005/019097
WO/2005/119190
1626/21666
1/26021661
H04Q
‫פיקוח תחנה ניידת של ערוץ בקרה קדמי‬
‫יעודי במצב שידור מקוטע‬
179709
4-SUBSTITUTED QUINOLINE
DERIVATIVES, METHOD AND
INTERMEDIATES FOR PREPARING
SAME AND PHARMACEUTICAL
COMPOSITIONS CONTAINING SAME
NOVEXEL
FR
0407124
29/06/2004
PCT/FR/2005/001598
WO/2006/010831
99
‫מערכת ושיטה לשליטה במטמריזם‬
179708
MOBILE STATION SUPERVISION OF
THE FORWARD DEDICATED
CONTROL CHANNEL WHEN IN THE
DISCONTINUOUS
TRANSMISSION MODE
QUALCOMM INCORPORATED
US
09/358634
21/07/1999
PCT/US/2000/019907
WO/2001/008439
G01J
C07D
,4 ‫תולדות קווינולין מותמרות בעמדת‬
‫ ותכשירי‬,‫שיטה וחומרי ביניים להכנתן‬
‫רוקחות המכילים אותם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179710
FRAME STRUCTURES FOR A
WIRELESS COMMUNICATION
SYSTEM WITH MULTIPLE RADIO
TECHNOLOGIES
QUALCOMM INCORPORATED
US
60/577083
04/06/2004
PCT/US/2005/019544
WO/2005/122425
/226121661
6/26021661
TABLE-STORAGE APPARATUS
OMER ASAF
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04Q
‫ מבוסס‬HANDOFF ‫מערכות ושיטות ל‬
‫ במערכות התקשורת האלחוטית‬PACKET
179712
HIGH DATA RATE INTERFACE
APPARATUS AND METHOD
QUALCOMM INCORPORATED
US
60/577500
04/06/2004
901411193
0110912004
US
PCT/US/2005/019530
WO/2005/122509
/622221660
‫מבני מסגרת עבור מערכות תקשורת‬
‫אלחוטיות בעלות טכנולוגיות רדיו מרובות‬
179711
SYSTEMS AND METHODS FOR
PACKET BASED HANDOFF IN
WIRELESS COMMUNICATION
SYSTEMS
QUALCOMM INCORPORATED
US
60/576194
01/06/2004
PCT/US/2005/019166
WO/2005/119989
H04Q
H04L
‫מערכות ושיטות ממשק לתקשורת נתונים‬
‫מהירה‬
179713
B65F
‫מתקן אחסון שולחני‬
‫עומר אסף‬
100
6226021661
179714
DUAL SMALL MOLECULE
INHIBITORS OF CANCER AND
ANGIOGENESIS
UNIVERSITY OF VIRGINIA PATENT
FOUNDATION
US
60/575927
01/06/2004
PCT/US/2005/019244
WO/2005/117876
6026021661
‫פרודות קטנות בעלות פעילות כפולה‬
‫המעכבות סרטן והיווצרות כלי דם‬
179715
DIAGNOSING OR PREDICTING THE
COURSE OF BREAST CANCER
VERIDEX, LLC
US
60/577155
04/06/2004
PCT/US/2005/019616
WO/2005/118875
6/26022000
179716
101
A01N
‫שילובים קוטלי פטריות המכילים נגזרת‬
‫של חומצה גליוקסאלית מתילאסתר‬
‫מתילאוקסים‬
179717
AMORPHOUS CLOPIDOGREL
HYDROCHLORIDE AND ITS
ANTITHROMBOTIC USE
IVAX CORPORATION
GB
0412172.9
01/06/2004
047439440
7410412004
GB
PCT/US/2005/019326
WO/2005/117866
C12Q
‫אבחון או ניבוי מהלך סרטן שד‬
FUNGICIDAL COMBINATIONS
COMPRISING A GLYOXALIC ACID
METHYLESTER METHYLOXIME
DERIVATIVE
BAYER AG
GB
9812331.8
08/06/1998
990399947
7110217999
GB
PCT/EP/1999/003883
WO/1999/063813
622602166/
C07D
C07D
‫קלופידוגרל הידרוכלוריד אמורפי ושימושו‬
‫האנטי–טרומבוטי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6126021661
179718
PHARMACEUTICAL COMPOSITION
CONTAINING IRBESARTAN
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/577427
04/06/2004
PCT/IB/2005/002689
WO/2005/118166
6226021661
6126021661
‫הרכב פרמצבטי המכיל אירבסרטן‬
‫טבע תעשיות פרמצבטיות בע"מ‬
179719
PROCESS FOR PREPARATION OF
AMORPHOUS FORM OF DRUG
TEVA GYOGYSZERGYAR
ZARTTKORUEN MUKODO
RESZVENYTARSASAG
US
60/576216
01/06/2004
901443114
2410912004
US
901499100
0410412004
US
PCT/US/2005/019485
WO/2005/117837
179720
179721
PROCESS FOR PRODUCING A 3 AMINOMETHYLTETRAHYDROFURAN
DERIVATIVE
MITSUI CHEMICALS, INC.
JP
2004-175322 14/06/2004
PCT/JP/2005/010171
WO/2005/121111
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61K
‫תהליך להכנת צורה אמורפית של תרופה‬
SECURITY MODULE COMPONENT
NAGRACARD S.A.
EP
04102505.7 03/06/2004
PCT/EP/2005/052519
WO/2005/119583
6126021661
B08B
G06K
‫יחידת מודול אבטחה‬
C07D
– : ‫תהליך להכנת תולדת‬
‫אמינומתילטטראהידרופורן‬
102
2/26021661
179724
METHOD FOR PRODUCING
ACETAMIDOPYRROLIDINE
DERIVATIVES AND NOVEL
BENZAMIDOACETIC ACID
DERIVATIVES AS INTERMEDIATES
THEREFOR
TEIJIN PHARMA LIMITED
2004JP
14/06/2004
175159
2004-714744 7410912004
JP
PCT/JP/2005/011187
WO/2005/121081
622602166/
C07D
‫שיטה להכנת תולדות אצטאמידופירולידין‬
‫ותולדות חדשות של חומצת‬
‫בנזאמידואצטת כחומרי ביניים עבורה‬
179726
A METHOD FOR ENHANCING
DIFFERENTIATION OF hES CELLS
INTO CARDIOMYOCYTES
ES CELL INTERNATIONAL PTE LTD.
C12N
hES ‫שיטה לשיפור התמיינותם של תאי‬
‫לקרדיומיוציטים‬
PCT/AU/2004/000727
WO/2005/118784
2/26021661
179727
HUMAN OBESITY SUSCEPTIBILITY
GENE ENCODING A TASTE
RECEPTOR AND USES THEREOF
INTEGRAGEN
US
60/578830
14/06/2004
PCT/IB/2005/002309
WO/2005/123948
103
C12Q
‫גן אנושי הגורם לנטייה להשמנה המקודד‬
‫קולטן טעם ושימושיו‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2/26021661
179728
INDOLES USEFUL IN THE
TREATMENT OF INFLAMMATION
BIOLIPOX AB
US
60/580401
18/06/2004
PCT/GB/2005/002391
WO/2005/123673
1626021661
6/26021661
‫אינדולים השימושיים לטיפול בדלקת‬
179729
NOVEL PIPERIDINE DERIVATES AS
MODULATORS OF CHEMOKINE
RECEPTOR CCR5
ASTRAZENECA AB
SE
0401657-2
24/06/2004
PCT/SE/2005/000952
WO/2006/001751
LENTICULAR DISPLAY DEVICE
ITZCHAK BAR-YONA
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫נגזרות חדשות של פיפרידין כמאפננים של‬
CCR5 ‫קולטן כמוקין‬
179730
NOVEL CIS-IMIDAZOLINES
F. HOFFMANN-LA ROCHE AG
US
60/580441
17/06/2004
901914799
2210412004
US
PCT/EP/2005/006167
WO/2005/123691
/622221660
C07D
179731
C07D
‫ציס–אימידאזולינים חדשים‬
G09F
‫מתקן תצוגה עדשתי‬
‫יונה‬-‫יצחק בר‬
104
1126021661
179732
NOVEL USE OF PEPTIDE
COMPOUNDS FOR TRETING
ESSENTIAL TREMOR AND OTHER
TREMOR SYNDROMES
SCHWARZ PHARMA AG
US
60/582084
24/06/2004
PCT/EP/2005/006750
WO/2006/000397
1626021661
179733
NOVEL PIPERIDINE-8AZABICYCLO(3.2.1)OCTAN
DERIVATIVES AS MODULATORS OF
CHEMOKINE RECEPTOR CCR5
ASTRAZENECA AB
SE
0401656-4
24/06/2004
PCT/SE/2005/000953
WO/2006/001752
2/26021661
179734
PYRIDAZIN-3(2H)-ONE DERIVATIVES
AND THEIR USE AS PDE4
INHIBITORS
ALMIRALL PRODESFARMA S.A.
ES
P200401500 18/06/2004
PCT/EP/2005/006304
WO/2005/123692
105
A61K
‫שימוש חדש של תרכובות פפטידיות‬
‫לטיפול ברעד הכרחי ובסינדרומי רעד‬
‫אחרים‬
C07D
–0–‫נגזרות חדשות של פיפרידין‬
‫)אוקטאן כמאפננים של‬:.0.1(‫אזאביציקלו‬
CCR5 ‫קולטן כמוקין‬
C07D
‫–און ושימושן‬H2)3(–‫נגזרות של פירידזינ‬
PDE4 ‫כמעכבי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1/26021661
179735
3AMINOCYCLOPENTANECARBOXAMIDES
AS MODULATORS OF CHEMOKINE
RECEPTORS
INCYTE CORPORATION
US
60/583482
28/06/2004
901924447
0717712004
US
PCT/US/2005/022909
WO/2006/004741
2/26021661
179736
PYRRAZOLO-PYRIMIDINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
04102837.4 21/06/2004
PCT/EP/2005/006302
WO/2005/123738
2/26021661
179737
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
C07D
‫נגזרות אינדול כאנטגוניסטים של קולטני‬
‫היסטמין‬
179738
MITOCHONDRIALLY TARGETED
ANTIOXIDANTS IN THE TREATMENT
OF LIVER DISEASES AND
EPITHELIAL CANCERS
ORIDIS BIOMED FORSCHUNGS-UND
ENTWICKLUNGS GMBH
EP
04103318.4 13/07/2004
PCT/EP/2005/053338
WO/2006/005759
‫–אמינוציקלופנטאנקרבוקסאמידים‬:
‫כווסתים של קולטני כמוקין‬
‫נגזרות של פירזולו–פירימידין‬
INDOLE DERIVATIVES AS
HISTAMINE RECEPTOR
ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
04102839.0 21/06/2004
PCT/EP/2005/006303
WO/2005/123716
2126/21661
C07D
A61K
‫חומרים נוגדי חימצון המכוונים‬
‫למיטוכונדריה לטיפול במחלות של הכבד‬
‫ובסרטן אפיתלי‬
106
1/26021661
179740
NON-INTEGRATIVE AND NONREPLICATIVE LENTIVIRUS,
PREPARATION AND USES THEREOF
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
FR
0407017
25/06/2004
PCT/FR/2005/001604
WO/2006/010834
1226021661
,‫לנטיוירוס לא–אינטגרטיבי ולא–רפלקטיבי‬
‫הכנתו ושימושו‬
179741
PYRIDAZIN-3(2H)-ONE DERIVATIVES
AND THEIR USE AS PDE4
INHIBITORS
ALMIRALL PRODESFARMA, S.A.
ES
P200401512 21/06/2004
PCT/EP/2005/006712
WO/2005/123693
/622221660
179742
107
A63F
‫מערכת אימון פיזית אינטראקטיבית‬
‫לטס גואו בע"מ‬
179743
PYRIMIDINE UREA DERIVATIVES
AS KINASE INHIBITORS
NOVARTIS AG
US
60/582425
24/06/2004
047232444
7910912004
GB
PCT/EP/2005/006815
WO/2006/000420
C07D
‫–און ושימושן‬H2)3(–‫נגזרות של פירידזינ‬
PDE4 ‫כמעכבי‬
INTERACTIVE PHYSICAL TRAINING
SYSTEM
LET'S GO LTD
1/26021661
C12N
C07D
‫נגזרות של פירימידין אוריאה כמעכבים של‬
‫קינאז‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2/26021661
179744
HUMAN OBESITY SUSCEPTIBILITY
GENE ENCODING A POTASSIUM
VOLTAGE-GATED CHANNEL AND
USES THEREOF
INTEGRAGEN
US
60/578829
14/06/2004
PCT/IB/2005/002356
WO/2005/123949
1126021661
1226021661
‫גן אנושי של לרגישות להשמנה המקודד‬
‫תעלת אשלגן המבוקרת על–ידי מתח‬
‫ושימושם‬
179745
PIPERIDINE DERIVATIVES AND
THEIR USE AS INSECTICIDES,
ACARICIDES, MOLLUSCICIDES OR
NEMATICIDES
SYNGENTA PARTICIPATIONS AG
GB
0414438.2
28/06/2004
PCT/IB/2005/002002
WO/2006/003494
179746
179747
NOVEL INDAZOLE CARBOXAMIDES
AND THEIR USE
SMITHKLINE BEECHAM
CORPORATION
US
60/582655
24/06/2004
PCT/US/2005/022870
WO/2005/002434
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A01N
,‫נגזרות פיפרידין ושימושן כקוטלי מזיקים‬
‫קוטלי קרציות או קוטלי תולעים‬
A SUPPORT STRUCTURE FOR A
MEDICAMENT
ASTRAZENECA AB
SE
0401654-9
24/06/2004
PCT/GB/2005/002440
WO/2006/000758
1/26021661
C12Q
B65D
‫מבנה תומך לתרופה‬
C07D
‫אינדזול קרבוקסמידים חדשים ושימושם‬
108
2/26021661
179748
ANTIBIOTICS CONTAINING BORINIC
ACID COMPLEXES AND METHODS
OF USE
ANACOR PHARMACEUTICALS, INC
US
10/867465
14/06/2004
PCT/US/2005/021214
WO/2006/007384
6/26021661
179749
IMPROVED METHOD FOR
PREPARING 3-HYDROXY-4HYDROXYMETHYL-PYRROLIDINE
COMPOUNDS
INDUSTRIAL RESEARCH LIMITED
NZ
533360
04/06/2004
PCT/NZ/2005/000114
WO/2005/118532
2026/21661
179750
GENETICALLY ENGINEERED
PYRROLOQUINOLINE QUINONE
DEPENDENT GLUCOSE
DEHYDROGENASE COMPRISING AN
AMINO ACID INSERTION
F. HOFFMANN-LA ROCHE AG
EP
04017069.8 20/07/2004
PCT/EP/2005/007844
WO/2006/008132
109
C07F
‫חומרים אנטיביוטיים המכילים תצמידים‬
‫של חומצה בורינית ושיטות לשימושם‬
C07D
–: ‫שיטה משופרת להכנת תרכובות של‬
‫–הידרוקסימתיל–פירולידין‬4–‫הידרוקסי‬
C12N
‫גלוקוז דהידרוגנז מהונדס גנתית המכיל‬
‫הכנסת חומצת‬
‫ התלוי בפירולוקינולין קינון‬,‫אמינו‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
/626021661
179751
HUMAN AUTISM PREDISPOSITION
GENE ENCODING A TRANSCRIPTION
FACTOR AND USES THEREOF
INTEGRAGEN
US
60/584130
01/07/2004
PCT/IB/2005/002319
WO/2006/003520
6026021661
‫גן אנושי לנטייה לאוטיזם המקודד פקטור‬
‫שעתוק ושימושם‬
179752
APPARATUS AND METHOD FOR
PHARMACEUTICAL PRODUCTION
SMITHKLINE BEECHAM
CORPORATION
US
60/578245
09/06/2004
901927992
2417012004
US
PCT/US/2005/020319
WO/2005/123569
6/26021661
179753
PROCESS FOR THE PREPARATION
OF ENTECAVIR AND NOVEL
INTERMEDIATES THEREOF VIA
CARBON - SILICON OXIDATION
BRISTOL-MYERS SQUIBB COMPANY
US
60/576899
04/06/2004
771743294
0210912004
US
PCT/US/2005/019633
WO/2005/118585
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C12Q
B67B
‫מתקן ושיטה לייצור תכשיר רוקחות‬
C07D
‫תהליך להכנת אנתקויר וחומרי ביניים‬
‫חדשים באמצעות חמצון פחמן–סיליקון‬
110
/226121661
179754
PYRAZOLE DERIVATIVES,
COMPOSITIONS CONTAINING SUCH
COMPOUNDS AND METHODS OF
USE
MERCK & CO., INC.
US
60/577116
04/06/2004
PCT/US/2005/018828
WO/2005/121097
6/26021661
‫ הרכבים המכילים אותן‬,‫נגזרות פירזול‬
‫ושיטות לשימוש בהן‬
179755
179756
APPLIANCE FOR CONTROLLING
TRANSPARENT OR REFLECTIVE
ELEMENTS
AUTOMATION & ROBOTICS
EP
04447138.1 09/06/2004
PCT/BE/2005/000094
WO/2005/121740
6/26021661
G01M
‫מכשור לבדיקת אלמנטים שקופים או‬
‫החזריים‬
179757
NOVEL FLUOROGLYCOSIDE
DERIVATIVES OF PYRAZOLES,
MEDICAMENTS CONTAINING THESE
COMPOUNDS, AND THE USE THEREOF
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102004028241.2 11/06/2004
PCT/EP/2005/005959
WO/2005/121161
111
G09F
‫חפת שרוול מרופד עם תווית זיהוי עם‬
‫למינציה עצמית‬
CUSHIONED WRISTBAND WITH
SELF-LAMINATING IDENTITY TAG
LASER BAND LLC
US
10/870500
17/06/2004
PCT/US/2005/020363
WO/2006/007356
6/26021661
C07D
C07H
‫נגזרות פלורוגליקוזידיות חדשות של‬
‫ תרופות המכילים אותן‬,‫פירזולים‬
‫ושימוש שלהן‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6226021661
179758
SUBSTITUTED TETRAHYDRO - 2H ISOQUINOLIN - 1 - ONE DERIVATIVES,
METHOD FOR THE PRODUCTION
THEREOF, AND USE OF THE SAME AS
MEDICAMENTS
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102004028973.5 16/06/2004
PCT/EP/2005/005871
WO/2005/123687
/622221660
179759
179760
179761
ELECTROMECHANICAL DEVICE
HAVING THREE-DIMENSIONAL
STATOR LAMINATIONS
GENERAL ELECTRIC COMPANY
US
US
30/11/2005
11/291944
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A01G
A01G
‫שרוול גמיש‬
‫אלגו השקיה בע"מ‬
FLEXIBLE SLEEVE
ELGO IRRIGATION LTD.
/622221660
‫ – איזוקווינולין‬H0 – ‫נגזרות טטראהידרו‬
‫ שיטה לייצורם ושימוש‬,‫ – און מותמר‬1 –
‫שלהן כתרופות‬
‫פיה זרם משתנה‬
‫אלגו השקיה בע"מ‬
VARIABLE JET NOZZLE
ELGO IRRIGATION LTD.
/622221660
C07D
B60J
‫התקן אלקטרומכני עם עטויי סטטורים‬
‫תלת – מימדיים‬
112
6/26021661
179763
C07D
‫תולדות בקטריוכלורופיל קטיוניות‬
‫ושימושיהן‬
CATIONIC BACTERIOCHLOROPHYLL
DERIVATIVES AND USES THEREOF
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/577196
07/06/2004
PCT/IL/2005/000602
WO/2005/120573
/626121661
AN INK COMPOSITION
KORNIT DIGITAL LTD.
IL
162231
793449
IL
901947230
US
IL
PCT/IL2005/00166
PCT/IL/2005/000559
WO/2005/115761
/626121661
‫ידע חברה למחקר ופיתוח בע"מ‬
179764
‫תערובת דיו לטקסטיל‬
‫קורנית דיגיטל בע"מ‬
30/05/2004
7710412004
7010212004
7010212004
179765
A PROCESS AND SYSTEM FOR PRINTING
IMAGES ON ABSORPTIVE SURFACES
KORNIT DIGITAL LTD.
IL
162231
30/05/2004
793449
7710412004
IL
901947230
7010212004
US
IL
PCT/IL2005/00166 7010212004
PCT/IL/2005/000558
WO/2005/115089
113
C09D
B41F
‫תהליך הדפסה דיגיטלי על משטחים‬
‫סופגים‬
‫קורנית דיגיטל בע"מ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6226021661
179767
PERSONAL NUTRITION CONTROL
DEVICES
Centrition Ltd.
US
60/575371
01/06/2004
901443907
3010912004
US
901934479
2117212004
US
901949047
0310212004
US
PCT/IL/2005/000576
WO/2005/119627
6026/21666
6026021661
‫מכשיר אישי לבקרת תזונה‬
179768
SYSTEM AND METHOD FOR EDGE
OF COVERAGE DETECTION IN A
WIRELESS COMMUNICATION
DEVICE
QUALCOMM INCORPORATED
US
09/348442
07/07/1999
PCT/US/2000/018599
WO/2001/003464
179769
179770
WIRELESS COMMUNICATION
SYSTEM WITH CONFIGURABLE
CYCLIC PREFIX LENGTH
QUALCOMM INCORPORATED
US
60/577083
04/06/2004
PCT/US/2005/019543
WO/2005/122517
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04Q
‫מערכת ושיטה לזיהוי קצה כיסוי במכשיר‬
‫תקשורת אלחוטי‬
TOURNIQUET AND METHOD OF USE
PHIL DURANGO LLC
US
60/521630
08/06/2004
PCT/US/2005/020111
WO/2005/122908
6/26021661
B01D
A61B
‫חוסם עורקים ושיטה לשימוש בו‬
H04L
‫מערכת תקשרות אלחוטית עם אורך‬
‫קידומת מעגלית הניתן לשינוי‬
114
6/26021661
179772
‫תרכובות לפטומיצין‬
LEPTOMYCIN COMPOUNDS
KOSAN BIOSCIENCES, INC.
US
60/577253
03/06/2004
901909947
7410912004
US
771742442
0710912004
US
PCT/US/2005/019591
WO/2005/117894
6126021661
179773
6126021661
02/06/2004
179774
179775
IMAGE-AUGMENTED INERTIAL
NAVIGATION SYSTEM (IAINS) AND
METHOD
Athena Technologies, Inc.
US
60/576037
02/06/2004
PCT/US/2005/019411
WO/2005/119178
115
G05D
‫מערכות ושיטות לשליטה במערכות‬
‫דינאמיות‬
SYSTEMS AND METHODS FOR
CONTROLLING DYNAMIC SYSTEMS
Athena Technologies, Inc.
US
60/576020
02/06/2004
PCT/US/2005/019434
WO/2006/071258
6126021661
G05D
‫ עמדה‬,‫מערכות ושיטות להערכת מיקום‬
‫או הזווית שבין כיוון הנסיעה לקו אורך‬/‫ו‬
‫מסויים של כלי רכב‬
SYSTEMS AND METHODS FOR
ESTIMATING POSITION, ATTITUDE,
AND/OR HEADING OF A VEHICLE
Athena Technologies, Inc.
US
60/576021
PCT/US/2005/019435
WO/2005/119387
C07D
G01C
) IAINS( ‫מערכת ניווט עם תמונה מוגדלת‬
‫ושיטה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179776
BIOHAZARD MASK SUITABLE FOR
CIVILIANS
DAVID R. FRERIKS.
US
10/861231
03/06/2004
PCT/US/2005/019561
WO/2006/083287
6/26021661
179777
PROCESS FOR FORMULATING FAST
DISPERSING DOSAGE FORMS
COMPRISING AT LEAST ONE FISH
GELATIN SELECTED ON THE BASIS
OF MOLECULAR WEIGHT
R.P. SCHERER TECHNOLOGIES, INC.
US
10/860106
03/06/2004
PCT/US/2005/019589
WO/2005/120464
/226121661
179778
A62B
‫מסיכה לזיהומים סביבתיים ביולוגיים‬
‫המתאימה לאזרחים‬
A61K
‫תהליך להכנת פורמולציה בצורות מינון‬
‫המתפזרות במהירות המכילות לפחות‬
‫ג'לטין דגי אחד הנבחר על בסיס משקל‬
‫מוליקולרי‬
G07C
‫גישה אקראית לציר הזמן לשם הקלטה‬
‫ופליבק של קובץ הניתן לפירמוט מבוסס‬
‫זמן‬
TIMELINE RANDOM ACCESS FOR
MULTI-FORMAT TIME-BASED FILE
RECORDING AND PLAYBACK
SMITHS AEROSPASE LLC
US
60/575490
01/06/2004
771034477
7210712004
US
PCT/US/2005/018899
WO/2005/119600
6226021661
179779
SLUDGE TREATMENT PROCESS
BIO-CHEM RESOURCES
US
60/575360
01/06/2004
PCT/US/2005/019174
WO/2005/118490
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C02F
‫תהליך לטיפול ברפש‬
116
6/22121660
179780
DISPOSABLE MEDICAL
INSTRUMENT
MICHAEL PORAT
6226021661
‫מכשיר רפואי חד–פעמי‬
‫מיכאל פורת‬
179781
179782
METHOD AND SYSTEM FOR WIDE
AREA SECURITY MONITORING,
SENSOR MANAGEMENT AND
SITUATIONAL AWARENESS
L-3 COMMUNICATIONS
CORPORATION
US
60/575894
01/06/2004
901414494
0710912004
US
901419040
0710912004
US
PCT/US/2005/019681
WO/2006/071259
6226021661
117
G06F
‫ ניהול‬,‫שיטה ומערכת לפיקוח אבטחה‬
‫אמצעי חישה וערנות לתרחישים של אזור‬
‫רחב‬
179783
METHOD AND SYSTEM FOR
PERFORMING VIDEO FLASHLIGHT
L-3 COMMUNICATIONS
CORPORATION
US
60/575894
01/06/2004
901414494
0710912004
US
901419040
0210912004
US
PCT/US/2005/019672
WO/2005/120071
H04N
‫מערכת אתראה עבור מעקב וידאו‬
VIDEO FLASHLIGHT/VISION ALERT
L-3 COMMUNICATIONS
CORPORATION
US
60/575894
01/06/2004
901414494
0710912004
US
901419040
0710912004
US
PCT/US/2005/019673
WO/2005/120072
6226021661
A61L
H04N
‫שיטה ומערכת וידאו בעזרת מודל סביבה‬
‫ממוחשב‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6126021661
179784
METHODS AND DEVICES FOR
FABRICATING AND ASSEMBLING
PRINTABLE SEMICONDUCTOR
ELEMENTS
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
60/577077
04/06/2004
901907097
7710412004
US
901940304
0410212004
US
901993397
7410312004
US
901911971
0410412004
US
PCT/US/2005/019354
WO/2005/122285
6126021661
179785
A METHOD FOR PRESERVING A
CELL BY FREEZING
ES CELL INTERNATIONAL PTE LTD.
AU
2004902933 02/06/2004
2004902444
7410412004
AU
PCT/AU/2005/000783
WO/2005/118785
6/22121660
179786
PROTECTION OF VEHICLE
CELLVLAR PHONES
HOLAN FARAGE
6026021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H01L
‫שיטות והתקנים לייצור והרכבה של‬
‫אלמנטים מוליכים למחצה הניתנים‬
‫להדפסה‬
C12N
‫שיטה לשימור תא על ידי הקפאה‬
B65B
‫מיגון רכב סלולרי‬
'‫גולן פרג‬
179787
H01L
118
EXPOSURE EQUIPMENT, EXPOSURE
METHOD AND DEVICE
MANUFACTURING METHOD
NIKON ENGINEERING CO. LTD
2004JP
10/06/2004
172569
2004-244290 2410412004
JP
2004-330442 7417712004
JP
PCT/JP/2005/010576
WO/2005/122221
1/2212166/
‫ שיטת חשיפה ושיטה לייצור‬,‫ציוד חשיפה‬
‫מתקן‬
179788
WATER DISTRIBUTION SYSTEM FOR
AN EVAPORATIVE COOLER
AZ EVAP, LLC
US
10/862040
04/06/2004
PCT/US/2004/043748
WO/2005/120679
6/26021661
‫מערכת הספקת מים עבור מצנן מאייד‬
179789
SUBSTITUTED
BENZOYLCYCLOHEXANDIONES AS
HERBICIDES
BAYER CROPSCIENCE GMBH
DE
102004029307.4 17/06/2004
PCT/EP/2005/006018
WO/2005/123710
6/26021661
119
B01F
179790
C07D
‫בנזואילציקלוהקסאנדיונים מותמרים‬
‫כקוטלי עשבים‬
C07D
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
NEW DISUBSTITUTED
PHENYLPIPERIDINES/PIPERAZINES
AS MODULATORS OF DOPAMINE
NEUROTRANSMISSION
A. CARLSSON RESEARCH AB
SE
0401464-3
08/06/2004
901411943
0410912004
US
0403742-3
2017212004
SE
901931430
2017212004
US
PCT/EP/2005/006147
WO/2005/121087
6/26021661
–‫פיפרזינים חדשים דו‬/‫פנילפיפרידינים‬
‫מותמרים כמאפננים העברה עצבית של‬
‫דופאמין‬
179791
PYRIDINYLISOXAZOLES AND THEIR
USE AS HERBICIDES
BAYER CROPSCIENCE GMBH
DE
102004029309.0 17/06/2004
PCT/EP/2005/006017
WO/2005/123726
6/22121660
179792
METHOD AND APPARATUS FOR
CARRYING OUT DEEP HOLES
AND/OR BOTTLE-BORING
MAGNAGHI AERONAUTICA S.P.A.
EP
05425869.4 06/12/2006
6226021661
179793
CAVITY RESONATOR, USE OF A
CAVITY RESONATOR, AND
OSCILLATOR CIRCUIT
HUBER+SUHNER AG
EP
04013104.7 03/06/2004
PCT/EP/2005/005900
WO/2005/119833
2126021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179795
C07D
‫פירידינילאיזוקסזולים ושימוש שלהם‬
‫כקוטלי עשבים‬
B23B
‫או‬/‫שיטה וציוד לביצוע חורים עמוקים ו‬
‫קדוחי–בקבוק‬
H01P
‫ שימוש במגביר‬,‫מגביר תהודה בעל חלל‬
‫ ומעגל מתנד‬,‫תהודה בעל חלל‬
C07C
120
A PHARMACEUTICAL COMPOSITION
AND ITS USE
TILLOTTS PHARMA AG
GB
0413729.5
18/06/2004
PCT/EP/2005/006412
WO/2005/123060
6/26021661
‫תכשיר רוקחות ושימושו‬
179796
‫שימוש אימאטיניב לטיפול במחלות הכבד‬
‫ובהדבקות נגיפיות‬
USE OF IMATINIB TO TREAT LIVER
DISORDERS AND VIRAL INFECTIONS
BIONICHE LIFE SCIENCES INC.
US
60/576573
04/06/2004
PCT/CA/2005/000869
WO/2005/117885
6/26021661
179797
MATERIAL SOLUBILISER REACTOR
FOR HYDROLYSIS AND/OR WET
FERMENTATION AND WASTE
TREATMENT PLANT WITH SUCH A
SOLUBILISER AND REACTOR
CHRISTIAN WIDMER
DE
102004027260.3 03/06/2004
70200404040349
7417012004
DE
PCT/EP/2005/005993
WO/2005/118147
6126021661
179798
METHODS FOR DETECTING GENE
EXPRESSION IN PERIPHERAL BLOOD
CELLS AND USES THEREOF
LINKAGENE LTD.
US
60/576599
04/06/2004
PCT/IL/2005/000590
WO/2005/118403
6126021661
121
C07D
179799
B03B
‫או‬/‫ריאקטור המסת חומר להידרוליזה ו‬
‫לתסיסה רטובה ומפעל לטיפול‬
‫בשפכים הכולל ממיס וריאקטור כנ"ל‬
B65B
‫שיטות לבדיקת ביטוי גנים בתאי דם‬
‫היקפיים ושימושים בהם‬
‫לינקג'ן בע"מ‬
H03F
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
GENERAL-PURPOSE WIDEBAND
AMPLIFIER
QUALCOMM INCORPORATED
US
60/576759
02/06/2004
701932444
0710912004
US
PCT/US/2005/019682
WO/2005/119907
6/26021661
179800
CODING AND MODULATION FOR
BROADCAST AND MULTICAST
SERVICES IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/577083
04/06/2004
PCT/US/2005/019529
WO/2005/122458
1/26121661
‫מגבר פס–רחב למטרות כלליות‬
‫קידוד ואפנון לשירותי שידור ושידור מרובב‬
‫במערכת תקשורת אלחוטית‬
179801
OBJECT PROCESS GRAPH SYSTEM
GRAPHLOGIC, INC.
US
60/577501
05/06/2004
701904944
2010412004
US
PCT/US/2005/018942
WO/2005/121954
6/26021661
179802
TRANSMISSION OF OVERHEAD
INFORMATION FOR BROADCAST
AND MULTICAST SERVICES IN A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/577083
04/06/2004
PCT/US/2005/019541
WO/2005/122627
6/26021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04L
179803
G06F
‫מערכת גרפים לתהליכי אובייקטים‬
H04Q
‫תמסורת תקורה לשירותי שידור ושידור‬
‫מרובב במערכת תקשורת אלחוטית‬
H04L
122
MULTICARRIER MODULATION
SYSTEM WITH CYCLIC DELAY
DIVERSITY
QUALCOMM INCORPORATED
US
60/577083
04/06/2004
PCT/US/2005/019542
WO/2005/122516
6/22121660
‫ בעלת‬MULTICARRIER ‫מערכת אפנון‬
‫גיוון השהיה מעגלי‬
179805
DISPENSER, DILUTION, AND MIXING
UP INSTALLATION
YESHAYA GERAFI
6/22121660
‫ ולערבוב‬,‫ למהילה‬,‫מתקן לרוקחות‬
‫ישעיה ג'רפי‬
179806
6/22121660
179807
IMPROVED DEVICE FOR THE
REMOTE CONTROL OF A FIRE ARM
"FN HERSTAL" S.A.
BE
2005/0587
05/12/2005
1226/21661
179808
C12P
‫פוליפפטידים מסונטזים באופן טבעי‬
‫באמצעות ניצול חומצות אמינו מקודדות‬
‫לא טבעיות‬
21/07/2004
0110312004
179809
PHARMACEUTICAL COMPOSITIONS
123
F41A
‫התקן משופר לבקרה מרחוק על כלי נשק‬
BIOSYNTHETIC POLYPEPTIDES
UTILIZING NON-NATURALLY
ENCODED AMINO ACIDS
6/26021661
A23N
‫מסחטת מיץ‬
‫לאה אהרונוביץ‬
FRUIT JUICER
YORAM AHARONOVITCH
AMBRX, INC.
US
60/590035
901949109
US
PCT/US/2005/025834
WO/2006/091231
A61K
A61K
‫תכשירי רוקחות‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/578043
08/06/2004
PCT/US/2005/019929
WO/2005/123076
2026121661
179810
APPARATUS AND PROCESS FOR
COOLING AND DE-STEAMING
CALCINED STUCCO
UNITED STATES GYPSUM COMPANY
US
10/891964
15/07/2004
PCT/US/2005/017485
WO/2006/019456
6/26021661
‫התקן ותהליך לקירור והזרמה מחדש של‬
‫טיח קירות שנשרף‬
179811
IDENTIFICATION OF TUMORS
AVIARADX, INC.
US
60/577084
04/06/2004
PCT/US/2005/019736
WO/2005/118879
6/26021661
179812
THE IMPORTANCE OF THE GENE
HoxB13 FOR CANCER
THE GENERAL HOSPITAL
CORPORATION
US
60/577085
04/06/2004
PCT/US/2005/019737
WO/2006/004600
2/26021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
F25D
179813
C12Q
‫זיהוי גידולים‬
C12Q
‫ לסרטן‬HoxB13 ‫חשיבותו של הגן‬
C07D
124
S-TENATOPRAZOLE SODIUM
MONOHYDRATE SALT AND USE
THEREOF IN THE FORM OF A
PROTON PUMP INHIBITOR
SIDEM PHARMA
FR
0406617
17/06/2004
PCT/FR/2005/001528
WO/2006/005853
2/22621666
179814
REGULATORS OF THE HEDGEHOG
PATHWAY,COMPOSITIONS AND
USES RELATED THERETO
JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE
US
60/159215
13/10/1999
901229213
3010412000
US
PCT/US/2000/028479
WO/2001/027135
6026021661
179815
LIQUID DEPOT FORMULATIONS
CAMURUS AB
GB
0412530.8
04/06/2004
040040143
7410712004
GB
040147744
7410412004
GB
PCT/GB/2005/002217
WO/2005/117830
6/22121660
179817
125
C07J
‫ תכשירים‬,HEDGEHOG ‫מווסתי מסלול‬
‫והשימוש בהם הקשורים למווסתים אלו‬
A61K
‫הרכבי מאגר נוזליים‬
A01G
‫אביזר להרכבת צמחים‬
‫אשל פרחים בע"מ‬
PLANT GRAFTING ACCESSORY
ESHEL FLOWERS LTD
6/22121660
‫–טנאטופראזול‬S ‫מלח נתרן חד מימי של‬
‫ושימוש בו כמעכב שאיבת מימנים‬
179818
E04H
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
ROOF-TOP PARKING SYSTEM AND
METHOD
HIGH PARKING LTD.
2/26/21660
‫מערכת ושיטה לחנייה על גגות‬
‫היי פארקינג בע"מ‬
179819
PROCESSES FOR PRODUCTION AND
PURIFICATION OF NORMAL PROPYL
BROMIDE
ALBEMARLE CORPORATION
US
60/673391
18/04/2005
PCT/US/2006/013778
WO/2006/113307
1/2602166/
179820
A PROCESS TO IMPROVE THE
NUTRIENT CONTENTS OF THE SOIL
IN THE CULTIVATED LANDS
CHINTHALA, VENKAT, REDDY
C07C
‫שיטת ייצור וטיהור של נורמל פרופיל‬
‫ברומיד‬
A01B
‫תהליך לשיפור תכולת חומרי ההזנה‬
‫באדמה בשדות מעובדים‬
PCT/IN/2004/000185
WO/2006/001030
2/26/21661
179821
KNITTED GLOVE WITH
CONTROLLED STITCH STRETCH
CAPABILITY
ANSELL HEALTHCARE PRODUCTS
LLC
US
10/892763
16/07/2004
771747094
7310112004
US
PCT/US/2005/024845
WO/2006/019815
1/26021661
REUSABLE FITTING FOR TUBING
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179822
D04B
‫כפפה סרוגה בעלת יכולת מבוקרת של‬
‫מתיחת התפרים‬
F16L
‫מתאם צנרת המתאים לשימוש חוזר‬
126
OMEGA FLEX, INC.
US
60/582904
PCT/US/2005/022869
WO/2006/004720
25/06/2004
2626/21661
179824
MOBILE PERSONAL VIDEO
RECORDER
NDS LIMITED
US
60/581597
21/06/2004
PCT/IL/2005/000383
WO/2005/125202
6/22121660
179825
PANEL MOUNTING SYSTEM AND
DEVICE
ELIYAHU SHALTIEL
6/26021661
127
‫מכשיר וידאו אישי נייד‬
E05D
‫התקן ומערכת להתקנת פנלים‬
‫אליהו שאלתיאל‬
179826
EXPOSURE APPARATUS, EXPOSURE
METHOD, AND DEVICE PRODUCING
METHOD
NIKON CORPORATION
2004JP
04/06/2004
167115
PCT/JP/2005/010217
WO/2005/119742
2126/21661
H04N
179827
H01L
‫ שיטת חשיפה ושיטה‬,‫מתקן חשיפה‬
‫לייצור מתקן‬
G06F
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
SCHEDULING IN A HIGH PERFORMANCE COMPUTING (HPC)
SYSTEM
RAYTHEON COMPANY
US
10/991598
17/11/2004
PCT/US/2005/012500
WO/2006/055028
6026021661
179829
LASER RADIATION DESORPTION
DEVICE FOR MANIPULATING A
LIQUID SAMPLE IN THE FORM OF
INDIVIDUAL DROPS, THEREBY
MAKING IT POSSIBLE TO CARRY
OUT THE CHEMICAL AND
BIOLOGICAL TREATMENT THEREOF
SANOFI-AVENTIS
FR
0406081
04/06/2004
PCT/FR/2005/001384
WO/2006/003292
6026021661
‫תכנון במערכת מחשוב בעלת ביצועים‬
) HPC( ‫גבוהים‬
‫מתקן לשחרור קרינת לייזר לתפעול דוגמה‬
‫ והמאפשר‬,‫נוזלית בצורת טיפות בודדות‬
‫ליישם טיפול כימי וביולוגי‬
179830
MULTIPURPOSE ENDOSCOPY SUITE
MEDIGUS LTD.
IL
162390
07/06/2004
PCT/IL/2005/000598
WO/2005/120329
/626021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B01L
179831
A61B
‫מערכת רב–שימושית לאנדוסקופ‬
‫מדיגוס בע"מ‬
C12Q
128
HUMAN AUTISM SUSCEPTIBILITY
GENE ENCODING PRKCB1 AND USES
THEREOF
INTEGRAGEN
US
60/584132
01/07/2004
PCT/IB/2005/002381
WO/2006/003523
6/26/21661
‫גן אנושי לנטייה לאוטיזם המקודד‬
‫ ושימושם‬PRKCB1
179832
A PROCESS FOR THE SYNTHESIS OF
TERBINAFINE AND DERIVATIVES
THEREOF
F.I.S. FABBRICA ITALIANA SINTETICI
S.p.A.
IT
MI2004A001154 09/06/2004
PCT/IT/2005/000121
WO/2005/121155
6122121660
179834
179835
PHARMACEUTICAL COMPOSITIONS
CONTAINING AMPHOTERICIN B
AND DELIVERY SYSTEMS
CONTAINING THE SAME
NEKTAR THERAPEUTICS
US
60/581586
21/06/2004
PCT/US/2005/021886
WO/2006/002140
6122121660
129
‫תהליך לסינתוז של טרבינאפין‬
‫ונגזרותיו‬
A45B
‫מניפה ושלט מתקפל‬
‫ארגו בע"מ‬
FOLDABLE FAN AND BANNER
ARGO LTD.
1226021661
C07F
179836
A61K
B ‫תכשירי רוקחות המכילים אמפוטריצין‬
‫ומערכות אספקה המכילות אותם‬
G01B
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
MEASURING TAPE AND DRAFTING
DEVICE
SIMON SIGLER
‫סרט–מידה ועזר שרטוט‬
‫שמעון סיגלר‬
1126/21661
179837
CYCLIC AND HETEROCYCLIC
COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
MORPHOCHEM
AKTIENGESELLSCHAFT FUR
KOMBINATORISCHE CHEMIE
DE
102004041163.8 25/08/2004
PCT/EP/2005/009204
WO/2006/021448
6122121660
‫תרכובות ציקליות והטרוציקליות בעלות‬
‫פעילות נגד חיידקים ותכשירי רוקחות‬
‫המכילים אותן‬
179838
179839
METHOD AND DEVICE TO PAINT
OUT-OF-REACH SURFACES
UZI EZRA HAVOSHA
6122121660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A47L
‫שיטה ומתקן לצבוע משטחים רחוקים‬
‫שרון רבי‬
179840
APPARATUS FOR CRIB FOR SUDDEN
INFANT DEATH PREVENTION
MOSHE GABBAI
6122121660
B23Q
‫שיטה ומתקן להעמדת מכשירים‬
‫אלקטרונים בצורה אנכית‬
‫ עו"ד‬,‫עוזי חבושה‬
METHOD AND DEVICE TO MOUNT
ELECTRONIC DEVICES VERTICALLY
UZI EZRA HAVOSHA
6122121660
C07D
A47D
‫התקן למיטת תינוק למניעת מוות בעריסה‬
179841
‫ענת גבאי‬
F16K
130
ONE-WAY VALVE FOR ENTRANCE
OF AIR, FOR FEEDING BOTTLE OF
BABIES, THAT ARE BUILT
PERFORATES AND INNER
COVERAGE
HEN GILAD
6/26021661
‫ עבור‬,‫שסתום חד כיווני לכניסת אויר‬
‫ הבנוי מנקב וכיסוי‬,‫בקבוקים למזון תינוקות‬
‫פנימי‬
‫חן גלעד‬
179843
N-(2-BENZYL)-2PHENYLBUTANAMIDES AS
ANDROGEN RECEPTOR
MODULATORS
MERCK & CO., INC.
US
60/577698
07/06/2004
PCT/US/2005/019554
WO/2005/120477
6026021661
6126/21661
A DELIVERY SYSTEM
SCHERING OY
EP
04396049.1
PCT/FI/2005/000314
WO/2006/005794
/626021661
131
‫–פנילבוטנאמידים‬0–)‫–בנזיל‬N–( 2
‫כמודולאטורים של רצפטור הקושר‬
‫אנדרוגן‬
179845
EFFICIENT PAGING IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM FLARION
TECHNOLOGIES, INC.
US
10/865616
10/06/2004
PCT/US/2005/020257
WO/2005/125234
C07C
H04Q
‫ ) יעיל במערכת תקשורת‬PAGING( ‫זימון‬
‫אלחוטית‬
179846
A61K
‫מערכת למתן תרופות‬
13/07/2004
179847
A01N
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫תערובות סינרגיסטיות של חומרים‬
‫אנתרנילאמידיים מדבירי מזיקים חסרי‬
‫חוליות‬
SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/584601
01/07/2004
901999013
2910312004
US
PCT/US/2005/023813
WO/2006/007595
/226121661
179848
H04Q
INTRA-CELL COMMON REUSE FOR A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/578214
08/06/2004
701999440
2017012004
US
PCT/US/2005/019167
WO/2005/125262
6122121660
)CELL( ‫שימוש חוזר שיתופי תוך–תאי‬
‫ברשתות תקשורת אלחוטיות‬
179849
C07C
CATECHOLAMINE RECEPTOR
MODULATION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
2026021661
‫וויסות של קולטני קאטקולמין‬
‫ידע חברה למחקר ופיתוח בע"מ‬
179850
USE OF (E)-5-(4-CHLORBENZYLIDEN)2,2-DIMETHYL-1-(1H-1,2,4-TRIAZOL-1YLMETHYL) CYCLOPENTANOL FOR
COMBATING RUST ATTACKS ON SOYA
PLANTS
BASF AKTIENGESELLSCHAFT
DE
102004029338.4 17/06/2004
PCT/EP/2005/006499
WO/2005/122771
1/26021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179851
A01N
–0,0–)‫–כלורבנזילידין‬E)–5–(4(–‫שימוש ב‬
–1–‫– טריאזול‬H1–4,2,1(–1–‫דימיתיל‬
‫ילמתיל) ציקלופנטאנול למלחמה‬
‫בחילדון התוקף צמחי סויה‬
C07C
132
PREPARATION OF BETA-AMINO
ACIDS HAVING AFFINITY FOR THE
ALPHA-2-DELTA PROTEIN
WARNER-LAMBERT COMPANY LLC.
US
60/586512
09/07/2004
901994047
2410312004
US
PCT/IB/2005/001966
WO/2006/008612
1226021661
179852
THROMBIN COMPOSITIONS
ZymoGenetics INC.
US
60/581824
22/06/2004
PCT/US/2005/021743
WO/2006/009989
6126/21661
INHIBITORS OF IAP
GENENTECH, INC.
US
60/585501
PCT/US/2005/023564
WO/2006/014361
6122121660
179854
133
C12N
‫תכשירים המכילים תרומבין‬
C07K
IAP ‫מעכבי‬
02/07/2004
179855
WORK TRANSFER DEVICE AND
METHOD OF TRANSFERRING WORK
TOKYO SEIMITSU CO., LTD.
2005JP
05/12/2005
350740
1/26/21661
‫הכנת בטא–אמינו חומצות בעלות זיקה‬
‫–דלתא‬0–‫לחלבון אלפא‬
179856
G01R
‫התקן להעברת עבודה ושיטה להעברת‬
‫עבודה‬
A61K
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫ באמצעות אפנון של‬HIV ‫טיפול בזיהום‬
T ‫תאי‬
TREATMENT OF HIV INFECTION BY
T-CELL MODULATION
SCHERING AKTIENGESELLSCHAFT
US
60/605173
30/08/2004
PCT/EP/2005/008325
WO/2006/024354
6/26021661
179857
METHOD AND SYSTEM FOR
UTILIZING SMART ANTENNAS IN
ESTABLISHING A BACKHAUL
NETWORK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/578677
10/06/2004
901971120
7217012004
US
771074441
7117212004
US
PCT/US/2005/019976
WO/2005/125021
1/26021661
‫שיטה ומערכת לשימוש באנטנות חכמות‬
‫לייסוד רשת בקהול‬
179858
SYSTEM AND METHOD FOR CALL
ROUTING AND PAGING ACROSS
DIFFERENT TYPES OF NETWORKS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/583708
29/06/2004
701937771
3710412004
US
PCT/US/2005/022220
WO/2006/012191
1/26021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04B
179859
H04L
‫מערכת ושיטה להתקשרות ודפדוף‬
‫במערכות תקשורת מסוגים שונים‬
A61K
134
ORAL SUSTAINED RELEASE
FORMULATION OF TEDISAMIL WITH
GASTRIC RETENTION PROPERTIES
‫פורמולציה אוראלית בעלת שחרור מושהה‬
‫של תדיסאמיל עם תכונות של עצירה‬
‫קיבתית‬
SOLVAY PHARMACEUTICALS B.V.
US
60/582798
28/06/2004
0470294141
2410912004
EP
PCT/EP/2005/052984
WO/2006/000583
2626021661
179860
APPARATUS AND METHODS FOR
REGULATING DELIVERY OF
ELECTRICAL ENERGY
LUTRON ELECTRONICS CO., INC.
US
10/865083
10/06/2004
PCT/US/2005/020595
WO/2005/124986
1226021661
179861
COMPRESSION RESISTANT
NONWOVENS
THE PROCTER & GAMBLE
COMPANY
US
60/581543
21/06/2004
PCT/US/2005/021751
WO/2006/009995
1226021661
179862
ABSORBENT ARTICLE WITH
LOTION-CONTAINING TOPSHEET
THE PROCTER & GAMBLE
COMPANY
US
60/581483
21/06/2004
PCT/US/2005/021752
WO/2006/009996
1022222000
135
179865
H02M
‫מערכת ושיטות לוויסות שליחה של‬
‫אנרגיה חשמלית‬
A61F
‫אריגים בלתי ארוגים עמידים בדחיסה‬
A61F
‫פריט סופג בעל יריעה עליונה המכילה‬
‫תחליב‬
A61K
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PHARMACEUTICAL COMPOSITION
COMPRISING 5 - [[4-[3 - METHYL- 4OXO - 3,4 - DIHYDRO - 2 QUINAZOLINYL]METHOXY]
PHENYLMETHYL]THIADIAZOLIDINE-2,4DIONE IN THE FORM OF A TABLET S
POWDER OR A CAPSULE AND THE
PROCESS FOR ITS PREPARATION
NOVO NORDISK A/S
DK
PA19980158 01/12/1998
PCT/DK/1999/000663
WO/2000/032191
6126021661
–4–‫ מתיל‬:–[4–[[.–‫תכשיר רוקחות המכיל‬
–0– ‫– דיהידרו‬4,: ,‫אוקסו‬
–‫קינזוליניל]מתוקסי]פניל‬
‫– דיאון בצורה‬4,0–‫מתיל]תיאדיאזולידין‬
‫ אבקה או כמוסה ותהליך להכנתו‬,‫טבלית‬
179866
DEHUMIDIFIER SYSTEM DEVICE
AND METHOD
CONCEPT & DESIGN LTD.
US
60/575822
02/06/2004
PCT/IL/2005/000578
WO/2005/119139
6022121660
‫התקן ושיטה למערכת הסרת לחות‬
‫רעיון ותכן בע"מ‬
179869
179870
OPTIMIZED DOSING WITH ANTI-CD4
ANTIBODIES FOR TOLERANCE
INDUCTION IN PRIMATES
TOLERRx, INC.
US
60/582181
22/06/2004
PCT/US/2005/022500
WO/2006/002377
1126021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61F
‫מנפק קומפקטי לטמפונים‬
‫לינה קרקוז‬
A COMPACT TAMPON DISPENSER
VITALY KARAKUZ
1226021661
F25B
C07K
CD4 ‫מינון מיטבי של נוגדנים נוגדי‬
‫להשריית סבילות בפרימאטים‬
179871
C07C
136
PROCESS FOR THE PREPARATION OF
GABAPENTIN
ZAMBON GROUP S.P.A.
IT
MI2004A001271 24/06/2004
PCT/EP/2005/052906
WO/2006/000562
6026021661
179872
METHODS AND COMPOSITIONS FOR
TREATING OPHTHALMIC
CONDITIONS WITH RETINYL
DERIVATIVES
SIRION THERAPEUTICS, INC.
US
60/582293
23/06/2004
901929994
7917712004
US
901990904
7710312004
US
901912404
7410412004
US
PCT/US/2005/020080
WO/2006/007314
1626021661
137
C07C
‫שיטות ותכשירים לטיפול בתנאים עייניים‬
‫עם תולדות רטיניל‬
179873
METHODS OF TREATMENT OF
ENDOBRONCHIAL INFECTIONS
NOVARTIS VACCINES &
DIAGNOSTICS, INC.
US
60/580848
18/06/2004
PCT/US/2005/021952
WO/2006/002178
6/26021661
‫תהליך להכנה של גבאפנטין‬
A61K
‫שיטות לטיפול בזיהומים אנדוברונכיאלים‬
179875
B08B
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
METHODS FOR WET CLEANING
QUARTZ SURFACES OF
COMPONENTS FOR PLASMA
PROCESSING CHAMBERS
LAM RESEARCH CORPORATION
US
10/863360
09/06/2004
PCT/US/2005/019466
WO/2005/123282
6022121660
179876
METHOD AND MECHANISM FOR
ACTIVATING SEXUAL TOYS AND
STIMULATION DEVICES AND
MASSAGE DEVICES
YAIR EILAM
6022121660
‫יאיר עילם‬
179877
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H05B
‫גילוי והתרעה לחוסר מתח‬
‫שקד אבישי‬
179883
4,6-DISUBSTITUTED PYRIMIDINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
ALTANA PHARMA AG
EP
04103011.5 28/06/2004
0470234444
2310312004
EP
PCT/EP/2005/053019
WO/2006/000589
/626021661
A61H
‫שיטה ומנגנון להנעת מכשירי עיסוי‬
REMOTE POWER SUPPLAY
DETECTOR
AVISHAI SHAKED
1/26021661
‫שיטות לניקוי רטוב של משטחי קוורץ‬
‫המהווים רכיבים בתאים לעיבוד פלזמה‬
179884
C07D
‫תולדות פירימידין בעלות שני מתמירים‬
‫ ותכשירי רוקחות המכילים‬9 ,4 ‫בעמדות‬
‫אותן‬
H01M
138
FUEL CELLS, MICRO-FUEL CELLS
AND METHODS FOR THE
PRODUCTION THEREOF
GEORGIA TECH RESEARCH
CORPORATION
US
60/584104
30/06/2004
PCT/US/2005/023746
WO/2006/014403
6126021661
‫ תאי דלק מיקרו ושיטות להכנתם‬,‫תאי דלק‬
179885
C07F
‫תכשיר נגד גדולים ממאירים המכיל גורם‬
‫המחזק את ההשפעה נגד גדולים‬
‫ממאירים‬
AN ANTITUMOR PREPARATION
CONTAINING AN ANTITUMOR
EFFECT FORTIFIER
TAIHO PHARMACEUTICAL CO., LTD.
2004JP
09/06/2004
171520
PCT/JP/2005/010182
WO/2005/120480
6022121660
179887
‫מכונה לחיתוך צמיגים‬
‫בנימין זאב ברנס‬
TIRE CUTTING MACHING
ILAN ELBAZ
2126121661
179888
COMPOUNDS AS CCR5 ANTAGONISTS
SHANGHAI TARGET DRUG CO. LTD.
CN
200410025006.0 09/06/2004
PCT/CN/2005/000659
WO/2005/121123
6/26021661
PERIOSTEAL DISTRACTION
139
B29B
179890
C07D
CCR5–‫תרכובות אנטגוניסטיות ל‬
A61B
‫דיסטרקציה פריוסטילי‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
OPHIR FROMOVICH
US
10/861401
PCT/IL/2005/000603
WO/2005/120366
2626021661
‫בן ציון כרמון‬
07/06/2004
179891
‫נוגדן ספציפי לגידול‬
TUMOR SPECIFIC ANTIBODY
VIVENTIA BIOTECH INC.
US
60/578291
10/06/2004
PCT/CA/2005/000899
WO/2005/121341
6022121660
179892
FLOW REDIRECTOR FOR
COMPRESSOR INLET
GENERAL ELECTRIC COMPANY
US
11/297749
08/12/2005
6022121660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
F02C
‫מכוון זרימה עבור פתח כניסה של מדחס‬
179893
GEMSTONE CONSTRUCTIONS
PARTICULARLY USEFUL FOR
DIAMONDS
JACKOB TSROR
IL
179471
21/11/2006
112612166/
C12N
179895
A44C
‫בניות אבני חן–שימושי במיוחד ליהלומים‬
‫יעקב צרור‬
B26D
140
METHOD FOR MANUFACTURING
SHEETS BASED ON HYDRAULIC
BINDER, PRODUCTION LINE FOR
PRODUCING SUCH SHEETS AND
APPARATUS FOR MAKING AN
IMPRESSION
LAFARGE PLATRES
EP
02290462.7 26/02/2002
0229773244
0910412002
EP
PCT/FR/2003/000606
WO/2003/072326
6226021661
179896
OPIOIDS FOR THE TREATMENT OF
THE RESTLESS LEG SYNDROME
EURO-CELTIQUE S.A.
EP
04013469.4 08/06/2004
PCT/EP/2005/005888
WO/2005/120506
6/26021661
179897
DYNAMIC RESTRICTIVE REUSE
SCHEDULER
QUALCOMM INCORPORATED
US
60/578258
09/06/2004
PCT/US/2005/020179
WO/2005/125263
6/26021661
141
179898
‫שיטה לייצור וקו ייצור ליריעות על בסיס‬
‫חומר מצמיד הידראולי והתקן להטבעה‬
A61K
‫אופיאואידים לטיפול בתסמונת הרגל‬
‫העצבנית‬
H04Q
‫מנהל לוח זמנים דינמי מגביל לשימוש‬
‫חוזר‬
H04Q
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
SOFT HANDOFF FOR REVERSE LINK
IN A WIRELESS COMMUNICATION
SYSTEM WITH FREQUENCY REUSE
) HANDOFF SOFT ( ‫העברת חיבור‬
‫בחיבור חוזר במערכת תקשורת אלחוטית‬
‫בשיטה מחזור תדרים‬
QUALCOMM INCORPORATED
US
60/578213
08/06/2004
701999744
2017012004
US
PCT/US/2005/020180
WO/2005/122628
2026/21661
179899
CATIONIC POLYMERS CONTAINING
2-HYDROXYETHYLMETHACRYLATE AS PROMOTERS
FOR ASA SIZING
LANXESS CORPORATION
US
60/580556
17/06/2004
PCT/US/2005/013334
WO/2006/007001
1126021661
179900
NOVEL USES OF PORPHYRIN
COMPOUNDS
DESTINY PHARMA LIMITED
GB
0414025.7
23/06/2004
PCT/GB/2005/002457
WO/2006/000765
6026021661
179901
PROCESS FOR PROTEIN ISOLATION
AVT PLASMA LIMITED
AU
2004903045 07/06/2004
2004909724
2217012004
AU
PCT/AU/2005/000796
WO/2005/121165
/226121661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179902
C08F
–0 ‫פולימרים קטיוניים המכילים‬
‫הידרוקסיאתיל מתאקרילאט כמקדמי‬
ASA ‫טיפולי שטח‬
C07D
‫שימושים חדישים בתרכובות פופירין‬
C07K
‫שיטה לבידוד חלבון‬
F42C
142
PROJECTILE, IN PARTICULAR AN
ANTI-INFRASTRUCTURE
PENETRATING BOMB AND METHOD
FOR PENETRATION OF SAID
PROJECTILE THROUGH A WALL
TDA ARMEMENTS S.A.S.
FR
0406184
08/06/2004
PCT/EP/2005/052483
WO/2005/124270
2/26021661
179903
1- (INDOLE-6-CARBONYL-DPHENYLGLYCINYL)-4-(1METHYLPIPERIDIN-4-YL)
PIPERAZINE-D-TARTRATE
ELI LILLY AND COMPANY
US
60/583599
30/06/2004
PCT/US/2005/020490
WO/2006/011955
2/26021661
‫ במיוחד פצצה חודרת נגד תשתיות‬,‫קליע‬
‫ושיטה לחדירת קליע האמור לעיל דרך קיר‬
–)‫ – פנילגליציניל‬D–‫–קרבוניל‬9–‫–(אינדול‬1
–D ‫–יל) פיפרזין‬4–‫– מתילפיפרידין‬1(–4
‫טרטרט‬
179904
COMPOUNDS AND METHODS FOR
INHIBITING THE INTERACTION OF
BCL PROTEINS WITH BINDING
PARTNERS
INFINITY PHARMACEUTICALS, INC.
US
60/580616
17/06/2004
901949307
0110312004
US
PCT/US/2005/021524
WO/2006/009869
C07D
C07D
‫תרכובות ושיטות לעיכוב של אינטראקציה‬
‫ והפרטנרים הקושרים‬BCL ‫בין חלבוני‬
\
1226021661
143
179905
C07D
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫פיפרזינדיונים כאנטגוניסטים של קולטן‬
‫אוקסיטוצין‬
PIPERAZINEDIONES AS OXYTOCIN
RECEPTOR ANTAGONISTS
GLAXO GROUP LIMITED
GB
0414093.5
23/06/2004
PCT/EP/2005/006760
WO/2006/000399
6/26/21661
179906
NOVEL HYDANTOIN DERIVATIVES
FOR THE TREATMENT OF
OBSTRUCTIVE AIRWAY DISEASES
ASTRAZENECA AB
SE
0401762-0
05/07/2004
PCT/SE/2005/001092
WO/2006/004532
6/26/21661
COMPOUNDS
ASTRAZENECA AB
SE
0401763-8
PCT/SE/2005/001093
WO/2006/004533
6/22121660
‫נגזרות חדשות של הידנטואין לטיפול‬
‫במחלה חסימתית של דרכי נשימה‬
179907
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫תרכובות‬
05/07/2004
179908
FLUSH TANK DRAIN VALVE
ASSEMBLY
OLIVEIRA & IRMAO, S.A.
IT
MI2005A002353 09/12/2005
6/22121660
C07D
179909
F16K
‫שסתום הרכבה למיכל ניקוז‬
F16K
144
FLUSH TANK DRAIN VALVE
ASSEMBLY WITH A SYSTEM FOR
REGULATING THE AMOUNT OF WATER
DRAINED
OLIVEIRA & IRMAO, S.A.
IT
MI2005A002354 09/12/2005
1/26021661
‫שסתום הרכבה למיכל ניקוז עם‬
‫מערכת לויסות כמות המים המנוקזים‬
179910
3AMINOCYCLOPENTANECARBOXAMIDES
AS MODULATORS OF CHEMOKINE
RECEPTORS
INCYTE CORPORATION
US
60/583482
28/06/2004
901924314
0717712004
US
PCT/US/2005/022793
WO/2006/004684
1626021661
‫–אמינוציקלופנטאנקרבוקסאמידים‬:
‫כמאפננים של קולטני כמוקין‬
179911
METHODS RELATED TO A SINGLE
NUCLEOTIDE POLYMORPHISM OF
THE G PROTEIN COUPLED
RECEPTOR, GPR40
PFIZER PRODUCTS INC.
US
60/584686
30/06/2004
771049020
2410712004
US
PCT/IB/2005/001962
WO/2006/006062
1226021661
1/26021661
145
C12Q
‫שיטות הקשורות לפולימורפיזם של‬
‫נוקלאוטיד יחיד של קולטן נצמד לחלבון‬
GPR40
179912
SUBSTITUTED DIKETOPIPERAZINES
AS OXYTOCIN ANTAGONISTS
GLAXO GROUP LIMITED
GB
0414092.7
23/06/2004
PCT/EP/2005/006761
WO/2006/000400
C07D
C07D
‫דיקטופיפרזינים מותמרים כאנטגוניסטים‬
‫של אוקסיטוצין‬
179913
C07C
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PROCESS FOR PREPARING
SYNTHETIC INTERMEDIATES
USEFUL IN PREPARING PYRAZOLE
COMPOUNDS
PFIZER INC.
GB
0414890.4
02/07/2004
PCT/IB/2005/002038
WO/2006/003501
1626021661
‫תהליך לייצור חומרי ביניים סינתטיים‬
‫שימושיים בייצור של תרכובות פירזול‬
179914
‫נגזרות של פירימידין‬
PYRIMIDINE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
04102999.2 28/06/2004
PCT/EP/2005/006649
WO/2006/000371
6/22121660
179915
PROCESS FOR PRESERVING FRESH
PRODUCE AND COATING
COMPOSITION THEREFOR
BASF CORPORATION
A45F
‫מכשיר כריכה למסמכים או למוצרים‬
‫דומים‬
BINDING TOOL FOR DOCUMENTS
OR THE LIKE
KING JIM CO., LTD.
2005JP
09/12/2005
356797
6126/2166/
C07D
179916
A23B
‫תהליך לשימור תוצרת טריה ותכשיר ציפוי‬
‫לשם כך‬
PCT/EP/2004/007187
WO/2006/002671
1126/21661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179917
C12Q
146
METHODS AND COMPOSITIONS FOR
MODULATING HEPATOCYTE
GROWTH FACTOR ACTIVATION
GENENTECH, INC.
US
60/591339
26/07/2004
PCT/US/2005/026446
WO/2006/014928
1026021661
179918
LOGICAL AND PHYSICAL MESH
NETWORK SEPARATION
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/586504
09/07/2004
PCT/US/2005/023210
WO/2006/017028
6026021661
179919
NEURAL STEM CELLS,
COMPOSITIONS CONTAINING THE
SAME AND METHODS FOR
PROMOTING THE DIVISION
THEREOF
THE UNIVERSITY COURT OF THE
UNIVERSITY OF EDINBURGH
GB
0412887.2
09/06/2004
040304440
7410212004
GB
040447044
7110312004
GB
PCT/GB/2005/002289
WO/2005/121318
1/26121661
147
179921
‫שיטות ותכשירים לאפנון שפעול גורם‬
‫גידול הפטוציטי‬
H04J
‫הפרדה לוגית ופיזית של רשת תקשורת‬
C12N
‫ תכשירים המכילים‬,‫תאי גבעול עצביים‬
‫אותם ושיטות לעודד את חלוקתם‬
C08L
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫שרפים פוליאתילנים המתאימים לייצור‬
‫צינורות‬
POLYETHYLENE PIPE FITTING
RESINS
INEOS MANUFACTURING BELGIUM
NV
EP
04253420.6 09/06/2004
PCT/EP/2005/005823
WO/2005/121238
6/26021661
179922
METHOD FOR STERILIZATION OF
BIOLOGICAL PREPARATIONS
I.M.T. INTERFACE MULTIGRAD
TECHNOLOGY LTD
US
60/577210
07/06/2004
PCT/IL/2005/000600
WO/2005/120591
6/26/21661
‫שיטה לעיקור תכשירים ביולוגיים‬
‫ אינטרפייס מולטיגרד טכנולוגיה‬.‫טי‬.‫אם‬.‫איי‬
‫בע"מ‬
179923
CRYSTALLIZED POLYETHYLENE
TEREPHTHALATE, WHICH
CONTAINS SILICONE, AND PROCESS
FOR ITS PREPARATION
ZEEV OFER
CH
01143/04
08/07/2004
PCT/IB/2005/001972
WO/2006/006064
2/26/21661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61L
179924
C08G
‫פוליאתילן טרפתלאט גבישי המכיל‬
‫סיליקון ותהליך להכנתו‬
C07D
148
2 - (1H-INDOLYLSULFANYL) - ARYL
AMINE DERIVATIVES FOR USE IN
THE TREATMENT OF AFFECTIVE
DISORDERS, PAIN ADHD AND STRESS
URINARY INCONTINENCE
H. LUNDBECK A/S
DK
PA200401121 16/07/2004
901444444
7910112004
US
901997139
7110912004
US
DK
PA200500893 7110912004
PCT/DK/2005/000491
WO/2006/007843
1/26021661
179925
SYSTEM AND METHOD FOR
FACILITATING SEARCH OVER A
DATA NETWORK
AMIR LAVI
US
60/582080
24/06/2004
PCT/IL/2005/000671
WO/2006/001008
1/26221661
179926
STEM CELL MATURATION FOR ALL
TISSUE LINES
PRIMEGEN BIOTECH LLC
US
10/864788
08/06/2004
PCT/US/2005/002487
WO/2005/123901
2026121661
149
179927
– )‫ – אינדולילסולפאניל‬H1( – 0 ‫נגזרות‬
‫אריל אמין לשימוש בטיפול בהפרעות‬
‫ ובריחת שתן‬ADHD ,‫ כאב‬,‫רגשיות‬
‫כתוצאה מעקה‬
G06F
‫מערכת ושיטה ליעול החיפוש ברשת‬
‫נתונים‬
‫אמיר לביא‬
C12N
‫הבשלת תאי גזע לכ שורות רקמות‬
C12N
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
THERAPEUTIC REPROGRAMMING,
HYBRID STEM CELLS AND
MATURATION
PRIMEGEN BIOTECH LLC
US
10/864788
08/06/2004
901444749
7410112004
US
PCT/US/2005/005052
WO/2005/123123
6/22121660
179928
SYSTEM FOR DRIVING ACCESSORY
MACHINES OF A DOUBLE-BODIED
TURBINE ENGINE
HISPANO-SUIZA
FR
0553816
09/12/2005
1/26021661
179929
METHOD FOR PRODUCING (Z) - 1 PHENYL - 1 DIETHYLAMINOCARBONYL - 2 AMINOMETHYL CYCLOPROPANE
HYDROCHLORIDE
SUMITOMO CHEMICAL COMPANY,
LIMITED.
2004JP
24/06/2004
186982
PCT/JP/2005/012011
WO/2006/001493
2626021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179931
‫ תאי גזע היברידים‬,‫תכנות מחדש טיפולי‬
‫והבשלה‬
F16H
‫מערכת הנעה לאביזרי מכונות של מנועי‬
‫טורבינה דו–גופיים‬
C07C
– Z) – 1( ‫שיטה עבור ייצור‬
‫ – אמינו מתי'ל‬0 – ‫דיאת'ילאמינוקרבוניל‬
‫ציקלופרופאן הידרוכלוריד‬
A61K
150
COMPOSITIONS AND METHODS FOR
TREATMENT OF CARDIOVASCULAR
DISEASE
VECTUS BIOSYSTEMS LIMITED
AU
2004903188 11/06/2004
PCT/AU/2005/000835
WO/2005/120545
2622121660
‫תכשירים ושיטות לטיפול במחלת כלי הדם‬
‫של הלב‬
179932
EDIBLE RED HOT CHILI PEPPER
SPREAD
MOSHE ABARO
1/26021661
‫ממרח רסק פלפל חריף אדום למאכל‬
‫משה אברו‬
179933
PHARMACEUTICAL COMPOSITIONS
CONTAINING PROTEOSOME BASED
COMPOSITIONS
THE BRIGHAM AND WOMEN'S
HOSPITAL, INC.
US
60/582999
25/06/2004
PCT/US/2005/022922
WO/2005/004749
6126/2166/
A23L
A61K
‫תכשירי רוקחות המכילים תכשירים‬
‫המבוססים על פרוטיאזום‬
179934
A61B
4‫שיטה פוסטורוגרפית המשתמשת ב‬
‫משטחים הניידים חופשית בשלושה‬
‫ממדים‬
‫טטראקס בע"מ‬
POSTURO-GRAPHIC METHOD RSING
FOUR THREE DIMENSIONALLY
MOVABLE PLA TFORMS
TETRAX LTD.
PCT/IL/2004/000596
WO/2006/003640
2622121660
ROLLER BEARING ARRANGEMENT
151
179935
F16C
‫סידור של תומך מכבש‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
IMO MOMENTENLAGER GMBH
DE
102005060499.4 15/12/2005
6/26021661
179936
EXPOSURE APPARATUS, EXPOSURE
METHOD, AND DEVICE PRODUCING
METHOD
NIKON CORPORATION
2004JP
10/06/2004
172568
PCT/JP/2005/010484
WO/2005/122220
6/26021661
179937
SUBSTRATE HOLDING DEVICE,
EXPOSURE APPARATUS HAVING
SAME, EXPOSURE METHOD,
METHOD FOR PRODUCING DEVICE,
AND LIQUID REPELLENT PLATE
NIKON CORPORATION
2004JP
09/06/2004
171116
2004-204004 7210112004
JP
PCT/JP/2005/010458
WO/2005/122219
6/26021661
179938
SMART IDENTIFICATION
DOCUMENT
ON TRACK INNOVATIONS LTD.
US
10/864353
10/06/2004
771070342
7417212004
US
PCT/IL/2005/000606
WO/2005/120726
2622121660
METHOD OF MAKING AN
ELECTRONIC DEVICE COOLING
SYSTEM
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
179939
H01L
‫ שיטת חשיפה ושיטה‬,‫מתקן חשיפה‬
‫לייצור מתקן‬
H01L
‫ מתקן חשיפה‬,‫מתקן להחזקת תשתית‬
‫ ולוח‬,‫ שיטה או מתקן יצור‬,‫שכולל אותו‬
‫לנוזל איטום‬
B05D
‫מסמך זיהוי חכם‬
‫און טרק אינובישנס בע"מ‬
H05K
‫שיטה לייצור מערכת קירור להתקן‬
‫אלקטרוני‬
152
GENERAL ELECTRIC COMPANY
US
11/297869
09/12/2005
2622121660
179940
METHOD OF MAKING AN
ELECTRONIC DEVICE COOLING
SYSTEM
GENERAL ELECTRIC COMPANY
US
11/297868
09/12/2005
6226/21661
179941
POLISHING COMPOSITION FOR
NOBLE METALS
CABOT MICROELECTRONICS
CORPORATION
US
10/901420
28/07/2004
PCT/US/2005/023654
WO/2006/023105
2/26021661
179942
ELECTROCHEMICAL METHODS,
DEVICES, AND STRUCTURES
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
60/578855
14/06/2004
901927047
2417012004
US
PCT/US/2005/020554
WO/2005/124918
6/26021661
179943
INK JET RECORDING PAPER
SPECIALTY MINERALS (MICHIGAN)
INC.
US
10/867535
14/06/2004
153
F25B
‫שיטה לייצור מערכת קירור להתקן‬
‫אלקטרוני‬
C09G
‫הרכב ליטוש עבור מתכות אצילות‬
H01M
‫ התקנים ומבנים אלקטרוכימיים‬,‫שיטות‬
C01F
‫נייר הדפסה להזרקת דיו‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PCT/US/2005/020201
WO/2005/123593
2622121660
179944
B43K
‫מטוש לתמיסות מימיות‬
‫נחום ולנשטיין‬
AQUEOUS SOLUTION APPLICATOR
NAHUM WALLENSTIEN
2622121660
179945
A61N
APPARATUS FOR TREATMENT OF
RHINITIS BY BIOSTIMULATIVE
ILLUMINATION
JOSEPH FELDMAN
‫מכשיר לטיפול בדלקת אף באמצעות‬
‫תאורה ביו סטימולטיבית‬
‫עמנואל מנדס‬
1026/21661
179946
‫שיטה לגילוי מטרות‬
METHOD FOR DETECTING TARGETS
ATLAS ELEKTRONIK GMBH
DE
102004029368.6 17/06/2004
PCT/EP/2005/004440
WO/2005/125064
6026021661
179947
F02G
‫מתנד זורמי‬
FLUIDIC OSCILLATOR
THOMAS CHARLES BRANNAM
SMITH
GB
0412868.2
10/06/2004
040049444
7110712004
GB
PCT/GB/2005/002278
WO/2005/121539
2126021661
179948
ELECTROACOUSTIC TRANSDUCER
ARRANGEMENT FOR UNDERWATER
ANTENNAS
ATLAS ELEKTRONIK GMBH
DE
102004038032.5 05/08/2004
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04B
G10K
‫מערך מתמר אלקטרואקוסטי לאנטנות‬
‫תת–ימיות‬
154
PCT/EP/2005/006383
WO/2006/015646
6026021661
179949
MIXTURE FOR APPLYING A COATING
LITIKOL S.R.L.
IT
MO2004A000155 18/06/2004
PCT/IB/2005/001650
WO/2005/123622
2126021661
179950
ELECTROACOUSTIC UNDERWATER
ANTENNA
ATLAS ELEKTRONIK GMBH
DE
102004037987.4 05/08/2004
PCT/EP/2005/006382
WO/2006/015645
6126/21661
179951
METHOD FOR PRODUCTION OF AN
ANTENNA SECTION FOR A SUBMARINE
ANTENNA
ATLAS ELEKTRONIK GMBH
DE
102004038033.3 05/08/2004
PCT/EP/2005/007165
WO/2006/015665
2626121661
179952
AUTOMATED DISPENSING SYSTEM
AND ASSOCIATED METHOD OF USE
MALLINCKRODT INC.
US
10/867918
15/06/2004
PCT/US/2005/016189
WO/2006/001913
155
C04B
‫עירוב להנחת ציפוי‬
B63G
‫אנטנה אלקטרואקוסטית תת–ימית‬
H01Q
‫שיטת ייצור חלק אנטנה לאנטנה‬
‫לצוללת‬
B65B
‫מערכת לחלוקה אוטומטית ושיטה‬
‫הקשורה לשימוש בה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
179953
METHODS OF CONTROLLING THE
INSTABILITY IN FLUID FILM
BEARINGS
EL-SHAFEI, ALY
US
60/579866
15/06/2004
771741192
0410912004
US
PCT/IB/2005/002732
WO/2005/122684
212602166/
179954
METHOD AND APPARATUS FOR
BOOTING A COMPUTER SYSTEM
T1 TECHNOLOGIES LIMITED
H04H
‫שיטות שליטה על חוסר יציבות של‬
‫מיסבים בעלי שכבות נוזליות‬
G06F
‫שיטה והתקן לאיתחול מערכת מחשב‬
PCT/NZ/2004/000122
WO/2005/124540
2/26021661
179955
SYNTHETIC NANO-SIZED
CRYSTALLINE CALCIUM
PHOSPHATE AND METHOD OF
PRODUCTION
PROMIMIC AB
SE
0401524-4
15/06/2004
PCT/SE/2005/000896
WO/2005/123579
6026021661
179956
ANTIBODIES FOR SELECTIVE
APOPTOSIS OF CELLS
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
60/577920
09/06/2004
PCT/IL/2005/000616
WO/2005/120166
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C01B
‫סידן פוספט גבישי סינתטי בגודל ננו‬
‫ושיטת ייצורו‬
A61K
‫נוגדנים להשריית מוות תאי מתוכנת‬
‫באופן סלקטיבי‬
‫מוסד הטכניון למחקר ופיתוח בע"מ‬
156
6026021661
179957
METHOD FOR FORMING OR CURING
POLYMER COMPOSITES
INDUSTRIAL COMPOSITES
ENGINEERING PTY LTD
AU
2004903096 09/06/2004
PCT/AU/2005/000829
WO/2005/120794
6026021661
179958
PROTECTED STENT DELIVERY
SYSTEM AND PACKAGING
DESIGN & PERFORMANCE-CYPRUS
LIMITED
US
10/865379
10/06/2004
PCT/IL/2005/000615
WO/2005/120395
1/26021661
179959
ALLOCATION OF RADIO RESOURCE
IN ORTHOGONAL FREQUENCY
DIVISON MULTIPLEXING SYSTEM
LG ELECTRONICS INC.
10-2004KR
25/06/2004
0048436
70-20040410112004
KR
0043739
157
B29C
‫שיטה להכנת תרכובות פולימריות‬
A61F
‫מערכת להשתלת סטנט ואריזה לסטנט‬
‫מוגנות‬
H04B
OFDM ‫הקצאת משאבי רדיו במערכת‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
70-20040774041
PCT/KR/2005/001977
WO/2006/001658
KR
3717212004
2222121660
179961
‫מחזיק גלילי נייר טואלט‬
‫יובל סגפי‬
TOILET PAPER ROLL HOLDER
YUVAL SEGFI
2/26021661
179962
179963
METHODS FOR TREATING OR
PREVENTING ERECTILE
DYSFUNCTION OR URINARY
INCONTINENCE
INOTEK PHARMACEUTICALS
CORPORATION
US
60/580040
16/06/2004
PCT/US/2005/021064
WO/2006/009718
1126021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07D
‫שיטות לטיפול או מניעה בהפרעה בזיקפה‬
‫או חוסר ריסון במתן שתן‬
179964
COLD ROLL FORMING APPARATUS
SMORGON STEEL LITESTEEL
PRODUCT PTY LTD.
AU
2004903390 23/06/2004
PCT/AU/2005/000898
WO/2006/000019
A61K
‫תכשירים ושיטות לשימוש בדימרים של‬
‫דיגאלטים‬
COMPOSITIONS AND METHODS OF
USE OF DIMER DIGALLATES
MARS, INCORPORATED
US
60/579303
14/06/2004
PCT/US/2005/020961
WO/2005/123096
2126021661
A47K
B21D
‫מערכת ליצירת גלילה בקור‬
158
1126021661
179965
IMPROVEMENTS IN WELDING
HOLLOW FLANGE MEMBERS
SMORGON STEEL LITESTEEL
PRODUCT PTY LTD.
AU
2004903388 23/06/2004
PCT/AU/2005/000897
WO/2006/000018
1/26021661
2626021661
‫שיפורים בריתוך איברים גליליים חלולים‬
179966
STEERABLE, FOLLOW THE LEADER
DEVICE
CARNEGIE MELLON UNIVERSITY
US
60/583094
25/06/2004
PCT/US/2005/022442
WO/2006/083306
179967
159
A61K
‫קפסולה עמידה כנגד לעיסה‬
179968
VACUUM ASSISTED CLOSURE
SYSTEM WITH PROVISION FOR
INTRODUCTION OF AGENT
KCI LICENSING, INC.
US
60/127595
02/04/1999
PCT/US/2000/008821
WO/2000/059424
A47C
‫התקן " עקוב אחר המנהיג" הניתן להיגוי‬
CAPSULE STABLE AGAINST
MASTICATION
ONO PHARMACEUTICAL CO., LTD.
2004JP
11/06/2004
174576
2004-722427 2010412004
JP
PCT/JP/2005/011092
WO/2005/120490
/226/21666
B21D
A61F
‫מערכת סגירה המסתייעת בוואקום ובעלת‬
‫אמצעי להחדרת חומר‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/22221666
179969
APPARATUS AND METHOD FOR
DISPENSING SMALL QUANTITIES OF
PARTICLES
POWDERJECT RESEARCH LIMITED
GB
9926335.2
05/11/1999
PCT/GB/2000/004220
WO/2001/033176
MOBILE DEVICE SUITABLE FOR
SUPPORTING APPARATUS FOR SITE
IMAGING WHILE IN TRANSIT
MENTORWAVE TECHNOLOGIES
LTD.
IL
162519
14/06/2004
794104
7917012004
IL
PCT/IL/2005/000610
WO/2005/121859
1/26021661
‫התקן ושיטה לחלוקה של כמויות קטנות‬
‫של חלקיקים‬
‫מכשיר נייד לתמיכה בהתקן להדמיה תוך‬
‫כדי תנועה‬
179971
AN INHALATION DEVICE AND A
METHOD FOR ASSEMBLING SAID
INHALATION DEVICE
ASTRAZENECA AB
SE
0401773-7
02/07/2004
PCT/SE/2005/000994
WO/2006/004496
2/26021661
179972
METHODS FOR IDENTIFYING STEM
CELLS BASED ON NUCLEAR
MORPHOTYPES
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
60/580575
17/06/2004
PCT/US/2005/021504
WO/2006/009860
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G01G
‫מנטורוב טכנולוג'יס בע"מ‬
A61M
‫אינהלטור ושיטה להרכבתו‬
G01N
‫שיטה לזיהוי תאי גזע המבוססת על‬
‫מורפוטיפים גרעיניים‬
160
2126021661
179973
‫מולטימרים של אוליגונוקלאוטיד המגרים‬
‫את מערכת החיסונית‬
IMMUNOSTIMULATORY
OLIGONUCLEOTIDE MULTIMERS
IDERA PHARMACEUTICALS, INC.
US
60/579985
15/06/2004
901499392
0910412004
US
PCT/US/2005/020911
WO/2006/002038
2126021661
179974
179975
4TRIFLUOROMETHOXYPHENOXYBENZOL4' - SULFONIC ACIDS, METHOD FOR THE
PRODUCTION AND USE THEREOF IN
MEDICAMENTS
SANOFI-AVENTIS DEUTSCHLAND GMBH
DE
102004031620.1
30/06/2004
PCT/EP/2005/006416
WO/2006/002764
161
C07D
‫טטראהידרואיזוקווינולינים מותמרים‬
,MMP ‫שנעשה בהם שימוש כמעכבי‬
‫שיטה לייצורם ושימוש שלהם בצורת‬
‫תרופות‬
SUBSTITUTED TETRAHYDROISO
QUINOLINES USED IN THE FORM OF
MMP INHIBITORS, METHOD FOR THE
PRODUCTION AND USE THEREOF IN
THE FORM OF DRUGS
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102004031850.6 30/06/2004
PCT/EP/2005/006415
WO/2006/002763
2126021661
A61K
C07D
– 4 ‫חומצה סולפונית‬
–‫טריפלואורומתוקסיפנוקסיבנזול‬
‫ שיטה להכנתה ושימוש שלה‬,'4
‫בתרופות‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6126021661
179976
MULTI-SHIP COHERENT
GEOLOCATION SYSTEM
BAE SYSTEMS INFORMATION AND
ELECTRONIC SYSTEMS
INTEGRATION INC.
US
10/867056
14/06/2004
PCT/US/2005/019423
WO/2005/124385
2222121660
‫מערכת איכון עיקבית רבת תחנות‬
179977
179978
MULTIMARKING FIBER-TYPE
FLUORESCENCE MICROSCOPIC
IMAGING METHOD AND SYSTEM
MAUNA KEA TECHNOLOGIES
FR
0406396
14/06/2004
PCT/FR/2005/001424
WO/2006/000704
6026021661
ASYMMETRICALLY SUBSTITUTED
BIARYLDIPHOSPHINE LIGANDS 1
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G01N
‫מערכת ושיטת הדמייה מסוג סיב‬
‫מקרוסקופי פלורוסנטי רב–סימוני‬
179979
ASYMMETRICALLY SUBSTITUTED
BIARYLDIPHOSPHINE LIGANDS 11
LONZA AG
EP
04014908.0 25/06/2004
PCT/EP/2005/006065
WO/2006/002731
6026021661
A61J
‫מוצץ משופר‬
IMPROVED PACIFIER
DR. MAROM RONELLA
6026021661
G01S
C07F
‫ ביארילדיפוספיניים המותמרים‬11 ‫ליגנדים‬
‫בצורה לא סימטרית‬
179980
C07F
‫ ביארילדיפוספיניים המותמרים‬1 ‫ליגנדים‬
‫בצורה לא סימטרית‬
162
LONZA AG
EP
04014909.8
PCT/EP/2005/006064
WO/2006/002730
25/06/2004
6026021661
179981
ASYMMETRICALLY SUBSTITUTED
BIARYLDIPHOSPHINE LIGANDS 111
LONZA AG
EP
04014911.4
PCT/EP/2005/006063
WO/2006/002729
‫ ביארילדיפוספיניים המותמרים‬111 ‫ליגנדים‬
‫בצורה לא סימטרית‬
25/06/2004
2026/21661
179982
HIGH PERFORMANCE STRENGTH
RESINS IN PAPERMAKING
INDUSTRIES
LANXESS CORPORATION
US
60/586394
08/07/2004
PCT/US/2005/013333
WO/2006/016906
1/26021661
2/26021661
SIGNAL ACQUISITION IN A
WIRELESS COMMUNICATION
SYSTEM
D21H
‫סיבים חזקים לביצועים משופרים‬
‫לתעשיית הנייר‬
179983
G02B
‫מאפנן אינטרפרומטרי עם טרנזיסטורי‬
‫פילם דקים‬
INTERFEROMETRIC MODULATORS
WITH THIN FILM TRANSISTORS
IDC, LLC
US
10/883902
02/07/2004
PCT/US/2005/022592
WO/2006/014247
163
C07F
179984
H04L
‫תפיסת אות במערכת תקשורת אלחוטית‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
QUALCOMM INCORPORATED
US
60/580809
18/06/2004
771022479
2217212004
US
PCT/US/2005/021051
WO/2006/009711
2/26021661
179985
BURST MODE RECEIVER BASED ON
CHARGE PUMP PLL WITH IDLE-TIME
LOOP STABILIZER
MATISSE NETWORKS, INC.
US
10/868894
17/06/2004
PCT/US/2005/021029
WO/2006/009707
6/26021661
‫מקלט שידור מתפרץ מבוסס על משאבת‬
‫ בעלת מייצב לופ בזמן סרק‬PLL ‫מטען‬
179986
LEADER-FOLLOWER POWER
CONTROL
VIASAT, INC.
US
10/903126
30/07/2004
PCT/US/2005/000354
WO/2006/022987
2222121660
A PORTABLE AND NON-INVASIVE
MEANS FOR MEASURING THE
STRESS CONDITION OF A SUBJECT
PATIENT
KLETSKIN SOLOMON
2222121660
TOOTHPASTE DISPENSER
OVAD ASSIF
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H03D
H04B
‫בקרת כוח של מוביל–עוקב‬
179987
A61B
‫אמצעי נייד ולא פולשני למדידת מצב עקה‬
‫בפציינט ושיטה למדידה‬
‫קלסקין סולומון‬
179988
A47K
‫דיספנסר למשחת שיניים‬
‫עובד אסיף‬
164
1/22221662
179989
SYSTEM AND METHOD FOR ADAPTIVE
BROADCAST RADAR SYSTEM
LOCKHEED MARTIN CORPORATION
US
60/253095
28/11/2000
WO
PCT/US2001/44267 2417712007
PCT/US/2001/044267
WO/2002/097467
2/26021661
179990
B21D
17/06/2004
2026021661
179991
2026021661
IMMEDIATE RELEASE
FORMULATIONS OF MEMANTINE
ORAL DOSAGE FORMS
A61K
‫פורמולציה בעלת שחרור מוהשה של‬
‫ממנטין‬
MODIFIED RELEASE FORMULATION
OF MEMANTINE
FOREST LABORATORIES, INC.
US
60/581242
17/06/2004
PCT/US/2005/021260
WO/2006/009769
165
‫מערכת ושיטה למערכת רדאר שידור‬
‫מסתגל‬
‫שיטה לייצור פרופילים מורחבים‬
‫ממתכת ופרופיל המיוצר על ידי‬
‫השיטה‬
METHOD FOR PRODUCING EXPANDED
METAL PROFILES AND PROFILE
PRODUCED BY THE METHOD
DALLAN S.p.A.
IT
VE2004A000027
PCT/EP/2005/006340
WO/2005/123298
G01S
179992
C07C
‫פורמולציות למתן דרך הפה לשחרור מידי‬
‫של ממנטין‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
MERZ PHARMA GMBH & CO. KGAA
US
60/581244
17/06/2004
PCT/US/2005/021284
WO/2006/096194
2026021661
179993
PROCESSES FOR PREPARING
GONADOTROPIN RELEASING
HORMONE RECEPTOR
ANTAGONISTS
WYETH
US
60/580665
17/06/2004
PCT/US/2005/021127
WO/2006/009736
2222121660
‫תהליכים להכנת אנטגוניסטים לרצפטורי‬
‫גונדוטרופין משחרר הורמונים‬
179994
IMPROVED PROCESS FOR
PREPARING IMIQUIMOD
CHEMAGIS LTD.
US
11/298711
12/12/2005
2122121660
179996
NATURAL PRESTRESS OF
CONCRETE ELEMENTS CAST IN
STAGES
SCARLAT ADRIAN
1/26021661
C07D
C07D
‫תהליך משופר ליצור אימיקווימוד‬
‫כימאגיס בע"מ‬
E04B
‫דריכה טבעית של אלמנטי בטון יצוקים‬
‫בשלבים‬
‫סקרלט אדריאן‬
179997
PROCESS FOR PURIFICATION OF IL18BP
ARES TRADING S.A.
EP
04103047.9 29/06/2004
901441299
7210112004
US
PCT/EP/2005/053010
WO/2006/003134
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07K
BP18 – IL ‫תהליך לניקוי של‬
166
1/26021661
179998
CHIMERIC PROTEINS AND USES
THEREOF
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/582827
28/06/2004
PCT/IL/2005/000689
WO/2006/001023
2/26021661
180000
METHOD OF ENHANCING THE
IMMUNE RESPONSE TO A VACCINE
PHARMA PACIFIC PTY LTD.
US
60/579186
12/06/2004
PCT/US/2005/020500
WO/2005/123112
2122121660
180001
COMPRESSION APPARATUS
TYCO HEALTHCARE GROUP LP
US
11/299568
12/12/2005
2122121660
180003
COMPRESSION SLEEVE HAVING AIR
CONDUIT
TYCO HEALTHCARE GROUP LP
US
11/299488
12/12/2005
167
C12N
‫חלבונים כימריים ושימושים עבורם‬
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K
‫שיטה להגברת תגובה חיסונית לתרכיב‬
A61B
‫מערכת לדחיסה‬
A61H
‫שרוול דחיסה עם תעלת אויר‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6126/21661
180004
‫שיטה והתקן לריבוב מוגבר בהעברת אות‬
‫ללויין‬
METHOD AND APPARATUS FOR
ENHANCED UPLINK MULTIPLEXING
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/588960
19/07/2004
771773193
2410412004
US
PCT/US/2005/023891
WO/2006/019562
2026/21661
180005
HIGH SPEED DOWNLINK PACKET
ACCESS CO-PROCESSOR FOR
UPGRADING THE CAPABILITIES OF
AN EXISTING MODEM HOST
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/591005
26/07/2004
PCT/US/2005/025540
WO/2006/020283
1/26021661
H04B
‫קו–מעבד לגישה מהירה של יחידת נתונים‬
‫מלוכדת הנקלטת מלויין עבור שדרוג‬
‫יכולות של מודם מארח‬
180006
METHOD FOR PRODUCING GASEOUS
DIAZOALKANES
DYNAMIT NOBEL GMBH
EXPLOSIVSTOFF-UND
SYSTEMTECHNIK
DE
102004030371.1 23/06/2004
PCT/EP/2005/006808
WO/2006/000414
1/26021661
H04J
180007
USE OF ETHER GROUP-CONTAINING
POLYMERS AS SOLUBILIZERS
BASF AKTIENGESELLSCHAFT
DE
102004031158.7 28/06/2004
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C07C
‫שיטה ליצור דיאזואלקאנים גאזיים‬
A01N
‫שימוש בפולימרים המכילים קבוצה‬
‫אתרית כחומרים מסיסים‬
168
PCT/EP/2005/053123
WO/2006/000592
2626021661
180008
METHOD AND INSTALLATION FOR
ACOUSTO-OPTIC IMAGING
UNIVERSITE PIERRE ET MARIE
CURIE
FR
0406592
17/06/2004
PCT/FR/2005/001446
WO/2006/005836
6126/21661
180009
LIQUID PESTICIDE COMPOSITIONS
BASF AKTIENGESELLSCHAFT
US
60/585073
06/07/2004
PCT/EP/2005/007256
WO/2006/002984
6/26/21661
180010
PHARMACEUTICAL COMPOSITION
OF PIPERAZINE DERIVATIVES
UCB FARCHIM SA
EP
04016519.3 14/07/2004
PCT/EP/2005/007340
WO/2006/005507
2226/21661
180011
POLYAMIDE
ASAHI KASEI EMD CORPORATION
2004JP
16/07/2004
210575
PCT/JP/2005/012730
WO/2006/008991
169
G03H
–‫שיטה והתקנה עבור הדמייה אקוסטו‬
‫אופטית‬
A01N
‫תכשירים נוזלים קוטלי פטריות‬
C07D
‫תכשיר רוקחות של תולדות פיפראזין‬
C08G
‫פולי אמיד‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
112212200/
180014
OPIOID AGONIST/ANTAGONIST
COMBINATIONS
EURO-CELTIQUE S.A.
US
60/068480
22/12/1997
PCT/US/1998/027257
WO/1999/032119
2122121660
180015
APPARATUS FOR MAINTAINING CO2
IN A BOTTLE CONTAINING
CARBONATED BEVERAGES
GOLAN FREDI HAWK
1/22221662
180016
SYSTEM AND METHOD FOR
ADAPTIVE BROADCAST RADAR
SYSTEM
LOCKHEED MARTIN CORPORATION
US
60/253095
28/11/2000
PCT/US/2001/044267
WO/2002/097467
2/26021661
180017
AMINO-5, 5DIPHENYLIMIDAZOLONE
DERIVATIVES FOR THE INHIBITION
OF BETA-SECRETASE
WYETH
US
60/580286
16/06/2004
PCT/US/2005/020720
WO/2006/009653
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61K
‫צירופים של אגוניסט ואנטגוניסט‬
‫אופיואידים‬
B65D
‫ בבקבוק למשקאות‬CO 0 ‫התקן לשימור‬
‫מוגזים‬
‫ עמלני פיתוח טכנולוגי בע"מ‬.‫ט‬.‫י‬.‫ע‬
G01S
‫מערכת ושיטה למערכת רדאר בעלת‬
‫שידור מסתגל‬
C07D
‫–דיפנילאימידאזולון‬. , .–‫נגזרות אמינו‬
‫לעיכוב של בטה–סקרטאז‬
170
2/26021661
180018
DIPHENYLIMIDAZOPYRIMIDINE
AND -IMIDAZOLE AMINES AS
INHIBITORS OF B-SECRETASE
WYETH
US
60/580187
16/06/2004
PCT/US/2005/020736
WO/2006/009655
2126021661
‫אמינים של דיפנילאימידאזופירימידין‬
‫–סקרטאז‬B ‫ואימידאזול כמעכבים של‬
180019
METHOD AND APPARATUS FOR
MIXING AND APPLYING A MULTICOMPONENT COATING
COMPOSITION
PPG INDUSTRIES OHIO, INC.
US
10/870301
17/06/2004
PCT/US/2005/021159
WO/2006/009744
2226121661
180021
171
G06F
‫מערכת עבור קביעת קירבה‬
180022
POLYNUCLEOTIDES AND
POLYPEPTIDES INVOLVED IN PLANT
FIBER DEVELOPMENT AND
METHODS OF USING SAME
EVOGENE LTD.
US
60/578833
14/06/2004
PCT/IL/2005/000627
WO/2005/121364
B05B
‫שיטה ומערכת לערבוב ויישום של‬
‫תרכובת ציפוי רב–רכיבית‬
SYSTEM FOR PROXIMITY
DETERMINATION
NDS LIMITED
US
60/583338
28/06/2004
PCT/IL/2005/000499
WO/2006/018826
2/26021661
C07D
C12Q
‫פולינוקלאוטידים ופוליפפטידים המעורבים‬
‫בהתפתחות סיבים בצמחים ושיטות‬
‫לשימושם‬
‫אבוג'ן בע"מ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
612612166/
180023
MODEL OPTIMIZATION OF
STRUCTURE WITH ADDITIONAL
MATERIALS
TIMBRE TECHNOLOGIES, INC.
US
357705
03/02/2003
6126/21661
‫אופטימיזציה של מודל למבנה עם חומרים‬
‫נוספים‬
180024
CRYSTAL OF 1,2-DIHYDROPYRIDINE
COMPOUND AND METHOD FOR
PRODUCING SAME
EISAI R&D MANAGEMENT CO. LTD.
2004JP
06/07/2004
198709
PCT/JP/2005/012388
WO/2006/004107
1/26021661
180025
METHOD FOR BILAYER RESIST
PLASMA ETCH
LAM RESEARCH CORPORATION
US
10/882842
30/06/2004
PCT/US/2005/022809
WO/2006/004693
2026021661
180026
COMPOUNDS, COMPOSITIONS AND
METHODS
CYTOKINETICS, INC.
US
60/581197
17/06/2004
PCT/US/2005/021100
WO/2006/009726
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
G06F
C07D
‫–דיהידרופירידין‬0 ,1 ‫גביש תרכובת של‬
‫ושיטה לייצורו‬
H01B
–‫שיטה לחרוט תוך פלאזמה על חומר דו‬
‫שכבתי‬
C07D
‫ תכשירים ושיטות‬,‫תרכובות‬
172
1626121661
180027
VIDEO COMPRESSION NOISE
IMMUNITY
AVOCENT CORPORATION
US
10/875679
25/05/2004
PCT/US/2005/017626
WO/2006/007135
6/26021661
‫חסינות מרעשי דחיסת וידיאו‬
180028
180030
180031
STABLE PHARMACEUTICAL
FORMULATIONS OF
BENZIMIDAZOLE COMPOUNDS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/580273
15/06/2004
901444233
7410112004
US
901497144
2110112004
US
PCT/US/2005/021085
173
A61B
‫מתקן להחדרת אנרגיה תרמית‬
‫אלכס רפופורט‬
THERMAL ENERGY APPLICATOR
ALEX RAPOPORT
US
60/580712
21/06/2004
901427494
7410112004
US
901422292
0410912004
US
901493923
3710712004
US
PCT/IL/2005/000649
WO/2005/122694
2126021661
G06K
‫סדר עדיפות לפקודות בדחיסת וידאו‬
‫דיגיטלית‬
DIGITAL VIDEO COMPRESSION
COMMAND PRIORITY
AVOCENT CORPORATION
US
10/875678
25/06/2004
PCT/US/2005/019256
WO/2006/007263
2026021661
G06K
A61K
‫פורמולציות רוקחיות יציבות של תרכובות‬
‫בנזימידאזול‬
‫טבע תעשיות פרמצבטיות בע"מ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
WO/2006/002077
1626021661
180033
METALOTHERMIC REDUCTION OF
REFRACTORY METAL OXIDES
H.C. STARCK, INC.
US
10/872998
21/06/2004
PCT/US/2005/021724
WO/2006/009982
1126021661
‫חיזור מתלותרמי של תחמוצות מתכתיות‬
‫שוברות קרני אור‬
180034
NON-INVASIVE GLUCOSE
MEASUREMENT
VIVOMEDICAL, INC.
US
60/585414
01/07/2004
PCT/US/2005/022139
WO/2006/007472
2/26021661
180038
H01R
‫מחבר והתקן משוכללים עבור מערכות‬
‫ממוחשבות בעלות חיבור גמיש‬
‫ווליטקס מיקרואלקטרוניקה בע"מ‬
180039
GAS FLOW ENHANCER FOR
COMBUSTION ENGINES
CRAIG, D. CUMMINGS
US
60/580146
15/06/2004
771034441
7410712004
US
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A61B
‫מדידת גלוקוז בלתי חודרנית‬
IMPROVED CONNECTOR AND
DEVICE FOR FLEXIBLY
CONNECTABLE COMPUTER
SYSTEMS
WALLETEX MICROELECTRONICS
LTD.
US
60/580573
17/06/2004
901974393
3010912004
US
901924992
7417712004
US
901914440
2410412004
US
PCT/IL/2005/000647
WO/2005/124932
6/26/21661
B22F
F01D
‫משפר זרימת גז עבור מנועי בעירה פנימית‬
174
PCT/US/2005/007971
WO/2006/001855
2/26021661
180040
TRACKING LOST AND STOLEN
MOBILE DEVICES USING LOCATION
TECHNOLOGIES AND EQUIPMENT
IDENTIFIERS
QUALCOMM INCORPORATED
US
60/580822
18/06/2004
701949409
3010912004
US
PCT/US/2005/021052
WO/2006/009712
2/26021661
‫מעקב אחר התקנים ניידים אבודים או‬
‫גנובים בעזרת טכנולוגיות מיקום ומזהי ציוד‬
180041
METHOD AND APPARATUS FOR
LINK CONTROL IN WIRELESS
COMMUNICATIONS
QUALCOMM INCORPORATED
US
60/580458
16/06/2004
901911914
0410412004
US
771749117
7010912004
US
PCT/US/2005/021054
WO/2006/009714
212602166/
NEW CHIRAL COLUMNS WITH
BROAD CHIRAL SELECTIVITY
VANDERBILT UNIVERSITY
G08G
180042
H04L
‫שיטה ומערכת לבקרת חיבור בתקשורת‬
‫אלחוטית‬
C07K
‫עמודים כיראליים חדשים בעלי אפשרות‬
‫רחבה לברירת כיראליות‬
PCT/US/2004/018762
WO/2006/001798
175
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
6/26021661
180043
POWER CONTROL USING ERASURE
TECHNIQUES
QUALCOMM INCORPORATED
US
60/580819
18/06/2004
701490171
7310112004
US
701491493
2210112004
US
771020104
2217212004
US
PCT/US/2005/020086
WO/2006/007316
6226/21661
180044
PYRAZOLE DERIVATIVES
DAIICHI PHARMACEUTICAL CO.,
LTD.
2004JP
01/07/2004
195497
PCT/JP/2005/012176
WO/2006/004027
2226/21661
180045
VISUALLY APPEALING
MICROWAVEABLE FROZEN MEAL
NESTEC S.A.
US
10/892365
16/07/2004
PCT/EP/2005/007483
WO/2006/008020
2026221660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
180046
H04L
‫בקרת כוח באמצעות שיטות מחיקה‬
C07D
‫נגזרות של פיראזול‬
A23L
‫ארוחה קפואה המושכת באופן חזותי‬
‫הניתנת להכנה במיקרו‬
G10L
176
APPARATUS AND METHOD FOR
GENERATING MULTI-CHANNEL
SYNTHESIZER CONTROL SIGNAL
AND APPARATUS AND METHOD
FOR MULTI-CHANNEL
SYNTHESIZING
KONINKLIJKE PHILIPS
ELECTRONICS N.V.
US
60/671582
15/04/2005
771272394
2110412004
US
PCT/EP/2006/000455
WO/2006/108456
1122221661
‫התקן ושיטה לייצור אות בקרת מסנטז‬
‫רב–ערוצי והתקן ושיטה לסינטוז רב–ערוצי‬
180049
COATED CUTTING INSERT AND
MANUFACTURING METHOD
THEREOF
SUMITOMO ELECTRIC HARDMETAL
CORP.
2004JP
03/12/2004
351705
PCT/JP/2005/021704
WO/2006/059551
2/26021661
180050
BUILDING SYSTEM
TRIPOD COMPONENTS PTY LTD
AU
2004903227 15/06/2004
2004903919
2010112004
AU
PCT/AU/2005/000837
WO/2005/124049
2/22121660
177
180053
B23B
‫שימה מצופה ושיטה לייצורה‬
E04D
‫מערכת בניה‬
G09F
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
METHOD APPARATUS AND DEVICE
FOR PROMOTING COMPANIES AND
PRODUCTS WITH PROMOTION
ADVERTISING WHILE USING FOOD
CONTAINERS
UZI EZRA HAVOSHA
2/22121660
‫שיטה מתקן והתקן לקידום חברות‬
‫ומוצרים באמצעות קידום ושיווק תוך‬
‫שימוש במיכלי מזון‬
‫ עו"ד‬,‫עוזי חבושה‬
180055
A METHOD FOR DUPLICATING
DENTURES
NASIM KHALIFA
6/26021661
‫שיטה לשכפול תותבות‬
‫נסם חליפה‬
180056
A TEST MEDIUM FOR DETECTING,
QUANTIFYING OR
DIFFERENTIATING BIOLOGICAL
MATERIALS
MICROLOGY LABORATORIES, LLC
US
10/867393
14/06/2004
PCT/US/2005/020215
WO/2005/123939
1226021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
C12Q
‫ כמוי והבחנת חומרים‬,‫מצע בדיקתי לגילוי‬
‫ביוליגיים‬
180057
TRITERPENE-CONTAINING OLEOGELFORMING AGENT, TRITERPENECONTAINING OLEOGEL AND METHOD
FOR THE PRODUCTION THEREOF
BIRKEN GMBH
DE
102004030044.5 22/06/2004
PCT/EP/2005/006710
WO/2005/123037
1/26021661
A61C
180064
A61K
‫גורם המיצר קריש שומני המכיל‬
‫ קריש שומני המכיל‬,‫טריטרפין‬
‫טריטרפין ושיטה להכנתו‬
C12N
178
USE OF MYCOBACTERIAL
MANNOSYLATED LIPOGLYCANS
PEPTIDE MIMOTOPES FOR
TREATING INFLAMMATION
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/582221
24/06/2004
PCT/IL/2005/000674
WO/2006/001011
2026021661
ManLAM –‫שימוש בפפטיד מימיטופי ל‬
‫להכנת תכשיר רוקחי לטיפול בדלקת‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
180065
MEMBRANE MODULE FOR IMMERSED
OPERATION
KOCH MEMBRANE SYSTEMS GMBH
DE
102004029141.1 17/06/2004
PCT/EP/2005/006448
WO/2005/123231
1226021661
180067
CHEMICAL COMPOUNDS
SMITHKLINE BEECHAM
CORPORATION
US
60/581913
22/06/2004
PCT/US/2005/021963
WO/2006/002185
2/26021661
180068
A MAGNETIC RESONANCE IMAGING
METHOD AND DEVICE USING A
STATIC AND HOMOGENEOUS
MAGNETIC FIELD
DORON KWIAT
179
B01D
‫מודול ממברני לפעולת שיקוע‬
C07C
‫תרכובות כימיות‬
G01V
‫שיטה ומכשיר להדמיה על ידי תהודה‬
‫מגנטית‬
‫דורון קויאט‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
IL
162501
791047
IL
PCT/IL/2005/000626
WO/2005/122060
2226/21661
14/06/2004
2210212004
180070
METHOD FOR ACQUIRING
BIOINFORMATION USING
MILIMETER-WAVE BAND
ELECTROMAGNETIC WAVE, DEVICE
FOR ACQUIRING AND DISPLAYING
BIOINFORMATION
INTELLECTUAL PROPERTY BANK
CORP.
2004JP
09/07/2004
203526
2004-203421 0910112004
JP
PCT/JP/2005/012757
WO/2006/006559
1/26021661
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫שיטה להשגת ביו–אינפורמציה באמצעות‬
‫שימוש בגל אלקטרוסגולי ברצועת גל‬
–‫ התקן להשגת והצגת ביו‬,‫מילימטרית‬
‫אינפורמציה‬
180071
MANUFACTURING OF QUICK
RELEASE PHARMACEUTICAL
COMPOSITIONS OF WATER
INSOLUBLE DRUGS AND
PHARMACEUTICAL COMPOSITIONS
OBTAINED BY THE PROCESS OF THE
INVENTION
NYCOMED DANMARK APS
DK
PA200401021 29/06/2004
PCT/DK/2005/000435
WO/2006/000228
A61B
A61K
‫ייצור של תכשירי רוקחות המשחררים‬
‫במהירות תרופות בלתי מסיסות במים‬
‫ותכשירי רוקחות המתקבלים ע"י‬
‫התהליך של האמצאה‬
180
2/26/21661
180072
COPPER (I) COMPOUNDS USEFUL AS
DEPOSITION PRECURSORS OF
COPPER THIN FILMS
ADVANCED TECHNOLOGY
MATERIALS, INC.
US
10/869532
16/06/2004
PCT/US/2005/008416
WO/2006/009590
6/26/21661
180073
PREPARATION OF NOVEL
SUBSTITUTED HALOARENE
COMPOUNDS
PFIZER PRODUCTS INC.
US
60/589152
19/07/2004
PCT/IB/2005/002098
WO/2006/011030
2026021661
180074
EPITHELIAL DELAMINATING
DEVICE
TISSUE ENGINEERING REFRACTION
INC.
US
60/580430
16/06/2004
PCT/US/2005/021347
WO/2006/007408
1/26021661
180075
HEAD-UP DISPLAY
HONEYWELL INTERNATIONAL INC.
US
10/879882
28/06/2004
PCT/US/2005/022702
WO/2006/124040
181
C07F
‫) יעילות כמטרימי‬I( ‫תרכובות נחושת‬
‫השקעה של קרומי נחושת דקים‬
C07D
‫הכנה של תרכובות הלורן מותמרות‬
‫חדשות‬
A61F
‫התקן להפרדה אפיתלית‬
G02B
‫תצוגת עילית‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1226021661
180076
PRODUCTION OF VALVE METAL
POWDERS WITH IMPROVED
PHYSICAL AND ELECTRICAL
PROPERTIES
H.C. STARCK, INC.
US
60/582579
24/06/2004
PCT/US/2005/021659
WO/2006/012076
1/26021661
‫יצור של אבקת מתכות לשסתומים בעלות‬
‫תכונות פיזיקליות ואלקטרוניות משופרות‬
180077
TREATMENT OF CONDITIONS
INVOLVING DEMYELINATION
Biogen Idec MA Inc.
US
60/582966
24/06/2004
901971291
0117012004
US
901924434
7417712004
US
901940414
7310412004
US
PCT/US/2005/022881
WO/2006/002437
1626021661
180078
RETINAL DERIVATIVES AND
METHODS FOR THE USE THEREOF
FOR THE TREATMENT OF VISUAL
DISORDERS
UNIVERSITY OF WASHINGTON
US
60/580889
18/06/2004
PCT/US/2005/021812
WO/2006/002097
2126021661
ADJUVANCY AND IMMUNE
POTENTIATING PROPERTIES OF
NATURAL PRODUCTS OF
ONCHOCERCA VOLVULUS
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
B22F
180079
A61K
‫טיפול בתנאים הכרוכים בדמיאלינציה‬
C07C
‫תולדות רטינאל ושיטות לשימוש בהן‬
‫לטיפול באי סדרים בראיה‬
A61K
‫תכונות של סיוע והגברת חסינות של‬
‫מוצרים טבעיים של אונקוקרקה וולוולוס‬
182
THE NEW YORK BLOOD CENTER,
INC.
US
60/580254
15/06/2004
PCT/US/2005/021004
WO/2005/122739
6/26/21661
180080
GAS BEARING SUBSTRATELOADING MECHANISM PROCESS
OC OERLIKON BALZERS AG
US
60/586645
09/07/2004
PCT/CH/2005/000392
WO/2006/005214
2126021661
180081
BI-METALLIC CONNECTORS
METHOD FOR PRODUCING THE
SAME, AND METHOD FOR
CONNECTING THE SAME TO A
STRUCTURE
PULSAR WELDING LTD.
US
60/580107
17/06/2004
PCT/IL/2005/000635
WO/2005/124929
1/26021661
180082
FAST ANALOG SAMPLER FOR
CONTINUOUS RECORDING AND
READ-OUT AND DIGITAL
CONVERSION SYSTEM
COMMISSARIAT A L'ENERGIE
ATOMIQUE
FR
04/51340
25/06/2004
183
B65G
‫מנגנון תהליך לטעינת חומר הנושא גז‬
H01R
‫ שיטה‬,‫מחברים העשויים משתי מתכות‬
‫לייצורם ושיטה לחיבורם למבנה‬
‫פולסר ריתוך בע"מ‬
G11C
‫דוגם אנלוגי מהיר עבור הקלטה רציפה‬
‫וקריאה ומערכת המרה דיגיטלית‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
PCT/EP/2005/052932
WO/2006/003106
6/26/21666
180083
APPARATUS AND METHOD FOR
CONTROLLING A DEMULTIPLEXER
AND A MULTIPLEXER USED FOR
RATE MATCHING IN A MOBILE
COMMUNICATION SYSTEM
SAMSUNG ELECTRONICS CO., LTD.
KR
1999/27407 08/07/1999
7999130094
2310117999
KR
7999131499
3010417999
KR
PCT/KR/2000/000739
WO/2001/005059
1/26021661
‫ציוד ושיטה עבור בקרת דימולטיפלקסר‬
‫ומולטיפלקסר בשימוש להתאמת קצב‬
‫במערכת תקשורת ניידת‬
180084
FLEXIBLE IMPACT RESISTANT
PRIMER
PRC-DESOTO INTERNATIONAL, INC.
US
10/879564
28/06/2004
PCT/US/2005/022593
WO/2006/025928
6/26/21661
C08G
‫צבע בסיס אלסטי עמיד בפני פגיעות‬
180085
PROCESS FOR THE PREPARATION
OF-4-AZASTEROIDS-OZONOLYSIS
LONZA AG
EP
04015746.3 05/07/2004
PCT/EP/2005/007190
WO/2006/002966
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H04B
C07J
‫–אזאסטרוידים–אוזונוליזה‬4 ‫תהליך להכנת‬
184
6/26/21661
180086
RADIATION DETECTOR HEAD
Orbotech Medical Solutions Ltd.
US
60/588191
14/07/2004
PCT/IL/2005/000704
WO/2006/006147
1026021661
180088
AZINE-CARBOXAMIDES AS ANTICANCER AGENTS
ASTRAZENECA AB
US
60/584129
01/07/2004
PCT/GB/2005/002522
WO/2006/003378
6/26021661
180089
EDUCATIONAL TOY
DUPREY INVENTIONS LLC
US
10/873137
23/06/2004
PCT/US/2005/020002
WO/2006/007308
1226/2200/
180090
?- LACTAM COMPOUNDS
FLORIDA STATE UNIVERSITY
US
034852
22/03/1993
094171
2010117993
US
2/26021661
185
180093
G01T
‫ראש לזיהוי קרינה‬
‫אורבוטק מדיקל סלושנס בע"מ‬
C07D
–‫אזין–קרבוקסאמידים כגורמים אנטי‬
‫סרטניים‬
G09B
‫צעצוע חינוכי‬
C07D
‫תרכובות של ?–לקטמים‬
C09D
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
METHOD FOR DEPOSITING ANTICORROSIVE COATING ONTO METAL
SURFACE
PIGMENTAN ANTICORROSIVE
PIGMENTS FOR PAINTS LTD.
US
60/578853
14/06/2004
PCT/IL/2005/000623
WO/2005/120722
2626021661
‫שיטה ליישום ציפוי נגד–חלודה על משטח‬
‫מתכת‬
180094
REDUCED SUSCEPTIBILITY
TOWARDS PATHOGENS, IN
PARTICULAR OOMYCETES, SUCH AS
DOWNY MILDEW IN LETTUCE AND
SPINACH
RIJK ZWAAN ZAADTEELT EN
ZAADHANDEL B.V.
EP
04076729.5 16/06/2004
PCT/EP/2005/006314
WO/2005/124108
2/22121660
180095
METHOD FOR ANTENATAL
ESTIMATION OF DOWN SYNDROME
RISK
MOR RESEARCH APPLICATIONS
LTD.
1/26021661
180096
INHALER DEVICE COUNTER
ASTRAZENECA AB
SE
0401787-7
05/07/2004
PCT/SE/2005/000995
WO/2006/004497
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫פיגמנטן פיגמנטים אנטיקורוזים לצבעים‬
‫בע"מ‬
C12N
‫ בפרט‬,‫רגישות מופחתת לפתוגנים‬
‫אומיציטים כגון קימחון פלומתי בחסה‬
‫ותרד‬
A61B
‫שיטה להערכה עוברית של סיכון‬
‫לסינדרום דאון‬
‫מור יישום מחקרים בע"מ‬
A61M
‫מונה לאינהלטור‬
186
1/26021661
180097
QUINOLINE THIAZOLINONES WITH
CDK1 ANTIPROLIFERATIVE
ACTIVITY
F. HOFFMANN-LA ROCHE AG
US
60/584931
01/07/2004
901944213
0310312004
US
PCT/EP/2005/006806
WO/2006/002828
1/26021661
1/26021661
187
A61M
‫אינהלטור בעל סיכון מופחת למנה שגויה‬
180101
EPITOPE ANALOGS
MANNKIND CORPORATION
US
60/581001
17/06/2004
901440992
7110912004
US
PCT/US/2005/021609
WO/2006/009920
C12Q
‫שיטות לחיזוי של תגובה תרופתית‬
‫לגורמים הפועלים על הקולטן של הורמון‬
‫הגדילה‬
180099
INHALER DEVICE THAT REDUCES
THE RISK FOR MISCOUNTING A
DOSAGE
ASTRAZENECA AB
SE
0401786-9
05/07/2004
PCT/SE/2005/000996
WO/2006/004498
2/26021661
‫תיאזולינונים של קוינולין בעלי פעילות‬
CDK1 ‫מונעת התפשטות של‬
180098
METHODS FOR PREDICTING
THERAPEUTIC PESPONSE TO
AGENTS ACTING ON THE GROWTH
HORMONE RECEPTOR
PHARMACIA & UPJOHN COMPANY
LLC
US
60/586380
08/07/2004
PCT/IB/2005/002086
WO/2006/006072
C07D
C07K
‫אנלוגים של אפיטופ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2126021661
180103
DISCRETELY CONTROLLED
MICROMIRROR WITH MULTI-LEVEL
POSITIONS
STEREO DISPLAY, INC.
US
10/872241
18/06/2004
PCT/US/2005/020944
WO/2006/009689
2/22121660
2/26121661
C AND P AGENCIES LTD
180105
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H01L
‫התקן לטיפול במצע למערכת קרן חלקיק‬
‫טעון‬
180106
SOLID AND CRYSTALLINE
IBANDRONIC ACID
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/582500
23/06/2004
901920079
7417012004
US
901990494
7910712004
US
PCT/US/2005/022410
WO/2006/002348
2/26021661
A63F
‫שיטה לדירוג נושאים הקשורים למשחקים‬
SUBSTRATE HANDLING DEVICE FOR
A CHARGED PARTICLE BEAM
SYSTEM
NANOBEAM LIMITED
GB
0413357.5
15/06/2004
PCT/GB/2005/050067
WO/2006/032930
1/26021661
‫מיקרו–מראה מבוקרת בצורה בדידה עם‬
‫מיקומים רבי–רמות‬
180104
METHOD FOR RANKING SUBJECTS
ASSOCIATED WITH GAMES
C AND P AGENCIES LTD.
G02B
180107
C07F
‫חומצה איבנדרונית במצב מוצק‬
‫וקריסטליני‬
‫טבע תעשיות פרמצבטיות בע"מ‬
C07D
188
LACTAM TACHYKININ RECEPTOR
ANTAGONISTS
MERCK & CO. INC.
US
60/581786
22/06/2004
PCT/US/2005/021840
WO/2006/002117
2026021661
180108
SULFAMATE AND SULFAMIDE
DERIVATIVES FOR THE TREATMENT
OF EPILEPSY AND RELATED
DISORDERS
JANSSEN PHARMACEUTICA, N.V.
US
60/580178
16/06/2004
PCT/US/2005/021513
WO/2006/007435
2126021661
‫תרכובות לקטם כאנטאגוניסטים לרצפטור‬
‫הקושר טכיקינין‬
‫נגזרות של סולפאמט וסולפאמיד לטיפול‬
‫באפילפסיה והפרעות דומות‬
180109
PLASMID HAVING THREE
COMPLETE TRANSCRIPTIONAL
UNITS AND IMMUNOGENIC
COMPOSITIONS FOR INDUCING AN
IMMUNE RESPONSE TO HIV
WYETH
US
60/580438
17/06/2004
901924943
0317712004
US
901992214
7910312004
US
PCT/US/2005/021168
WO/2006/009746
2/26121661
180110
SYSTEM AND METHOD FOR
MAINTAINING OBJECTS IN A
LOOKUP CACHE
IBM CORPORATION
US
10/870458
17/06/2004
PCT/EP/2005/052283
WO/2005/124559
189
C07D
C12N
‫פלזמיד בעל שלוש יחידות שיעתוקיות‬
‫שלמות ותרכובות אימונוגניות לגרימת‬
HIV–‫תגובה חיסונית ל‬
G06F
‫מערכת ושיטה לתחזוקת אובייקטים‬
‫במטמון חיפוש‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
1622121660
180210
A METHOD OF FABRICATING HEAT
SINKS AND HEAT EXCHANGERS
MICROFLOW LTD
1622121660
‫שיטה לייצור גוף קירור ומחליפי–חום‬
‫מיקרופלו בע"מ‬
180212
A PLANT-GROWING SYSTEM AND
METHOD
SHULAMIT (SYLVIE) SHAPIRO
‫שולמית (סילבי) שפירא‬
180215
MICROWAVE GENERATOR
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102004031333.4 29/06/2004
PCT/EP/2005/006127
WO/2006/000296
180217
IN-VIVO IMAGING OPTICAL DEVICE
GIVEN IMAGING LTD.
US
11/319769
29/12/2005
1622121660
180221
IMPROVED RAPID-EXCHANGE
CATHETER
GRENADIER EHUD
1622121660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A01G
‫מערכת ושיטה לגידול צמחים‬
6/26021661
1622121660
F28F
H03B
‫מחולל מיקרוגל‬
A61B
‫התקן אופטי תוך גופי‬
‫גיוון אימג'ינג בע"מ‬
A61B
‫קטטר משופר להחלפה מהירה‬
‫חרמוני ישראל‬
180222
A42B
190
STORAGE BAG FOR MOTORCYCLE
HELMET
FELDMAN MAXIM
1222121660
‫תיק אכסון לקסדת אופנוע‬
‫פלדמן מקסים‬
180230
METHOD FOR DOWNLOADING
DATA FILES TO A GROUP OF
CLIENTS VIA A PROXY WITH A
LIMITED STORAGE
ECI TELECOM LTD
1222121660
‫שיטה להורדת קבצי נתונים לקבוצות‬
‫ בעל זיכרון מוגבל‬PROXY ‫לקוחות דרך‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
180231
TNCOMMING CALL AS A TOOL TO
RETREARE DATA AND PRESENT IT
IN REAL TIME FROM DATA BASE BY
MIDDLEWARE SDFTMARE WICH
CONNECT TO TELEPHONY MEANS
DARIA AHARONEE BALDINGER
1222121660
191
H04M
‫שיחה טלפונית נכנסת כאמצעי לשליפת‬
‫נתונים והצגתם על צג בזמן אמת ממאגרי‬
‫מידע נתונים שונים באמצעות תוכנה‬
‫אחידה שמתחברת לאמצעי טלפוניה‬
‫שונים‬
‫דריה אהרוני בלדינגר‬
180232
A DEVICE FOR MOVING A BODY
LINEARLY BETWEEN TWO
PREDETERMINED POSITIONS
SAGEM DEFENSE SECURITE
FR
0513168
22/12/2005
1222121660
G06F
180234
G01C
‫התקן להזזת גוף באופן לינארי בין שתי‬
‫עמדות קבועות מראש‬
H01M
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
A BATTERY, ELECTRICAL
EQUIPMENT, AND A POWERING
METHOD IMPLEMENTING MEANS
FOR SHORT-CIRCUITING THE
BATTERY
SAGEM DEFENSE SECURITE
FR
0513200
22/12/2005
1222121660
180235
A METHOD OF MANAGING THE
SUPPLY OF ELECTRICAL POWER, AN
ELECTRICAL POWER SUPPLY
CIRCUIT, AND A METHOD OF
POWERING AN APPLIANCE WHEN
COLD
SAGEM DEFENSE SECURITE
FR
0513199
22/12/2005
1222121660
‫ מכשיר חשמלי ושיטה להפעלה‬,‫סוללה‬
‫על ידי קיצור הסוללה‬
‫ מעגל‬,‫שיטה לניהול הספקה של חשמל‬
‫חשמלי להספקת חשמל ושיטה להפעלת‬
‫מכשיר קר‬
180236
PRINTING MATERIAL CONTAINER,
AND BOARD MOUNTED ON
PRINTING MATERIAL CONTAINER
SEIKO EPSON CORPORATION
2005JP
26/12/2005
372028
2009-220147 7710412009
JP
1222121660
180237
DEBURRING TUMBLER PIN
MUL-T-LOCK TECHNOLOGIES LTD.
1222121660
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
H05B
180245
B41D
‫מיכל לחומרי הדפסה ומכסה תואם‬
E05B
‫פין תוף המוריד גרדים‬
‫מולטילוק טכנולוגיות בע"מ‬
B61B
192
REAL TIME PLANNING AND
SCHEDULING FOR A TEAM OF
UNMANNED VEHICLE
HONEYWELL INTERNATIONAL INC.
US
11/393086
30/03/2006
1222121660
‫תיכנון ותיזמון בזמן אמת של רכיבים ללא‬
‫נהג‬
180261
DEVICE, SYSTEM AND METHOD FOR
IN-VIVO SENSING OF A BODY
LUMEN
GIVEN IMAGING LTD.
US
11/319772
29/12/2005
1/22121660
‫התקן מערכת ושיטה לחישה תוך גופית‬
‫של חללים בגוף‬
‫גיוון אימג'ינג בע"מ‬
180267
INDIVIDUAL BIO-ELECTROMAGNETIC HYGIENE OF
HUMAN/ANIMAL ORGANISM
(BODY) METHODS AND MEANS
KATSEN-POLAK ELEHA
1/22121660
DEVICE FOR ENABLING ANGULAR
POSITION OF A PROJECTILE FIN
GIAT INDUSTRIES
193
A61N
‫היגיינה ביו–חשמלי–מגנטית אישית של‬
‫בעל–חיים‬/‫אורגניזם (גוף) של בן–אדם‬
‫שיטות ואמצעים‬
‫פולק אלנה‬-‫כצן‬
180268
MOBILE FHONE WITH LOUDSPEAKER, WHICH IS ACIVATED BY
SLIDE-OPENING OR DOOR OPENING OF THE PHOVE.
DR. HAIM AMRAM BEN-SIMHON
1122121660
A61B
H04M
‫טלפון נייד עם רמקול אשר מופעל ע"י‬
‫החלקה של חלק אחד של המכשיר על פני‬
‫משנהו או ע"י פתיחת דלתות‬
180294
‫שמחון‬- ‫דר'' חיים עמרם בן‬
G01C
‫מכשיר למדידת זוית של סנפיר קליע‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
FR
05.13310
26/12/2005
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
- ‫ לחוק הפטנטים תשכ"ז‬09 ‫הודעה לפי סעיף‬
1679
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬:/ ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬.7 ‫הפטנטים בדרך הקבועה בתקנה‬
.1690 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי – מהדורה שביעית‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬1//9
194
according to the Eighth Edition of the
International Patent Classification (2006)
195
‫המהדורה השמינית של הסיווג הבינלאומי‬
)0//9 ‫של פטנטים (משנה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
228711
‫ המסוגלים לשינוי ביטוי גנים‬.‫א‬.‫נ‬.‫מבני ד‬
‫ושימושיהם‬
]1/[
DNA CONSTRUCTS CAPABLE OF
ALTERING THE EXPRESSION OF
GENES AND USES THEREOF
]11[
]/2[
]12[
01.12.1993
07/985586
]/1[ 03.12.1992
]//[ US
Int. Cl.8 A61K 048/00, C07K 014/435, 014/505, 014/61, C12N 005/06, 005/08,
015/12, 015/18, 015/19, 015/87, 015/90
TRANSKARYOTIC THERAPIES,
INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
]/2[
]//[
[57] DNA construct which alters the
expression of a targeted gene in a cell
when the DNA construct is homologusly
recombined with a target site within the
chromosomal DNA of the cell, the target
site being upstream of the transcription site
of the targeted gene, the DNA construct
comprising:
(a) a targeting sequence homologous to the
target site;
(b) an exogenous regulatory sequence;
(c) an exon;
(d) an amplifiable marker gene; and
(e) an unpaired splice-donor site at the 3'
end of the exon;
wherein, following homologous
recombination of the targeting sequence
with the target site, the chromosomal DNA
of the cell comprises the construct-derived
exon in addition to all endogenous exons
of the targeted gene.
__________
]22[]12[
222018
‫תווך על בסיס קולגן‬
]1/[
COLLAGEN-BASED MATRIX
]11[
]12[
19.07.1994
Int. Cl.8 A61L 027/00, 027/24, 031/00, 031/04, A61P 001/02, C07K 014/78, C08H
001/06
COLBAR LIFESCIENCE LTD.
‫ הרצליה‬,‫קולבר לייף סאיינס בע"מ‬
LIHU KOLTON & ASSOCIATES,
,‫ליהו קולטון ועמיתים עורכי פטנטים‬
P.O.BOX 40120
,4/10/ .‫ד‬.‫ ת‬, ‫קניון הראל מבשרת ציון‬
MEVASERET ZION
‫מבשרת ציון‬
90805
]/2[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
196
[57] Method for preparing a cross-linked
fibrillar collagen based matrix the method
comprising the steps of: providing a
fibrillar collagen based membrane
comprising reconstituted collagen fibrils;
reacting said membrane with a reducing
sugar under conditions wherein at least
some of the molecules of said collagen
fibrils become cross-linked to one another
forming a fibrillar collagen based matrix;
and subjecting said matrix to critical point
drying.
__________
]22[]12[
221221
‫גן פרוטיאז מוירוס פפיה רינגספוט‬
]1/[
PAPAYA RINGSPOT VIRUS
PROTEASE GENE
]11[
]/2[
23.11.1995
366490
]/1[ 30.12.1994
]//[ US
PCT/US95/07185
6/66062001
WO
Int. Cl.7 A01H 001/00, 005/00, C07K 014/08, C12H 1582, C12N 009/50, 015/57
CORNELL RESEARCH FOUNDATION,
INC., U.S.A.
SEMINIS VEGETABLE SEEDS, INC.,
U.S.A.
DR. SHLOMO COHEN & CO.,,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST,
‫ תל אביב‬,1146/ .‫ד‬.‫ ת‬, 104 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]12[
]/2[
]//[
[57] An isolated and purified DNA
molecule comprising essentially of DNA
encoding the NIa protease of the FLA.83
W-type strain of papaya ringspot virus or
an isolated and purified DNA molecule
comprising DNA encoding the NIa
protease of the USA P-type (HA
attenuated) strain of papaya ringspot virus.
__________
197
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
LIPID VESICLES WHICH BIND
APOPROTEINS, THERAPEUTIC
COMPOSITIONS CONTAINING
THEM AND USES THEREOF
]11[
]/2[
30.08.1996
08/521670
]/1[ 31.08.1995
6/2111//1
/266/62001
06266/6/0
/266/62001
Int. Cl.8 A61K 009/00, 009/127, 038/00
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/1997/007785
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]12[
]/2[
]//[
]//[
[57] A therapeutic lipoprotein
composition for intravenous administration
to a subject, prepared by: mixing small
unilamellar vesicles composed of
phosphatidylcholine phospholipids having
phase transition temperatures between
210321
‫וסיקולות ליפידיות הקושרים‬
‫ תכשירים לריפוי המכילים‬,‫אפופרוטאינים‬
‫אותן ושימושיהן‬
]//[
US
US
US
‫יישום חברה לפיתוח המחקר של‬
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
about -10o and 37oC with a mixture of
apoproteins consisting essentially of
apoproteins from classes A and C, under
conditions effective to form lipoprotein
particles composed of said vesicles and
associated A and C apoproteins.
__________
]22[]12[
210723
‫פפטידים סינתטיים המעכבים פעילות של‬
IL–6
]1/[
SYNTHETIC PEPTIDES THAT
INHIBIT IL-6 ACTIVITY
]11[
]/2[
26.09.1996
115453
]/1[ 28.09.1995
]//[ IL
22/60/
6266162000
IL
Int. Cl.8 A61K 038/04, 038/10, A61P 019/10, 035/00, 037/00, C07K 007/06, 007/08,
014/715
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
INTERLAB LTD.,,
,‫אינטר לאב בע"מ‬
KIRYAT WEIZMANN
‫ נס ציונה‬,‫קרית ויצמן‬
NES ZIONA 76110
]12[
]/2[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
198
[57] Peptide capable of inhibiting the
activity of IL-6, which peptide is selected
from the group consisting of the sequences
of the following residue ranges of SEQ ID
NO:1:135-148; 143-158; 13-23; 122-133;
114-133; and 148-157.
__________
]22[]12[
]1/[
COMPACT MULTISTAGE
SPARK-GAP SWITCH
]11[
]12[
]/2[
29.05.1998
Int. Cl.8 H01T 004/16
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY
LTD.
DR. MARK FRIEDMAN LTD.,
BEIT SAMUELOFF, 7 HAOMANIM
STREET
TEL AVIV
]//[
[57] A spark gap switch (28) comprising:
(a) a first substantially planar electrode
(20a) including a discharge portion (24a)
and a support portion (26a); and
(b) a second substantially planar electrode
(20b) parallel to and spaced apart from
said first electrode and including a
discharge portion (24b) and a support
portion (26b), said discharge portions
being mutually opposite, and said support
portions being mutually staggered; and
199
216111
‫קומות קומפקטי‬-‫מתג מרווח ניצוץ רב‬
,‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ‬
‫חיפה‬
,‫ד"ר מרק פרידמן ושות‬
‫ תל אביב‬,7 ‫בית שמואלוב רח' האומנים‬
(c) a third substantially planar electrode
(20c) parallel to said second electrode and
including a discharge portion (24c) and a
support portion (26c), said second
electrode being between said first electrode
and said third electrode and spaced apart
from said first electrode and said third
electrode, said discharge portions of said
second and third electrodes being mutually
opposite, said support portions of said
second and third electrodes being mutually
staggered.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
218233
‫תהליך לטיהור אנטגוניסט של רצפטור‬
E. COLI –‫ מ‬1–‫אנושי של אינטרלוקין‬
‫רקומביננטי‬
]1/[
PROCESS FOR THE
PURIFICATION OF HUMAN
INTERLEUKIN-1 RECEPTOR
ANTAGONIST FROM
RECOMBINANT E. COLI
]11[
]/2[
]12[
]/2[
]//[
]//[
21.05.1997
96109153.5
]/1[ 07.06.1996
]//[ EP
Int. Cl.8 C07K 001/00, 001/18, 014/54, C12N 001/21, C12R 001/19
GRUPPO LEPETIT S.P.A., ITALY
WO/1997/047650
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
[57] A process for purifying human
Interleukin-1 receptor antagonist (IL-1ra)
from a mixture made from a strain of
recombinant E. coli, which comprises:
(a) loading the mixture, which has been
buffered at a pH value lower than 6.2 and
optionally diluted to reduce its ionic
strength to a conductivity value lower than
3.0 mS/cm2, onto a cationic exchange
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
matrix and eluting with an aqueous
buffered solution having a pH value from
about 7.5 to 9.0 and an ionic strength such
that the conductivity value is lower than
3.0 mS/cm2 to obtain an eluate;
(b) applying the eluate directly onto an
anionic exchange matrix and eluting with
an aqueous buffered solution having a pH
value of about 7.5 to 9.0 and an ionic
200
strength such that the conductivity value is
higher than 9 mS/cm2 to obtain a second
eluate; and
(c) recovering IL-1ra from the second
eluate.
__________
]22[]12[
]1/[
NUCLEIC ACID MOLECULES
ENCODING IL-1/TNF- A –
ACTIVATED KINASE (ITAK),
ITAK POLYPEPTIDES, AND
METHODS OF MAKING THE
SAME
]11[
]/2[
]12[
]/2[
]//[
]//[
19.06.1997
633414
]/1[ 10.06.1996
Int. Cl.8 C12N 009/12, 015/54
IMMUNEX CORPORATION, U.S.A.
WO/1997/047750
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] An isolated nucleic acid molecule
comprising a sequence selected from the
group consisting of (a) the sequence of
nucleotides in SEQ ID:NO 1, from
nucleotide number 1 to nucleotide number
2940; (b) nucleic acid molecules capable
of hybridization to the complement of a
nucleic acid molecule of (a) under
218010
‫חומצת גרעין המקודדות לקינזה‬
ITAK ) ( ‫המשופעלת על ידי‬
ACTIVATED KINASE –a – TNF /1 –IL
‫ פוליפפטידים כאלה שיטות להכנתם‬,
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
conditions of moderate stringency and
which encode a polypeptide that is capable
of phosphorylating a beta-casein substrate;
and (c) nucleic acid molecules which are
degenerate, as a result of the genetic code,
with respect to the nucleic acid molecules
of (a) or (b).
__________
201
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
MODIFICATION OF EGG
COMPOSITION BY CHICKEN
FEED SUPPLEMENTS AND THE
RESULTING EGGS OBTAINED
]11[
]12[
]01[
]/2[
]//[
14.09.1995
Int. Cl.8 A23K 001/18
DIVISION FROM 115307
NIVA SHAPIRA
DR. MARK FRIEDMAN LTD.,
BEIT SAMUELOFF, 7 HAOMANIM
STREET
TEL AVIV
[57] An egg comprising:
(a) not more than 15.5% poly unsaturated
fatty acids of the egg's fatty acids of the
concentration;
217362
‫שינוי הרכב ביצים על–ידי תוספות למזון‬
‫עופות והביצים המתקבלות‬
‫ אביב‬-‫ תל‬,‫ניבה שפירא‬
,‫ד"ר מרק פרידמן ושות‬
‫ תל אביב‬,7 ‫בית שמואלוב רח' האומנים‬
(b) 2-11 mg vitamin E per 59 grams of
whole shell egg; and
(c) 10-60 μg of edible carotenoids per
gram of egg yolk.
__________
]22[]12[
217387
‫דסולפוראז הומוציסטאיני מהפרוטוזואה‬
‫טריכומונס ואגינלים ואסאים עבור‬
‫הומוציסטאין‬
]1/[
HOMOCYSTEINE
DESULPHURASE FROM THE
PROTOZOAN TRICHOMONAS
VAGINALIS AND ASSAY FOR
HOMOCYSTEINE
]11[
]/2[
]12[
23.08.1997
9617683.9
]/1[ 23.08.1996
]//[ GB
Int. Cl.8 A61K 038/51, A61P 035/00, C07K 016/40, C12N 001/15, 001/19, 001/21,
005/10, 009/88, 015/60, C12Q 001/527, C12R 001/90, G01N 033/68
THE UNIVERSITY COURT OF THE
UNIVERSITY OF GLASGOW,
UNITED KINGDOM
WO/1998/007872
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
]/2[
]//[
]//[
[57] Method of assaying homocyteine in
a sample comprising the steps of:
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
202
(a) contacting the sample with an enzyme
that catalyses the degradation of
homocysteine to release reaction products:
α-ketobutyrate, hydrogen sulphide and
ammonia, and
(b) determining any one of said reaction
products formed by enzyme degradation of
homocysteine by said enzyme.
__________
]22[]12[
217162
‫תכשיר לעין המכיל פקטור ניורוטרופי‬
‫לטיפול במחלה תיפקודית של עצב אופטי‬
]1/[
OPHTHALMIC COMPOSITION
CONTAINING A NEUROTROPHIC
FACTOR FOR TREATING AN
OPTIC NERVEFUNCTIONAL
DISORDER
]11[
]/2[
]12[
]/2[
12.09.1997
243179/96
]/1[ 13.09.1996
]//[ JP
Int. Cl.8 A61K 009/06, 009/08, 038/00, 038/18, A61P 027/06, C07K 014/475
ADVANCED MEDICINE RESEARCH
INSTITUTE, JAPAN
WO/1998/010785
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] Ophthalmic composition for treating
glaucoma by external administration which
comprises an effective amount of a brainderived neurotrophic factor for treating
glaucoma in combination with a
pharmaceutically acceptable carrier,
wherein the composition is a form selected
from the group consisting of an ophthalmic
solution and an ophthalmic ointment and
wherein the composition includes at least
one agent selected from the group
consisting of an isotonicity-imparting
agent, a viscosity-imparting agent, a
suspending agent, an emulsifier, a
preservative and a pH adjuster.
__________
203
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
VARIABLE FOCUS LENSES
]11[
]/2[
]12[
]/2[
09.09.1997
9619198.6
]/1[ 13.09.1996
Int. Cl.8 G02B 003/14
JOSHUA DAVID SILVER, UNITED
KINGDOM
WO/1998/011458
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]//[
[57] A method of fabricating a variable
focus lens, comprising the steps of:
providing a first ring (8) having a crosssection which is generally L-shaped, the
upper end of the L forming an axially
extending deformable rim; interengaging
second and third rings (10,12) to engage a
first transparent flexible membrane
(2) and to retain said first flexible
membrane across the second ring (10);
interengaging said first ring (8) with said
second and third rings (10, 12) to engage a
second transparent flexible membrane (2)
and to retain said second flexible
membrane across the second ring (10),
217132
‫עדשות בעלות פוקוס משתנה‬
]//[
GB
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
whereby the first and second flexible
membranes define a cavity therebetween,
the second and third rings being
accommodated in the angle of the L; and
holding said first, second and third rings
(8, 10, 12) together by deforming said rim
of the first ring (8) over the third ring (12),
such that said first and second flexible
membranes are each tensioned across said
second ring; the first, second and third
rings (8, 10, 12) all being formed from a
material sufficiently rigid to allow the
rings to positively interengage with an
adjacent ring.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
204
]22[]12[
]1/[
BLAST RESISTANT AND BLAST
DIRECTING CONTAINER
ASSEMBLIES
]11[
]/2[
]12[
]/2[
]//[
]//[
11.04.1997
717042
]/1[ 20.09.1996
Int. Cl.8 F42B 039/14
ALLIEDSIGNAL INC., U.S.A.
WO/1998/012496
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A blast resistant container assembly
for receiving an explosive (66), said
container assembly comprising:
(a) a container (70) of blast resistant
material, said container being collapsible
for storage when empty and comprising at
least three bands of blast resistant material,
a first inner band (62) being nested within
a second band which is nested within a
211280
‫מיכלים עמידים לפיצוץ ומכווני פיצוץ‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
third band (64), said bands being
orientated relative to one another to
substantially enclose a volume and to form
a container wall having a thickness
substantially equivalent to the sum of
thicknesses of at least two of the bands;
and
(b) blast mitigating material located within
the container.
__________
205
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
211216
‫נוגדן נגד פפטידים הקשורים לפאר את‬
‫הורמון אנושי‬
]1/[
ANTIBODY AGAINST HUMAN
PARATHORMONE RELATED
PEPTIDES
]11[
]/2[
24.09.1997
8/255196
]/1[ 26.09.1996
]//[ JP
0-12/20/
1/66/6200/
JP
Int. Cl.8 A61K 039/395, A61P 035/00, C07K 016/18, 016/26, 016/46, C12N 005/16,
015/13, 015/62, 015/63, C12P 021/08
CHUGAI SEIYAKU KABUSHIKI
KAISHA, JAPAN
WO/1998/013388
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
]12[
]/2[
]//[
]//[
[57] Chimeric L chain comprising a L
chain C region of a human antibody and an
L chain V region of a mouse monoclonal
antibody against a human parathyroid
hormone related protein, wherein the L
chain V region comprises the amino acid
sequence as shown in SEQ ID NO:45.
__________
]22[]12[
]1/[
]11[
]12[
]/2[
]//[
]//[
METHOD FOR DETECTING
ABNORMAL EPITHELIAL CELL
SHEDDING
04.02.1997
Int. Cl.8 A61K 049/00
PHANOS TECHNOLOGIES, INC.,
U.S.A.
WO/1998/033530
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A method for assessing the shedding
rate of mature surface epithelial cells on a
mucosal surface of the gastrointestinal
tract of a warm-blooded animal,
comprising applying to mature surface
202761
–‫שיטה לגילוי נשירת תאים אפיתליים לא‬
‫נורמלית‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
epithelial cells at a target site a labeling
composition comprising a dye, and
determining the rate at which the dye is
lost from the target site.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
206
]22[]12[
202282
‫ ואנלוגים שלהם‬X ‫מוטנטי המטה של גורם‬
‫ותכשירים המכילים אותם‬
]1/[
FACTOR X DELETION MUTANTS
AND ANALOGUES THEREOF
AND PREPARATIONS
CONTAINING THE SAME
]11[
]/2[
]12[
]/2[
27.02.1998
A336/97
]/1[ 27.02.1997
]//[ AT
Int. Cl.8 A61K 038/48, C12N 009/64, 015/57
BAXTER AKTIENGESELLSCHAFT,
AUSTRIA
WO/1998/038318
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A factor X deletion analogue
comprising a factor X amino acid sequence
in which amino acids Arg180 to Arg234 of
SEQ ID NO:44 are deleted, and having a
modification in said amino acid sequence
between Gly173 and Arg179 of SEQ ID
NO:44, said modification resulting in a
processing site for a protease that does not
naturally cleave between Gly173 and
Arg179 of SEQ ID NO:44.
__________
]22[]12[
202061
‫ בעלי אתר חיתוך‬X ‫אנלוגים של פקטור‬
‫פרוטאיז שעבר שינוי‬
]1/[
FACTOR X ANALOGUES HAVING
A MODIFIED PROTEASE
CLEAVAGE SITE
]11[
]/2[
]12[
]/2[
27.02.1998
A335/97
]/1[ 27.02.1997
]//[ AT
Int. Cl.8 A61K 038/48, C12N 009/64, 015/57
BAXTER AKTIENGESELLSCHAFT,
AUSTRIA
WO/1998/038317
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A factor X analogue characterized in
that it has a modification in the region of
the natural Factor Xa activation cleavage
site having the sequence Gly228-R6-R5R4-R3-R2-Arg 234-R1, said modification
207
representing a processing site for a
protease not naturally cleaving in this
region of the factor X sequence, and
wherein
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
(a) R1 is an amino acid selected from the
group consisting of lle, Val, Ser, Thr and
Ala,
(b) R2 is an amino acid selected from the
group consisting of Pro, Gly, Lys and Arg,
(c) R3 is an amino acid selected from the
group consisting of Phe, Lys, Met, Gln,
Ser, Val, Arg and Pro,
(d) R4 is an amino acid selected from the
group consisting of Asp, lle, Ser, Met, Pro,
Thr, Arg and Lys,
(e) R5 is an amino acid selected from the
group consisting of Asn, Lys, Ser, Glu,
Ala, Gln, His and Arg, and
(f) R6 is an amino acid selected from the
group consisting of Asp, Phe, Thr, Arg,
Leu and Ser.
__________
]22[]12[
]1/[
APPARATUS FOR INDUCING
FORCES BY FLUID INJECTION
]11[
]12[
]/2[
25.08.1999
Int. Cl.8 F15D 001/02, 001/04
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION
LTD.
YUVAL YASSOUR, DANIEL B.
LEVIN
MILLER-SIERADZKI ADV & PAT
ATT,
P.O.BOX 6145
HAIFA 31061
]/1[
]//[
[57] An apparatus for controlling a fluid
injection and in particular gaseous fluid
injection induced forces comprising: a high
pressure source (102); a high pressure
reservoir fluidically connected to said high
pressure source; an injection surface (104);
at least one of a plurality of conduits (1);
wherein the conduit has an outlet (3)
positioned on said injection surface and an
inlet (2) fluidically connected to said high
pressure reservoir and is provided with a
plurality of fins mounted on the internal
wall of said conduit said fins arranged in
two arrays (45) substantially opposite each
other; wherein each of the fins of either
one of said fin arrays excluding the fin
nearest to the inlet and the fin nearest to
the outlet of said conduit is positioned
substantially opposite to one of a plurality
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
202371
‫התקן ליצירת כוחות ע"י הזרקת נוזל‬
‫ חיפה‬,‫מוסד הטכניון למחקר ופיתוח בע"מ‬
‫ לוין‬.‫ דניאל ב‬,‫יובל יסעור‬
,‫שרצקי עו"ד ועו"פ‬-‫מילר‬
‫ חיפה‬,914. .‫ד‬.‫ ת‬, 10‫מחניים‬
of cavities each cavity defined between
two consecutive fins of one of said arrays
of fins and a portion of said conduit
internal walls; whereby when fluid flows
through said conduit a plurality of vortices
is facilitated within said cavities, each
vortex positioned in one at said cavities,
said vortices may exist at least temporarily
during said flow thus forming an
aerodynamic blockage allowing a central
core-flow between tips of the fins, thus
limiting the mass flow rate and
maintaining a substantial pressure drop
within the conduit, and when an object
blocks said outlet the flow stops and the
pressure drop is eliminated thus effectively
forcing the object away, and whereas when
said object almost blocks said outlet the
internal pressure drop through said conduit
208
is substantially increased with respect to a
gap between the injection surface and the
facing surface of said object thus said
conduit acts like a fluidic return spring
when injecting from close distance toward
an object (105).
__________
]22[]12[
201131
‫שיטה לביקוע חלבונים ממוזגים‬
]1/[
METHOD FOR CLEAVAGE OF
FUSION PROTEINS
]11[
]/2[
]12[
23.04.1998
60/044254
]/1[ 25.04.1997
]//[ US
Int. Cl.8 A61K 038/27, 038/58, C07K 014/61, 014/815, C12N 009/50, 015/15,
015/57, 015/62
SEMBIOSYS GENETICS INC.,
CANADA
WO/1998/049326
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]/2[
]//[
]//[
[57] A method for the preparation of a
recombinant polypeptide comprising:
(a) introducing into a host cell an
209
expression vector comprising:
(1) a nucleic acid sequence capable of
regulating transcription in a host cell,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
operatively linked to
(2) a chimeric nucleic acid sequence
encoding a fusion protein, the chimeric
nucleic acid sequence comprising (i) a
nucleic acid sequence encoding a propeptide derived from an autocatalytically
maturing zymogen, linked in reading
frame to (ii) a nucleic acid sequence
heterologous to the propetide and encoding
the recombinant polypeptide; wherein the
heterologous nucleic acid sequence is
located immediately downstream of the
nucleic acid sequence encoding the propeptide; operatively linked to
(3) a nucleic acid sequence encoding a
termination region functional in said host
cell,
(b) growing the host cell to produce said
fusion protein; and
(c) altering the environment of the fusion
protein so that the pro-peptide is cleaved
from the fusion protein to release the
recombinant polypeptide.
__________
]22[]12[
201327
‫תולדות איזוניטריל ותהליכים להכנתן‬
]1/[
ISONITRILE DERIVATIVES AND
PROCESSES FOR THE
PREPARATION THEREOF
]11[
]/2[
14.05.1998
197202160
]/1[ 14.05.1997
]//[ DE
20/162011
2/6616200/
DE
Int. Cl.8 C07C 291/10, C07F 005/06, 007/08, 009/16, 009/28, 009/30, 009/38, C07H
021/00
MORPHOCHEM AG, GERMANY
WO/1998/051697
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
]//[
[57] A compound of the formula
wherein X has the structure:
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
210
and each PG independently of any others is
an optionally orthogonal protecting group;
each of the radicals R6 independently of
any others represents a hydrogen atom, an
unsubstituted or substituted alkyl,
cycloalkyl, alkoxyalkyl or aryl group or a
heterocycle;
the radicals U, W, K and Y each
independently of the others represents an
unsubstituted or substituted alkyl alkanyl,
alkynyl, alkanoyl, alkoxyalkanoyl,
cycloalkyl or aryl group, an unsubstituted
or substituted heterocycle or the group
NR5, wherein R6 is as defined above;
a, b, c, n, o and p each independently of
the others is an integer from 0 to 10;
Q is a 2, 3 or 4 valent component and is an
unsubstituted or substituted alkyl, aryl,
alkenyl, alkynyl, mono- or polyvalent
alkanoyl, cycloalkyl, alkoxyalkanoyl,
cycloalkanoyl or aroyl group or an
unsubstituted or substituted heterocycle, or
one of the groups NR5, P, P(O), P(S), B,
BR5 and SO2, wherein R5 is as defined
above.
__________
]22[]12[
200112
‫התקן ושיטה לחיבור זרמי חוזי דיגיטלי‬
]1/[
APPARATUS AND METHOD OF
SPLICING DIGITAL VIDEO
STREAMS
]11[
]/2[
]12[
]/2[
]//[
]//[
02.04.1999
055156
]/1[ 04.04.1998
]//[ US
Int. Cl.8 H03M 007/30, H04J 003/06, H04L 013/08, H04N 007/24
OPTIBASE LTD.
‫ הרצליה‬,‫אופטיבייס בע"מ‬
WO/1999/052067
PEARL COHEN ZEDEK LATZER,
‫ עורכי פטנטים‬,‫פרל כהן צדק לצר עורכי דין‬
5 SHENKAR STREET,
,‫ונוטריונים‬
P.O.BOX 12704
,107/4 .‫ד‬.‫ ת‬, .‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
HERZLIYA 46733
‫הרצליה‬
[57] A method for splicing digitally
encoded data streams, including an old
data stream and a new data stream,
comprising:
(a) without the use of a clock reference
signal, modifying a current timing
reference of the new data stream to
correspond with a splice-out point of the
old data stream and a splice-in of the new
data stream, thereby forming a modified
new data stream timing reference, wherein
said modified new data stream timing
reference further corresponds with a timing
211
gap between a first decoding time for
decoding a last frame of the old data
stream and a second decoding time for
decoding a first frame of the new data
stream; and
(b) aligning a portion of the new data
stream with a portion of the old data
stream according to said modified new
data stream timing reference, such that a
transition from the old data stream to the
new data stream, during playback, will be
substantially imperceptible.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
206210
‫שימוש משולב של כרום וביוטין להכנת‬
‫תכשיר רוקחי ומכשירים כאלה‬
]1/[
USE OF CHROMIUM IN
COMBINATION WITH BIOTIN
FOR THE PREPARATION OF
PHARMACETUTICAL
COMPOSITION AND SUCH
COMPOSITIONS
]11[
]/2[
31.07.1998
908819
]/1[ 08.08.1997
]//[ US
226122
6066/6200/
US
Int. Cl.8 A61K 033/00, 033/24, A61P 003/10
NUTRITION 21, U.S.A.
WO/1999/007387
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] Use of synthetic chromic
tripicolinate in an amount between 50 and
1000μg per day of chromium in
combination with between 25μg and
200mg per day of biotin where the
amounts of chromic tripicolinate and biotin
are selected together to provide a greater
than additive effect, in the manufacture of
a combined preparation for simultaneous,
separate, or sequential administration to an
individual for reducing hyperglycaemia
and stabilizing the level of serum glucose.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
212
]22[]12[
206822
‫ גלוקוראונידאז מיקרוביאלי‬β
]1/[
MICROBIAL Β GLUCURONIDASE
]11[
]/2[
]12[
]/2[
09.09.1998
60/058263
]/1[ 09.09.1997
]//[ US
Int. Cl.8 A01K 067/00, C12N 009/24, 015/03, 015/31, 015/82
CENTER FOR THE APPLICATION
OF MOLECULAR BIOLOGY IN
INTERNATIONAL AGRICULTURE,
AUSTRALIA
WO/1999/013085
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] An isolated nucleic acid molecule
comprising a nucleic acid sequence
encoding a secreted form of microbial
Bacillus β-glucuronidase.
__________
]22[]12[
206878
‫מלחי תוספות לחומצות של מורפין‬
‫אלקלואידים' הכנתם ותכשירי רוקחות‬
‫המכילים אותם לנתינה דרך העור ודר הריר‬
]1/[
ACID ADDITION SALTS OF
MORPHINE ALKALOIDS, THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM FOR TRANDERMAL AND
TRANSMUCOSAL APPLICATION
]11[
]/2[
05.09.1998
197422969
]/1[ 25.09.1997
]//[ DE
20///6611
1066/6200/
DE
Int. Cl.8 A61K 031/485, 035/00, A61P 025/30, 029/00, C07D 489/00
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/1999/015528
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
]//[
213
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
[57] Analgesic acid addition salts of
morphine alkaloid and organic acid, said
morphine alkaloid of the formula
where R1 is selected from the group
consisting of H, C1- to C6-alkyl residues,
preferably methyl, ethyl-, propyl, i-propyl,
C(O)CH3; R2 is selected from the group
consisting of the monad residues H, OH,
OC(O)CH3, whereby in this case the fourth
valence of the (6)-C atom is occupied by
H, or the dyad residues =O, =CH2; R3 is
selected from the group consisting of –
CH3, cyclopropyl, cyclobutyl and allyl;
and where the bond at C7/C8 may be
saturated, or a nitroxyl group may be
present at N17, characterized in that said
organic acid is selected from monoesters
of C3- to C16-dicarboxylic acids with
monohydric C1- to C4-alcohols, especially
methanol, C2- to C6- or C8- to C16- sulfonic
acids, the group of halogen, p- and mhydroxyl, alkyl, hydroxyalkyl, alkoxyalkyl
and/or alkoxy- substituted benzoic acids,
as well as of the aminosubstituted benzoic
acids, which may optionally be alkylated at
the N atom, substituted or non- substituted
5-ring or 6-ring heterocycles comprising at
least one N or S atom and having a
carboxyl group function, especially a
carboxy, carboxymethyl, carboxyethyl or
the optionally branched carboxypropyl or
carboxybutyl groups as substituents,
saturated or unsaturated, optionally
substituted, oxo-carboxylic acids having 5
to 10 C atoms, phenoxy- substituted
saturated C2- to C4-carboxylic acids,
aliphatic, aromatic or heterocylic C2- to
C12-amino acids, wherein one amino group
is substituted with an optionally substituted
C2- to C6-alkanoyl group or an optionally
substituted benzoyl group, and in that the
acid addition salt has a skin permeability
with a flux of at least 2.34 μg/cm2.h.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
206117
214
‫פוליפפטידים מופרשים וטרנסממברנליים‬
‫וחומצות גרעין המקודדות עבורם‬
]1/[
SECRETED AND
TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC
ACIDS ENCODING THE SAME
]11[
]/2[
16.09.1998
60/059122
]/1[ 17.09.1997
]//[ US
06261022/
2/6606200/
US
06261022/
2/6606200/
US
062610221
2/6606200/
US
0626102//
2/6606200/
US
062610212
2/6606200/
US
062610220
2/6606200/
US
06261010/
2/6606200/
US
062610100
2/6606200/
US
062601211
216266200/
US
0626011//
2/6266200/
US
0626011/1
2/6266200/
US
06260///0
126266200/
US
062601/20
1/6266200/
US
06260/212
1/6266200/
US
06260/6/1
1/6266200/
US
06260/21/
1/6266200/
US
062601/2/
1/6266200/
US
06260/21/
1/6266200/
US
06260/216
1/6266200/
US
06260//10
1/6266200/
US
06260//1/
1/6266200/
US
06260/1/0
1/6266200/
US
06260/1/2
1/6266200/
US
06260/116
1/6266200/
US
06260/1/1
1/6266200/
US
06260/1//
1/6266200/
US
06260/10/
1/6266200/
US
06260////
106266200/
US
06260/121
106266200/
US
06260///1
106266200/
US
06260///1
106266200/
US
06260////
106266200/
US
06260//6/
106266200/
US
06260///1
106266200/
US
06260/26/
/26266200/
US
06260///6
/26266200/
US
06260/1//
6/6226200/
US
06260//60
6/6226200/
US
0626012/0
216226200/
US
062601//0
2/6226200/
US
Int. Cl.8 C07K 014/47, 014/705, 016/18, 016/28, C12N 015/12, 015/52, 015/62
GENENTECH, INC., U.S.A.
WO/1999/014328
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] An isolated nucleic acid molecule
having at least 80% sequence identity to a
nucleotide sequence which encodes a
215
polypeptide comprising an amino acid
sequence which has the amino acid
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
sequence shown in Figure 2 (SEQ ID
NO:2) as shown in the specification.
__________
]22[]12[
203276
‫מערכת להקצבת רוחב סרט‬
]1/[
BANDWIDTH ALLOCATION
SYSTEM
]11[
]/2[
]12[
]/2[
]/1[
]//[
20.03.2000
283598
]/1[ 01.04.1999
]//[ US
Int. Cl.8 H04H 001/00, H04N 007/12, 007/173
NDS LIMITED, UNITED KINGDOM
SHLOMO KIPNIS, STEVE EPSTEIN
‫ סטיב אפשטיין‬,‫שלמה קיפניס‬
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
[57] A bandwidth allocation method
comprising: receiving user information
characterizing preferences of a plurality of
broadcast item users; processing the user
information to produce community
information, the community information
comprising, for each one of a plurality of
communities, community profile
information; assigning a bandwidth to each
one of the plurality of communities;
assigning an item profile to each of a
plurality of items to be broadcast; and
choosing at least some of the plurality of
items to be broadcast based, at least in
part, on a measure of affinity between each
of the plurality of items to be broadcast
and the community profile information for
one of the plurality of communities, and, at
least in part, on the bandwidth assigned to
each one of the plurality of communities.
__________
]22[]12[
]1/[
GLOBAL ACCESS SYSTEM OF
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
203667
‫מערכת גישה גלובלית של מידע‬
216
‫הקשור למולטי–מדיה‬
MULTI-MEDIA RELATED
INFORMATION
]11[
]/2[
]12[
]/2[
]//[
]//[
14.08.1998
9/284084 ]/1[ 16.10.1997 ]//[
26212221
6/66/6200/
Int. Cl.8 G06F 007/08
DENTSU INC., JAPAN
WO/1999/021186
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.
P.O.B. 1426
TEL AVIV 61013
[57] A system for granting access to
selected information of a library of
multimedia, said system comprising:
(a) a memory for storing said library of
multimedia;
(b) a data input device for entering a set of
information attributes for said multimedia
stored in said memory;
The
applications
for division
from this
application
have not yet
been
published
JP
JP
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1409 .‫ד‬.‫ ת‬, :1 ‫רח' יבנה‬
(c) a data retriever for retrieving
information about a particular medium of
said library in accordance with said
entered attribute; and
(d) an output device for providing said
retrieved information.
574414457441445744143574414257441475744140574414957441445744141
‫בקשות‬
‫חלוקה‬
‫מבקשה זו‬
‫שטרם‬
4‫פורסמו‬
___________
]22[]12[
217
203128
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫מנגנון הרחבה המודע לאיכות שירות‬
]1/[
EXPANSION MECHANISM
AWARE OF QUALITY OF
SERVICE
]11[
]/2[
]12[
]/2[
01.05.2000
9916329.7
]/1[ 12.07.1999
Int. Cl.8 H04L 012/56, H04Q 011/04
VIRATA LIMITED, UNITED
KINGDOM
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
[57] Data communication system
comprising a plurality of peripherals
having respective interfaces, the interfaces
having device drivers and being coupled to
a common bus for communication with a
management system; the communication
including data transport in real time
whereby management of each interface
depends on the type of interface and on the
type of data being transported, the
interfaces have different real time
requirements; characterised in that an
]//[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
ATM SAR and scheduler is provided
which employs a predefined PHY level
interface with different levels of service,
the PHY interface being used as a QoS
(Quality of Service) aware common
master-slave bus for the peripherals which
act as slave devices, whereby respective
device driver requirements are simplified
or eliminated based on using ATM
scheduling and QoS properties for each
peripheral.
__________
]22[]12[
]1/[
CARBOXYLIC ACID
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
201828
‫הטרוציקלים מותמרות בחומצה‬
218
SUBSTITUTED HETEROCYCLES
AS METALLOPROTEINASE
INHIBITORS
]11[
]/2[
]12[
]/2[
]//[
]//[
‫קרבוקסילית כמעכבי מטלופרוטאינאז‬
18.12.1998
60/068200
]/1[ 19.12.1997
]//[ US
12/6/2
206216200/
US
Int. Cl.8 A61K 031/55, A61P 043/00, C07D 223/12
AMGEN, INC., U.S.A.
WO/1999/032452
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
[57] A compound of the formula
or a pharmaceutically acceptable salt
thereof, wherein
m is 1 or 2; and n is 0, 1 or 2;
R1 is (1) an alkyl, alkenyl, alkynyl,
cycloalkyl or heterocyclyl radical
optionally substituted by 1-3 radicals of –
OH, -OR3, -SR3, -S(O)R3, -S(O)2R3, C(O)R3,
-NR3R4, aryl, heteroaryl, cycloalkyl or
heterocyclyl; or (2) an aryl radical
optionally substituted by an optionally
substituted monocyclic heteroaryl or
heterocyclyl radical of 5-6 ring members
which is optionally substituted by a phenyl
radical or monocyclic heteroaryl radical of
5-6 ring members; or (3) a heteroaryl
radical optionally substituted by an
optionally subsituted phenyl or a
monocyclic heteroaryl or heterocyclyl
radical of 5-6 ring members which is
optionally subsituted by phenyl radical or
219
monocyclic heteroaryl radical of 5-6 ring
members; wherein the phenyl, aryl,
heteroaryl, cycloalkyl and heterocyclyl
radicals of (1), (2) and (3) are optionally
substituted by 1-3 radicals of hydroxyl, OR3, -SR3, -S(O)R3, -S(O)2R3, -C(O)R3, NR3R4, amino, alkanoylamino,
alkylsulfonylamino, alkoxycarbonylamino,
alkoxycarbonyl, cyano, halo, azido, alkyl
or haloalkyl; provided that the total
number of phenyl, aryl, heteroaryl,
cycloalkyl and heterocyclyl radicals in R1
is 0-3; wherein each R3 is independently an
alkyl, haloalkyl, aryl, heteroaryl, aryl-alkyl
or heteroaryl-alkyl radical, wherein the
aryl and heteroaryl radicals are optionally
substituted by 1-3 radicals of hydroxy,
alkoxy, alkylthiol, amino, alkanoylamino,
alkylsulfonylamino, alkylsulfinyl,
alkylsulfonyl, alkoxycarbonylamino,
alkyoxcarbonyl, cyano, halo, azido, alkyl,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
haloalkyl or haloalkoxy; and each R4 is
independently a hydrogen or alkyl radical;
R11 is a –C(O)-R31, -C(O)-OR30, -C(O)NR32R31, -S(O)2-NR32R31 radical; R5 and
R6 are each independently a hydrogen or
alkyl radical; or CR5-C6 is C=C; wherein
R9 and R10 are each independently –B-A,
provided that the combined total number
of aryl, heteroaryl, cycloalkyl and
heterocyclyl radicals in R9, R10 and R11 is
0-3; wherein each B is independently a
(1) bond;
(2) alkyl, alkenyl or alkynyl radical
optionally substituted by (a) 1-3 radicals of
amino, alkylamino, dialkylamino,
alkanoylamino, alkoxycarbonylamino,
alkylsulfonylamino, hydroxy, alkoxy,
alkylthio, cyano, or halo, and/or (b) 1-2
radicals of heterocyclyl, aryl or heteroaryl
optionally substituted by 1-3 radicals of
amino, alkylamino, di-alkylamino,
alkanoylamino, alkoxycarbonylamino,
alkylsulfonylamino, hydroxy, alkoxy,
alkylthio,cyano, alkyl, haloalkyl or
haloalkoxy; or
(3) aryl or heteroaryl radical optionally
substituted by 1-3 radicals of amino,
alkylamino, dialkylamino, alkanoylamino,
alkoxycarbonylamino, alkylsulfonylamino,
alkoxycarbonyl, hydroxy, alkoxy,
The applications for division
from this application have
not yet been published
alkylthio, cyano, halo, azido, alkyl,
haloalkyl or haloalkoxy;
each R31 is independently hydrogen radical
or R30;
wherein each R32 is independently
(1) hydrogen radical;
(2) alkyl, alkenyl or alkynyl radical
optionally substituted by 1-3 radicals of
amino, alkylamino, dialkylamino,
hydroxyl, alkoxy, alkylthio, cyano or halo;
or
(3) aryl, heteroaryl, arylalkyl,
heteroarylalkyl, heterocyclyl,
heterocyclyalkyl, cycloalkyl or
cycloalkylalkyl radicals optionally
substituted by 1-3 radicals of amino,
alkylamino, dialkylamino, hydroxy,
alkoxy, alkylthio, cyano, alkyl, haloalkyl
or haloalkoxy; and
each R34 is independently hydroxy, alkyl,
aryl, heteroaryl, arylalkyl or
heteroarylalkyl radical, wherein the aryl
and heteroaryl radicals are optionally
substituted by 1-3 radicals of amino,
alkylamino, dialkylamino, alkanoylamino,
alkoxycarbonylamino, alkylsulfonylamino,
hydroxy, alkoxy, alkylthio, alkylsulfinyl,
alkylsulfonyl, cyano, halo, alkyl, haloalkyl
or haloalkoxy.
5742443
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]1/[
OPIOID AGONIST/ANTAGONIST
COMBINATIONS
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
201726
‫צירופים של אגוניסט אופיאודי ואנטגוניסט‬
‫לחומר זה‬
220
]11[
]/2[
]12[
]/2[
]/1[
]//[
]//[
22.12.1998
60/068480
]/1[ 22.12.1997
]//[ US
Int. Cl.8 A61K 009/00, 009/20, 009/48, 045/00, 045/06
EURO-CELTIQUE S.A.,
LUXEMBOURG
ROBERT F. KAIKO, ROBERT D.
COLUCCI
WO/1999/032119
SOROKER-AGMON,
,‫אגמון‬-‫סורוקר‬
14 SHENKAR STREET,
‫ הרצליה פיתוח‬,14 ‫בית נולטון רחוב שנקר‬
HERZLIYA PITUAH 46725
[57] An oral dosage form, comprising an
orally therapeutically effective dose of an
opioid agonist, and an opioid antagonist,
the dosage form having a ratio of opioid
antagonist to opioid agonist that provides a
combination product which is
analgesically effective when the
combination is administered orally, but
which (i) is aversive in physically
dependent human subjects when
administered at the same dose or at a
higher dose than said therapeutically
effective dose; and (ii) maintains an
analgesic effect but does not increase
analgesic efficacy of the opioid agonist
relative to the same therapeutic dose of
opioid analgesic when administered to
human patients without said opioid
antagonist.
5740074
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
____________
]22[]12[
]1/[
221
ORAL PHARMACEUTICAL
EXTENDED RELEASE DOSAGE
FORM
201718
‫צורת מינון פרמצבטית למתן דרך הפה‬
‫בעלת שחרור מוארך‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]11[
]/2[
]12[
]/2[
]/1[
]//[
]//[
17.12.1998
9704869-8
]/1[ 22.12.1997
]//[ SE
Int. Cl.8 A61K 009/00, 009/20, 009/22, C07D 471/02, 495/02
ASTRAZENECA AB, SWEDEN
PER-GUNNAR KAREHILL, PER
JOHAN LUNDBERG
WO/1999/032091
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
[57] An enteric coated pharmaceutical
extended release dosage form of a H+, K+ATPase inhibitor, characterized in that the
dosage form comprises a core material of a
hydrophilic matrix or a hydrophobic
matrix resulting in an extended release of
the H+, K+- ATPase inhibitor for a
minimum of 2 and a maximum of 12 hours
and the H7, K+ - ATPase inhibitor, and that
the H+, K+ -ATPase inhibitor is a
compound of formula I, an alkaline salt
thereof, one of the single enantiomers
thereof or an alkaline salt of one of the
enantiomers of a compound of formula I
wherein
N in the benzimidazole moiety means that
one of the ring carbon atoms substituted by
R6-R9 optionally may be exchanged for a
nitrogen atom without any substituents; R1,
R2 and R3 are the same or different and
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
222
selected from hydrogen, alkyl, alkoxy
optionally substituted by fluorine,
alkylthio, alkoxyalkoxy, dialkylamino,
piperidino, halogen, phenyl, and
phenylalkoxy;
R4 and R5 are the same or different and
selected from hydrogen, alkyl and
arylalkyl;
R6 is hydrogen, halogen, trifluoromethyl,
alkyl or alkoxy;
R6-R9 are the same or different and
selected from hydrogen, alkyl, alkoxy,
halogen, halo-alkoxy, alkylcarbonyl,
alkoxycarbonyl, oxazolinyl, trifluoroalkyl,
or adjacent groups R6-R9 form ring
structures which may be further
substituted; R10 is hydrogen or forms an
alkylene chain together with R3; and
R11 and R12 are the same or different and
selected from hydrogen, halogen or alkyl.
__________
]22[]12[
208237
‫קליטה‬/‫התקן ושיטה לשידור‬
]1/[
APPARATUS AND METHOD FOR
TRANSMISSION/RECEPTION
]11[
]/2[
08.11.1999
10-316417
]/1[ 06.11.1998
]//[ JP
22-116/1/
6/66/62000
JP
Int. Cl.8 H04B 014/00, H04J 011/00, H04L 027/04, 027/12, 027/20, 027/22
MATSUSHITA ELECTRIC
INDUSTRIAL CO., LTD., JAPAN
WO/2000/028688
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] A transmission method comprising
the steps of: inputting a first information
sequence comprising a plurality of bits in
series and a second information sequence
comprising a plurality of bits in series
through different routes, dividing each of
the first information sequence and the
second information sequence so as to
generate a sequence of bits including at
least one bit of the first information
sequence and at least one bit of the second
information sequence, in which the first
information sequence is more important
than the second information sequence; and
223
modulating the sequence of bits to provide
a transmission signal in such a way that
each of the symbols is expressed using
three or more bits on an orthogonal
coordinate system including an in-phase
component and a quadrature component,
wherein a bit corresponding to the first
information sequence is arranged on at
least the first bit of each of the symbols,
and bits corresponding to the first
information sequence are arranged on both
the first bit and the second bit of at least
one of the symbols.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
DEVICE FOR RECORDING AN
ELECTROCARDIOGRAM
]11[
]/2[
]12[
]/2[
]//[
]//[
27.01.1999
98/00919
]/1[ 28.01.1998
Int. Cl.8 A61B 005/04
MGI S.A.S., FRANCE
WO/1999/038436
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A device for recording an
electrocardiogram including a portable
housing and means for acquiring,
processing and storing electrical signals
delivered by electrodes positioned so that
they may be applied on the patient's
thorax, characterized in that said housing
has a first series of three metal electrodes
(4, 5, 6) positioned so that they may be
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
208326
.‫ג‬.‫ק‬.‫מכשיר להקלטת א‬
]//[
FR
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
applied on the patient's thorax, for
acquiring three precordial signals and a
second series of two metal electrodes (7, 8)
positioned so that the fingers may be
applied thereon, for acquiring two
peripheral signals, as well as a skin
electrode for acquiring a third peripheral
signal, connected to the housing by a
connecting cable.
224
__________
]22[]12[
208717
–‫–אמינואטיל‬4–‫תהליך עבור הכנת‬
‫ און מוגן‬:–‫פירולידין‬
]1/[
PROCESS FOR PREPARING
PROTECTED 4-AMINOMETHYLPYRROLIDIN-3-ONE
]11[
]/2[
04.03.1999
1998/7079
]/1[ 04.03.1998
]//[ KR
200/2//0/0
206266200/
KR
Int. Cl.8 C07D 207/22, 207/24, 207/36, 471/04
LG LIFE SCIENCES LTD.,
REPUBLIC OF KOREA
WO/1999/044991
DR. YITZHAK HESS & PARTNERS,
,‫ עו"פ‬,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON STREET
‫ תל אביב‬,94.1 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
P.O.B. 6451
TEL AVIV 61063
]12[
]/2[
]//[
]//[
[57] A process for preparing a compound
of the formula
225
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
in which P1 and P2 are protecting groups, comprising
(a) reaction of a compound of the formula
wherein P1 is as defined for formula (1);
with a Raney-nickel catalyst in a solvent
under hydrogen to produce a compound of
the formula
wherein P1 is as defined for formula (1);
(b) protecting the amino group to produce
a compound of the formula
wherein P1 and P2 are as defined for
formula (1); and
(c) selective reduction of the double bond
to produce the compound of formula (1).
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
226
]22[]12[
208116
–]‫–אינדן‬.',1–‫תרכובות ספירו[ציקלופרופן‬
‫)–און בעלות פעילות נגד גידולים‬H'6(7'
]1/[
SUBSTITUTED
SPIRO[CYCLOPROPANE-1,5'INDEN]-7'(6'H)-ONE COMPOUNDS
HAVING ANTI-TUMOR
ACTIVITY
]11[
]/2[
]12[
19.02.1999
026633
]/1[ 20.02.1998
]//[ US
Int. Cl.8 A61K 031/04, 031/095, 031/122, 031/13, 031/185, 031/195, 031/21,
031/357, 031/403, 031/435, 031/5375, 038/05, 038/06, 038/07, 038/08, 038/10, A61P
035/00, 035/02, 035/04, C07C 049/497, 049/517, 049/737, 049/753, 059/76, 062/38,
069/013, 069/73, 069/757, 205/44, 225/14, 225/20, 235/40, 323/22, 323/23, 323/58,
323/59, 323/60, C07D 207/16, 211/08, 265/28, 317/44, 401/04, 401/12, 405/04,
405/12, 413/04, 413/12, C07K 005/02, 005/06, 005/10, 007/00
REGENTS OF THE UNIVERSITY OF
CALIFORNIA, U.S.A.
WO/1999/042429
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]/2[
]//[
]//[
[57] A compound of the formula:
wherein
R1 is hydrogen, hydroxy, mercapto, amino,
halo, carboxy, nitro, or –(CH2)n-(X)-(Y);
n is 0 to 4;
X is oxy, thio, -N(R2)-, or absent;
Y is (C3-C6) cycloalkyl, aryl, heteroaryl, a
saccharide, an amino acid, a peptide, or a 1
to 15 membered branched or unbranched
carbon chain optionally comprising 1, 2 or
3 non-peroxide oxy, thio, or –N(Ra)-;
wherein said chain may optionally be
substituted on carbon with 1, 2 or 3, oxo,
hydroxy, carboxy, halo, mercapto, nitro, -
227
N(Rb)(Rc), (C3-C6) cycloalkyl, aryl,
heteroaryl, saccharides, amino acids, or
peptides; and wherein said chain may
optionally be saturated or unsaturated;
R2 is carboxy, (C1-C6) alkanoyl, (C1-C6)
alkoxycarbonyl, halo (C1-C6) alkyl, C(=O)NRdRe, a saccharide, an amino acid,
a peptide, or (C1-C6) alkyl substituted by 1
or 2 hydroxy, (C1-C6) alkoxy, (C1-C6)
alkanoyloxy, carboxy, amino acids,
peptides, saccharides, or – C(=O)NRdRe;
R3 is hydrogen, (C1-C6) alkyl, (C1-C6)
alkoxy, (C1-C6) alkylthio, aryl, heteroaryl,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
aryloxy, or heteroaryloxy; R4 is hydrogen
or (C1-C6) alkyl; and R5 is hydroxy, (C1C6) alkoxy, or (C1-C6) alkanoyloxy; or R4
and R5 taken together are ethylendioxy;
R6 is hydrogen, carboxy, (C1-C6) alkanoyl,
(C1-C6) alkoxycarbonyl, halo (C1-C6)
alkyl, -C(=O)NRfRg,a saccharide, an
amino acid, a peptide, or (C1-C6) alkyl
optionally substituted 1 or 2 hydroxy, (C1C6) alkoxy, (C1-C6) alkanoyloxy, carboxy,
amino acids, peptides, saccharides, or –
C(=O)NRfRg;
Ra is hydrogen, (C1-C6) alkyl, (C1-C6)
alkanoyl, phenyl or benzyl; and Rb, Rc, Rd,
Re, Rf and Rg are each independently
hydrogen, (C1-C6) alkyl, (C1-C6) alkanoyl,
phenyl or benzyl; or Rb and Rc, Rd and Re,
or Rf and Rg, together with the nitrogen to
which they are attached, are pyrrolidino,
piperidino, or morpholino; wherein any
aryl, heteroaryl, aryloxy, or heteroaryloxy
of Y, or R3 may optionally be substituted
by 1, 2 or 3 (C1-C6) alkyl, (C1-C6) alkoxy,
(C1-C6) alkanoyl, (C1-C6) alkanoyloxy,
(C1-C6) alkoxycarbonyl, hydroxy (C1-C6)
alkyl, halo (C1-C6) alkyl, hydroxy, halo,
carboxy, mercapto, nitro, -N(Rh)(Rj);
wherein each Rh and Rj is independently
hydrogen, (C1-C6) alkyl, (C1-C6) alkanoyl,
phenyl or benzyl; or Rh and Rj together
with the nitrogen to which they are
attached are pyrrolidino, piperidino, or
morpholino;
or a pharmaceutically acceptable salt
thereof, or a compound of the formula:
wherein
R2 is (C1-C6) alkyl;
R3 is hydrogen, (C1-C6) alkyl, (C1-C6)
alkoxy, (C1-C6) alkylthio, aryl, heteroaryl,
aryloxy, or heteroaryloxy;
R4 is hydrogen or (C1-C6) alkyl; and R5 is
hydrogen, (C1-C6) alkoxy, or (C1-C6)
alkanoyloxy; or R4 and R5 taken together
are ethylenedioxy; R6 is hydrogen,
carboxy, (C1-C6) alkanoyl, (C1-C6)
alkoxycarbonyl, halo (C1-C6) alkyl, C(=O)NRfRg, a saccharide, an amino acid,
a peptide, or (C1-C6) alkyl optionally
substituted by 1 or 2 hydroxy, (C1-C6)
alkoxy, (C1-C6) alkanoyloxy, carboxy,
amino acids, peptides, saccharides, or –
C(=O)NRfRg;
R7 is carboxy, (C1-C6) alkanoyl, (C1-C6)
alkoxycarbonyl, halo (C1-C6) alkyl, -
C(=O)NRdRe, a saccharide, an amino acid,
a peptide, or (C1-C6) alkyl subsituted by 1
or 2 hydroxy, (C1-C6) alkoxy, (C1-C6)
alkanoyloxy, carboxy, amino acids,
peptides, saccharides, or – C(=O)NRdRe;
Rd, Re, Rf and Rg are each independently
hydrogen, (C1-C6) alkyl, (C1-C6) alkanoyl,
phenyl or benzyl; or Rd and Re, or Rf and
Rg, together with the nitrogen to which
they are attached, are pyrrolidino,
piperidino, or morpholino; wherein any
aryl, heteroaryl, aryloxy, or heteroaryloxy
of R3 may optionally be substituted by 1,
2, or 3 (C1-C6) alkyl, (C1-C6) alkoxy, (C1C6) alkanoyl, (C1-C6) alkanoyloxy, (C1-C6)
alkoxycarbonyl, hydroxy (C1-C6) alkyl,
halo (C1-C6) alkyl, hydroxy, halo, carboxy,
mercapto, nitro, or –N(Rh)(Rj); wherein
each Rh and Rj is independently hydrogen,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
228
(C1-C6) alkyl, (C1-C6) alkanoyl, phenyl or
benzyl; or Rh and Rj together with the
nitrogen to which they are attached are
pyrrolidino, piperidino, or morpholino; or
a pharmaceutically acceptable salt thereof.
__________
]22[]12[
207030
‫שיטות לגילוי יחסי גומלין בין חלבון לחלבון‬
]1/[
METHOD FOR DETECTING
PROTEIN-PROTEIN
INTERACTIONS
]11[
]/2[
26.03.1999
60/079480
]/1[ 26.03.1998
]//[ US
6/0/11
1/66/6200/
US
Int. Cl.8 C12N 015/11, 015/62, 015/81, G01N 033/48
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/1999/049294
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] A method for detecting an
interaction between a first test protein and
a second test protein, comprising:
(a) providing yeast or bacterial host cells
of opposite mating type, one or both of
which contain a reporter gene which
expresses a detectable protein when the
reporter gene is activated by an amino acid
sequence including a transcriptional
activation domain when the transcriptional
activation domain is in sufficient proximity
to the reporter gene;
(b) providing a first chimeric gene the first
chimeric gene comprising a DNA
sequence that encodes a first hybrid
protein, the first hybrid protein
comprising:
(i) a DNA-binding domain that recognizes
a binding site on the reporter gene in the
host cell; and
229
(ii) a first test protein or fragment thereof
that is to be tested for interaction with at
least one second test protein or fragment
thereof;
(c) providing a second chimeric gene, the
second chimeric gene comprising a DNA
sequence that encodes a second hybrid
protein, the second hybrid protein
comprising:
(i) the transcriptional activation domain;
and
(ii) a second test protein or fragment
thereof that is to be tested for interaction
with the first test protein or fragment
thereof; wherein interaction between the
first test protein and the second test protein
in the host cell causes the transcription
activation domain to activate transcription
of the reporter gene;
(d) introducing the second chimeric gene
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
into a host cell of a first mating type such
that the second hybrid protein is expressed
and subsequently introducing said cells
into an arraying means thereby creating a
master library plate;
(e) introducing cells from the master
library plate into a second arraying means
in liquid medium, thereby creating a
mating set;
(f) introducing the first chimeric gene into
a host cell of the opposite mating type to
the host cell in step (d) such that the first
hybrid protein is expressed and
subsequently introducing said cell into the
mating set, thereby allowing mating to
occur in liquid medium;
(g) selecting for outgrowth of cells which
express the reporter gene, thereby creating
a selected mating set;
(h) removing a portion of the selected
mating set to a third arraying means
thereby creating a rescue set;
(i) determining whether the reporter gene
has been expressed in cells in the selected
mating set; and
(j) analyzing cells from the rescue set
which are the same as cells in the selected
mating set in which the reporter gene is
expressed, wherein detection of expression
of the reporter gene in a cell is indicative
of an interaction between the first test
protein and the second test protein.
__________
]22[]12[
]1/[
LOW PROFILE MODULAR
ELECTRICAL JACK AND
COMMUNICATION CARD
INCLUDING THE SAME
]11[
]/2[
]12[
]/2[
]//[
]//[
25.03.1999
60/079447
]/1[ 26.03.1998
Int. Cl.8 H01R 024/04
BEL FUSE LTD., HONG KONG
WO/1999/049541
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET
P.O.B. 6451
TEL AVIV 61063
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
207112
‫מגבה חשמלי מודולרי בעל פרופיל נמוך‬
‫וכרטיס טלקומוניקציה הכולל אותו‬
]//[
US
,‫ עו"פ‬,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.1 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
230
[57] A modular electrical jack (14),
comprising: an outer housing part (42), and
an inner housing assembly (44) connected
to said outer housing part and defining at
least one plug-receiving receptacle (22)
with said outer housing part, said inner
housing assembly including
contact/terminal members (34), at least one
of said contact/terminal members
including a terminal portion (34b) adapted
to be connected to a substrate (30), an
arcuate contact portion (34a) extending
into a respective one of said at least one
plug-receiving receptacle and an
intermediate bridging portion (34c)
connecting said terminal portion and said
contact portion, characterized in that said
bridging portion is inclined in relation to
an inner surface (54a) of said outer
housing part (42) such that only said
arcuate contact portion of said bridging
portion bears against an inner surface of
said outer housing part and remaining
portions of said bridging portion are
spaced from said inner surface, and in that
said outer housing part comprises a groove
(62) formed in the inner surface which
receives said arcuate contact portion.
__________
231
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
PROCESS FOR THE
PREPARATION OF
TETRABROMOBISPHENOL-A
]11[
]/2[
]12[
]/2[
10.05.1999
096332
]/1[ 11.06.1998
Int. Cl.8 C07C 037/62, 039/00, 039/367
ALBEMARLE CORPORATION,
U.S.A.
WO/1999/064384
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]//[
[57] A process for producing
tetrabromobisphenol-A, which process
comprises:
(a) feeding, to a reactor, a solution
comprised of bisphenol-A, water and a
water miscible solvent to at least partially
form a reaction mass having a liquid phase
containing from above 15 to 65 wt%
water, the wt% being based upon the
amount of water and water miscible
solvent in the liquid phase;
(b) during (a) feeding a stream of gaseous
bromine to the reaction mass, such gaseous
201111
A– ‫תהליך להכנת טטראברומוביספנול‬
]//[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
feed stream having a Reynold's number ≥
40,000;
(c) during (a), providing for the presence,
in the reaction mass of (i) from about 50 to
20,000 ppm unreacted bromine and (ii)
about 20 wt% or less of HBr, the ppm and
wt% HBr values being based upon the total
weight of the liquid phase of the reaction
mass; and
(d) during (a), forming a reaction mass
precipitate phase which comprises at least
about 95 wt% tetrabromobisphenol-A, the
wt% being based on the total weight of the
precipitate phase.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232
]22[]12[
]1/[
CHEMICAL SYNTHESIS OF
MORPHOLINE DERIVATIVES
]11[
]/2[
]12[
]/2[
10.06.1999
9813025.5
]/1[ 16.06.1998
Int. Cl.8 C07D 413/02
MERCK SHARP & DOHME LTD,
UNITED KINGDOM
WO/1999/065900
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
201161
‫יצור כימי של תולדות מורפולין‬
]//[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] A process for the preparation of a
compound of the formula
wherein R2 and R3 are independently
selected from the group consisting of:
(1) hydrogen,
(2) C1-6 alkyl
(3) C2-6 alkenyl, and
(4) phenyl; R6, R7 and R8 are
independently selected from the group
consisting of:
(1) hydrogen,
(2) C1-6 alkyl,
(3) fluoro,
(4) chloro,
(5) bromo,
233
(6) iodo, and
(7) –CF3; R11, R12 and R13 are
independently selected from the group
consisting of:
(1) hydrogen,
(2) C1-6 alkyl,
(3) fluoro,
(4) chloro,
(5) bromo,
(6) iodo, and
(7) –CF3; and Z is C1-4 alkyl, which
comprises:
(i) reacting a compound of the formula
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
or a salt thereof, wherein R2, R3, R6, R7,
R8, R11, R12, R13 and Z are as previously
defined, which compound of the formula
wherein LG is a leaving group selected
from halogen or an alkyl- or arylsulfonate
group, in an organic solvent and in the
presence of a base; and
(ii) collecting the resultant crystalline
compound of formula (I).
__________
]22[]12[
262201
‫שימוש לתולדה פירידאזינון להכנת תרופה‬
]1/[
USE OF A PYRIDAZINONE
DERIVATIVE IN THE
MANJFACTURE OF A
MEDICAMENT
]11[
]/2[
]12[
]/2[
]//[
]//[
26.05.1999
099945
]/1[ 19.06.1998
]//[ US
Int. Cl.8 A61K 031/50, A61P 009/04, C07D 237/04
ORION CORPORATION, FINLAND
WO/1999/066932
DR. YITZHAK HESS & PARTNERS,
,‫ עו"פ‬,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON STREET
‫ תל אביב‬,94.1 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
P.O.B. 6451
TEL AVIV 61063
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
234
[57] Use of (R)-N-[4-(1, 4, 5, 6tetrahydro-4-methyl-6-oxo-3-pyridazinyl)
phenyl]-acetamide in the manufacture of a
medicament for use in the treatment of
neurohumoral imbalance caused by
alterations of cardiac function to prevent
the development of heart failure and for
increasing calcium sensitivity of
contractile proteins of cardiac muscle.
__________
]22[]12[
]1/[
MECHANICAL HEART VALVE
]11[
]/2[
]12[
]/2[
02.06.1999
60/088184
]/1[ 05.06.1998
Int. Cl.8 A61F 002/24
TRIFLO MEDICAL, INC., U.S.A.
DIDIER LAPEYRE, FRANCE
]//[
]//[
WO/1999/062437
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A rotatable leaflet (110) for a
prosthetic heart valve (100) comprising: a
main portion including leading and trailing
edge surfaces, and inner and outer surfaces
connecting the leading and trailing edge
surfaces, wherein the inner surface
generally defines a convex curvature (120)
proximate the leading edge surface to the
262231
‫שסתום לבבי מכני‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
trailing edge surface and the outer surface
generally defines a convex curvature
proximate the leading edge surface and a
concave curvature proximate the trailing
edge surface; and first and second winglet
portions situated on opposite ends of the
leaflet to facilitate rotation of the leaflet.
__________
235
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
262211
,‫ תהליך הכנתן‬,‫נגזרות טטראהידורוקוינולין‬
‫תכשירים רוקחיים המכילים אותו ושימושם‬
‫מהכנת תכשירים רפואיים לדיכוי האפקט‬
‫של חומצות אמינו ממוקטבות על‬
NMDA ‫הרצפטור‬
]1/[
TETRAHYDROQUINOLINE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS THEREOF AND
THEIR USE FOR THE
PREPARATION OF
THERAPEUTIC AGENTS FOR
ANTAGONISING THE EFFECTS
OF EXCITATORY AMINO ACIDS
ON THE NMDA RECEPTOR
COMPLEX
]11[
]/2[
08.06.1999
9812410.0
]/1[ 10.06.1998
]//[ GB
0/21/6/6/
266606200/
GB
Int. Cl.8 A61K 031/47, A61P 025/00, C07D 401/04
GLAXO WELLCOME SPA, ITALY
WO/1999/064411
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] A compound of the formula
or a salt or a non-toxic metabolically labile
ester thereof, wherein Y represents a
carbon atom; Z is the group CH which is
linked to the group Y via a double bond
and X is CH or Z is methylene or NR11 and
X is a carbon atom linked to the group Y
via a double bond; A represents a C1-2
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
alkylene chain and which chain may be
subsituted by one or two groups selected
from C1-6 alkyl optionally substituted by
hydroxy, amino C1-4 alkyl amino or C1-4
dialkyl amino or which chain may be
substituted by the group =O; R represents
a halogen atom or C1-4 alkyl group; R1
236
represents a hydrogen, a halogen atom or
C1-4 alkyl group; R2 represents phenyl
which may be substituted with up to 3
groups selected from halogen, hydrogen,
or (CH2)nR3 wherein R3 is COR4, NR6R5,
NHCOR7, NHCONR9R8 or a NHSO2R10
group or R2 is a 5 membered heteroaryl
group containing 1 to 3 heteroatoms
selected from oxygen, sulphur and
nitrogen; or a 6 membered heteroaryl
group containing 1 to 3 nitrogen atoms, R4
represents an amino, a hydroxyl or C1-4
alkoxy group; R5 and R6 each
independently represent hydrogen or C1-4
alkyl group or
R5 and R6 together with the nitrogen atom
to which they are attached represent a
saturated 5-7 membered heterocyclic
group optionally containing an additional
heteroatom selected from oxygen, sulphur
or nitrogen; R7 represents a hydrogen atom
or C1-4 alkyl, C1-4 alkoxy, or phenyl; R8
represents hydrogen or C1-4 alkyl group; R9
represents hydrogen, optionally substituted
C1-4 alkyl (optionally substituted by one or
more hydroxy, carboxyl and amino group),
or phenyl;
R11 represents hydrogen or C1-4 alkyl
group; R10 represents hydrogen, C1-4 alkyl
or a nitrogen protecting group, n is zero or
an integer from 1 to 2.
__________
]22[]12[
262683
‫ שיטה לייצורו‬,‫מתקן לטיפול בבעיות זיקפה‬
‫ושימוש שלו‬
]1/[
DEVICE FOR THE TREATMENT
OF ERECTILE DYSFUNCTION,
METHOD OF PREPARATION AND
USE THEREOF
]11[
]/2[
]12[
]/2[
25.06.1999
60/090674
]/1[ 25.06.1998
]//[ US
Int. Cl.7 A61F 005/41, 5416137, A61M 037/00
LAVIPHARM LABORATORIES,
INC., U.S.A.
WO/1999/066870
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]//[
]//[
[57] A delivery device for treatment of
erectile dysfunction in a patient,
comprising a disk formed from a
filmogenic polymer, and having an
effective dose of a therapeutic agent
selected from the group consisting of: a
vasodilator, a smooth muscle relaxant, an
antidepressant, a parasympathetic
stimulator, a rennin-angiotensin system
inhibitor, a local anesthetic, an a-blocker,
and a calcium channel blocker.
__________
237
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
EXPONENTIAL CURRENT
GENERATOR AND METHOD
]11[
]/2[
]12[
]/2[
30.06.1999
109504
]/1[ 02.07.1998
Int. Cl.8 H03F 003/45
QUALCOMM INCORPORATED,
U.S.A.
WO/2000/002310
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]//[
]//[
[57] An apparatus for generating a
current pair, Ip, Im wherein the ratio of the
pair is exponentially related to a control
signal, the apparatus comprising: a
differential amplifier (465), the differential
amplifier generating the current pair Im, Ip
as a function of the control signal and a
bias current, Ibias, where Ibias is a function of
a boost current Iboost and the sum of Ip and
262316
‫מחולל זרם מעריכי‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
Im equals Ibias; and a correction feedback
circuit (610), coupled to the differential
amplifier, the feedback circuit sensing one
of Im and Ip and generating the boost
current Iboost when one of Im and Ip is one of
less than a minimum value and greater
than a maximum value, to keep said one of
Im and Ip above said minimum value or
below said maximum value.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
262118
238
]1/[
COMPOSITIONS CONTAINING
AT LEAST ONE ACTIVE
SUBSTANCE HAVING AN
INFLUENCE ON THE LEVELS OF
LIPIDS IN THE BLOOD
]11[
]/2[
]12[
]/2[
07.07.1999
19830732.2
]/1[ 09.07.1998
Int. Cl.8 A61K 009/70, 045/00
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2000/002541
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]//[
]//[
[57] Preparation in the form of
transdermal therapeutic system containing
at least one active substance which has an
influence on the lipid blood levels and at
least one auxiliary substance enhancing the
permeation of the active substance through
the skin in a self-adhesive matrix layer
which can be covered at the side facing
away from the skin with an active
substance-impermeable backing layer,
characterized in that the said active
substance is selected from the group of
active substances inhibiting
hydroxymethylglutaryl-CoA reductase, the
self-adhesive matrix layer is a mass based
on polyacrylate, or a mass based on
silicone, and that the said auxiliary
substance is selected from the group
consisting of pyrrolidone derivatives, fatty
acids, fatty alcohols, fatty acid esters, fatty
‫תכשירים המכילים לפחות חומר פעיל‬
‫אחד בעל השפעה על רמות הליפידים בדם‬
]//[
DE
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
ethers, paraffin derivatives, terpenes,
ethylene glycol monoalkyl ethers,
polyoxyethylene alkyl ethers,
polyoxyethylene aryl ethers,
polyoxyethylene alkyl esters,
polyoxypropylene alkyl esters,
polyoxypropylene alkyl ethers, propylene
glycol fatty acid derivatives, glycerol fatty
acid esters, polysorbates, poloxamers,
dialkyl sulfoxides, urea and urea
derivatives, glycerol, native oils,
laurocaprames, phospholipids, amides,
amino acids, N, N-dimethyl formamide, Nmethyl formamide, acetonides, calcium
thioglycolate, propylene glycol,
polyethylene glycol, alkyl sulfate, sodium
lauryl sulfate, tetrahydrofurfuryl alcohol,
macrocylic compounds or polar solvents
such as panthenol.
__________
]22[]12[
239
262182
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
PLASTER WHICH CONTAINS
STEROIDS, AND A METHOD
FOR PRODUCTION AND USE
THEREOF
]11[
]/2[
]12[
]/2[
07.07.1999
19830651.2
]/1[ 09.07.1998
Int. Cl.8 A61K 009/00
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2000/002540
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]//[
]//[
[57] Medicinal self-adhesive composition
for transdermal application of an estrogen
in combination with a gestagen, containing
(a) 25-90%-wt, of a self-adhesive acrylate
copolymer,
(b) 1-15%-wt. of a film-forming acrylate
copolymer which contains 10-90%-wt. of
‫ שיטה‬,‫תחבושת המכילה סטרואידים‬
‫ליצורה והשימוש בה‬
]//[
DE
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
methacrylic acid and 10-90%-wt. of
methyl methacrylate,
(c) 1-30%-wt. of tack-increasing adhesive
resin additives,
(d) 0.2-2.0%-wt. of estrogen and
(e) 1-5%-wt. of gestagen.
__________
]22[]12[
262866
–‫רטייה טופיקלית עם חומרים לא‬
‫סטרואידים אנטיראומטיים בעלי קבוצה‬
‫חומצית‬
]1/[
TOPICAL PATCH WITH NONSTEROID ANTIRHEUMATIC
AGENTS HAVING AN ACID
GROUP
]11[
]/2[
]12[
]/2[
06.07.1999
19830649.0
]/1[ 09.07.1998
]//[ DE
Int. Cl.8 A61K 009/00, 009/70, A61L 015/44, C07C 059/48
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2000/002539
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
]//[
]//[
[57] Topical patch containing as active
substance a non-steroid antirheumatic
agent having a free carboxyl group,
comprising a backing layer inert to the
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
active substance, which backing layer is
made of a material that is elastic in at least
one direction, a self-adhesive, active
substance-containing matrix layer based on
a polyacrylate adhesive, which
240
polyacrylate adhesive is crosslinked with
multivalent metal ions and comprises free
carboxyl groups, the said matrix
containing a fatty acid, and a protective
sheet to be removed prior to use,
characterized in that said active substancecontaining matrix consists of one layer and
is free of hydroxyl groups, and that said
backing layer is made of an elastic
polyester woven fabric or polyester knitted
fabric, or a nonwoven, a woven fabric or a
knitted fabric of polyethylene
terephthalate, or a closed-cell, elastic
foam.
__________
]22[]12[
262863
‫תהליך צילום יבש לייצור מנה אחת של‬
‫תכשירי חומר פעיל שטוחים‬
]1/[
DRY COPYING PROCESS FOR
PRODUCING FLAT, SINGLEDOSE ACTIVE INGREDIENT
PREPARATIONS
]11[
]/2[
]12[
]/2[
02.07.1999
19830650.4
]/1[ 09.07.1998
]//[ DE
Int. Cl.8 A61K 009/00, B05B 005/053, H02N 013/00
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2000/002533
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
]//[
]//[
[57] Method for metering active
ingredient in powder form onto a
predetermined area, characterized in that
the active ingredient is transferred as
electrically charged powder to a roll with
the opposite charge, the active ingredient
transferred to the roll is transferred to a
two-dimensional substrate with an electric
charge opposite to the active ingredient,
the active ingredient transferred to the
substrate is fixed by means of a heat
treatment.
__________
]22[]12[
241
262711
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
LIPID/POLYMER CONTAINING
PHARMACEUTICAL
COMPOSITIONS AND
PROCESSES FOR THE
PREPARATION
THEREOF
]11[
]/2[
16.07.1999
60/093243
]/1[ 17.07.1998
062262/11
116606200/
06221/60/
6166/62000
Int. Cl.8 A61K 009/50, 031/00
SKYEPHARMA INC., U.S.A.
WO/2000/003660
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
]//[
[57] A lipid/polymer-containing
pharmaceutical composition comprising: a
biodegradable microsphere having a
matrix, said matrix comprising at least one
‫תכשירי רוקחות המכילים שומן\פולימר‬
‫ותהליכים להכנתם‬
]//[
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
type of biodegradable polymer and at least
one type of lipid; and a physiologically
active substance which is releasable from
the biodegradable microsphere.
__________
]22[]12[
]1/[
APPARATUS AND METHOD FOR
LOADING WEIGHTS
]11[
]/2[
]12[
]/2[
]//[
01.02.2001
497110
]/1[ 03.02.2000
Int. Cl.8 A63B 021/062
YIFAT GURION OFER
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] Apparatus for varying the load on an
exercise machine (300), the apparatus
comprising: a stack (314) of weights (312)
in slidable communication with at least
one load-bearing member (354); and
weight selection devices (330)
characterized in that each of said weight
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
262121
‫מתקן ושיטה להעמסת משקולות‬
]//[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
selection devices (330) is housed within a
corresponding one of said weights, each of
said weight selection devices comprising a
motor (341) and a locking element (350) to
selectably lock its corresponding weight to
said at least one load-bearing member
(354).
242
__________
]22[]12[
262016
‫ אומפרזול‬,‫תהליך להכת אומפרזול‬
‫ תכשירים ותכשירים‬,‫המתקבל מתהליך זה‬
‫רוקחיים המכילים אותו‬
]1/[
PROCESS FOR THE PREPARTION
OF OMEPRAZOLE,
OMEPRAZOLE OBTAINED BY
SAID PROCESS, COMPOSITIONS
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]11[
]/2[
]12[
]/2[
]//[
]//[
06.08.1999
60/096037
]/1[ 11.08.1998
]//[ US
Int. Cl.8 A61K 031/44, A61P 001/00, C07D 401/12
ASTRAZENECA AB, SWEDEN
WO/2000/009497
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
[57] A process for the preparation of
omeprazole, of the formula
243
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
which comprises treating, at about -5 to
+5oC, a buffered solution of pyrmetazole,
of the formula
in a non-alcoholic organic reaction solvent,
with an equivalent amount of an oxidizing
agent relative to the number of moles of
said pyrmetazole, the oxidizing agent
dissolved in the non-alcoholic organic
reaction solvent in admixture with an
alcoholic solvent at about 0-5oC followed
by aging in the presence of an aqueous
base.
__________
]22[]12[
262616
‫טכנולוגיות תקשורת רב–טונית בדידה בעלת‬
‫ ביטול‬,‫נשא אוגר וקומבינציות עם איפוס קוד‬
‫ תקשורת מנחה חוזרת ומערך‬,‫הפרעה‬
‫אנטנות ניתן להתאמה‬
]1/[
STACKED-CARRIER DISCRETE
MULTIPLE TONE
COMMUNICATION
TECHNOLOGY AND
COMBINATIONS WITH CODE
NULLING, INTERFERENCE
CANCELLATION,
RETRODIRECTIVE
COMMUNICATION AND
ADAPTIVE ANTENNA ARRAYS
]11[
]12[
18.08.1998
Int. Cl.8 H04B 001/69, 007/04, 007/06, 007/08, H04J 013/02, H04L 005/02, 027/06,
H04Q 007/00
BRN PHOENIX, INC., U.S.A.
WO/2000/011823
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
]/2[
]//[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
244
[57] A multiple access communication
system, comprising: at least one radio
transmitter for transmitting a plurality of
radio frequency (RF) carriers; at least one
radio receiver for receiving said at least
one subset of at least two of said plurality
of radio frequency carriers; at least one
spreader connected to each of the
transmitters for independently and
redundantly modulating the amplitude and
phase of at least two of said (RF) carriers
with a first digital spreading gain and first
data; at least one despreader connected to
each of the receivers for independently
demodulating the amplitude and phase of
at least two of said (RF) carriers with said
first digital spreading gain to recover said
first data; and multiple access means
connected to the transmitters, receivers,
spreaders and despreaders for providing
separate channels of communication by at
least one of space-division multiple access
(SDMA), frequency-division multiple
access (FDMA) and code-division multiple
access (CDMA).
__________
]22[]12[
262163
-': ‫תכשירי רוקחות המכילים‬
-0(-':-‫דסאמינו‬
‫מתוקסימורפולינו)דוקסורוביצין‬
‫לטיפול בגידול הכבד‬
]1/[
PHARMACEUTICAL COMPOSITIONS
COMPRISING 3'-DESAMINO-3'-(2METHOXYMORPHOLINO)DOXORUBICIN
FOR THE TREATMENT OF A LIVER
TUMOR
]11[
]/2[
]12[
]/2[
]//[
]//[
27.08.1999
9820012.4
]/1[
14.09.1998
]//[ GB
Int. Cl.8 A61K 031/65, A61P 035/00, C07H 015/252, C12P 019/56
PHARMACIA & UPJOHN S.P.A, ITALY
WO/2000/015203
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
‫תל אביב‬
TEL AVIV 61040
245
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
[57] Use of methoxymorphilino
doxorubicin (MMDX) of the formula
in the preparation of a medicament,
formulated for intrahepatic administration
via the hepatic artery in the treatment of a
human liver tumour.
__________
]22[]12[
]1/[
PORTABLE INTRAVENOUS
FLUID WARMING SYSTEM
]11[
]/2[
]12[
]/2[
17.09.1999
156324
]/1[ 18.09.1998
Int. Cl.8 A61F 007/00, 007/12
ESTILL MEDICAL
TECHNOLOGIES,INCORPORATED,
U.S.A.
WO/2000/016722
S. HOROWITZ & CO.,
41-45 ROTSHILD BLV
TEL AVIV 65784
]//[
]//[
[57] A portable intravenous fluid
warming system comprising: a housing
(34) having an intravenous fluid input port
and intravenous fluid output port; a
plurality of groups of rigid interconnected
high thermal conductive material tube
sections (52-64) in said housing carrying
said intravenous fluid to be warmed
between said input port and said output
port, each one of said tube sections having
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
262172
‫מערכת ניידת לחימום נוזלים המיועדים‬
‫ורידית‬-‫להזרקה תוך‬
]//[
US
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל אביב‬,41-4.‫שדרות רוטשילד‬
an outer periphery; a first group of said
plurality of tube sections in said housing
for receiving intravenous fluid to be
warmed from said input port and forming a
group of staged heating sections; a final
section of tube in said housing for
dispensing said warmed I.V. fluid to said
output port and forming a final heating
stage; and a like plurality of flexible
independently controlled heating elements
246
as said plurality of tube sections for
heating the intravenous fluid therein, each
one of said flexible heating elements being
wrapped around, in contact with, and
surrounding at least the majority of the
peripheral surface of a corresponding tube
section.
__________
]22[]12[
]1/[
MODULAR ELECTRICAL
CONNECTOR ASSEMBLIES WITH
MAGNETIC FILTER AND/OR
VISUAL INDICATOR
]11[
]/2[
]12[
]/2[
]//[
]//[
14.10.1999
60/104137
]/1[ 14.10.1998
Int. Cl.8 H01R 003/00
BEL FUSE LTD., HONG KONG
WO/2000/022697
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET
P.O.B. 6451
TEL AVIV 61063
[57] A connector assembly (8) for
mounting on a main printed circuit board,
comprising: a jack (10, 50) defining a
plug-receiving receptacle (16) and
including an outer housing part (68) and an
inner housing part (70); circuit coupling
means including contact portions (18a)
arranged in said receptacle (16) and
adapted to engage contacts of a mating
plug when situated in said receptacle and
terminal portions (18b) adapted to engage
247
261331
‫מחבר חשמלי מודולרי מורכב יחד עם‬
‫או אינדיקטור ויזואלי‬/‫פילטר מגנטי ו‬
]//[
US
,‫ עו"פ‬,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.1 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
the main printed circuit board (126) and
being electrically coupled to said contact
portions; a light pipe element (30)
arranged in said jack and comprising at
least one light transmitting section (32)
arranged such that said at least one light
transmitting section is visible from a front
face (82) of said jack, and light generating
means (164) for generating light, said light
generating means being arranged such that
light generated by said light generating
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
means is transmitted through said at least
one light transmitting section to said front
face of said jack; an internal printed circuit
board (183) arranged in said jack, a first
set of contacts (60) arranged in said jack
(10) including said contact portions (18a)
arranged in said receptacle (16) and being
connected to said internal printed circuit
board (183) wherein said outer housing
part (68) comprises a top wall (72),
opposed side walls (74), a bottom wall
(76) and a comb portion (90) defining a
plurality of slots for receiving ends of said
contacts said top and side walls having a
length greater than a length of said bottom
wall to thereby define a cavity (78) at a
rear of said outer housing part rearward of
said comb portion, said inner housing part
comprising a front flat portion (98), a
vertical wall (100) extending perpendicular
to and upwards from said front portion and
a rear portion (101) extending rearwardly
from a lower portion of said vertical wall
and defining a second cavity, said vertical
wall and rear portion being situated in said
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
cavity, and a second set of contacts (182)
connected to said internal printed circuit
board and including said terminal portions
adapted to engage the main printed circuit
board, said internal printed circuit board
said internal printed circuit board including
a wiring pattern for electrically coupling
said first set of contacts and said second
set of contacts, said front portion of said
inner housing part including channels
(104) at a front edge, channels (108) in a
lower surface and slots (106) extending
from said lower surface to an upper surface
alongside said vertical wall, said vertical
wall of said inner housing part including
channels at an upper edge whereby said
first set of contacts pass through said
channels at said front edge of said inner
housing part, through said channels in said
lower surface of said inner housing part,
through said slots in said front portion and
through said channels at said upper edge of
said vertical wall and connect to said
internal printed circuit.
248
‫__________‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫‪249‬‬
]22[]12[
260221
‫תרכובות תרופתית הכוללת גורם נגד סרטן‬
‫ולפחות פפטיד אחד‬
]1/[
PHARMACEUTICAL
COMPOSITION COMPRISING AN
ANTI-CANCER AGENT AND AT
LEAST ONE PEPTIDE
]11[
]/2[
]12[
]/2[
]//[
]//[
26.11.1999
98/15073
]/1[ 30.11.1998
]//[ FR
Int. Cl.8 A61K 045/00, 047/48, C07K 004/00
SYNT:EM S.A., FRANCE
WO/2000/032237
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
[57] Use of a peptide selected from the
group consisting of:
(a) X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11X12-X13-X14-X15-X16 (I)
wherein in formula (I), the residues X1 to
X16 are amino acid residues, 6 to 10 of
which are hydrophobic amino acids, and
X6 is tryptophan;
(b) BXXBXXXXBBBXXXXXXB (II);
(c) BXXXBXXXBXXXXBBXB (III)'
wherein in formulae (II) and (III):
the B groups may be the same or different
and represent an amino acid residue in
which the side chain comprises a basic
group, and the X groups may be the same
or different and represent an aliphatic or
aromatic amino acid residue;
(d) the retro form of said formula (I), (II)
or (III) peptides, which is composed of D
and/or L configuration amino acids; and
(e) a fragment of said amino acids
composed of a sequence of at least 5
successive amino acids of formula (I), (II)
or (III) peptides, for the preparation of a
drug intended for the treatment and/or
prevention of chemoresistant cancers, in
which the drug comprises any one of
peptides a) to e) associated with at least
one anti-cancer agent, to carry said agent
to the cancerous cells and prevent the
occurrence of resistance of said cells to
said agent.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
260281
250
‫מקור אדים בעל פתח קווי ותהליך ציפוי‬
]1/[
VAPOR SOURCE HAVING
LINEAR APERTURE AND
COATING PROCESS
]11[
]/2[
12.11.1999
60/108187
]/1[ 12.11.1998
602///0//
2662262000
Int. Cl.8 C23C 014/24, 014/26, 014/56
FLEX PRODUCTS, INC., U.S.A.
WO/2000/028103
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
]//[
[57] A linear aperture deposition
apparatus for coating a substrate,
comprising:
(a) a source box containing a charge of
source material;
(b) a heating element within the source box
adapted to heat the source material to
produce a vapor of the source material;
(c) a chimney having at least one inlet in
communication with the source box and a
]//[
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
rectangular slot outlet for directing the
vapor from the source box to the substrate;
(d) a baffle disposed within the source box
and configured to restrict the flow of vapor
from the source box to the substrate; and
(e) a containment and cooling vessel
disposed around the source box and
configured to prevent heating of the
substrate.
__________
]22[]12[
251
260210
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫תכשירים לטיפול מקומי המכילים‬
‫אסקומיצינים‬
]1/[
TOPICAL COMPOSITIONS
COMPRISING ASCOMYCINS
]11[
]/2[
]12[
]/2[
]//[
]//[
01.12.1999
9826656.2
]/1[ 03.12.1998
]//[ GB
Int. Cl.8 A61K 009/00, 047/44, A61P 031/00
NOVARTIS AG, SWITZERLAND
WO/2000/032234
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
[57] A composition for topical
administration of an ascomycin for
treatment of skin disorders, which
composition comprises a carrier vehicle
comprising
(i) means to retain water in the outer skin
layer comprising a urea, an inorganic salt,
or a carboxylic acid, and
(ii) means to hinder water evaporating
from the skin, whereby the composition is
water free or may comprise water in an
amount of from 0 to about 10% w/w.
__________
]22[]12[
]1/[
PROCESS FOR THE
MANUFACTURE OF LIQUID
FILLED CAPSULES
]11[
]/2[
]12[
]/2[
11.11.1999
98121831.6
]/1[ 17.11.1998
Int. Cl.8 A61J 003/00, 003/07
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2000/028942
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] A process for encapsulating a shear
sensitive fill mass into a capsule,
characterized in that said fill mass is
260221
‫תהליך ליצור כמוסות מלאות בנוזל‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
heated and subsequently cooled,
immediately prior to the encapsulation.
__________
]22[]12[
]1/[
MEDICAMENTS COMPRISING
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
260106
‫תרופות המכילות חלקיקים מצופים של‬
252
COATED DRUG PARTICLES,
METHOD FOR PREPARING THE
SAME, FORMULATIONS
COMPRISING THEM AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS FOR
TREATING RESPIRATORY
DISEASES
]11[
]/2[
]12[
]/2[
]//[
]//[
18.11.1999
60/108847
]/1[ 18.11.1998
062226102
/66226200/
Int. Cl.8 A61K 009/00
UNIVERSITY OF FLORIDA, U.S.A.
WO/2000/028969
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
[57] A medicament comprising a plurality
of coated drug particles, each having an
average particle size of less than 500 μm in
diameter, the surface of said particles
comprising at least a first layer of
biodegradable and biocompatible
polymeric coating particles, wherein the
‫ תכשירי רוחות‬,‫ שיטה להכנתן‬,‫תרופה‬
‫המכילים אותם ושימושם בהכנת תרופות‬
‫לטיפול באי–סדרים בנשימה‬
]//[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
average thickness of said coating layer is
between 1 and 500 nm, the coated drug
particles being obtainable through a
process comprising depositing said
polymeric coating particles onto the
surface of host drug particles by a process
comprising pulsed laser ablation.
__________
]22[]12[
]1/[
253
PRESSURISED METERED DOSE
INHALERS
260116
‫משאפים בעלי מנה קצובה בלחץ‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]11[
]/2[
]12[
]/2[
]//[
]//[
23.11.1999
MI98A002559 ]/1[ 25.11.1998
MI99A001712
/666/62000
Int. Cl.8 A61K 009/00, 009/72
CHIESI FARMACEUTICI S.P.A.,
ITALY
WO/2000/030608
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] Pressurised metered dose inhalers
containing a composition for aerosol
administration containing a solution of
budesonide or epimers thereof, an
hydrofluorocarbon propellant and a cosolvent, part or all of the internal surfaces
]//[
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
of said inhalers consisting of stainless
steel, anodized aluminium or being lined
with an inert organic coating selected from
perfluoroalkoxyalkane, epoxy-phenol resin
or fluorinated-ethylene-propylene
polyether sulfone.
5719497
The applications for division
from this application have
not yet been published
IT
IT
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_____________
]22[]12[
]1/[
IRRIGATION UNIT SUPPORT
STAKE AND A SYSTEM
INCLUDING IT
]11[
]12[
]/2[
]/1[
]//[
23.05.2001
Int. Cl.8 B05B 015/06
DAN MAMTIRIM
YOEL TZUR, ZOHAR KATZMAN
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A sprinkler mounting stake (10)
comprising a lower ground insertion
portion and an upper sprinkler support
portion; said sprinkler support portion
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
260021
‫תומך ליחידת השקייה ומערכת הכוללת‬
‫אותה‬
‫ אביזרי השקעה לחקלאות נוי‬,‫דן ממטירים‬
‫ זהר קצמן‬,‫יואל צור‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
comprising a lateral projection (34)
extending essentially parallel to a
longitudinal axis (84) of the stake and
fitted for insertion into a corresponding
offset support member receptacle (60) of a
sprinkler; and a retention member (42) for
254
releasably engaging a corresponding
securing member of the sprinkler.
__________
]22[]12[
]1/[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
LIPOPHILIC DRUGS AND
METHODS FOR THE
PREPARATION THEREOF
]11[
]/2[
]12[
]/2[
]//[
]//[
10.12.1999
60/111951
]/1[ 11.12.1998
Int. Cl.8 A61K 038/00, 047/00
PHARMASOLUTIONS, INC., U.S.A.
WO/2000/033862
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A pharmaceutical composition
comprising a pharmaceutically effective
amount of a lipophilic drug in association
with a pharmaceutical carrier, said carrier
255
260372
‫תכשירי רוקחות המכילים תרופות‬
‫ליפופיליות ושיטות להכנתן‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
comprising (a) a lipophilic drug
solubilizing effective amount of a
propylene glycol ester of C6-C18 fatty acid
having at least about 60% by weight of
monoester based on the total weight of the
propylene glycol ester and (b) a non-ionic
surfactant, said non-ionic surfactant being
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
present in an amount sufficient to form a
microemulsion with the propylene glycol
ester and drug when brought into contact
with an aqueous medium.
__________
]22[]12[
]1/[
NMR SPECTROSCOPIC IN VITRO
ASSAY USING
HYPERPOLARIZATION
]11[
]/2[
23.12.1999
9828852.5
]/1[ 30.12.1998
002/60066
6166/62000
Int. Cl.8 G01R 033/465
GE HEALTHCARE LIMITED,
UNITED KINGDOM
WO/2000/040988
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] An in vitro assay method to detect a
physical or chemical change involving a
biological species which comprises:
(a) performing an assay using an assay
reagent containing at least one NMR active
nucleus other than a noble gas to perform
an assay, wherein the assay reagent is the
biological species and is either
(i) introduced as an initial reagent; or
(ii) formed in situ during the assay; or
(iii) formed as a product of the assay;
and
260118
‫בדיקת הרכב בתוך מבחנה באמצעות‬
‫ספקטרוסקופיית תמ"ג בקיטוב יתר‬
]//[
GB
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
(b) hyperpolarising at least one NMR
active nucleus of the assay reagent;
wherein steps (a) and (b) are performed
simultaneously or sequentially in either
order, and
(c) analyzing the assay reagent and/or the
assay by NMR to obtain a spectrum which
is dependent on the environment of the
NMR active nucleus; and
(d) optionally using the NMR data
obtained in step (c) to generate further
assay result(s).
__________
]22[]12[
]1/[
PHENYLPHENANTHRIDINE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
266211
‫תולדות פנילפנאנתרידין ותכשירי רוקחות‬
‫המכילים אותן‬
256
]11[
]/2[
]12[
]/2[
]//[
]//[
12.01.2000
99100694.1
]/1[ 15.01.1999
]//[ EP
Int. Cl.8 A61K 031/435, A61P 011/08, C07D 221/12, 401/10, 403/10, 413/10
ALTANA PHARMA AG, GERMANY
WO/2000/042020
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
[57] Compounds of the formula
in which
R1 is hydroxyl, 1-4C-alkoxy, 3-7Ccycloalkoxy, 3-7C-cycloalkylmethoxy or
completely or predominantly fluorinesubstituted 1-4C-alkoxy,
R2 is hydroxyl, 1-4C-alkoxy, 3-7Ccycloalkoxy, 3-7C-cycloalkylmethoxy or
completely or predominantly fluorinesubstituted 1-4C-alkoxy,
or in which
R1 and R2 together are a 1-2Calkylenedioxy group,
R3 is hydrogen or 1-4C-alkyl,
R31 is hydrogen or 1-4C-alkyl,
or in which
R3 and R31 together are a 1-4C-alkylene
group,
R4 is hydrogen or 1-4C-alkyl,
R5 is hydrogen,
R51 is hydrogen,
or in which
R5 and R51 together represent an
additional bond,
257
R6 is O-R7, S-R8, C(O)-R9, CH2-R10,
S(O)2-aryl, O-S(O)2-R11, pyrrolidin-1-yl,
pyrrolidin-1-yl-2-one, pyrrolidin-1-yl-2,5dione, piperidin-1-yl, piperidin-1-yl-2-one
or piperidin-1-yl-2,6-dione, where
R7 is 3-7C-cycloalkyl, 3-7Ccycloalkylmethyl, 1-4C-alkoxy-1-4Calkyl, aryl or phenyl-1-4C-alkyl,
R8 is hydrogen, 1-4C-alkyl, 1-4Calkylcarbonyl, arylcarbonyl,
trifluoromethyl, difluoromethyl,
trichloromethyl or phenyl,
R9 is 1-4C-alkyl, 3-7C-cycloalkyl, 3-7Ccycloalkylmethyl, 1-pyrrolidinyl, 1piperidinyl, 1-piperazinyl, 4methylpiperazinyl, 4-morpholinyl or aryl,
R10 is hydroxyl, halogen, cyano, carboxyl,
1-4C-alkoxy, phenoxy, 1-4Calkoxycarbonyl, aminocarbonyl, mono-or
di-1-4C-alkylaminocarbonyl, N(R15)R16
or 1-4C-alkylcarbonylamino, and
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
R11 is 1-4C-alkyl, amino, mono-or di-14C-alkylamino or aryl,
aryl is phenyl, pyridyl, or R12-substituted
phenyl, where
R12 is hydroxyl, halogen, carboxyl, nitro,
amino, cyano, 1-4C-alkyl, trifluoromethyl,
1-4C-alkoxy, 1-4C-alkoxycarbonyl, 1-4Calkylcarbonylamino, 1-4Calkylcarbonyloxy or aminocarbonyl,
R13 is hydrogen, hydroxyl, halogen,
cyano, nitro, amino, 1-4C-alkyl,
trifloromethyl, 1-4C-alkoxy, completely or
predominantly fluorine-substituted 1-4Calkoxy, phenyl, phenyl-1-4C-alkyl, C(O)OR14, C(O)-N(R15)R16, N(17)R18,
S(O)2-R19, S(O)2-N(R15) R16 or has one
of the meanings of R6, where
R14 is hydrogen, 1-4C-alkyl, 3-7Ccycloalkyl or 3-7C-cycloalkylmethyl,
R15 is hydrogen, 1-4C-alkyl, 3-7Ccycloalkyl or 3-7C-cycloalkymethyl,
R16 is hydrogen, 1-4C-alkyl, 3-7Ccycloalkyl, 3-7C-cycloalkylmethyl or aryl,
or where R15 and R16, together and
including the nitrogen atom to which both
are bonded, represent a 1-pyrrolidinyl, 1piperidinyl, 1-piperazinyl, 4methylpiperazin-1-yl, hexahydroazepinyl
or 4-morphilinyl radical,
R17 is hydrogen, 1-4C-alkyl, S(O)2-R19 or
S(O)2-aryl,
R18 is 1-4C-alkyl, 1-4C-alkylcarbonyl, 37C-cycloalkylcarbonyl, 3-7Ccycloalkylmethylcarbonyl, S(O)2-R19 or
S(O)2-aryl, and
R19 is 1-4C-alkyl,
R20 is hydrogen, hydroxyl, halogen, nitro,
amino, 1-4C-alkyl, trifloromethyl, 1-4Calkoxy, completely or predominantly
fluorine-substituted 1-4C-alkoxy, 3-7Ccycloalkoxy, 3-7C-cycloalkylmethoxy,
CH2-R10, carboxyl, 1-4C-alkoxycarbonyl,
1-4C-alkylcarbonyloxy, 1-4Calkylcarbonylamino or aminocarbonyl, and
the salts, the N-oxides and the salts of the
N-oxides of these compounds.
__________
]22[]12[
]1/[
]11[
]/2[
SYSTEM AND METHOD FOR THE
AUTOMATIC IDENTIFICATION
OF ACCESSORIES COUPLED TO
A WIRELESS COMMUNICATION
DEVICE
11.01.2000
229131
]/1[ 12.01.1999
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
266137
‫מערכת ושיטה לזיהוי אוטומטי של אביזרים‬
‫המוצמדים להתקן תקשורת אל–חוטי‬
]//[
US
258
]12[
]/2[
]//[
]//[
Int. Cl.8 H04B 001/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2000/042797
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A wireless communication system,
comprising: a housing; a wireless
communication device contained within
the housing, the wireless communication
device including a transceiver for
transmitting and receiving data and audio
communications between the wireless
communication device and a remote
location; an accessory port mounted on the
housing and accessible to an external
accessory to allow the external accessory
to be coupled to the wireless
communication device, the accessory port
including at least one data line; a processor
included in the wireless communication
device and communicatively coupled to
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
the accessory port to sense activity on the
data line when the external accessory is
coupled to the accessory port, the
processor further sensing identification
data associated with the external accessory
and using the identification data to identify
the external accessory; and a storage area
associated with the wireless
communication device to store codes
corresponding to a plurality of external
accessories, the processor comparing the
sensed identification data with the stored
codes to identify the external accessory
when the external accessory is coupled to
the wireless communication device.
__________
]22[]12[
266186
‫נגזרות של מונוסכרידיים כמעכבי הידבקות‬
‫תאים‬
]1/[
DERIVATIVES OF
MONOSACCHARIDES AS CELL
ADHESION INHIBITORS
]11[
]/2[
10.01.2000
229155
]/1[ 12.01.1999
]//[ US
/22/1/
6262662000
US
Int. Cl.8 A61K 031/70, 038/05, A61P 011/00, 017/00, 019/00, 025/00, 037/08, C07H
015/02, 019/00
]12[
259
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]/2[
]//[
]//[
RANBAXY LABORATORIES
LIMITED, INDIA
WO/2000/042053
,‫ עו"ד‬,‫רחל פשר אייקנאר‬
‫ ת"א‬,4.‫טאגור‬
[57] A compound of the formula
and its pharmaceutically acceptable salts,
esters, enantiomers, diastereomers, Noxides, amides, or prodrugs, wherein R is
C1 to C15 alkyl, alkene, straight chain or
branched alkyne, aryl, substituted aryl or
alkylaryl, R' is SO2C6H5, SO2C6H4CH3-p,
or SO2C6H4Cl-p, phenyl or C6H4—R'"-p
wherein R'" is Cl, NO2, OCH3, CH3,
CH2COOH, CH2COOH, CH2COLDVP,
CH2 CODVP, CH2COVP, wherein LDVP,
DVP and VP represent tripeptide (Leucylaspartyl-valyl-prolyl), tripeptide (aspartylvalyl-prolyl) and (valyl-prolyl),
respectively,
R" is H or CH3, and (
)
represents epiglucofuranose,
epiallofuranose, xylofuranose or
ribofuranose configurations.
__________
]22[]12[
]1/[
METHOD AND APPARATUS FOR
FLOOD IRRIGATION
]11[
]/2[
08.11.1999
256459
]/1[ 23.02.1999
PCT/US99/19936
/666/62000
Int. Cl.8 A01G 025/00
RUFUS M. HOLLOWAY JR., U.S.A.
WO/2000/049853
REINHOLD COHN AND PARTNERS,
]12[
]/2[
]//[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
266822
‫שיטה והתקן להשקיה בשטף‬
]//[
US
WO
,‫ריינהולד כהן ושותפיו‬
260
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A flood irrigation apparatus (10)
comprising: a water reservoir (11); a
plurality of flood plains (12)
accommodated with a spillway to allow
water to flow from the plurality of flood
plains by gravity flow; a water collection
area (13) disposed at an elevation lower
than the plurality of flood plains; a conduit
(540) having an entrance opening
associated with the water collection area,
an exit opening associated with the water
reservoir, and a corresponding opening
associated with each of the respective
plurality of flood plains, the conduit being
operable to convey water from the water
collection area to the water reservoir, to
each of the respective plurality of flood
plains, or to the water reservoir and each of
the respective plurality of flood plains; and
a pump (14) attached to the conduit and
operable to pump water from the water
collection area through the conduit and
into the water reservoir, each of the
respective plurality of flood plains, or the
water reservoir and each of the respective
plurality of flood plains.
__________
]22[]12[
]1/[
AERODYNAMIC PROJECTILES
AND METHODS OF MAKING THE
SAME
]11[
]/2[
]12[
]/2[
06.03.2000
266060
]/1[ 10.03.1999
Int. Cl.8 F42B 012/46
PERFECT CIRCLE PROJECTILES,
LLC, U.S.A.
WO/2000/053999
]//[
261
263218
‫קליע אירודינמיים ושיטות ייצורם‬
]//[
US
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]//[
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A projectile shell comprising a
generally hemispherical portion (3) and a
generally cylindrical portion (5), said
hemispherical portion having an inner
surface and an outer surface which forms a
wall and a hemispheric interior volume
and said cylindrical portion having an
inner surface and an outer surface which
forms a wall and an interior volume having
the same general shape and volume as the
interior of the hemispherical portion,
wherein said cylindrical portion has a
length which is at least about equal to onehalf the diameter of said hemispherical
portion, and wherein said hemispherical
portion is joined to said cylindrical portion
at a rim (2).
__________
]22[]12[
]1/[
KITS AND METHODS FOR
RADIOLABELING PROTEINS
AND PEPTIDES
]11[
]/2[
]12[
]/2[
29.02.2000
259338
]/1[ 01.03.1999
Int. Cl.8 A61K 051/00, 051/08, 051/10
IDEC PHARMACEUTICALS
CORPORATION, U.S.A.
WO/2000/052031
WOLFF, BREGMAN AND GOLLER,
]//[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
263221
‫ערכות ושיטות לסימון של חלבונים‬
‫ופפטידים עם רדיו איזוטופ‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
262
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A method for radiolabeling a
chelator-conjugated antibody or antibody
fragment with a therapeutic radioisotope
for administration to a patient comprising
(i) mixing the chelator-conjugated
antibody or antibody fragment with a
solution comprising the therapeutic
radioisotope or salt thereof, and
(ii) incubating the mixture for a sufficient
amount of time under amiable conditions
such that a radiolabeled antibody or
antibody fragment is produced having
sufficient radioncorporation, sufficient
immunoreactivity, and a specific activity
of at least about 5 mCi/mg, such that the
radiolabeled antibody or antibody
fragment may be administered directly to
the patient without further purification of
the radiolabeled antibody or antibody
fragment from unincorporated
radioisotope.
__________
]22[]12[
263172
‫בתולדות איסוסרין‬
]1/[
ISOSERINE DERIVATIVES
]11[
]/2[
]12[
]01[
]/2[
23.12.1993
995443
]/1[ 23.12.1992
]//[ US
Int. Cl.8 C07C 233/82, 263/16, 271/22, C07D 307/54, 407/12, 413/12, C07F 009/655
DIVISION FROM 121540
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
19B KEREN HAYESOD ST.
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
P.O.B. 1352,
JERUSALEM 91013
]//[
[57] A compound of the formula
or a salt thereof
where
R1 is optionally substituted aryl or alkoxy,
263
R2 is optionally substituted alkoxy,
R3 and R4 are independently R5, R5-OC(O)-, or (R5)(R6)N-C(O)-,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
R4 is H,
R5 and R6 are independently hydrogen,
optionally substituted alkyl, alkenyl,
alkynyl, cycloalkyl, cycloalkenyl, aryl or
heterocyclo; and
L is alkyl sulfonyl, aryl sulfonyloxy,
chloro or a phosphorus oxy group; with the
proviso that,
(a) when R1 is phenyl, R2 is methoxy and
R3 is benzyl or isobutyl, L is not chloro;
(b) when R1 is phenyl, R2 is methoxy and
R3 is benzyl, L is not methanesulfonyloxy;
(c) when R1 is benzyloxy, R2 is methoxy
and R3 is phenyl, methoxycarbonyl, tbutoxycarbonyl or benzyl, L is not
methansulfonyloxy;
(d) when R1 is methoxy or ethoxy, R2 is
methoxy, R3 is hydrogen, L is not chloro;
(e) when R1 is t-butoxy, R2 is methoxy, R3
is methoxycarbonyl, L is not toxyloxy; and
(f) when R1 is t-butoxy, R2 is methoxy, R3
is cyclohexylmethyl, L is not
methanesulfonyloxy.
__________
]22[]12[
263083
‫פפטידים מאקרוציקליים המעכבים וירוס‬
‫ פרוטאז‬C 3NS ‫צהבת‬
]1/[
MACROCYCLIC PEPTIDES
INHIBITING THE HEPATITIS C
VIRUS NS3 PROTEASE
]11[
]/2[
]12[
03.04.2000
60/128011
]/1[ 06.04.1999
]//[ US
Int. Cl.8 A61K 038/00, A61P 031/12, C07D 207/16, 401/12, C07K 005/078, 005/08,
005/12
BOEHRINGER INGELHEIM
(CANADA) LTD., CANADA
WO/2000/059929
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]/2[
]//[
]//[
[57] Compounds of the formula
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
264
wherein W is CH or N,
R21 is H, halo, C1-6 alkyl, C3-6 cycloalkyl,
C1-6 haloalkyl, C1-6 alkoxy, C3-6
cycloalkoxy, hydroxy, or N(R23)2,
wherein each R23 is independently H, C1-6
alkyl or C3-6 cycloalkyl;
R22 is H, halo, C1-6 alkyl, C3-6 cycloalkyl,
C1-6 haloalkyl, C1-6 thioalkyl, C1-6 alkoxy,
C3-6 cycloalkoxy, C2-7 alkoxyalkyl, C3-6
cycloalkyl, C6 or 10 aryl or Het, wherein
Het is a five-, six-, or seven-membered
saturated or unsaturated heterocycle
containing from one to four heteroatoms
selected from nitrogen, oxygen and sulfur;
said cycloalkyl, aryl or Het being
substituted with R24, wherein R24 is H,
halo, C1-6 alkyl, C3-6 cycloalkyl, C1-6
alkoxy, C3-6 cycloalkoxy, NO2,
N(R25)2, NH-C(O)-R25; or NH-C(O)-NHR25, wherein each R25 is independently: H,
C1-6 alkyl or C3-6 cycloalkyl; or R24 is
NH-C(O)-OR26 wherein R26 is C1-6 alkyl or
C3-6 cycloalkyl; R3 is hydroxy, NH2, or a
group of formula – NH-R31, wherein R31 is
C6 or 10 aryl, heteroaryl, -C(O)-R32, C(O)-NHR32 or –C(O)-OR32, wherein R32
is C1-6 alkyl or C3-6 cycloalkyl;
D is a 5 to 10-atom saturated or
unsaturated alkylene chain optionally
containing one to three heteroatoms
independently selected from: O, S, or NR41, wherein R41 is H, C1-6 alkyl, C3-6
cycloalkyl or –C(O)-R42, wherein R42 is
C1-6 alkyl, C3-6 cycloalkyl or C6 or 10 aryl;
R4 is H or from one to three substituents at
any carbon atom of said chain D, said
substituent independently selected from
the group consisting of: C1-6 alkyl, C1-6
haloalkyl, C1-6 alkoxy, hydroxy, halo,
amino, oxo, thio or C1-6 thioalkyl, and A is
amide of formula –C(O)-NH-R5, wherein
R5 is selected from the group consisting of:
C1-8 alkyl, C3-6 cycloalkyl, C6 or 10 aryl or
C7-16 aralkyl; or A is a carboxylic acid or a
pharmaceutically acceptable salt or ester
thereof. Also claimed as novel are the
compounds of the formula
wherein X is PG or R2;
each PG is independently a
protecting group;
R2 is a group of formula
wherein R21, R22 and W are as defined
265
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
above; A' is protected carboxylic acid; and
n is 2; and of the formula:
and of the formula:
wherein X, PG, R2, A', R3, D are as
defined above; n is 0 or 2; D' is as defined
for D, but being 2 to 5 atoms shorter; and
of the formula
wherein R3, D, A' are as defined above;
and of the formula:
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
266
wherein R2 R3, A' are as above; m is 1 to 5;
n is 1 to 5; and Cbz is benzyloxycarbonyl;
and of the formula:
wherein R2, R3, m n, A' Clz are as defined
above; and of the formula
wherein R2, R3, m, n, A' are as defined above.
__________
]22[]12[
]1/[
USE OF AMOXYCILLIN AND
POTASSIUM CLAVULANATE IN
THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
BACTERIAL INFECTIONS AND
MODIFIED RELEASE
PHARMACEUTICAL
COMPOSITION COMPRISING
THEM
]11[
]/2[
11.04.2000
60/129074
267
]/1[
13.04.1999
263372
‫שימוש באמוקסיסילין ואשלגן קלבולנט‬
‫להכנת תרופה לטיפול בזיהומים חיידקיים‬
‫ותכשרי רוקחות עם שחרור מתואם‬
‫המכילים אותם‬
]//[
US
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]12[
]/2[
]//[
]//[
062216/1/
1166/62000
062210/2/
2162662000
Int. Cl.8 A61K 009/00, 009/20
BEECHAM PHARMACEUTICALS
(PTE) LIMITED, SINGAPORE
WO/2000/061116
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
[57] A modified release pharmaceutical
formulation comprising: amoxycillin and
potassium clavulanate in a ratio from 14:1
to 20:1 in which all of the potassium
clavulanate and a first part of amoxycillin
are formulated with pharmaceutically
acceptable excipients which allow for
immediate release of the potassium
clavulanate and the first part of
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
amoxycillin, to form an immediate release
phase, and further comprising a second
part of amoxycillin formulated with
pharmaceutically acceptable excipients
which allow for slow release of the second
part of amoxycillin, to form a slow release
phase, and in which the ratio of
amoxycillin in the immediate and slow
release phases is from 3:1 to 1:3.
__________
]22[]12[
263310
‫שיטה להפעלת רכב בסביבה עם לחץ‬
‫פסיכולוגי גבוה‬
]1/[
METHOD OF VEHICLE
OPERATION IN AN
ENVIRONMENT OF HIGH
PSYCHOLOGICAL PRESSURE
]11[
]12[
]/2[
24.09.2001
Int. Cl.8 G01C 021/00, 023/00, G06G 007/78
RAFAEL ARMAMENT
,‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ‬
DEVELOPMENT AUTHORITY
‫חיפה‬
LTD.
ANAT KOTZEV, DAN HELFMAN
‫ דן הלפמן‬,‫ענת קוצב‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן ושות‬
BEIT SAMUELOFF, 7 HAOMANIM
‫ תל אביב‬,7 ‫בית שמואלוב רח' האומנים‬
]/1[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
268
STREET
TEL AVIV
[57] A method of operating a plurality of
vehicles, each said vehicle having a
respective pilot, one of the pilots being a
commander, the method comprising the
steps of:
(a) for each vehicle, receiving a respective
initial status report from each of a plurality
of subsystems of said each vehicle;
(b) based on said initial status reports: for
each vehicle:
(i) formulating at least one respective first
course of action, and
(ii) presenting said at least one respective
first course of action to the commander;
(c) for each vehicle, assigning one of said
at least one respective first course of action
to each said vehicle, by the commander;
(d) for each vehicle, subsequently
receiving a respective subsequent status
report from each said subsystem of each
said vehicle, said subsequent status reports
being received continuously at a rate that
exceeds an assimilation rate ot the pilot of
each vehicle and
(e) based on said subsequent status reports:
for each vehicle:
(i) formulating at least one respective
subsequent course of action, and
(ii) if, for one of the vehicles, at least one
of said at least one respective subsequent
course of action differs from said
respective assigned course of action,
presenting said at least one respective
subsequent course of action to at least one
pilot selected from the group consisting of
the pilot of said one vehicle and the
commander.
__________
]22[]12[
]1/[
APPARATUS FOR TEAT
TREATMENT
]11[
]/2[
]12[
]/2[
]//[
]//[
04.05.2000
9901647-9
]/1[ 06.05.1999
Int. Cl.8 A01J 007/04
DELAVAL HOLDING AB, SWEDEN
WO/2000/067562
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
269
263123
‫התקן לטיפול בפטמות‬
]//[
SE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
[57] An apparatus for cleaning teats of an
animal; the apparatus comprising: a teat
cleaning device having cleaning means for
performing a cleaning action with regard
to a teat of an animal; characterised by
means for establishing the identity of the
animal to be cleaned; control means for
controlling the teat cleaning device in
dependence on the established identity
such that an individually adapted cleaning
action is obtained, said control means
including an information storage unit
having data records relating to a plurality
of individual animals, wherein a data
record includes control information
indicative of a pre-determined cleaning
requirement for an individual animal;
means for fetching a selected control
information data record in response to the
established identity; and means for
delivering the selected control information
to the teat cleaning device so as to cause
the teat cleaning device to perform the
cleaning action in accordance with the predetermined cleaning requirement for the
identified animal.
__________
]22[]12[
]1/[
VACUUM ASSISTED CLOSURE
SYSTEM WITH PROVISION FOR
INTRODUCTION OF AGENT
]11[
]/2[
]12[
]/2[
]//[
]//[
31.03.2000
60/127595
]/1[ 02.04.1999
Int. Cl.8 A61F 013/00, A61M 001/00
KCI LICENSING, INC., U.S.A.
WO/2000/059424
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
263111
‫מערכת סגירה המסתייעת בוואקום ובעלת‬
‫אמצעי להחדרת חומר‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
270
[57] A therapeutic combination for
promoting wound healing in mammals,
said therapeutic combination comprising: a
porous pad (11) which is permeable to
fluids and adapted for positioning within a
sealable space defined in part by a wound
surface (12); a tube (14) having a first end
in fluid communication with said porous
pad and a second end in fluid
communication with a vacuum source, said
vacuum source being adapted to apply
negative pressure to said porous pad
through said tube; and said porous pad
being predisposed with a wound healing
factor.
5719994
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
____________
]22[]12[
]1/[
SYNTHETIC METHODS FOR
PREPARING PROCYANIDIN
OLIGOMERS
]11[
]/2[
]12[
]/2[
]//[
]//[
29.03.2000
292244
]/1[ 15.04.1999
Int. Cl.8 C07D 311/32
MARS, INCORPORATED, U.S.A.
WO/2000/063201
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
271
263726
‫שיטות סינטטיות להכנת אליגומרים של‬
‫פרוציאנידין‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
[57] A process for the preparation of a
procyanidin dimer, which process includes
the steps of:
(a) protecting each phenolic hydroxyl
group of a procyanidin monomer with a
removable protecting group which does
not deactivate the A ring of the monomer,
wherein the protecting step is carried out in
an aprotic solvent;
(b) optionally blocking the C-8 position of
the monomer of step (a) with a halo group;
(c) activating for coupling the C-4 position
of the compound of step (a) or step (b) by
introducing an acyloxy group using a lead
(IV) salt of an organic acid to provide an
activated compound; and
(d) coupling the activated compound of
step (c) with an unprotected procyanidin
monomer in the presence of a coupling
catalyst to produce the dimer.
__________
]22[]12[
]1/[
METHOD AND APPARATUS FOR
DIVIDING A CONDUIT INTO
COMPARTMENTS
]11[
]/2[
]12[
]/2[
21.06.2000
338364
]/1[ 23.06.1999
Int. Cl.8 H02G 003/00
TVC COMMUNICATIONS, L.L.C.,
U.S.A.
WO/2000/079662
DR. SHLOMO COHEN & CO.,,
124 IBN GABIROL ST,
P.O.B. 11490,
TEL AVIV 62038
]//[
]//[
[57] Apparatus for dividing a
longitudinally extending conduit (12) into
compartments (20-24) comprising a
longitudinally extending insert (10), said
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
263768
‫שיטה ומערכת לחלוקת צינור לתאים‬
]//[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,1146/ .‫ד‬.‫ ת‬, 104 ‫אבן גבירול‬
insert being formed of at least two layers
of a plaint material (14-17) said layers
having lateral edges (18) and being
attached to each other near said lateral
edges to form at least one compartment
between said layers.
272
__________
]22[]12[
]1/[
AUTHENTICATED CARDS
]11[
]/2[
]12[
]/2[
]/1[
]//[
]//[
13.04.2000
60/129235
]/1[ 14.04.1999
Int. Cl.8 G06K 019/06
POWER PAPER LTD.
SHALOM LUSKI, ZVI NITZAN
WO/2000/062248
G.E. EHRLICH (1995) LTD.,
AYALON TOWER 15TH FLOOR
11 MENACHEM BEGIN STREET
52521 RAMAT GAN
[57] An authenticated card (10)
comprising a flat card body (12) being
formed with at least one region (14)
thereon being irreversibly transformable
from a first state into a second state, said
second state being identifiable by a card
holder as different from said first state;
wherein said at least one region includes
273
263123
‫כרטיסים מאומתים‬
]//[
US
‫ קיבוץ עינת‬,‫פאור פייפר בע"מ‬
‫ צבי ניצן‬,‫שלום לוסקי‬
,‫) בע"מ‬166.( ‫ארליך‬.‫אי‬.‫ג'י‬
,11 ‫ רחוב מנחם בגין‬1. ‫מגדל אילון קומה‬
‫רמת גן‬
an electro-chromic substance (24) capable
of irreversibly changing its color as a
response to an electrical potential; further
comprising an integrated power source
(16), such that activating said power
source to exert said electrical potential
results in irreversible change in color of
said electro-chromic substance.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
263113
‫–פוספינוטריצין ע"י‬L ‫תהליך להכנת‬
‫טרנסאמינציה אנזימטית עם אספרטט‬
]1/[
PROCESS FOR THE
PREPARATION OF LPHOSPHINOTHRICIN BY
ENZYMATIC TRANSAMINATION
WITH ASPARTATE
]11[
]/2[
]12[
]/2[
30.03.2000
19919848.9
]/1[ 30.04.1999
]//[ DE
Int. Cl.8 C07C 047/06, C07F 009/30, C12N 001/20, C12P 007/24, 009/00, 013/04
BAYER CROPSCIENCE GMBH,
GERMANY
KLAUS BARTSCH
WO/2000/066760
PEARL COHEN ZEDEK LATZER,
‫ עורכי פטנטים‬,‫פרל כהן צדק לצר עורכי דין‬
5 SHENKAR STREET,
,‫ונוטריונים‬
P.O.BOX 12704
,107/4 .‫ד‬.‫ ת‬, .‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
HERZLIYA 46733
‫הרצליה‬
]/1[
]//[
]//[
[57] A process for preparing L-2-amino4-(hydroxymethylphosphinyl) butyric acid
(L-phosphinothricin, L-PPT) of the
formula (I), its derivatives which are
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
selected from the group of carboxylic
esters and carboxamides and phosphinic
esters and/or its respective salts
274
from 4-(hydroxymethylphosphinyl)-2oxobutyric acid (HMPB, PPO) of the
formula
its derivatives which are selected from the
group of carboxylic esters and
carboxamides and phosphinic esters and/or
its respective salts as acceptor by
enzymatic transamination in the presence
of aspartate as donor, where the
transamination takes place in the presence
of one or more acceptor-specific aspartate
transminases (Asp-TA) to give
oxaloacetate and the compound of the
formula (I), its derivatives and/or salts.
__________
]22[]12[
263182
‫קידוד של נשאי מיקרו‬
]1/[
ENCODING OF MICROCARRIERS
]11[
]/2[
]12[
]/2[
12.04.2000
60/129551
]/1[ 16.04.1999
]//[ US
Int. Cl.8 C12Q 001/68, C40B 002/000000 G01N 033/532, 033/533, 033/546, 033/554
TIBOTEC N.V., BELGIUM
UNIVERSITEIT GENT, BELGIUM
]//[
]//[
WO/2000/063695
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] An encoded microcarrier,
characterized in that the microcarrier is
encoded by a preserved code written on the
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
surface of the microcarrier or at an internal
depth of the microcarrier.
__________
275
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
261201
‫ – אצטילציסטאין להכנת‬N ‫שימוש ב‬
‫תרופות מתאימות למתן‬
‫תוך ורידי למניעת לחץ חמצוני בחולים‬
‫העוברים דיאליזה‬
]1/[
USE OF N-ACETYLCYSTEINE
FOR THE
PREPARATION OF A
MEDICAMENT SUITABLE
FOR INTRAVENOUS
ADMINISTRATION TO
PREVENT OXIDATIVE STRESS IN
DIALYSED PATIENTS
]11[
]/2[
]12[
]/2[
]//[
]//[
18.04.2000
MI99A000831 ]/1[ 21.04.1999
]//[ IT
Int. Cl.8 A61K 031/195, A61P 013/12, C07C 323/58
ZAMBON GROUP S.P.A., ITALY
WO/2000/064421
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
[57] Use of N-acetylcysteine or
pharmaceutically acceptable salts thereof
for the preparation of a medicament
suitable to intravenous administration to
prevent oxidative stress in dialysed
patients.
__________
]22[]12[
]1/[
METHOD AND ARRANGEMENT
FOR SCROLLABLE CROSS POINT
NAVIGATION IN A USER
INTERFACE
]11[
]/2[
]12[
]/2[
]//[
]//[
20.04.2000
9901443-3
]/1[ 22.04.1999
Int. Cl.8 G06F 003/033
NOKIA CORPORATION, FINLAND
WO/2000/065429
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
[57] A method for nagivating a graphical
user interface, comprising the steps of:
receiving a first user input comprising a
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
261267
‫שיטה וארגון לניווט נקודת הצטלבות‬
‫בממשק משתמש‬
]//[
SE
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
request to scroll a first scrollable bar such
that a first object field of the first
scrollable bar is positioned within a focus
276
area, wherein the focus area is based on a
cross-point where the first scrollable bar
overlaps a second scrollable bar; receiving
a second user input comprising a request to
scroll the second scrollable bar such that
the second object field of the second
scrollable bar overlaps the first object field
in the focus area; and combining the first
object field and the second object field in
the focus area.
__________
]22[]12[
261031
‫מערכת דיגיטלית לרישום וידיאו‬
]1/[
DIGITAL VIDEO LOGGING
SYSTEM
]11[
]/2[
]12[
]/2[
]//[
]//[
08.05.2000
307718
]/1[ 10.05.1999
]//[ US
Int. Cl.8 G08B 013/194, 013/196, G11B 027/031, 027/10, H04N 005/76, 007/18
NICE SYSTEMS LTD.
‫ רעננה‬,‫נייס מערכות בע"מ‬
WO/2000/069161
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
[57] A digital video logging system
comprising: a logging apparatus able to
synchronize at least two digitally formatted
277
video inputs; and digital storage apparatus
to store said digitally formatted input.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
AERATED COMPOSITION AND
PROCESS FOR PREPARING
SUCH AN AERATED
COMPOSITION
]11[
]/2[
]12[
]/2[
06.11.2001
00310834.7
]/1[ 06.12.2000
Int. Cl.8 A23G 000/93200
UNILEVER PLC, UNITED
KINGDOM
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
261031
‫הרכב אוורירי ותהליך לייצורו‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
278
[57] A composition comprising a fat
phase and having an overrun of at least
90%, characterized in that at least 50%
w/w of said fat phase is liquid at -5oC.
__________
]22[]12[
261081
‫תולדות בנזנסולפונאמיד מותמרות‬
,‫סינאמואילאמינואלקיל תהליך להכנתן‬
‫ ותכשירי רוקחות המכילים‬,‫השמוש בהן‬
‫אותן‬
]1/[
CINNAMOYLAMINOALKYLSUBSTITUTED
BENZENESULFONAMIDE
DERIVATIVES, PROCESSES FOR
THEIR PREPARATION, THEIR
USE AND PHARMACEUTICAL
PREPARATIONS COMPRISING
THEM
]11[
]/2[
]12[
06.05.2000
19923086.2
]/1[ 20.05.1999
]//[ DE
Int. Cl.8 A61K 031/18, 031/64, A61P 009/00, C07C 311/53, 311/58, 335/42, C07D
307/40, 307/52, 309/06, 317/48
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2000/071513
PEARL COHEN ZEDEK LATZER,
‫ עורכי פטנטים‬,‫פרל כהן צדק לצר עורכי דין‬
5 SHENKAR STREET,
,‫ונוטריונים‬
P.O.BOX 12704
,107/4 .‫ד‬.‫ ת‬, .‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
HERZLIYA 46733
‫הרצליה‬
]/2[
]//[
]//[
[57] A compound of the formula
in which
X is oxygen, sulfur or cyanoimino;
Y is –(CR(5)2)n-;
Z is NH or oxygen;
the residues A(1), A(2) and A(3), which
are independent of one another and can be
identical or different, are hydrogen,
halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy,
methylenedioxy, formyl or
279
trifluoromethyl;
R(1) is
(1) (C1-C4)-alkyl; or
(2) –O-(C1-C4)-alkyl; or
(3) –O-(C1-C4)-alkyl-E(1)- (C1-C4)-alkylD(1), in which D(1) is hydrogen or –E(2)(C1-C4)-alkyl-D(2), in which D(2) is
hydrogen or –E(3)- (C1-C4)-alkyl, where
E(1), E(2) and E(3), which are independent
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
of one another and can be identical or
different, are O, S or NH; or
(4) –O-(C1-C4) – alkyl which is substituted
by a residue of a saturated 4-membered to
7-membered heterocycle which contains
one or two oxygen atoms as ring
heteroatoms; or
(5) –O-(C2-C4)-alkenyl; or
(6) –O-(C1-C4)-alkyl-phenyl in which the
phenyl group is unsubstituted or is
substituted by one or two identical or
different substituents from the group
consisting of halogen, -(C1-C4)-alkyl, -(C1C4)-alkoxy and trifluoromethyl; or
(7) –O-phenyl which is unsubstituted or is
substituted by one or two identical or
different substituents from the group
consisting of halogen, -(C1-C4)-alkyl, -(C1C4)-alkoxy and trifluoromethyl; or
(8) halogen; or
(9) phenyl which is unsubstituted or is
substituted by one or two identical or
different substituents from the group
consisting of halogen, -(C1-C4) – alkyl, (C1-C4) – alkoxy, -S(O)m-(C1-C4)-alkyl,
phenyl amino, hydroxy, nitro,
trifluormethyl, cyano, hydroxycarbonyl,
carbamoyl, -(C1-C4)-alkoxycarbonyl and
formyl; or
(10) (C2-C5)-alkenyl which is
unsubstituted or is substituted by a
substituent from the group consisting of
phenyl, cyano, hydroxycarbonyl
and -(C1-C4)-alkoxycarbonyl; or
(11) -(C2-C5) – alkynyl which is
unsubstituted or is substituted by a
substituent from the group consisting of
phenyl and -(C1-C4)-alkoxy; or
(12) monocyclic or bicyclic heteroaryl
having one or two identical or different
ring heteroatoms from the group consisting
of oxygen, sulfur and nitrogen; or
(13) –S(O)m-phenyl which is unsubstituted
or is substituted by one or two identical or
different substituents from the group
consisting of halogen, (C1-C4)-alkyl, (C1C4)-alkoxy and trifluoromethyl; or
(14) –S(O)m-(C1-C4)-alkyl;
R(2) is hydrogen, (C1-C6)-alkyl or (C3-C7)cycloalkyl, but is not hydrogen if Z is
oxygen;
the residues R(3) and R(4), which are
independent of one another and can be
identical or different, are phenyl which is
unsubstituted or is substituted by one or
two identical or different substituents from
the group consisting of halogen, (C1-C4)alkyl, (C1-C4)-alkoxy and trifluoromethyl,
or hydrogen or -(C1-C4)-alkyl; the residues
R(5), which are all independent of one
another and can be identical or different,
are hydrogen or (C1-C3)-alkyl;
m is 0, 1 or 2;
n is 1, 2, 3 or 4;
in all its stereoisomeric forms and mixtures
thereof in all ratios, and/or its
physiologically tolerable salts for the
inhibition of ATP-sensitive potassium
channels or for the stimulation of the vagal
nervous system.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
280
]22[]12[
261387
0 ‫אגוניסטים של אדרנוצפטור בטא‬
]1/[
BETA 2 ADRENOCEPTOR
AGONISTS
]11[
]/2[
]12[
02.06.2000
9913083.3
]/1[ 04.06.1999
]//[ GB
Int. Cl.8 A61K 031/13, 031/16, 031/395, A61P 043/00, C07C 233/43, 311/08, C07D
215/26
NOVARTIS AG, SWITZERLAND
WO/2000/075114
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
]/2[
]//[
]//[
[57] Compounds of the formula
in free or salt or solvate form, where
Ar is a group of the formula
R1 is hydrogen, hydroxy, or C1-C10 –
alkoxy;
R2 and R3 are each independently
hydrogen or C1-C10-alkyl;
R4, R5, R6 and R7 are each independently
hydrogen, halogen, cyano, hydroxy, C1C10-alkoxy, phenyl, C1-C10-alkyl, C1-C10alkyl substituted by one or more halogen
atoms or one or more hydroxy or C1-C10
alkoxy groups, C1-C10 – alkyl interrupted
by one or more hetero atoms, C2-C10-
281
alkenyl, tri- C1-C10 – alkylsilyl, carboxy,
C1-C10 – alkoxycarbonyl, or –CONR11R12,
where R11 and R12 are each independently
hydrogen or C1-C10 – alkyl,
or R4 and R5, R5 and R6, or R6 and R7
together with the carbon atoms to which
they are attached denote a 5- or 6membered carbocyclic ring or a 5- or 6membered O-heterocyclic ring containing
one or two oxygen atoms;
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
R8 is –NHR13 where R13 is hydrogen, C1C10 – alkyl, C1-C10-alkyl interrupted by one
or more hetero atoms, or –COR14 where
R14 is hydrogen, or R13 is –SO2R17 where
R17 is C1-C10 – alkyl or C1-C10 – alkyl
interrupted by one or more hetero atoms,
and R9 is hydrogen, or R8 is –NHR18 where
–NHR18 and R9, together with the carbon
atoms to which they are attached, denote a
6-membered N-heterocycle;
R10 is –OR19 is hydrogen;
X is C1-C10-alkyl;
n is 1 or 2;
q and r are each zero or 1, the sum of q+r
is 1 or 2; and the carbon atom marked with
an asterisk* has the R or S configuration,
or a mixture thereof, when R1 is hydroxy
or C1-C10 – alkoxy.
__________
]22[]12[
‫משטח שזהותו מקודדת‬
]1/[
IDENTITY CODED SURFACE
]11[
]/2[
24.05.2000
PQ0559
]/1[ 25.05.1999
PQ1313
/666062000
PQ3457
2162662000
PQ4392
6262162000
Int. Cl.8 G06K 019/06
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/072250
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] A method of producing a surface
having a region, the method including the
steps of:
(a) defining coded data, the coded data
being comprised of a plurality of
codewords and being indicative of: a
region identity associated with the region;
and a plurality of points within the region;
The applications for division
from this application have
not yet been published
261180
]//[
AU
AU
AU
AU
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
(b) disposing the coded data within a
region on the surface in the form of a
plurality of sets of symbols, each set of
symbols corresponding to a one of the
plurality of codewords and wherein the
step of disposing includes interleaving on
the surface the symbols of each set with at
least one symbol of at least another set of
the plurality of sets of symbols.
5740929
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
____________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
282
]22[]12[
]1/[
BRUSH-SEAL DESIGNS FOR
TURBINES AND SIMILAR
ROTARY APPARATUS
]11[
]/2[
]12[
]/2[
]//[
]//[
05.04.2001
09/543951
]/1[ 06.04.2000
Int. Cl.8 F01D 011/02, F16J 015/32
TURBOCARE, INC., U.S.A.
WO/2001/076348
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A retractable packing segment (201)
for an apparatus that extracts work from
the expansion of a gaseous working fluid,
said apparatus comprising: a rotating shaft
disposed in a casing, wherein a plurality of
packing segments are disposed in a ring
and centered on an axis defined by said
shaft to provide a seal therearound, each
said packing segment being retractable and
comprising: an inner face (205) for sealing
against said shaft and an outer face (206)
supporting a T-shaped extension, said
inner and outer faces and said extension
261178
‫תכנונים של אטם מברשת עבור טורבינות‬
‫והתקנים סיבוביים דומים‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
spanning opposing common side ends, said
common side ends cut parallel with radii of
said axis, and at least one brush seal (217)
disposed on the inner face of said segment,
said brush seal having opposing ends, at
least one of said ends cut non-parallel with
radii of said axis and extending past one of
said common side ends, and bristles (219)
of said brush disposed at approximately
the same non-parallel direction, wherein
said plurality of packing segments provide
a continuous 360o brush seal around said
shaft.
__________
283
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
BI-MODAL CONTROL SYSTEM
AND METHOD FOR
PARTITIONING A SHARED
OUTPUT BUFFER IN A
CONNECTION-ORIENTED
NETWORK
]11[
]/2[
]12[
]/2[
26.05.2000
321904
]/1[ 28.05.1999
Int. Cl.8 H04L 012/56, H04Q 011/04
NETWORK EQUIPMENT
TECHNOLOGIES, INC., U.S.A.
JAMES P. SCOTT, EDWARD G.
CAVASIAN
WO/2000/074433
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O. BOX 45087,
JERUSALEM 91450
]/1[
]//[
]//[
[57] A method for self-configuration of a
switch, the switch including a plurality of
input ports, the input ports including
characteristics that define a hierarchy of
data traffic classes, the method
comprising: estimating an ambient load
based on characteristics for a number of
connections for an input port in the
plurality of input ports; calculating a
partition boundary for a buffer based on
the estimated load and a data traffic class
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
261813
‫מערכת בקרה–דו–מצבית ושיטה לחלוקת‬
‫חוצץ פלט משותף ברשת בעלת אופי‬
‫חיבורי‬
]//[
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./07 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
associated with the input port; and
configuring the partition boundary in the
buffer according to the calculation,
wherein the configuration of the partition
boundary sets an amount of data the buffer
can store for a first data traffic class in the
hierarchy of data traffic classes; and
dynamically re-configuring the partition
boundary in the buffer to adapt to changes
in the ambient load.
284
__________
]22[]12[
]1/[
APPARATUS AND METHOD FOR
TRAFFIC SHAPING IN A
NETWORK SWITCH
]11[
]/2[
]12[
]/2[
26.05.2000
60/136953
]/1[ 28.05.1999
Int. Cl.8 H04L 012/56
NETWORK EQUIPMENT
TECHNOLOGIES, INC., U.S.A.
RICHARD LEMYRE, STANLEY M.
REYNOLDS, TODD L. LOWPENSKY
WO/2000/074321
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O. BOX 45087,
JERUSALEM 91450
]/1[
]//[
]//[
[57] A shaper unit comprising: a Cell
Descriptor (CD) processing block
comprising a processing block that
receives and processes a plurality of CDs,
a SHAPE RAM that hold a mapping table
from a ConnectionID to a ShapeID, a
285
261818
‫מתקן ושיטה לעיצוב תנועה במתג רשת‬
‫תקשורת‬
]//[
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./07 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
COIN RAM that stores heads and tails of
"later" lists, and a DATA BUFFER array
that stores the plurality of CDs; and a
ShapedID processing block comprising a
processing block that processes a plurality
of ShapeIDs, a Generic Cell-Rate
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
algorithm (GCRA) RAM that stores pershape GCRA configuration and state data,
and a LINK RAM that stores a Calendar
Queue linked list array; wherein the CD
processing block outputs the plurality of
ShapeIDs to the ShapeID processing
block, the plurality of ShapeIDs
corresponding to the plurality of CDs
received by the CD processing block; and
wherein the ShapeID processing block
processes the plurality of ShapeIDs to
control the scheduling of the plurality of
CDs out of the shaper unit.
__________
]22[]12[
261186
‫השימוש בבוטוליניום נוירוטוקסין להכנת‬
‫תרופה‬
]1/[
USE OF A BOTULINUM
NEUROTOXIN FOR THE
MANUFACTURE OF A
MEDICAMENT
]11[
]/2[
]12[
]/2[
26.05.2000
19925739.6
]/1[ 07.06.1999
]//[ DE
Int. Cl.8 A61K 038/16, A61P 025/00, C07K 014/33
MERZ PHARMA GMBH & CO.
KGAA, GERMANY
WO/2000/074703
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]//[
]//[
[57] Use of a botulinum neurotoxin from
Clostridium botulinum of type A, B, C, D,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
286
E, F or G or a mixture of two or more such
neurotoxins, characterized in that the
neurotoxin or mixture of neurotoxins is
free of the complexing proteins which
naturally form complexes with botulinum
neurotoxins, for the manufacture of a
medicament, substantially as described in
the specification, for cosmetic treatment or
treatment of dystonia or disorders of the
nervous system in a human or animal
subject already exhibiting neutralizing
antibodies against such botulinum
neurotoxin complexes.
__________
]22[]12[
]1/[
ARRANGEMENT AND METHOD
IN A SWITCHED
TELECOMMUNICATION SYSTEM
]11[
]/2[
]12[
]/2[
20.06.2000
9902245-1
]/1[ 23.06.1999
Int. Cl.8 H04L 012/66, H04Q 011/04
TELEFONAKTIEBOLAGET LM
ERICSSON
(PUBL), SWEDEN
WO/2000/079830
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A device in a switched
telecommunication system including: a
switched domain including at least one
switch; at least one service network
connected to the switched domain, which
service network can provide a service; a
user port for a user in at least one of the
switches in the switched domain,
287
268261
‫מיכלול ושיטה במערכת תיקשורת‬
‫ממותגת‬
]//[
SE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
characterised in that the device includes: at
least one local network terminal at the
user, which network terminal has an uplink
port which is connected to the user port;
service ports in the network terminal for
user devices, and means for configuring
the service ports for the respective user
devices.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
PROCESS FOR THE
MANUFACTURE OF COATED
GRANULES WITH MASKED
TASTE
]11[
]/2[
]12[
]/2[
]//[
]//[
30.06.2000
99/09047
]/1[ 08.07.1999
Int. Cl.8 A61K 009/00, 009/16
ETHYPHARM, FRANCE
WO/2001/003672
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A process for manufacturing coated
granules with masked taste, and immediate
release of the active principle, according to
which: the constituents of a powder
comprising at least the active principle and
a granular disintegrant are first dry-mixed;
the powder obtained is then granulated, in
the presence of a mixture of excipients
268121
‫תהליך ליצור גרעינים מצופים עם טעם‬
‫מוסווה‬
]//[
FR
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
comprising at least one binder for binding
the particles together to give grains; the
grains formed are then coated by spraying
with a suspension comprising at least one
coating agent and a membrane
disintegrant; finally, the coated granules
obtained are dried.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
288
]22[]12[
]1/[
PREPARATION AND METERING
OF COMPONENTS WITH CO2
]11[
]/2[
]12[
]/2[
]//[
]//[
21.06.2000
MI99A001416 ]/1[ 25.06.1999
Int. Cl.8 A23L 001/304, B65D 083/14
ABIOGEN PHARMA S.P.A., ITALY
WO/2001/000507
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] Pressurised containers containing
inorganic salts, in powder form or
saturated aqueous solution, and carbon
268111
‫הכנה וכיול של מרכיבים המעורבבים עם‬
‫פחמן דו–חמצני‬
]//[
IT
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
dioxide, said salts dissolving
instantaneously once introduced under
pressure in an aqueous phase.
__________
]22[]12[
]1/[
SCHEDULING AND ADMISSION
CONTROL OF PACKET DATA
TRAFFIC
]11[
]/2[
]12[
]/2[
10.07.2000
99113820.7
]/1[ 15.07.1999
Int. Cl.8 H04L 012/56
TELEFONAKTIEBOLAGET LM
ERICSSON
(PUBL), SWEDEN
WO/2001/006714
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A method for processing in a
communications system a data packet
stream carrying real-time data traffic, with
the steps of: receiving a first
synchronization control packet that
includes a number of synchronization
control parameters related to a succeeding
synchronization entity; reading at least one
synchronization control parameter from
289
268320
‫תיזמון ובקרת מתירות של תעבורת יחידת‬
‫נתונים‬
]//[
EP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
the synchronization control packet;
receiving at least one payload data packet;
determining for each payload data packet a
delivery deadline, and sorting the at least
one payload data packet according to its
determined delivery deadline into a first
queue and setting a time stamp in the first
queue to the determined delivery deadline.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
5719419
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_____________
]22[]12[
]1/[
LIPOSOME COMPOSITION
HAVING RESISTANCE TO
FREEZE/THAW DAMAGE
]11[
]/2[
]12[
]/2[
]//[
]//[
14.07.2000
60/144380
]/1[ 16.07.1999
Int. Cl.8 A61K 009/00, 009/127
ALZA CORPORATION, U.S.A.
WO/2001/005372
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
[57] A liposome composition having
protection from freeze/thaw damage
comprising: a suspension of liposomes
wherein each liposome contains an
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
268331
‫תכשיר של ליפוסום בעל עמידות בפני‬
‫הפשרה‬/‫נזקי הקפאה‬
]//[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
entrapped aqueous medium having an
inner osmolarity, the liposomes being
suspended in an external medium
comprising a water soluble salt and a
290
cryoprotectant, said external medium
having an outer liposome osmolarity
higher than the inner liposome osmolarity
thereby establishing a lower inside/higher
outside osmotic gradient across each
liposome.
__________
]22[]12[
]1/[
METHOD AND APPARATUS FOR
AVOIDING DATA LOSS DURING
A PPP RENEGOTIATION ON A
UM INTERFACE
]11[
]/2[
]12[
]/2[
14.07.2000
353108
]/1[ 14.07.1999
Int. Cl.8 H04Q 007/32, 007/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/005175
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]//[
]//[
[57] A method of preventing data loss
during a PPP renegotiation on a Um
interface, said method comprising:
determining, on a MT2 device, whether
said renegotiation is occurring on said Um
interface; and asserting flow control of
268388
‫שיטה והתקן למניעת איבוד נתונים במשא‬
Um ‫ בממשך‬PPP ‫ומתן חוזר מסוג‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
data to be output from said TE2 device to
said MT2 device, over a Rm interface,
when said determining determines that said
PPP renegotiation is occurring on said Um
interface.
__________
]22[]12[
291
268836
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫מערכת ושיטה למתן מענה חזותי מיידי‬
‫לקלט משתמש במערכת לקוח‬
]1/[
SYSTEM AND METHOD FOR
PROVIDING IMMEDIATE
VISUAL RESPONSE TO USER
INPUT AT A CLIENT SYSTEM
]11[
]/2[
]12[
]/2[
]//[
]//[
20.07.2000
360876
]/1[ 23.07.1999
]//[ US
Int. Cl.8 G06F 015/00, G09G 005/00, H04L 029/06
CITRIX SYSTEMS, INC., U.S.A.
WO/2001/008378
BOROCHOV, KORAKH, ELIEZRI &
,'‫בורוכוב קורח אליעזרי ושות‬
CO,
‫אביב‬-‫ תל‬,.01// .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
15 TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM
P.O.BOX 58100
TEL AVIV 61580
[57] In a client-server system including a
client node transmitting user-provided
input to a server node having an
application program executing thereon
wherein the user-provided input elicits a
response from the server node that is
transmitted back to the client node for
display, a method for reducing perceived
response time to the user-provided input
comprising the steps of:
(a) receiving user input at a client node
from an input device for input to the
application program executing on the
server node;
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
(b) transmitting the user input to the
application program executing on the
server node over a communication link;
(c) generating at the client node a
prediction of the server response to the
user input;
(d) displaying the generated prediction of
the server response on a display screen at
the client node;
(e) receiving a server response to the user
input from the server node; and
(f) replacing the generated prediction of
the server response displayed on the
display screen with the server response
received from the server node.
292
__________
]22[]12[
268766
‫היצע שירותים מוגבר יחד עם מערכת‬
‫מאובטחת ושיטה להתאמה לפרופיל המנוי‬
]1/[
SERVICE PLATFORM WITH
SECURE SYSTEM AND METHOD
FOR SUBSCRIBER PROFILE
CUSTOMIZATION
]11[
]/2[
]12[
]/2[
27.07.2000
361676
]/1[ 27.07.1999
]//[ US
Int. Cl.8 G06F 002/100000 H04L 029/06, 029/08, H04M 011/00
ADC TELECOMMUNICATIONS,
INC., U.S.A.
WO/2001/008022
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] A system for customizing a profile
of a subscriber having access to a service
platform comprising: a subscriber service
manager configured to receive a subscriber
request at the service platform, the
subscriber service manager upon receiving
the subscriber request generating a
transaction identifier, storing a copy of the
transaction identifier, and communicating
the transaction identifier to the subscriber;
and a customization module configured to
receive and process a customization
293
message sent to the system, the received
customization message including
subscriber profile data and a transaction
identifier; the customization module, upon
receipt of the customization message,
comparing the transaction identifier in the
received customization message with the
copy of the transaction identifier stored by
the subscriber service manager, and
registering the subscriber profile data when
the transaction identifier and the copy of
the transaction identifier correspond.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
______________
]22[]12[
268717
‫שיטה לטיפול בסרטן המבוססת על אפקט‬
‫אוג'ר‬
]1/[
AUGER EFFECT-BASED
CANCER THERAPY METHOD
]11[
]12[
]/2[
30.01.2002
Int. Cl.8 A61N 005/10, A61P 035/00, C07D 487/00, 487/22, G21G 004/04
BEN GURION UNIVERSITY OF
‫ הרשות למחקר‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
THE NEGEV RESEARCH AND
‫שבע‬-‫ באר‬,‫ופיתוח‬
DEVELOPMENT AUTHORITY
YUVAL GOLAN, BRENDA H.
‫ משה פרג'י‬,‫ גד שני‬,‫ ברנדה לסטר‬,‫יובל גולן‬
LASTER, GAD SHANI, MOSHE
FARAGGI
PYERNIK RUTMAN,
,‫פיירניק רוטמן עו"פ‬
BEIT ETSION
‫ באר‬,1//10 .‫ד‬.‫ ת‬, 61 ‫בית עציון רח' הרצל‬
HERZL ST. 91
‫שבע‬
P.O.B. 10012
BEER SHEVA
]/1[
]//[
[57] A therapeutic composition for use in
Auger electron therapy of tumors,
comprising a therapeutically effective
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
amount of a complex of a heavy element
with a polydentate, pyrrole-containing
macrocylic ligand substituted with charged
chemical groups, wherein said complex is
capable of bringing said heavy element
294
into close proximity to the nuclear DNA of
cells in said tumors, and wherein said
heavy element is capable of emitting
Auger electrons, together with a
pharmaceutically acceptable carrier.
__________
]22[]12[
267208
‫תקשורת בין משתמש ושרת מחשבים דרך‬
‫ שיטה מוצר ומערכת של תוכנית‬,HTTP
‫מחשב‬
]1/[
COMMUNICATION BETWEEN
CLIENT AND SERVER
COMPUTERS VIA HTTP,
METHOD, COMPUTER
PROGRAM PRODUCT AND
SYSTEM
]11[
]/2[
]12[
]/2[
]//[
]//[
13.06.2001
60/211629
]/1[ 14.06.2000
]//[ US
Int. Cl.8 G06F 009/00, 015/173, H04L 029/06, 029/08
SAP AG, GERMANY
WO/2001/097012
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
[57] A method for communication
between a client computer and a server
computer , both computers using the
hypertext transfer protocol (HTTP), the
client computer using an HTTP-browser;
the method comprising the following steps:
sending a first request from the client
computer to the server computer; upon
receiving the first request, the server
computer (i) allocating a resource at the
server computer, the resource with an
identifier, and (ii) returning a
295
predetermined close instruction to the
browser, the close instruction carrying the
identifier; upon unloading the close
instruction from the browser of the client
computer, sending a second request from
the client computer to the server computer
the second request carrying the identifier
and indicating to de-allocate the resource;
and upon receiving the second request
from the client computer, by the server
computer de-allocating the resource.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
267222
,:–‫–מתיל‬0–‫–הידרוקסי‬0 ‫–פניל‬N ‫נגזרות‬
‫–טריפלואורופרופאנאמיד מותמרות‬:,:
‫המגבירות פעילות של דהידרוגנאז‬
‫פירובאט‬
]1/[
SUBSTITUTED N-PHENYL 2HYDROXY-2-METHYL-3,3,3TRIFLUOROPROPANAMIDE
DERIVATIVES WHICH ELEVATE
PYRUVATE DEHYDROGENASE
ACTIVITY
]11[
]/2[
30.08.2000
9920814.2
]/1[ 04.09.1999
]//[ GB
66600/261
1266/61666
GB
Int. Cl.8 A61K 031/167, A61P 003/10, 009/08, C07C 317/40, 317/44, 317/50, 323/65,
C07D 205/04, 207/12, 213/71, 213/73, 295/12
ASTRAZENECA AB, SWEDEN
WO/2001/017956
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
41-45 ROTSHILD BLV
‫ תל אביב‬,41-4.‫שדרות רוטשילד‬
TEL AVIV 65784
]12[
]/2[
]//[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
296
[57] Compounds of the formula
wherein:
n is 1 or 2;
R1 is chloro, fluoro, bromo, methyl or
methoxy;
R2 is selected from one of the following
three groups:
(i) halo, nitro, hydroxy, amino, or cyano;
(ii) –X1-R5 wherein X1 is direct bond, -O-,
-S-, -OS2-, -NR6-, -CO-, -CONR6-, NR6CO-, -NR6SO2- NR6CONR7-; wherein
R6 and R7 are independently hydrogen or
C1-4 alkyl optionally substituted with one
or more A; and R5 is selected from C1-6
alkyl optionally substituted with one or
more A, C3-7 cycloalkyl optionally
substituted with one or more A, C3-7
cycloalkyl C1-6 alkyl optionally substituted
with one or more A, C2-6 alkenyl optionally
substituted with one or more A, C2-6
alkynyl optionally substituted with one or
more A, phenyl optionally substituted with
one or more D, phenyl C1-6 alkyl optionally
substituted with one or more D, heteroaryl
ring optionally substituted on a ring carbon
by one or more D or (heteroaryl ring) C1-6
alkyl optionally substituted on a ring
carbon with one or more D; wherein said
heteroaryl ring is a carbon linked 6membered ring containing 1-2 nitrogen
atoms or a carbon linked 5-membered ring
containing 1-3 heteroatoms selected
independently from O, N and S; and
wherein if said 5-membered heteroaryl
ring contains an –NH- moiety that nitrogen
may be optionally substituted with a group
selected from G;
(iii) a nitrogen-linked 4-8 membered
297
heterocyclic group optionally substituted
on a ring carbon by one or more D and
wherein if said heterocyclic group contains
an –NH- moiety that nitrogen may be
optionally substituted with a group
selected from G; R3 is C1-6 alkyl optionally
substituted with one or more A, C3-7
cycloalkyl optionally substituted with one
or more A, phenyl optionally substituted
with one or more D, a carbon-linked 6membered heteroaryl ring containing 1-2
nitrogen atoms optionally substituted on a
ring carbon by one or more D, or a carbon
linked 5-membered heteroaryl ring
containing 1-3 heteroatoms selected
independently from O, N and S optionally
substituted on a ring carbon by one or
more D and wherein if said 5-membered
heteroaryl ring contains an –NH- moiety
that nitrogen may be optionally substituted
with a group selected from G; A is selected
from hydroxy, amino, halo, carboxy, N(C1-4 alkyl) amino, N, N-di-(C1-4 alkyl)
amino, carbamoyl and C1-6 alkoxy; D is
selected from:
(i) –Xa-Rc wherein Xa is a direct bond, -O-,
S-, -SO-, -SO2-, -CO-, -NRdSO2-, NRdCO-, -NRdCONRe-, -NRd- or –
CONRd-; wherein Rd and Re are
independently hydrogen or C1-4 alkyl
optionally substituted with one or more
hydroxy or C1-4 alkoxy; and Rc is selected
from hydrogen or C1-6 alkyl optionally
substituted with one or more hydroxy or
C1-4 alkoxy;
(ii) a 4-8 membered Het which is
optionally substituted on a ring carbon
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
with one or more groups selected from
hydroxy, halo, C1-4 alkoxy, C1-4 alkyl or
cyano and wherein if said 4-8 membered
Het contains an –NH- moiety that nitrogen
may be optionally substituted with a group
selected from G;
(iii) –Xa-C1-6 alkyl-Xb-Rc wherein Xa and
Rc are as defined hereinbefore and Xb is –
S-, -SO- or –SO2-;
(iv) cyano or halo; and
(v) –Xc-Rf wherein Xc is –C(O)- or –SO2
and Rf is a nitrogen-linked 4-8 membered
heterocyclic group optionally substituted
on a ring carbon by one or more groups
selected from hydroxy, halo, C1-4 alkoxy,
C1-4 alkyl or cyano and wherein if said
heterocyclic group contains an –NH-
moiety that nitrogen may be optionally
substituted with a group selected from G;
G is selected from C1-6 alkyl optionally
substituted with one or more A, C1-6
alkanoyl optionally substituted with one or
more A, C1-6 alkylsulphonyl optionally
substituted with one or more A, C1-6
alkoxycarbonyl optionally substituted with
one or more A, carbamoyl, N-(C1-6 alkyl)
carbamoyl optionally substituted with one
or more A, N-(C1-6 alkyl)2 carbamoyl
optionally substituted with one or more A
and benzoyl optionally substituted with
one or more A; and R4 is hydrogen or
fluoro; or pharmaceutically acceptable
salts or in vivo hydrolysable esters thereof.
__________
]22[]12[
]1/[
DEVICES FOR VERTEBRAL DISC
AUGMENTATION
]11[
]/2[
18.08.2000
60/149490
]/1[ 18.08.1999
0622026/1
1162662000
0622/1000
1262162000
06//0/
/666061666
Int. Cl.8 A61F 002/44
INTRINSIC THERAPEUTICS, INC.,
U.S.A.
WO/2001/012107
S. HOROWITZ & CO.,
41-45 ROTSHILD BLV
TEL AVIV 65784
]12[
]/2[
]//[
]//[
[57] An implant for implantation between
a nucleus (20) and an annulus (10) and
across a defect in the annulus in an
intervertebral disc, comprising: a barrier
(12) having a concave surface facing the
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
267212
‫מכשירים להגדלת דיסק חולייתי‬
]//[
US
US
US
US
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל אביב‬,41-4.‫שדרות רוטשילד‬
nucleus in the implanted orientation,
wherein said barrier is dimensioned to
extend along the annulus across and
beyond the periphery of the area defining a
defect (16).
298
__________
]22[]12[
267128
‫בקרת קצב נתונים מסתגלת עבור רשתות‬
‫השלחה צרה‬
]1/[
ADAPTIVE DATA RATE
CONTROL FOR NARROWCAST
NETWORKS
]11[
]/2[
16.08.2000
60/149615
]/1[ 16.08.1999
]//[ US
120211
6066/61666
US
Int. Cl.8 H04B 007/185, H04L 001/00, 001/20
VIASAT, INC., U.S.A.
WO/2001/013540
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
]12[
]/2[
]//[
]//[
[57] In a narrowcast network system, a
subscriber terminal apparatus comprising:
first circuitry configured to receive data
transmission using a selectable carrier;
second circuitry configured to produce at
least one signal quality metric based on a
received data transmission; and third
299
circuitry configured to communicate said
signal quality metric to a hub station; said
first circuitry further configured to receive
a data transmission containing carrier
assignment information, said first circuitry
further configured to select a carrier based
on said carrier assignment information.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
267127
‫ שיטה להכנתן‬,‫תולדות פנילפיפרזינים‬
‫ותכשירי רוקחות המכילים אותן‬
]1/[
PHENYLPIPERAZINE
DERIVATIVES, METHOD FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]11[
]/2[
22.08.2000
99202710.2
]/1[ 23.08.1999
]//[ EP
2621///
1/66/62000
NL
Int. Cl.8 A61K 031/395, A61P 025/00, C07D 401/14, 413/14, 417/14
SOLVAY PHARMACEUTICALS
B.V., THE NETHERLANDS
WO/2001/014330
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] Compounds of the formula
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
300
wherein:
X is (1) a group of the formula
wherein
S1 is hydrogen or halogen,
S2 and S3 are independently hydrogen,
alkyl (1-6C) phenyl or benzyl, S4
represents two hydrogen atoms or an oxo
group, S5 is H or alkyl (1-4C), and Y is C,
O or S,
or(2) a group of the formula
wherein R is H, alkyl (1-4C), alkoxyalkyl
(2-6C), alkenyl (2-4C) or alkynyl (2-4C),
or (3) a group of the formula
wherein Z is CH2, O or N,
or (4) a group of the formula
301
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
or (5) a group of the formula
wherein A is O or N, linked to the
piperazine ring with position 5 to 8,
or (6) a group of the formula
wherein S6 and S7 represent hydrogen
atoms or an oxo group,
or (7) a group of the formula
wherein one of the dotted lines can
represent a double bond,
P=T=Q=nitrogen
or P=T=nitrogen and Q=CH or CH2
or P=Q=nitrogen and T=CH, CH2, C-CH3
or CH-CH3
or P=nitrogen, and T and Q are CH or CH2
or P=nitrogen, T is CH or CH2 and Q is
sulphur;
m has the value 2 to 6;
n has the value 0-2;
R5 and R6 are independently H or alkyl (13C); or R5+R6 represent a group –(CH2)-p
wherein p has the value 3-5, and
R7 is alkyl (1-3C), alkoxy (1-3C), halogen
or cyano; or R6+R7 (R7 at position 7 of the
indole group) represent a group –(CH2)q
wherein q has the value 2-4, and salts
thereof.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
302
]22[]12[
]1/[
METHOD OF PRODUCTION OF
CASTABLE PLASTIC BONDED
CHARGE EXPLOSIVE OR
PROJECTILE PROPELLANT
]11[
]/2[
]12[
]/2[
19.02.2002
10107948.6
]/1[ 20.02.2001
Int. Cl.8 F42B 023/00
RHEINMETALL W & M GMBH,
GERMANY
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
[57] A method of making pourable,
plastic-bound charge explosives or rocket
propellants, comprising providing a charge
explosive or rocket propellant admixed
with a polymer; providing a metal powder,
said powder comprising powder grains
with essentially spherical shape,
267167
‫שיטה לייצור של חומר נפץ של מטען או‬
‫חומר דחיפה של קליע המקושר על ידי‬
‫חומר פלסטי וניתן ליציקה‬
]//[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
treating the metal powder with a reagent
which is reactive with polar groups and
provides –SiR3 groups wherein Si is
silicon; and R is hydrocarbyl; and after
said treating, adding the treated metal
powder to said explosive.
__________
]22[]12[
]1/[
METHOD FOR IMPROVING THE
COLOR OF DISCOLORED
DIAMONDS
]11[
]/2[
]12[
]/2[
21.02.2002
60/150979
]/1[ 25.08.1999
Int. Cl.8 B01J 003/06
BALLATAIRE INTERNATIONAL
LLC., U.S.A.
WO/2001/014050
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A method for improving the color of
discolored natural diamond, comprising:
(a) placing said discolored natural diamond
in a pressure transmitting medium;
(b) consolidating said pressure transmitting
303
267178
‫שיטה לשפור הצבע של יהלומים עם צבע‬
‫מוכתם‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
medium into a pill;
(c) exposing said pill to elevated pressure
and elevated temperature within the
graphite stable or diamond stable range of
the carbon phase diagram for a time
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
sufficient to improve the color of said
diamond; and
(d) recovering said diamond.
__________
]22[]12[
]1/[
6H-IMIDAZO[4,5C]TETRAZOLO[1,5C]QUINOLINES, A PROCESS FOR
THEIR PREPARATION AND THE
PREPARATION THEREFROM OF
1H-IMIDAZO[4,5-C]QUINOLINE4-AMINES
]11[
]/2[
]12[
]01[
]/2[
22.10.1996
673712
]/1[ 21.06.1996
Int. Cl.8 C07D 471/04, 471/14
DIVISION FROM 127348
MINNESOTA MINING AND
MANUFACTURING COMPANY,
U.S.A.
WO/1997/048704
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
267027
– .,1[‫]טטרזולו‬C– .,4[‫–אימידאזו‬H9
‫ תהליך להכנתם והכנה מהם‬,‫]קווינולינים‬A
– 4–‫] קווינולין‬C– .,4[‫ אימידאזו‬H1 ‫של‬
‫אמינים‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] A compound of the formula
wherein R is hydrogen, straight chain or
branched chain alkoxy containing one to
four carbon atoms, halogen, and straight
chain or branched chain alkyl containing
one to four carbon atoms; R1 is selected
from the group consisting of hydrogen,
alkyl of one to about six carbon atoms,
hydroxy alkyl wherein the alkyl moiety
contains one to about 6 carbon atoms, and
arylalkyl wherein the alkyl moiety contains
one to about three carbon atoms; and R2 is
selected from the group consisting of
hydrogen, alkyl of one to about four
carbon atoms, alkoxyalkyl wherein the
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
304
alkoxy moiety contains one to about four
carbon atoms and the alkyl moiety
contains one to about four carbon atoms,
hydroxyl alkyl wherein the alkyl moiety
contains one to about four carbon atoms,
haloalkyl wherein the alkyl moiety
contains one to about four carbon atoms,
and aryloxymethyl.
It is used as an intermediate in a process
comprising reacting the compound with a
triphenylphosphine to provide (1-
substituted) (2-substituted) Ntriphenylphosphinyl-1-1H-imidazo [4,5-c]
quinolin-4-amine;
(vi) hydrolyzing the resultant compound to
provide a (1-substituted) (2-substituted)
1H-imidazo [4, 5-c] quinolin-4-amine and
(vii) isolating the final compound or a
pharmaceutically acceptable addition salt
thereof.
__________
]22[]12[
]1/[
ZEROTREE ENCODING OF
WAVELET DATA
]11[
]/2[
]12[
]/2[
10.08.2000
09/390255
]/1[ 03.09.1999
Int. Cl.8 H04N 007/26
INTEL CORPORATION, U.S.A.
INDIAN INSTITUTE OF
TECHNOLOGY, INDIA
WO/2001/019089
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A method comprising: providing
wavelet coefficients that indicate an image,
the bits of each wavelet coefficient being
associated with a different bit order so that
each bit order is associated with one of the
bits of each wavelet coefficient; expressing
the wavelet coefficients is signed binary
305
267031
‫קידוד איפוס עץ של נתוני גלון‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
representation; determining whether a rate
of coded bits exceeds a predetermined bit
rate, and generating the coded bits to
indicate zerotree roots that are associated
with the bit orders and regulating the
generation based on whether the rate
exceeds the predetermined bit rate.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
ORAL PHARMACEUTICAL
FORMS OF ADMINISTRATION
WITH A DELAYED ACTION
]11[
]/2[
]12[
]/2[
]//[
]//[
03.08.2000
19940944.7
]/1[ 31.08.1999
Int. Cl.8 A61K 009/00, C07C 217/54
GRUNENTHAL GMBH, GERMANY
WO/2001/015681
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] At least partially sustained-release,
oral pharmaceutical forms of
administration of tramadol, characterized
in that the sustained-release portion of the
pharmaceutical active substance is present
267628
‫צו רות רוקחיות למתן פוני פעילות מושהית‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
as a compound, formed in situ, of tramadol
and another, acidic pharmaceutical active
substance and/or auxiliary substance with a
water solubility of ≤100 mg/ml.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
306
]22[]12[
267121
‫מגביל לקביעת כמות‬
]1/[
DOSE SETTING LIMITER
]11[
]/2[
]12[
]/2[
]//[
]//[
04.09.2000
PA199901309 ]/1[ 16.09.1999
Int. Cl.8 A61M 005/315
NOVO NORDISK A/S, DENMARK
WO/2001/019434
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] An injection device comprising: a
housing (1) holding a cartridge (2), an
injection button (16) for releasing a set
dose, a piston rod (3) for moving forward a
piston inside the cartridge and, a limiting
mechanism which prevents setting of a
dose which exceeds the amount of liquid
left in a cartridge, said limiting mechanism
comprising: a dose setting member (6)
coupled to the injection button and, a
driver (9) coupled to the piston rod,
wherein the dose setting member and the
driver move relatively to each other when
the dose setting member is rotated to set a
dose whereby the injection button is
moved away from the housing, and the
dose setting member and the driver move
]//[
DK
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
together when the set dose is released by
moving back the injection button whereby
the piston rod is moved forward
characterized in that, the driver is provided
with a track having an end-wall defining a
track-length which is related to the total
amount of medicament in the cartridge and
which track is engaged by a track follower
coupled to the dose setting member to
follow rotation of the dose setting member
such that the track follower and the dose
setting member rotate together relatively to
the driver when a dose is set, and the track
follower and the dose setting member
rotate simultaneously with the driver when
a dose is released.
__________
307
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
APPARATUS AND PROCESS FOR
CONDITIONING MAMMALIAN
BLOOD
]11[
]/2[
]12[
]/2[
15.09.2000
60/154215
]/1[ 16.11.1999
Int. Cl.8 A61J 003/00, A61M 001/00
VASOGEN IRELAND LIMITED,
IRELAND
WO/2001/019318
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.
P.O.B. 1426
TEL AVIV 61013
]//[
]//[
[57] Apparatus (20) for conditioning
mammalian blood for subsequent use in a
medical procedure, the apparatus
including: a cabinet (21) having a secure
environment and a door (26) providing the
only access to the secure environment; an
input system for transporting a blood
charge from a source to the cabinet; a flask
(56) removably contained in said secure
environment and coupled to the input
system to receive said charge; stressors
coupled to the cabinet and positioned for
operation to create a conditioned charge in
the flask; an output system (37) coupled to
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
267101
‫התקן ותהליך להתניית דם יונקים‬
]//[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1409 .‫ד‬.‫ ת‬, :1 ‫רח' יבנה‬
the flask and including a receiver for the
conditioned charge; the apparatus being
characterized by: a control system
contained in the cabinet and operable upon
closing the door to lock the door and to
then automatically condition the charge
and to cause the charge to move from the
flask to the receiver, whereby a charge
from the input system is conditioned and
delivered to the receiver, the door is then
unlocked and the conditioned charge is
ready to be removed and used to complete
the medical procedure.
308
__________
]22[]12[
]1/[
BUILDING BLOCK OR PANEL
]11[
]/2[
]12[
]/2[
15.09.2000
PQ2854
]/1[ 15.09.1999
Int. Cl.8 E04C 001/39
HENDRIK CORPORAAL,
AUSTRALIA
WO/2001/020092
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O. BOX 45087,
JERUSALEM 91450
]//[
]//[
[57] A building block or panel having a
shape of a parallelpiped comprising four
edge faces (11, 13 15, 17) and two
opposed major faces (19, 21) said edge
faces being formed to be interlockingly
engagable with the edge faces of similar
building blocks, each edge face comprising
lateral zones which are located to one or
the other side of the central longitudinal
axis of the edge face, one zone of each
edge face being formed with a recess (23)
309
267111
‫בלוק או פנל לבניה‬
]//[
AU
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./07 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
and the other zone of each edge face being
formed with a projection (31) of a
complementary configuration to the one
zone, the recesses on opposed edge faces
being of corresponding configuration
wherein, each recess has a base which is
substantially parallel to the edge face and
opposed end faces which are of
complementary profile, substantially
parallel and inclined with respect to the
edge face.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
METHOD FOR PRODUCTION OF
ARYL ALKYL ETHERS
]11[
]/2[
]12[
]/2[
04.10.2000
19949319.7
]/1[ 13.10.1999
Int. Cl.8 C07C 041/00, 041/09, 043/20
RUTGERS CHEMICALS AG,
GERMANY
WO/2001/011120
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] Process for the preparation of aryl
alkyl ethers comprising the step of reacting
a hydroxy aromatic with an alcohol in the
presence of a catalyst wherein a mixture,
homogeneous at atmospheric pressure,
comprising a hydroxy aromatic, an alcohol
and a catalyst is introduced into a reactor
and reacted at a temperature of from 250 to
267812
‫שיטה להכנת אריל אלקיל אתרים‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
370oC and the concentration of products in
the reaction mixture is adjusted in such a
manner that the catalyst does not
precipitate even during the distillative
working-up, wherein the process is a
continuous process and the ratio of catalyst
to hydroxyaromatic is 1:32 to 1:60.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
310
]22[]12[
267871
‫תרופות לטיפול ברקמות ממאירות‬
]1/[
DRUGS FOR THE TREATMENT
OF MALIGNANT TUMOURS
]11[
]/2[
24.10.2000
9903838-2
]/1[ 25.10.1999
]//[ SE
062202/6/
1162662000
US
6661/16-6
1266061666
SE
062121/20
1266061666
US
Int. Cl.8 A61K 031/47, A61P 035/00, C07D 213/20, 213/38, 491/02
ACTIVE BIOTECH AB, SWEDEN
WO/2001/030758
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] Use of a compound of the formula
(I) for the manufacture of a medicament
for the treatment of breast and prostatic
cancer
wherein
A is selected from OR41 and NR42 R43
wherein
R41 is selected from hydrogen,
pharmaceutically acceptable inorganic and
organic cations; and CORA wherein RA is
selected from alkyl and aryl groups; R42
and R43 are the same or different and
selected from hydrogen, methyl, ethyl, npropyl, iso-propyl, and cyclopropyl; or R42
is CORB wherein RB is (C1-C4) alkyl, or
CORB is a 2-acyloxymethylbenzoyl group
wherein RC is selected from methyl, ethyl,
phenyl and benzyl;
R is selected from hydrogen, methyl, ethyl,
n-propyl, iso-propyl, n-butyl, iso-butyl,
sec-butyl and allyl; with the proviso that R
is not hydrogen when A is OR41; R' is
selected from hydrogen, methyl, methoxy,
fluoro, chloro, bromo, cyano,
trifloromethyl, and OCHxFy,
wherein x=0-2,
311
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
y=1-3 with the proviso that
x+y=3;
and with the proviso that R' is not
hydrogen when R is methyl and A is OR41;
R'' is selected from hydrogen, fluoro and
chloro, with the proviso that R'' is selected
from fluoro and chloro only when R' is
selected from fluoro and chloro; R5 is
selected from hydrogen, methyl, ethyl, npropyl, iso-propyl, methoxy, ethoxy,
fluoro, chloro, bromo, trifluoromethyl,
dimethylamino and OCHxFy, and
OCH2CHxFy
wherein x= 0 – 2,
y = 1 -3 with the proviso that
x + y = 3 and
with the further provisos that R5 is not
fluoro when A is OR41; and that R5 is
hydrogen only when A is NR42 R43 and R'
is trifluoromethyl;
R6 is hydrogen; or
R5 and R6 taken together are
methylenedioxy;
or any tautomer thereof.
__________
]22[]12[
267782
–0' ‫ – קרבונאמידים‬0 – ‫ – ביפניל‬1' ,1
‫ שימוש בהם‬,‫ שיטה לייצורם‬,‫מותמרים‬
‫כתרופה ותכשירי רוקחות המכילים‬
‫תרכובות אלו‬
]1/[
2'-SUBSTITUTED1,1'-BIPHENYL 2 - CARBONAMIDES, METHOD
FOR THE PRODUCTION
THEREOF, USE THEREOF AS
MEDICAMENT AND
PHARMACEUTICAL
PREPARATIONS CONTAINING
SAID COMPOUNDS
]11[
]/2[
]12[
19.09.2000
19947457.5
]/1[ 02.10.1999
]//[ DE
Int. Cl.8 A61K 031/165, 031/17, 031/18, 031/325, 031/395, A61P 009/06, C07C
233/11, 233/87, 235/32, 235/38, 271/22, 271/54, 275/24, 275/28, 311/13, 311/19,
335/12, C07D 213/40, 233/54
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/025189
PEARL COHEN ZEDEK LATZER,
‫ עורכי פטנטים‬,‫פרל כהן צדק לצר עורכי דין‬
5 SHENKAR STREET,
,‫ונוטריונים‬
P.O.BOX 12704
,107/4 .‫ד‬.‫ ת‬, .‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
HERZLIYA 46733
‫הרצליה‬
]/2[
]//[
]//[
[57] Antiarrhythmic compounds of the formula
in which:
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
312
R(1) is C(O)OR(9), SO2R(10), COR(11),
C(O)NR(12)R(13) or C(S)NR(12)R(13);
R(9) is CxH2x-R(14);
x is 0, 1, 2, 3, or 4,
where x cannot be 0 if R(14) is OR(15) or
SO2Me; R(14) is alkyl having 1, 2, 3, 4, 5
or 6 carbon atoms, cycloalkyl having 3, 4,
5, 6, 7, 8, 9, 10 or 11 carbon atoms, CF3,
C2F5, C3F7, CHF2, OR(15), SO2Me,
phenyl, naphthyl, biphenylyl, furyl, thienyl
or an N-containing heteroaromatic having
1, 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms,
where phenyl, naphthyl, biphenylyl, furyl,
thienyl and the N-containing heteroaromatic are unsubstituted or substituted
by 1, 2 or 3 substituents selected from the
group consisting of F, Cl, Br, I, CF3,
OCF3, NO2, CN, COOMe, CONH2,
COMe, NH2, OH, alkyl having 1, 2, 3 or 4
carbon atoms, alkoxy having 1, 2, 3 or 4
carbon atoms, dimethylamino, sulfamoyl,
methylsulfonyl and methylsulfonylamino;
R(15) is alkyl having 1, 2, 3, 4 or 5 carbon
atoms, cycloalkyl having 3, 4, 5 or 6
carbon atoms, CF3 or phenyl which is
unsubstituted or substituted by 1, 2 or 3
substituents selected from the group
consisting of F, Cl, Br, I, CF3, NO2, CN,
COOMe, CONH2, COMe, NH2, OH, alkyl
having 1, 2, 3 or 4 carbon atoms, alkoxy
having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsulfonyl
and methylsulfonylamino;
R(10), R(11) and R(12) independently of
one another are defined as R(9); R(13) is
hydrogen, alkyl having 1, 2, 3 or 4 carbon
atoms or CF3; R(2) is hydrogen, alkyl
having 1, 2, 3 or 4 carbon atoms or CF3;
R(3) is CyH2y-R(16);
y is 0, 1, 2, 3 or 4,
where y cannot be 0 if R(16) is OR(17) or
SO2Me;
R(16) is alkyl having 1, 2, 3, 4, 5 or 6
carbon atoms, cycloalkyl having 3, 4, 5, 6,
7, 8, 9, 10 or 11 carbon atoms, CF3, C2F5,
C3F7, CH2F, CHF2, OR(17), SO2Me,
phenyl, naphthyl, furyl, thienyl or an Ncontaining heteroaromatic having 1, 2, 3,
313
4, 5, 6, 7, 8 or 9 carbon atoms, where
phenyl, naphthyl, furyl, thienyl and the Ncontaining heteroaromatic are
unsubstituted or substituted by 1, 2 or 3
substituents selected from the group
consisting of F, Cl, Br, I, CF3, OCF3, NO2,
CN, COOMe, CONH2, COMe, NH2, OH,
alkyl having 1, 2, 3 or 4 carbon atoms,
alkoxy having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsulfonyl
and methylsulfonylamino;
R(17) is hydrogen, alkyl having 1, 2, 3, 4
or 5 carbon atoms, cycloalkyl having 3, 4,
5 or 6 carbon atoms, CF3, phenyl or 2-, 3or 4-pyridyl, where phenyl or 2-, 3- or 4pyridyl are unsubstituted or substituted by
1, 2 or 3 substituents selected from the
group consisting of F, Cl, Br, I, CF3,
OCF3, NO2, CN, COOMe, CONH2,
COMe, NH2, OH, alkyl having 1, 2, 3 or 4
carbon atoms, alkoxy having 1, 2, 3 or 4
carbon atoms, dimethylamino, sulfamoyl,
methylsulfonyl and methylsulfonylamino;
or
R(3) is CHR(18)R(19);
R(18) is hydrogen or CzH2z-R(16), where
R(16) is defined as indicated above; z is 0,
1, 2 or 3;R(19) is COOH, CONH2,
CONR(20)R(21), COOR(22), CH2OH;
R(20) is hydrogen, alkyl having 1, 2, 3, 4
or 5 carbon atoms, CvH2v-CF3 or CwH2wphenyl,
where the phenyl ring is unsubstituted or
substituted by 1, 2 or 3 substituents
selected from the group consisting of F, Cl,
Br, I, CF3, OCF3, NO2, CN, COOMe,
CONH2, COMe, NH2, OH, alkyl having 1,
2, 3 or 4 carbon atoms, alkoxy having 1,
2, 3 or 4 carbon atoms, dimethylamino,
sulfamoyl, methylsulfonyl and
methylsulfonylamino; v is 0, 1, 2 or 3; w is
0, 1, 2, or 3; R(21) is hydrogen or alkyl
having 1, 2, 3, 4 or 5 carbon atoms;
R(22) is alkyl having 1, 2, 3, 4 or 5 carbon
atoms; R(4) is hydrogen, alkyl having 1, 2,
3, 4, 5 or 6 carbon atoms or CF3; or R(3)
and R(4) together are a chain of 4 or 5
methylene groups, of which one methylene
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
group can be replaced by –O-, -S, -NH-, N(methyl)- or –N(benzyl)-;
R(5), R(6), R(7) and R(8) independently of
one another are hydrogen, F, Cl, Br, I, CF3,
NO2, CN, COOMe, CONH2, COME, NH2,
OH, alkyl having 1, 2, 3 or 4 carbon atoms,
alkoxy having 1, 2, 3 or 4 carbon atoms,
dimethylamino, sulfamoyl, methylsulfonyl
or methylsulfonylamino;
R(30) and R(31) independently of one
another are hydrogen or alkyl having 1, 2
or 3 carbon atoms; or R(30) and R(31)
together are a chain of 2 methylene groups;
or their pharmaceutically acceptable salts.
__________
]22[]12[
]1/[
PROCESS TO PREPARE
ARYLTRIAZOLINONES AND
NOVEL INTERMEDIATES
THERETO
]11[
]/2[
12.10.2000
60/159247
]/1[ 13.10.1999
60200///0
2/66061666
Int. Cl.8 C07D 249/12
FMC CORPORATION, U.S.A.
WO/2001/027092
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]12[
]/2[
]//[
]//[
261210
‫תהליך להכנת ארילטריאזולנונים וחומרי‬
‫ביניים חדשים שלהם‬
]//[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A process for preparing a compound
of the formula
comprised of carbonylating an amidrazone
of the formula
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
314
with at least one carbonylating agent
and wherein X and Y are independently
selected from hydrogen, halogen, nitro,
and amino;
Z is selected from hydrogen, halogen,
alkyl, alkoxy, nitro, amino, or
alkylsulfonylamino;
W is –NHR where R is hydrogen, alkyl, or
haloalkyl; and,
R1 is hydrogen, alkyl, haloalkyl, alkoxy,
acetyl, or aryl.
__________
]22[]12[
]1/[
DRY POWDER COMPOSITION
CONTAINING A DI- OR
TRIPEPTIDE
]11[
]/2[
12.04.2000
60/162451
]/1[ 29.10.1999
06220/1/0
6/62262000
0622/1/00
1662162000
0622/////
1/66261666
0622///21
1/66261666
Int. Cl.8 A61K 009/12, 038/00, 047/18
NEKTAR THERAPEUTICS, U.S.A.
WO/2001/032144
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
]//[
[57] A dry powder composition
comprising an active agent and a di- or
261273
‫תכשיר אבקתי יבש המכיל די–או‬
‫טריפפטיד‬
]//[
US
US
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
tripheptide comprising at least two
leucines.
__________
315
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
261216
‫שיטות ותכשירים המשתמשים‬
‫בקינאזולינונים‬
]1/[
METHODS AND COMPOSITIONS
UTILIZING QUINAZOLINONES
]11[
]/2[
26.10.2000
60/198253
]/1[ 27.10.1999
]//[ US
06212/26/
1266061666
US
Int. Cl.8 A61K 031/517, A61P 035/00, 037/00, C07D 239/88
CYTOKINETICS, INC., U.S.A.
JEFFREY T. FINER, GUSTAVE
BERGNES, BAINIAN FENG,
WHITNEY W. SMITH, JOHN C.
CHABALA
WO/2001/030768
JEREMY M. BEN-DAVID & CO.
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
LTD.,
,4./07 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
HAR HOTZVIM HI-TECH PARK,
‫ירושלים‬
P.O. BOX 45087,
JERUSALEM 91450
]12[
]/2[
]/1[
]//[
]//[
[57] Compounds of the formula
wherein
(1) R1 is benzyl;
R2 is ethyl;
R2 is hydrogen;
R3 is 2-fluorophenyl;
R4 is 2-dimethylaminoethyl;
R5-R8 are hydrogen;
(2) R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 3-fluorophenyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(3) R1 is benzyl;
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
R2 is ethyl;
R2' is hydrogen;
R3 is 4-fluorophenyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(4) R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 3-bromophenyl;
R4 is 2-dimethyaminoethyl;
R5 – R8 are hydrogen;
(5) R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
316
R3 is 4-bromophenyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(6) R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 1-naphthyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(7) R1 is benzyl:
R2 is methyl;
R2' is hydrogen;
R3 is 3-bromophenyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(8) R1 is benzyl;
R2 is methyl;
R2' is hydrogen;
R3 is 4-bromophenyl;
R4 is 2-dimethylaminoethyl;
R5- R8 are hydrogen;
(9) R1 is benzyl;
R2 is methyl;
R2' is hydrogen;
R3 is 4-bromophenyl;
R4 is 2-aminoethyl;
R5 – R8 are hydrogen;
(10) R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 4-bromophenyl;
R4 is 2-aminoethyl;
R5 – R8 are hydrogen;
(11) the R-isomer wherein
R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 4-bromophenyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(12) the R-isomer wherein
R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 1-naphthyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(13) the R-isomer wherein
R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 4-bromophenyl;
R4 is 2-dimethylaminoethyl;
R5 – R8 are hydrogen;
(14) the R-isomer wherein
R1 is benzyl;
R2 is ethyl;
R2' is hydrogen;
R3 is 4-bromophenyl;
R4 is 2-aminoethyl;
R5, R6 and R8 are hydrogen and R7 is
chlorine.
__________
317
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
261171
‫תרכובות אוריאה בעלות פעילות‬
‫אנטגוניסטית לקולטן מוסקריני‬
]1/[
UREA COMPOUNDS HAVING
MUSCARINIC RECEPTOR
ANTAGONIST ACTIVITY
]11[
]/2[
]12[
07.12.2000
456170
]/1[ 07.12.1999
]//[ US
Int. Cl.8 A61K 031/4468, 031/4523, 031/454, A61P 011/06, 013/10, 025/28, C07D
207/14, 211/58, 211/60, 223/12, 401/00, 405/12, 471/10, 471/14, 491/08, 495/08
THERAVANCE, INC., U.S.A.
WO/2001/042213
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]/2[
]//[
]//[
[57] Compounds of the formula
wherein:
A is phenyl or pyridyl;
B" is –NH-;
R1 is hydrogen;
R2 is pyrrolyl, pyridinyl, imidazolyl or
phenyl;
K is a bond or a methylene group;
K" is a bond;
B is pyrrolidine, piperidine, or
hexahydroazepine;
R46 is alkyl, substituted alkyl, cycloalkyl,
substituted cycloalkyl, or heterocycle; R47
is alkyl, substituted alkyl, aryl, acyl,
heterocycle, or –COOR50 where R50 is
alkyl; or
R46 and R47 together with the nitrogen
atom to which they are attached form a
heterocycle, which is optionally substituted
with 1 to 5 substituents independently
selected from the group consisting of
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
alkoxy, substituted alkoxy, cycloalkyl,
substituted cycloalkyl, cycloalkenyl,
substituted cycloalkenyl, acyl, acylamino,
acyloxy, amino, substituted amino,
aminoacyl, aminoacyloxy, oxyaminoacyl,
azido, halogen, hydroxyl, keto, thioketo,
carboxyl, carboxylalkyl, thioaryloxy,
thioheteroaryloxy, thioheterocyclooxy,
thiol, thioalkoxy, substituted thioalkoxy,
aryl, aryloxy, heteroaryl, heteroaryloxy,
heterocyclic, heterocyclooxy,
hydroxyamino, alkoxyamino, nitro, -SOalkyl, -SO-substituted alkyl, -SO-aryl, SO-heteroaryl, -SO2-alkyl, -SO2substituted alkyl, -SO2-aryl, -SO2heteroaryl, alkyl, substituted alkyl, alkenyl,
substituted alkenyl, alkynyl, and
substituted alkynyl; X is a group of
formula:
318
-Xa-Z-(Ya-Z)m-Yb-Z-Xawherein
m is an integer of from 0 to 20;
Xa at each separate occurrence is selected
from the group consisting of –O-, -S-, NR-, -C(O)-, -C(O)O-, -C(O)NR-, -C(S)-,
-C(S)O-, -C(S)NR- or a covalent bond;
Z at each separate occurrence is selected
from the group consisting of alkylene,
cycloalkylene, substituted cycloalkyene,
alkenylene, substituted alkenylene,
alkynylene, substituted alkynylene,
cycloalkenylene, substituted
cycloalkenylene, arylene, heteroarylene,
heterocyclene, or a covalent bond;
Ya and Yb at each separate occurrence are
selected from the group consisting of –O-,
-C(O)-, -OC(O)-, -C(O)O-, -NR-, -S(O)n-,
-C(O)NR'-, -NR'C(O)-, NR'C(O)NR'- NR'C(S)NR'-, -C(=NR')-NR'-, -NR'C(=NR')-, -OC(O)-NR'-, -NR'-C(O)-O-, N=C(R")-NR'-, -NR'-C(R")=N-, P(O)(OR')-O-, -O-P(O)(O')-, -S(O)nCR'R", -S(O)n-NR'-, -NR'-S(O)n-, -S-S-, and a
covalent bond; where n is 0, 1 or 2; and
R, R' and R" at each separate occurrence
are selected from the group consisting of
hydrogen, alkyl, substituted alkyl,
cycloalkyl, substituted cycloalkyl, alkenyl,
substituted alkenyl, cycloalkenyl,
substituted cycloalkenyl, alkynyl,
substituted alkynyl, aryl, heteroaryl and
heterocyclic; provided at least one of Xa,
Ya, Yb or Z is not a covalent bond; or
pharmaceutically acceptable salts thereof.
__________
]22[]12[
261001
‫שיטה לייצורם של פראוקסיקרבונאטים‬
‫ושימושם בפילמור רדיקלי של מונימרים‬
]1/[
METHOD FOR PRODUCING
PEROXYDICARBONATES AND
THEIR USE IN THE RADICAL
POLYMERIZATION OF
MONOMERS
]11[
]/2[
]12[
]/2[
]//[
]//[
03.11.2000
433907
]/1[ 04.11.1999
]//[ US
Int. Cl.8 C07C 407/00, 409/34, C08F 004/34, 014/06
OXY VINYLS LP, U.S.A.
WO/2001/032613
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
[57] A process for producing
peroxydicarbonates comprising the steps
of:
(a) reacting at least one inorganic peroxide
with at least one alkali metal hydroxide, in
a first vessel to form at least one alkali
metal peroxide,
(b) charging at least one haloformate, at
319
least one dispersant and water, into a
second vessel equipped with
homogenizing means and cooling means,
(c) begin mixing the contents of said
second vessel, and
(d) metering said at least one alkali metal
peroxide produced in said first vessel into
said second vessel while homogenizing the
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
contents of said second vessel until
substantially all of the alkali metal
peroxide has reacted with the haloformate
to form peroxydicarbonate.
__________
]22[]12[
261616
1.,14 ‫אנדרוגנים מותמרים במתילן בעמדות‬
]1/[
14,15 - BETA-METHYLENE
SUBSTITUTED ANDROGENS
]11[
]/2[
]12[
]/2[
29.11.2000
99204080.8
]/1[ 02.12.1999
]//[ NL
Int. Cl.8 A61K 031/565, A61P 005/26, C07J 053/00
N.V. ORGANON, THE
NETHERLANDS
WO/2001/040255
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060, TEL AVIV 61040
]//[
]//[
[57] A compound of the formula
wherein
R1 is O, (H, H), (H,OR), NOR, with R
being hydrogen, (C1-6) alkyl, (C1-6) acyl;
R2 is hydrogen, or (C1-6) alkyl;
R3 is hydrogen; or R3 is (C1-6) alkyl, (C2-6)
alkenyl, or (C2-6) alkynyl, each optionally
substituted by halogen;
R4 is hydrogen, (C1-6) alkyl, or (C2-6)
alkenyl;
R5 is (C1-6) alkyl;
R6 is hydrogen, halogen, or (C1-4) alkyl;
R7 is hydrogen, or (C1-6) alkyl;
R8 is hydrogen, hydroxy, (C1-6) alkoxy,
halogen, or (C1-6) alkyl;
R9 and R10 are indepdendntly hydrogen; or
R9 and R10 are independently (C1-6) alkyl,
(C2-6) alkenyl, (C3-6) cycloalkyl, (C5-6)
cycloalkenyl, or (C2-6) alkynyl, each
optionally substituted by (C1-5) alkoxy, or
halogen;
R11 is hydrogen, SO3H, (C1-15) acyl; and
the dotted lines indicate optional bonds,
selected from a ∆4, ∆5(10), or ∆11 double
bond, or a ∆4.9 or ∆4.11 diene system, with
the proviso that when R1 is O, R2 is H, R3
is H or (C1-6) alkyl, R4 is H, R5 is methyl,
R6 is H, R7 is H, R8 is H, R9 is H, R10 is a
∆4 double bond alone R11 cannot be H.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
320
]22[]12[
]1/[
PROCESS FOR THE
PREPARATION OF KETIMINES
]11[
]/2[
]12[
]/2[
07.11.2000
99811055.5
]/1[ 16.11.1999
Int. Cl.8 C07C 249/02, 251/20
CIBA SPECIALTY CHEMICALS
HOLDING INC., SWITZERLAND
WO/2001/036377
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
261318
‫תהליך להכנת קטאימינים‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] A process for the preparation a
compound of the formula
which comprises reacting (a) an isomeric
mixture consisting of from 75 to 95% of a
compound of the formula
and from 5 to 25% of a compound of the
formula
321
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
with methylamine, in a suitable solvent, to
form a sertraline-imine isomeric mixture
consisting of from 75 to 95% of formula
(1a) and from 5 to 25% of the formula
or reacting an isomeric mixture consisting
of from 75 to 95% of a compound of
formula (2a) and from 5 to 25% of a
compound of formula (2b) with
methylamine, in a suitable solvent, using
suitable methods of isolation to form an
enriched sertraline-imine isomeric mixture,
consisting of <1% of a compound of
formula (1b) (A2); and then subjecting the
sertraline-imine isomeric mixture obtained
according to reaction route (A1) or (A2), in
a suitable solvent, to recrystallisation (B),
in accordance with the following scheme:
wherein in formulae (1a), (1b), (2a) and
(2b) R1, R2 and R3 are each independently
of the others hydrogen, halogen,
trifluoromethyl or C1-C4 alkoxy.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
261372
322
]1/[
ANALGESIC COMPOSITIONS
CONTAINING BUPRENORPHINE
‫תכשירים אנאלגסיים המכילים בופרנורפין‬
]11[
]/2[
17.11.2000
9927359.1
]/1[ 19.11.1999
]//[ GB
0622/016/
2/66261666
US
]12[ Int. Cl.8 A61K 045/00, 045/06, A61P 025/04, C07D 489/02
]/2[ RECKITT BENCKISER
HEALTHCARE (UK) LIMITED,
UNITED KINGDOM
]//[ WO/2001/035942
]//[ LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
[57] An analgesic composition in
naloxone is in the range of from 12.5:1 to
parenteral unit dosage form or in a unit
27.5:1, or
dosage form suitable for delivery via the
(ii) an amount of naltrexone or nalmefene
mucosa comprising an amount of
such that the ratio by weight of
buprenorphine which is less than the
buprenorphine to naltrexone or namefene
clinical dose requires to achieve pain relief
is in the range of from 12.5:1 to 22.5:1
and
whereby the analgesic action of the
(i) an amount of naloxone such that the
buprenorphine is potentiated by the low
ratio by weight of buprenorphine to
dose of naloxone, naltrexone or nalmefene.
__________
]22[]12[
]1/[
MEDICAL DEVICE WITH
POSITION SENSOR HAVING
ACCURACY AT HIGH
TEMPERATURES
]11[
]/2[
]12[
]/2[
]//[
14.05.2002
882127
]/1[ 15.06.2001
Int. Cl.8 A61B 005/00, 005/05
BIOSENSE, INC., U.S.A.
DR. SHLOMO COHEN & CO.,,
124 IBN GABIROL ST,
P.O.B. 11490,
TEL AVIV 62038
[57] A medical device and position
sensor combination comprising:
323
261163
‫מכשיר רפואי עם חיישן למיקום בעל דיוק‬
‫בטמפרטורות גבוהות‬
]//[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,1146/ .‫ד‬.‫ ת‬, 104 ‫אבן גבירול‬
(a) a medical device having a body;
(b) a position sensor (10) attached to the
body, the position sensor having a core
(12) made of a high permeable material,
the material being a magnetic material that
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
produces a magnetic field that switches
polarity and causes a substantially uniform
voltage pulse upon an application of an
external field, the position sensor being
used for determining position coordinates
of the portion of the body of the medical
device, the position sensor maintaining
accuracy at ≤1 mm at temperatures greater
than 75oC.
__________
]22[]12[
]1/[
METHODS AND COMPOSITIONS
TO DEFOLIATE CROP PLANTS
AND MINIMIZE PLANT
REGROWTH FOLLOWING
DEFOLIATION
]11[
]/2[
]12[
]/2[
]//[
]//[
05.12.2000
461383
]/1[ 15.12.1999
Int. Cl.8 A01N 047/34, 057/20, 061/00
BASF CORPORATION, U.S.A.
WO/2001/043552
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A method of defoliating crop plants
and minimizing regrowth following
defoliation comprising applying to the
locus of a growing crop plant in need of
261880
‫שיטות ותכשירים להסרת עלים בצמחי‬
‫יבול והקטנת הגידול החוזר בצמחים לאחר‬
‫הסרת העלים‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
defoliation a defoliating effective amount
of between about 0.005 to about 0.091b
ai/A of diflufenzopyr and between about
0.25 to about 2.5 lb ai/A of ethephon.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
261712
324
]1/[
FAULT CURRENT AND
DIFFERENTIAL CURRENT
DETECTION SYSTEM CAPABLE
OF PREVENTING SPURIOUS
TRIGGERING OF A
PROTECTION SYSTEM DUE TO
TRANSIENT INTERFEREN
]11[
]/2[
]12[
]/2[
08.06.2001
589802
]/1[ 09.06.2000
Int. Cl.8 H02H 001/04
SIEMENS AKTIENGESELLSCHAFT,
GERMANY
WO/2001/095453
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] A fault or differential current
detection software program contained in a
computer readable medium, wherein the
fault or differential current detection
software program includes instructions to
instruct a controller to perform a routine
comprising:
(a) determining if a detected current
generated on a conductor is greater than or
equal to a first predetermined current
threshold based on a detection signal
corresponding to said detected current;
(b) refraining from outputting a control
signal for a predetermined delay period
after said detected current is greater than or
equal to said first predetermined threshold;
‫מערכת לגילוי זרם כשל וזרם הפרש‬
‫המסוגלת למנוע דירבון כוזב של מערכת‬
‫הגנה כתוצאה מדופקי הפרעה במעבר‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
(c) determining if said detected current is
greater than or equal to a second
predetermined current threshold after said
predetermined delay period is over;
(d) determining if said detected current is a
fault or differential current after said
detected current is greater than or equal to
said second predetermined current
threshold; and
(e) when said detected current is said fault
or differential current, outputting said
control signal at least indirectly to a switch
to instruct said switch to isolate said fault
current from an electric device connected
to said conductor.
__________
]22[]12[
325
261106
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫מערכת צילום מודיעין מוטסת‬
]1/[
AIRBORNE RECONNAISSANCE
SYSTEM
]11[
]12[
]/2[
30.05.2002
Int. Cl.8 F41G 007/00, G01C 011/02, G02B 027/64
RAFAEL-ARMAMENT
,‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ‬
DEVELOPMENT AUTHORITY
‫חיפה‬
LTD.
ISRAEL GREENFELD, ZVI YAVIN,
‫ ברנד אול‬,‫ צבי יבין‬,‫ישראל גרינפלד‬
BERND UHL
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
]/1[
]//[
[57] An airborne reconnaissance system
comprising: gimbals having at least two
degrees of freedom; at least one array of
light sensors positioned on the gimbals, for
being directed by the same within at least
two degrees of freedom; map storage
means for storing at least one Digital
Elevation Map of an area of interest,
divided into portions; inertial Navigation
System for real-time providing to a
gimbals control unit navigation and
orientation data of the aircraft with respect
to a predefined global axes system; portion
selection unit for selecting, one at a time,
another area portion from the area of
interest; servo control unit for: (A)
receiving from said Digital Elevation Map
one at a time a coordinates set of the
selective area portion, said set comprising
the x:y coordinates of said area portion,
and the elevation z of the center of that
portion;
(B) receiving continuously from said
inertial navigation system present location
and orientation data of the aircraft;
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
(C) repeatedly calculating and conveying
into a gimbals servo unit in real time and at
a high rate signals for:
(a) during a direction period, signals for
directing accordingly the gimbals
including said at least one array of lightsensing units towards said x:y:z
coordinates of the selected area portion,
and;
(b) during an integration period, in which
the array sensors intergrate light coming
from the area portion, providing to the
gimbals unit signals for compensating for
the change in direction towards the x:y:z
coordinates of the selected portion
evolving from the aircraft motion;
gimbals servo for effecting direction of the
gimbals in at least two degrees of freedom
according to the signals provided from said
Servo Control Unit; sampling means for
simultaneously sampling at the end of the
integration period pixel levels from each of
said array sensors, a set of all of said
sampled pixel levels forms an image of
said area portion; and storage means for
storing a plurality of area portion images.
326
__________
]22[]12[
261131
‫שיטה ומערכת לבקרת מכשירים‬
]1/[
METHOD AND SYSTEM FOR
DEVICE CONTROL
]11[
]/2[
]12[
]/2[
20.10.2000
PQ4392
]/1[ 01.12.1999
]//[ AU
Int. Cl.8 B41J 003/42, 029/38, G08C 019/00
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2001/041099
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] A method of enabling on-demand
control of a device, the device being
operative to perform at least one function
in response to control instructions from a
computer system the method including the
steps of on-demand printing, onto a
surface, a control interface containing
information relating to the device function
and coded data indicative of an identity of
the control interface and of at least one
reference point of the control interface, the
information and coded data being printed
simultaneously on the surface; receiving,
327
in the computer system, indicating data
from a sensing device regarding the
identity of the control interface and a
position of the sensing device relative to
the control interface, the sensing device,
when placed in an operative position
relative to the control interface, sensing the
indicating data using at least some of the
coded data; and effecting, in the computer
system and from the indicating data, an
operation relating to at least one parameter
of the control instructions.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
FLUIDIZED BED PROCESSOR
HAVING A HYDRO
DYNAMICALLY ACTIVE LAYER
AND METHOD FOR USE
THEREOF
]11[
]12[
]/2[
]/1[
]//[
05.06.2002
Int. Cl.8 B01J 008/18, 008/24
P.T.T. LTD.
ROMAN MARYAKHIN
REINHOLD COHN AND
PARTNERS,
21 AHAD HAAM STREET
P.O.B. 4060
TEL AVIV 61040
[57] A fluid bed processor device
especially useful for processing particulate
material, at a reactively high mass and heat
exchange efficiency comprising:
(a) an inlet chamber (1a), having an
opening in which process gas (8a) is forced
to intrude at a predetermined velocity;
(b) a processing chamber accommodating
the particulate material to be processed;
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232231
–‫התקן למצע מרחף בו שכבה הידרו‬
‫דינאמית פעילה ושיטה לשימוש בו‬
‫ בע"מ‬P.T.T.
‫רומן מריאכין‬
,‫ריינהולד כהן ושותפיו‬
‫אביב‬-‫ תל‬,4/9/ .‫ד‬.‫ ת‬, 01 ‫רחוב אחד העם‬
(c) a nozzle grid located in the base of the
processing chamber and forming a barrier
(13) between the inlet chamber and the
processing chamber, and comprising a
plurality of nozzles, each having a free
passageway through which said process
gas stream is forced to flow from the inlet
chamber to the processing chamber as a jet
having an outflow velocity into said
328
process chamber in a velocity range of 20
m/s to 350 m/s, such that a steady
circulatory motion of particulate material
is swept by circulatory gaseous flow set up
between.
__________
]22[]12[
232271
,‫–אנדרוסטאן בלתי רוויות‬1.,14 ‫תרכובות‬
‫שיטה להכין אותן ותכשירי רוקחות‬
‫המכילים אותן‬
]1/[
UNSATURATED 14,15 CYCLOPROPANE
- ANDROSTANES, A METHOD
FOR THEIR
PRODUCTION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]11[
]/2[
]12[
]/2[
]//[
]//[
21.11.2000
19959696.4
]/1[ 08.12.1999
]//[ DE
Int. Cl.8 A61K 031/565, A61P 005/26, 005/34, C07J 053/00
SCHERING AG, GERMANY
WO/2001/042275
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
[57] Unsaturated 14, 15-cyclopropanoandrostanes of the formula
329
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
in which
R1 represents a hydrogen atom, a hydroxy
group, a C1-10 alkyl, C1-10 alkyloxy, C1-15
acyloxy, C4-15 aryloxy, C7-15 aralkyloxy, or
a C7-15 alkylaryloxy group, R2 represents a
hydrogen atom, a hydroxy group, C1-10
alkyl, C1-10 acyl, C1-10 acyloxy, C6-15 aryl,
C7-15 aralkyl or a C7-15 alkylaryl group, a –
(CH2)nCH2Y group, in which n=0, 1 or 2
and Y represents a halogen atom,
especially a fluorine, chlorine, bromine or
iodine atom, a pseudohalogen, especially a
cyano, azide or rhodanide group, a –
(CH2)m-CH=CH(CH2)p-R6 group in which
m = 0, 1, 2 or 3 and p = 0, 1 or 2 and R6
represents a hydrogen atom, a C1-10 alkyl,
C6-15 aryl, C7-15 aralkyl or C7-15 alkylaryl
group or a hydroxy group, a C1-10 alkyloxy
group or a C1-10 acyloxy group, a –
(CH2)oC≡CR7 group in which o = 0, 1 or 2
and R7 represents a hydrogen atom, a
halogen atom, especially a fluorine,
chlorine, bromine or iodine atom, a C1-10
alkyl, C6-15 aryl, C7-15 aralkyl, C7-15
alkylaryl or C1-10 acyl group,
R1 and R2 together represent a keto,
methylene or difluromethylene group or,
with inclusion of the C-17, form a
spirooxirane or a 2, 2-dimethyl-1,3-
dioxolane, there being a double bond
between C-1 and C-2, there being an α or β
cyclopropane group between C-14 and C15,
R3 represents a hydrogen atom or an α or β
C1-10 alkyl group,
R4 represents a halogen atom, especially a
fluorine, chlorine or bromine atom or a
pseudohalogen, especially a rhodanide or
an azide group, or a hydroxy or a C1-3
perfluoroalkyl group and R5 represents a
C1-4 alkyl group, whereby a C1-10 alkyloxy
group is a heterocyclic, cyclic or acylic
group, in which the alkyl rest contains 1 to
10 carbon atoms, and wherein a
heterocyclic group includes also groups,
which may have one or two hetero atoms
in the ring, which may be selected from a
nitrogen atom, an oxygen atom and a
sulfur atom, whereby the aryl rest of the
C6-15 aryl, C7-15 alkylaryl, C7-15
alkylaryloxy, C7-15 aralkyl and C7-15
aralkyloxy group may be further
substituted, with the proviso that, if there is
a double bond in the 1, 2 position R4, in
addition to the meanings given above, may
be a hydrogen atom, as well as their
pharmaceutically tolerated salts.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
330
]22[]12[
‫מכלול סטנט‬
]1/[
STENT ASSEMBLY
]11[
]/2[
10.09.2001
60/239923
]/1[ 13.10.2000
0/12//
1/66/61662
Int. Cl.8 A61F 002/06
HENRY M. ISRAEL
WO/2002/030327
DEKEL PATENTS LTD.,,
18 MENUHA VENAHALA ST,
REHOVOT 76209
]12[
]/2[
]//[
]//[
232221
[57] A stent assembly (40) comprising:
an upstream portion (42), adapted to
modify a flow characteristic of embolic
material (20) disposed in a blood stream
flowing through said upstream portion; and
a downstream portion (44), in fluid
communication with said upstream portion
and adapted for the blood stream to flow
therethrough, characterized by said
]//[
US
US
‫ בני ברק‬,‫ ישראל‬.‫הנרי מ‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,07 ‫ חדר‬10 ‫מנוחה ונחלה‬
downstream portion comprising a trapping
region for trapping therein said embolic
material, wherein said upstream portion
comprises a downstream convergence and
said trapping region comprises a divergent
portion (46), said trapping region having a
greater cross-sectional area than the
downstream end of said upstream portion.
__________
331
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
METHOD FOR PRODUCING A
COMPLEX NONWOVEN FABRIC
AND RESULTING NOVEL FABRIC
]11[
]/2[
]12[
]/2[
]//[
]//[
16.11.2000
00/00298
]/1[ 11.01.2000
Int. Cl.8 D04H 001/46, 013/00
RIETER PERFOJET, FRANCE
WO/2001/051693
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A method for producing a complex
nonwoven fabric which consists in
continuously producing a complex in
which a fibrous web based on cellulosic
fibers is sandwiched between two webs of
continuous filaments, which method
consists: in producing a first web of
continuous filaments, the bundle of
extruded and drawn continuous filaments
being received on a moving conveyor belt
in the form of a nonbonded lap; in
232201
‫שיטה ליצור אריג שאינו קלוע והאריג‬
‫החדש המיוצר‬
]//[
FR
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
depositing on this web, by the airlaid
technique, a second web of cellulosic
fibers; in depositing on the fibrous web a
second web of nonbonded continuous
filaments; in transferring the complex thus
formed onto a water-jet bonding unit and
in consolidating the assembly by hydroentanglement, and in drying the hybrid
nonwoven produced and then taking it up,
for example in the form of a wound
package.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232613
332
,‫תוסף לתכשיר חיבור לצמצום סדקים‬
‫בקיעים והצטמקות‬
]1/[
JOINT COMPOUND ADDITIVE
FOR REDUCTION OF
CRACKING, CRATERING
AND SHRINKAGE
]11[
]/2[
]12[
]/2[
16.11.2001
724674
]/1[ 28.11.2000
]//[ US
Int. Cl.8 C04B 024/20, 111/72, C08J 009/32
UNITED STATES GYPSUM
COMPANY, U.S.A.
WO/2002/044254
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] A composition comprising: a joint
compound comprising a binder and a filler,
wherein said binder comprises latex and
wherein said filler and said binder are
present in a ratio of from about 100:1 to
about 10:1; water; and, a surfactant
additive consisting essentially of a
hydrocarbon substituted sulfate, sulfonate,
sulfuric acid or sulfonic acid, wherein said
hydrocarbon is an aliphatic, olefinic,
alicyclic or aromatic group, or
combinations thereof, having from 12 to
24 carbon atoms.
__________
]22[]12[
333
232612
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫תהליך לייצור של תכשיר המתעכל במעיים‬
‫או חומצה‬/‫המכיל חומצה אראכידונית ו‬
‫דוקוסאהקסאאנואית בצורת פוספוליפידים‬
‫ותכשיר המתקבל על ידו‬
]1/[
PROCESS FOR THE
PRODUCTION OF AN ENTERAL
FORMULA CONTAINING
ARACHIDONIC ACID AND /OR
DOCOSAHEXAENOIC ACID IN
THE FORM OF PHOSPHOLIPIDS
AND THE FORMULA OBTAINED
BY SAME
]11[
]/2[
19.02.1998
804700
]/1[ 21.02.1997
]//[ US
/11/2/
1/66/6200/
US
0//1/0
6/6266200/
US
Int. Cl.8 A23J 007/00, A23L 001/30, A61K 009/10, 031/202, A61P 043/00, C07C
057/03, C07F 009/10
DIVISION FROM 131126
UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION, U.S.A.
ABBOTT LABORATORIES, U.S.A.
WO/1998/036745
DR. YITZHAK HESS & PARTNERS,
,‫ עו"פ‬,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON STREET
‫ תל אביב‬,94.1 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
P.O.B. 6451
TEL AVIV 61063
]12[
]01[
]/2[
]//[
]//[
[57] A process for the production of an
enteral formula containing arachidonic
acid and/or docosahexaenoic acid in the
form of phospholipids, said process
comprising the steps of:
(a) forming a 2-15% by weight aqueous
dispersion of said phospholipids;
(b) subjecting said dispersion to deaeration;
(c) combining said de-aerated dispersion
with at least one member selected from the
group of protein, carbohydrate, vitamins
and minerals to form said enteral formula;
and
(d) homogenizing said enteral formula.
__________
]22[]12[
]1/[
USE OF LIPID CONJUGATES FOR
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232117
‫שימוש בתצמידים שומניים להכנת תרופות‬
334
‫המשמשות לטיפול במחלות‬
THE PREPARATION OF
MEDICAMENTS FOR USE IN THE
TREATMENT OF DISEASE
]11[
]/2[
]12[
]/2[
]//[
]//[
10.01.2001
60/174907
]/1[ 10.01.2000
0622//061
2666261666
Int. Cl.8 A61K 047/48
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/2001/051003
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
US
US
‫יישום חברה לפיתוח המחקר של‬
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A phosphatidylethanolamine
conjugate of the formula
wherein
R1 is a linear, saturated, mono-unsaturated,
or poly-unsaturated, alkyl chain ranging in
length from 2 to 30 carbon atoms; R2 is a
linear, saturated, mono-unsaturated, or
poly-unsaturated, alkyl chain ranging in
length from 2 to 30 carbon atoms; Y is
either a bond or spacer group ranging in
length from 2 to 30 atoms, wherein said
spacer comprises –CO-alkylene-NH-, -
CO-alkylene-CO-or a combination thereof;
and X is either a physiologically
acceptable monomer, dimer, or oligomer,
wherein n is unity, or a physiologically
acceptable polymer, wherein n is a number
from 1 to 1,000, whereby X is a
glycosaminoglycan; wherein if Y is a bond
the phosphatidylethanolamine is directly
linked to X via a carboxylic group.
__________
]22[]12[
]1/[
335
PERSONALIZED HARDWARE
232876
‫חומרה אישית‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]11[
]/2[
]12[
]/2[
]//[
]//[
18.12.2000
60/177087
]/1[ 20.01.2000
0622/0/10
2066/61666
06220216/
1166/61666
0621///1/
6162661666
Int. Cl.8 H01L 023/544
ZAVITAN SEMICONDUCTORS
INC., U.S.A.
WO/2001/054194
DEKEL PATENTS LTD.,,
18 MENUHA VENAHALA ST,
REHOVOT 76209
[57] A method of individualizing an
electrical circuit on a wafer carrying a
plurality of electrical circuits, comprising:
providing at least one layer for forming at
least a portion of at least one logic circuit
produced for each electrical circuit,
forming, for each electrical circuit, a resist
layer over said at least one layer for
defining an image for forming said at least
one portion of said at least one logic circuit
which is identical for each electrical
]//[
US
US
US
US
,‫דקל פטנט בע"מ‬
‫ רחובות‬,07 ‫ חדר‬10 ‫מנוחה ונחלה‬
circuit, characterized by modifying said
image for at least one of said logic circuits
during lithographic processing including at
least one general exposure process,
whereby after said general exposure
process the image for at least one of said
logic circuits is differently exposed
compared to the corresponding logic
circuits of said remaining electrical
circuits.
__________
]22[]12[
]1/[
METHOD FOR DATA MATRIX
PRINT QUALITY VERIFICATION
]11[
]/2[
]12[
]/2[
22.01.2001
489023
]/1[ 21.01.2000
Int. Cl.8 B41J 002/00, 002/175
ROBOTIC VISION SYSTEMS, INC.,
U.S.A.
WO/2001/053101
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]//[
]//[
[57] A method for verifying data matrix
print quality comprising the steps of:
locating a data matrix mark (1); decoding
said data matrix mark; measuring a print
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232701
‫שיטה לוידוא איכות הדפסת רשת נתונים‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
quality (2) of said data matrix mark;
measuring additional aspects that affect
print quality, said additional aspects
comprising at least one of the following:
cell placement uniformity; and cell size
uniformity; measuring an overall matching
score; displaying at least one of a center
336
offset, size offset, on/off cells, wrong cells,
and/or codewords based on the error
correction; performing standard
morphological operations for enhancing
the image quality to achieve more robust
measurements; and resampling an image of
said data matrix to achieve better
measurements.
__________
]22[]12[
]1/[
CHEMICAL AND/OR
BIOLOGICAL
DECONTAMINATION SYSTEM
]11[
01.02.2001
337
232113
‫או ביולוגית‬/‫מערכת טיהור כימית ו‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]/2[
]12[
]/2[
]//[
]//[
60/179499
]/1[ 01.02.2000
]//[ US
Int. Cl.8 A01N 025/32, 063/00, A61K 038/43
TIAX LLC, U.S.A.
WO/2001/056380
SANFORD T.COLB & CO.,
,,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT
[57] A chemical and biological warfare
decontamination composition comprising:
at least one biocide selected from
benzalkonium chloride (BAC),
tetrakishydroxymethyl phosphonium
sulfate (THPS), (phosphonium, tetrakis
(hydroxymethyl)-sulfate)), triclosan
(2,4,4'-trichloro-2'-hydroxydiphenyl ether),
streptomycin, sodium omadine,
Dichlorophen and methylene
bisthiocyanate; and at least one enzyme
active against organophosphorus
compounds, wherein the composition
possesses decontamination activity against
chemical warfare agents, including Sarin,
and biological warfare agents, including
anthrax spores.
__________
]22[]12[
]1/[
CATHETER FOR CONTROLLING
THE ADVANCEMENT OF A
GUIDE WIRE
]11[
]/2[
]12[
]/2[
29.01.2001
495203
]/1[ 31.01.2000
Int. Cl.8 A61M 025/01
INTRALUMINAL THERAPEUTICS,
INC., U.S.A.
JEFFERY WHITE, JOHN M. NEET,
THOMAS R. WINSTON, JOHN
WARDLE, DIEGO D. CUETO
WO/2001/054762
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O. BOX 45087,
JERUSALEM 91450
]/1[
]//[
]//[
[57] A catheter for controlling the
advancement of a guide wire (108)
extending therethrough, said catheter
comprising: a catheter body (102) having a
proximal end (104) and a distal end (106),
said catheter body comprising a distal
portion (114) coupled to a proximal
portion (112), said distal portion more
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232112
‫צנתר לבקרת התקדמות חוט מנחה‬
]//[
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./07 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
flexible than said proximal portion, said
catheter body further having at least one
central lumen therethrough configured to
receive said guide wire, and a first side
lumen (116) and a second side lumen (118)
extending from the catheter body proximal
end to the catheter body distal end and
positioned on opposite sides of said
catheter body; and said second side lumen
338
extending from the catheter body proximal
end to the catheter body distal end and
positioned on opposite sides of said
catheter body; a first control wire
extending from said catheter body
proximal end to said catheter body distal
end through said first side lumen, said first
control wire coupled to said catheter body
distal end; and a second control wire
extending from said catheter body
proximal end to said catheter body distal
end through said second side lumen, said
second control wire coupled to said
catheter body distal end.
__________
]22[]12[
]1/[
NEEDLELESS SYRINGE WITH
TWO INJECTION SPEED LEVELS
]11[
]/2[
]12[
]/2[
]//[
]//[
23.02.2001
00/02633
]/1[ 01.03.2000
Int. Cl.8 A61M 005/00, 005/30
CROSSJECT, FRANCE
WO/2001/064269
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A needleless syringe (31), for
injection of a liquid active principle
contained in a reservoir (32) situated
between, on the one hand, an injector (33)
comprising at least one injection conduit,
and, on the other hand, a thrust means
subjected to the action of a gas generator,
said thrust means comprising an end which
is directed toward the active principle and
constitutes a delivery head (34) whose
cross section is equal to the cross section
339
232212
‫מזרק חסר מחט עם שתי מהירויות הזרקה‬
]//[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
of the reservoir whose opposite end is
directed toward the gas generator has a
drive head (38) whose cross section is
greater than the cross section of the
delivery head; characterized in that the
delivery head is formed as one piece, and
in that the drive head is active along a
drive travel of said drive head in its drive
cylinder, said drive travel being less than
the height of the reservoir of liquid active
principle.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
PREDICTIVE AUTOMATIC
ROAD-INCIDENT DETECTION
USING AUTOMATIC VEHICLE
IDENTIFICATION
]11[
]/2[
]12[
]/2[
]//[
]//[
14.03.2001
60/189858
]/1[ 15.03.2000
Int. Cl.8 G08G 001/01
RAYTHEON COMPANY, U.S.A.
WO/2001/069569
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A method of detecting an incident
along a roadway, comprising the
unordered steps of: arranging a plurality of
readers at intervals along a roadway for
reading uniquely identified data from each
one of a plurality of vehicles; correlating
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
232137
‫גילוי ע"י חיזוי אוטומטי של אירוע בכביש‬
‫בשימוש בזיהוי רכב אוטומטי‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
the data with previously read data to obtain
information regarding each one of the
plurality of vehicles; determining the
number of vehicles potentially affected by
the incident along the roadway; and
comparing the number of vehicles
potentially affected by the incident to a
sample threshold.
340
__________
]22[]12[
]1/[
TWIN PLASMA TORCH
APPARATUS
]11[
]/2[
04.04.2001
0008797.3
]/1[ 10.04.2000
66110/06/
2066061666
Int. Cl.8 H05H 001/44
TETRONICS LIMITED, UNITED
KINGDOM
WO/2001/078471
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
]//[
[57] A twin plasma torch assembly
comprising:
(a) at least two plasma torch assemblies
(10, 20) of opposite polarity supported in a
housing, said assemblies being spaced
apart from one another and comprising:
(i) a first electrode (1) in a first torch
assembly;
(ii) a second electrode (2) in a second torch
which is or is adapted to be spaced apart
from the first electrode by a distance
sufficient to achieve a plasma arc
therebetween in a processing zone;
341
231221
‫התקן צמד מבערי פלסמה‬
]//[
GB
GB
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
(b) means (51, 53) for introducing a
plasma gas into the processing zone
around each electrode;
(c) means (42, 44) for introducing shroud
gas to surround the plasma gas;
(d) means (112) for supplying feed
material into the processing zone, and
(e) means for generating a plasma arc in
the processing zone;
characterized in that distal ends of first and
second electrodes do not project beyond
the housing.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
POLYMERIZABLE
COMPOSITION OF ALLYL
FUNCTIONAL MONOMERS
]11[
]/2[
29.03.2001
546267
]/1[ 10.04.2000
0/66//
6266/61666
Int. Cl.8 C08F 218/00
PPG INDUSTRIES OHIO, INC.,
U.S.A.
WO/2001/077194
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] A polymerizable composition
comprising:
(a) a first allyl functional monomer having
at least two allyl groups, said first allyl
functional monomer being selected such
that a substantially completely cured
polymerizate of said first allyl functional
monomer has a 15 second Barcol 934
hardness of at least 40; and
(b) a second allyl functional monomer,
which is different from said first allyl
functional monomer and is selected from,
(i) polyether diol bis (allyl carbonate);
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
231286
‫תכשיר הניתן לפלמור של מונומרים‬
‫אליליים פונקציונליים‬
]//[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
(ii) polylactone diol bis (allyl carbonate);
and
(iii) mixtures of (i) and (ii), wherein said
second allyl functional monomer (b) is
present in said polymerizable composition
in an amount to provide a substantially
completely cured polymerizate of said
composition having improved organic
photochromic substance incorporation
relative to a substantially completely cured
polymerizate of said composition free of
(b), and heat distortion temperature of at
least 40oC.
342
__________
]22[]12[
]1/[
METHOD OF DETERRING BIRDS
FROM PLANT AND
STRUCTURAL SURFACES
]11[
]/2[
]12[
]/2[
]//[
]//[
27.03.2001
549637
]/1[ 14.04.2000
Int. Cl.8 A01N 025/04, 061/00
ARKION LIFE SCIENCES, U.S.A.
WO/2001/078510
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A method for deterring birds from
roosting, perching or loafing on a plant or
solid surface comprising applying to the
surface a non-toxic deterrent consisting of
9, 10-anthraquinone that triggers one or
more of the following, a visual cue or a
post-ingestinal response, in said birds,
231271
‫שיטה להרחקת ציפורים ממשטחי צמחים‬
‫ומבנים‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
wherein the 9, 10-anthraquinone is in the
form of finely-divided particles having an
average size of less than 50 micrometers
and wherein the 9, 10-anthraquinone is
applied at a level of at least 0.2 mg/sq
meter.
__________
]22[]12[
343
231132
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
COLD PIECE OF A CRYOGENIC
COOLER WITH IMPROVED
HEAT TRANSFER
]11[
]/2[
]12[
]/2[
11.01.2002
10104969.2
]/1[ 03.02.2001
Int. Cl.8 F25B 009/14
AEG INFRAROT-MODULE GMBH,
GERMANY
WO/2002/063220
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]//[
[57] Cold part (3) of a cryocooler with: a
piston-shaped regenerator (5) having at
both ends orifices through which a
refrigerant (11) can flow, a closed cylinder
in which the regenerator moves cyclically
between a compressor-side and an
expansion-side end position, and with a
heat exchanger (10) arranged on the end
‫קטע קר של מקרר קריאוגני עם מחליף‬
‫חום משופר‬
]//[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
face, characterized in that the inside of the
heat exchanger and that the end of the
regenerator which faces the heat exchanger
are ribbed in such a way that the ribbings
(9, 13) engage one into the other in the
expansion-side end position of the
regenerator.
__________
]22[]12[
]1/[
COMPOSITIONS CONTAINING
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
230212
‫תכשירים המכילים פוליקרבונאט‬
344
POLYCARBONATE
]11[
]/2[
]12[
]/2[
]//[
]//[
28.05.2001
10028412.4
]/1[ 08.06.2000
Int. Cl.8 C08K 005/103, C09D 169/00
BAYER AKTIENGESELLSCHAFT,
GERMANY
WO/2001/094486
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] Composition containing
polycarbonate, at least one fatty acid ester
and one or more compounds of the formula
wherein R1, R2, R3 and R4 are the same or
different and are selected from the group
consisting of C1-alkyl to C8-alkyl, halogen
and –CN, and R5 is H or C1-alkyl to C20alkyl.
__________
]22[]12[
345
230230
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
PLASMA PROCESSING DEVICE
]11[
]/2[
]12[
]/2[
28.03.2002
2001-094274 ]/1[ 28.03.2001
Int. Cl.8 H01L 021/31
TADAHIRO OHMI, JAPAN
TOKYO ELECTRON LIMITED,
JAPAN
WO/2002/080248
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A plasma processing apparatus (10),
comprising: a processing vessel (11)
defined by an outer wall and having a
stage (13) for holding a substrate (12) to be
processed; an evacuation system (11G)
coupled to said processing vessel; a plasma
gas supplying part (31) for supplying
plasma gas to said processing vessel; a
microwave antenna (17) provided on said
processing vessel in correspondence to
said plasma gas supplying part, said
microwave antenna being supplied with
electric power through a coaxial
waveguide (21A), and a microwave power
‫התקן לעיבוד פלסמה‬
]//[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
source coupled to said microwave antenna
electrically, said microwave antenna being
defined by a first outer surface forming a
microwave radiation surface and a second
outer surface opposing said first outer
surface; wherein an outer waveguide
constructing said coaxial waveguide is
coupled to said second outer surface, and a
center conductor (21B) constructing said
coaxial waveguide, an end part of which is
separated from said first outer surface,
forms capacitive coupling with said first
outer surface.
__________
]22[]12[
]1/[
PLASMA PROCESSING DEVICE
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
230231
‫התקן לעיבוד פלסמה‬
346
]11[
]/2[
]12[
]/2[
]//[
]//[
28.03.2002
2001-094273 ]/1[ 28.03.2001
Int. Cl.8 H01L 021/31
TADAHIRO OHMI, JAPAN
TOKYO ELECTRON LIMITED,
JAPAN
WO/2002/080251
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A plasma processing apparatus,
comprising: a processing vessel (11)
defined by an outer wall and having a
stage (13) for holding a substrate (12) to be
processed; an evacuation system coupled
to said processing vessel; a plasma gas
supplying part provided on said processing
vessel as a part of said outer wall so as to
face said substrate on said stage, said
plasma gas supplying part comprising a
shower plate (14) facing said substrate on
said stage at a first side thereof, said
shower plate having a plasma gas passage
(14A-14C) and a plurality of apertures
communicating with said plasma gas
passage, and a cover plate provided on a
second side of said shower plate opposite
]//[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
to said first side; a microwave antenna (20)
provided on said processing vessel in
correspondence to said plasma gas
supplying part in an intimate contact with
said cover plate; a microwave power
source coupled to said microwave antenna
electrically, and a contact surface (18)
between said microwave antenna and said
cover plate of said plasma gas supplying
part is sealed in a manner such that a
pressure thereof can be adjusted, said
microwave antenna being defined by said
contact surface forming a microwave
radiation surface, said contact surface
contacting with said cover plate of said
plasma gas supplying part, and an outer
surface opposing said contact surface.
__________
]22[]12[
347
230820
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
– ‫ – אלפא – פלואורו‬9 – ‫ – אלפא – כלורו‬6
–17– ‫– מתיל‬19 – ‫ – אלפא – הידרוקסי‬17
–1,4– ‫בטא – מתוקסיקרבוניל – אנדרוסט‬
–17 ‫דיאנים שעברו אסטריפיקציה בעמדה‬
‫אלפא על ידי קבוצה‬
]1/[
9-ALPHA-CHLORO-6-ALPHAFLUORO-17- ALPHA-HYDROXY16-METHYL-17-BETAMETHOXYCARBONYLANDROST-1,4- DIENES
ESTERIFIED IN POSITION 17ALPHA BY A CYCLIC GROUP
]11[
]/2[
]12[
]/2[
]//[
]//[
26.06.2001
0015876.6
]/1[ 28.06.2000
]//[ GB
Int. Cl.8 A61K 031/56, 031/58, A61P 011/00, C07J 003/00, 017/00, 033/00, 043/00
NOVARTIS AG, SWITZERLAND
WO/2002/000679
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B 5352
BEER-SHEVA 84152
[57] Compounds of the formula
where R is a monovalent cyclic organic
group having from 3 to 15 atoms in the
ring system.
__________
]22[]12[
]1/[
SALINE/SEWAGE WATER
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
236200
‫שפכים‬/‫מערכת לטיהור מי מלח‬
348
RECLAMATION
SYSTEM
]11[
]/2[
]12[
]/2[
18.07.2001
618337
]/1[ 18.07.2000
]//[ US
Int. Cl.8 B01D 001/22, 001/28, 003/08, 003/10, 003/28, C02F 001/08
JACK G. BITTERLY,, U.S.A.
STEVEN E. BITTERLY,, U.S.A.
]//[
]//[
WO/2002/005920
DR. SHLOMO COHEN & CO.,,
124 IBN GABIROL ST,
P.O.B. 11490,
TEL AVIV 62038
[57] A boiler and condenser system
comprising:
(a) a housing (50);
(b) at least three spaced-apart and
generally concentric shells (32, 34, 40)
within the housing extending about an axis
of rotation (132), the at least three shells
comprising an inner shell closest the axis
of rotation, an outer shell farthest from the
axis of rotation and a middle shell between
the inner shell and the outer shell, the
shells forming two spaces, an inner space
(38) defining a boiler between the inner
shell and the middle shell, and an outer
space (36) defining a condenser between
the middle shell and the outer shell; each
space having two ends;
(c) rotation means (160) for rotating the
shells about the axis of rotation at an
349
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,1146/ .‫ד‬.‫ ת‬, 104 ‫אבן גבירול‬
angular velocity sufficient to cause the
fluid in the boiler to form a thin film along
the middle shell;
(d) a compressor (220) having a lower
pressure side and a higher pressure side,
the lower pressure side communicating
with the inner space and decreasing the
pressure in the inner space, the higher
pressure side communicating with the
outer space;
(e) a source of fluid (170), an injector
(186) operably connected to the source of
fluid and to the inner space transmitting
the fluid into the inner space;
(f) an outlet from the outer space through
which fluid can flow; and
(g) a collector (268) in the housing into
which fluid from the outlet collects.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
LEAD-FREE TIN PROJECTILE
]11[
]/2[
]12[
]01[
]/2[
]//[
]//[
04.12.1998
993458
]/1[ 18.12.1997
Int. Cl.8 F42B 005/16
DIVISION FROM 136817
OLIN CORPORATION, U.S.A.
WO/1999/031454
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A lead-free projectile used in a
cartridge having a powdered chemical
propellant consisting of essentially pure tin
having a tin content of at least 99.8%, by
236231
‫מטול בדיל ללא עופרת‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
weight, a yield strength of 11.0 MPa or
less, and a hardness of less than 5 HB and
formed to an aerodynamic profile.
__________
]22[]12[
]1/[
MINIATURIZED WEARABLE
OXYGEN CONCENTRATOR
]11[
]/2[
]12[
]/2[
]//[
]//[
02.08.2001
60/222591
]/1[ 02.08.2000
Int. Cl.8 B01D 053/047
WEARAIR OXYGEN INC., CANADA
WO/2002/009848
DEBORAH GADOR, BLUM, GADOR
& CO.,
53 DERECH HASHALOM
23 RD FLOOR
GIVATAYIM 53454
[57] A gas concentrator for enriching a
target component gas concentration and
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
236166
‫מרכז חמצן מיניאטורי הניתן ללבישה‬
]//[
US
,'‫ גדור ושות‬,‫דבורה גדור עו"ד בלום‬
‫ גבעתיים‬,0: ‫ קומה‬, .: ‫דרך השלום‬
minimizing a waste component gas
concentration in a gas flow comprising: an
350
air compressor (22), an air-tight first
container in fluid communication with said
compressor, through a first gas conduit, an
air-tight second container in fluid
communication with said first container
through a second gas conduit, wherein said
first container contains a molecular sieve
bed for adsorbing a waste component gas,
a gas flow controller controlling a plurality
of repeating cycles of sequential actuation
of valves (28) mounted to said gas
conduits, said valves sequentially
regulating air flow through said conduits,
said gas flow controller and said valves
providing:
(a) means for first preventing gas flow
between said first and second containers
and allowing compressed gas from said
compressor into said first container during
a first gas pressurization phase, whereby
said first container is pressurized to
threshold pressure level to create a gas
packet having an incrementally enriched
target component gas concentration;
(b) means (34) for sequentially next
preventing gas flow into said first
container from said compressor and
allowing gas flow from said first container
into said second container during an air
packet transfer phase, wherein said gas
packet is transferred to said second
container;
351
(c) means for sequentially next preventing
gas flow into said second container from
said first container and allowing gas to
vent to atmosphere out from said first
container through a vent valve of said first
container;
(d) means for sequentially next allowing
gas flow between said first and second
containers from said second container into
said first container during an air packet
counter-flow phase, wherein said gas
packet flows from said second container to
said first container;
(e) means for sequentially next preventing
gas flow venting from said first container
through said vent valve of said first
container, and
(f) means for sequentially cycling said gas
flow controller and said valves through
said plurality of repeating cycles of
sequential actuation of said valves so as to
incrementally increase said target
component gas concentration in said gas
packet per cycle in said plurality of
repeating cycles as said gas packet is
shunted back and forth between said first
and second containers, a gas flow conduit
in fluid communication with said second
container for delivering a portion of said
gas packet for an end use downstream.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
HIGH PRESSURE AND HIGH
TEMPERATURE PRODUCTION
OF DIAMONDS
]11[
]/2[
]12[
]/2[
08.08.2001
60/224485
]/1[ 11.08.2000
Int. Cl.8 B01J 003/06
DIAMOND INNOVATIONS, INC.,
U.S.A.
WO/2002/013958
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.
P.O.B. 1426
TEL AVIV 61013
]//[
]//[
[57] A method for changing the color of
discolored natural diamond, wherein the
discolored natural diamond is selected
from the group consisting of rough
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
236012
‫ייצור יהלומים בלחץ ובחום גבוהים‬
]//[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1409 .‫ד‬.‫ ת‬, :1 ‫רח' יבנה‬
diamond, pre-cut diamond and polished
diamond, the method comprising: (a)
blocking the natural diamond to streamline
the shape of the natural diamond, such that
near surface imperfections and nonuniformites of the natural diamond are
removed;
352
(b) placing the streamlined natural
diamond in a pressure transmitting
medium; (c) consolidating the pressure
transmitting medium into a pill wherein
the pressure transmitting medium is
consolidated in excess of 90% of its
theoretical density; (d) exposing the pill to
elevated temperature and elevated pressure
within the graphite-stable range or within
the diamond forming range of the carbon
phase diagram for a time sufficient to
change the color of the diamond; and (e)
recovering the diamond.
__________
]22[]12[
]1/[
WATER-SUPPLY PACK
ASSEMBLY
]11[
]/2[
]12[
]/2[
]//[
]//[
29.08.2001
650680
]/1[ 30.08.2000
Int. Cl.8 B60N 003/18
AMIT BEN-SASSON
WO/2002/018171
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A water-supply pack assembly
adapted to supply water to a driver (15)
occupying a seat (10) in an automobile
having a back and a headrest (12), said
headrest being engaged by the driver's
head, such assembly comprising:
(a) a fixture (16) attachable to the headrest,
the fixture comprising a hood strapped
onto the headrest,
(b) a water-supply pack (17) suspended
from the hood so that the water supply
pack is then behind the back of the seat, at
353
236666
‫מכלול לאספקת מים‬
]//[
US
‫עמית בן ששון‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
a position close to the head of the driver,
said pack including a water-fillable
container having an outlet, and
(c) an elongated flexible tube (20) coupled
to said outlet and terminating in a
mouthpiece (21), said tube extending
between said outlet and said outlet and said
driver, whereby the driver with the
mouthpiece in place, can then suck water
from the container without interrupting his
driving activity.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
____________
]22[]12[
]1/[
METHOD OF OBSERVING
EXPOSURE CONDITION FOR
EXPOSING SEMICONDUCTOR
DEVICE AND ITS APPARATUS
AND METHOD OF
MANUFACTURING
SEMICONDUCTOR DEVICE
]11[
]/2[
]12[
]/2[
17.02.2003
2002-039444 ]/1[ 18.02.2002
Int. Cl.8 G03F 009/00
HITACHI HIGH-TECHNOLOGIES
CORPORATION, JAPAN
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]//[
[57] A method of monitoring an exposure
condition, comprising the steps of:
photographing a resist pattern using an
electron microscope so as to obtain an
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
236326
‫שיטה לצפיה בתנאי חשיפה לחשיפת‬
‫התקן מוליך למחצה והמתקן שלו ושיטה‬
‫לייצור התקן מוליך למחצה‬
]//[
JP
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
electron-beam image of said resist pattern,
said resist pattern having a configuration
which is formed by being exposed under a
predetermined exposure condition and on
354
which effective exposure quantities differ
depending on the places; measuring, using
said electron-beam image, a characteristic
size of said resist pattern at a plurality of
locations at which said effective exposure
quantities differ from each other; and
estimating deviation quantities in an
exposure quantity and focal-point position
of said predetermined exposure condition
from correct values by using information
on model data created in advance and said
information on said characteristic size
measured at said plurality of locations at
which said effective exposure quantities
differ from each other, said model data
causing various exposure conditions to be
related with characteristic sizes of said
resist pattern formed under said various
exposure conditions.
__________
]22[]12[
]1/[
GLASS BODIES WITH POROUS
COATINGS
]11[
]/2[
03.03.2003
10209949.9]/1[ 06.03.2002
45
Int. Cl.8 C03C 017/25
SCHOTT AG, GERMANY
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]12[
]/2[
]//[
[57] An alkali-free or alkali-poor glass
body having a plurality of sides and
provided with an adherent and antireflective coating on at least one of said
sides, wherein said adherent and antireflective coating contains phosphorus and
236827
‫גופים מזכוכית עם ציפוים נקבוביים‬
]//[
DE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
porous SiO2; and wherein said alkali-free
or alkali-poor glass body contains no alkali
metal oxides or less than 12 percent by
weight of said alkali metal oxides and said
coating is provided with pores with a pore
diameter of 2 nm to 50 nm.
__________
355
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
PROCESS FOR DISPENSING
PORTIONS OF FROZEN
AERATED EDIBLE PRODUCTS
]11[
]/2[
]12[
]/2[
12.03.2003
02252321.1
]/1[ 28.03.2002
Int. Cl.8 A23G 009/28, B65D 085/78
UNILEVER PLC, UNITED
KINGDOM
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
[57] A process for dispensing into a
container a portion of a consumable
product comprising a frozen aerated
product with particulate inclusions of a
specified size range wherein the process
comprises the steps of: loading a serving of
particulate inclusions of said specified size
range into a supplying means metering the
flow of a serving of frozen aerated product
from a source of frozen aerated product
236787
‫תהליך להנפקת מנות של מוצרי מזון‬
‫קפואים ומאווררים‬
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
through a mixing chamber; transferring the
serving of particulate inclusions from the
supplying means to the mixing chamber
throughout the time said serving of frozen
aerated product is flowing through the
mixing chamber; mixing the particulate
inclusions and the frozen aerated product
to form the consumable product;
dispensing the consumable product into the
container.
__________
]22[]12[
]1/[
ANNEALED AMORPHOUS
ALLOYS FOR MAGNETOACOUSTIC MARKERS
]11[
]/2[
]12[
]/2[
18.09.2001
677245
]/1[ 02.10.2000
Int. Cl.8 G01N 027/00
VACUUMSCHMELZE GMBH,
GERMANY
SENSORMATIC ELECTRONICS
CORPORATION, U.S.A.
WO/2002/029832
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]//[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
236112
‫מורפות אמורפיות‬/‫סגסוגות מוקשחות‬
‫עבור סמנים מגנטי–אקוסטיים‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
356
[57] A method of annealing a magnetic
amorphous alloy article comprising the
steps of:
(a) providing an unannealed amorphous
alloy article having an alloy article having
an alloy composition and a longitudinal
axis;
(b) disposing said unannealed amorphous
alloy article in a zone of elevated
temperature while subjecting said
amorphous alloy article to a tensile force
along said longitudinal axis, and without a
magnetic field other than an ambient
magnetic field, to produce an annealed
article; and
(c) selecting said alloy composition to
comprise at least iron and nickel and at
least one element from the group
consisting of V, Nb, Ta, Cr, Mo and W so
that the annealed article has an induced
magnetic easy plane perpendicular to said
longitudinal axis due to a combination of
said composition, said temperatue and said
tensile stress.
__________
]22[]12[
236186
‫עיכוב של תלות בגורם גידול של תאים‬
‫סרטניים‬
]1/[
INHIBITION OF THE GROWTH
FACTOR DEPENDENCY OF
TUMOR CELLS
]11[
]/2[
17.10.2001
10051609.2
]/1[ 18.10.2000
]//[ DE
0621/2626
2/62661666
US
Int. Cl.8 A61K 031/56, A61P 035/00, C07C 053/00, C07J 001/00, 011/00, 041/00
SCHERING
AKTIENGESELLSCHAFT,
GERMANY
WO/2002/032429
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] Use of a compound of the formula
357
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
in which
R1 stands for a methyl or ethyl group,
R2 stands for a radical of formula CnFmHo,
whereby n is 2, 3, 4, 5, or 6, m> 1 and m +
o = 2n +1,
R3 stands for a free, etherified, or esterified
hydroxy group, R4 and R5 each stand for a
hydrogen atom, together for an additional
bond or a methylene group, St stands for a
steroidal ABC-ring system of partial
formula A, B or C
in which
R6 means a hydrogen atom, a straightchain C1-C4 alkyl group or a branched C3C4 alkyl group or a halogen atom,
R7 means a hydrogen atom, a straightchain C1-C4 alkyl group or a branched C3C4 alkyl group, or, if St stands for a
steroidal ABC-ring system A or B, in
addition R6 and R7 together mean an
additional bond,
X means an oxygen atom, a hydroxyamino
grouping = N – OH or two hydrogen
atoms,
R8 means a radical Y or an aryl radical that
is optionally substituted with a group Y in
several places, whereby Y is a hydrogen
atom, a halogen atom, an –OH, -NO2, -N3,
-CN, -NR9aR9b, -NHSO2R9, -CO2R9, C1C10 alkoxy, C1-C10 alkanoyloxy,
benzoyloxy-C1-C10 alkanoyl, C1-C10
hydroxyalkyl or benzoyl group, and R9a
and R9b are the same or different and like
R9 represent a hydrogen atom or a C1-C10
alkyl group, and for radicals –NR9aR9b,
also their physiologically compatible salts
with acids and for radicals –CO2R9 with R9
in the meaning of hydrogen, also their
physiologically compatible salts bases, for
the manufacture of a medicament for the
treatment of steroid resistant breast cancer.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
358
]22[]12[
236183
‫שימוש בנוגדי פרוגסטינים למניעה וטיפול‬
‫במחלות תלויות–הורמונים‬
]1/[
USE OF ANTIPROGESTINS FOR
PROPHYLAXIS AND
TREATMENT OF HORMONEDEPENDENT DISEASES
]11[
]/2[
17.10.2001
60/240998
]/1[ 18.10.2000
]//[ US
66116//261
2/62661666
EP
Int. Cl.8 A61K 031/56, A61P 035/00, C07J 001/00
SCHERING
AKTIENGESELLSCHAFT,
GERMANY
WO/2002/032430
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] Use of the antiprogestin 11β-(4acetylphenyl)-17β-hydroxy-17α-(1,1,2,2,2pentafluoroethyl)-estra-4, 9-dien-3-one or
a pharmaceutically acceptable derivative
or analogue thereof for the manufacture of
a medicament for the prophylaxis or
treatment of a type of cancer selected from
the group of breast cancer, ovarian cancer,
endometrial cancer, myeloma, anovulatory
infertility and/or meningoma in a mammal.
__________
]22[]12[
236181
‫שימוש בנוגדי פרוגסטינים להשראת‬
‫אפופטזה בתא‬
]1/[
USE OF ANTIPROGESTINS FOR
THE INDUCTION OF APOPTOSIS
IN A CELL
]11[
]/2[
17.10.2001
00250342.3
]/1[ 18.10.2000
]//[ EP
0621/6002
2/62661666
US
Int. Cl.8 A61K 031/57, A61P 035/00, C07J 001/00
SCHERING
AKTIENGESELLSCHAFT,
GERMANY
WO/2002/032432
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] Use of the antiprogestin 11β-(4-
359
acetylphenyl)-17β-hydroxy-17α-(1,1,2,2,2May 15, 2007 – ‫כ"ז באייר התשס"ז‬
pentafluoroethyl)-estra-4,9-dien-3-one or a
pharmaceutically acceptable derivative or
analogue thereof for the preparation of a
medicament for the treatment of a type of
cancer selected from the group of breast
cancer, ovarian cancer, endometrial cancer,
myeloma, and meningoma with a high risk
amount of tumor cells in the S-phase, as a
result of the induction of apoptosis, said
medicament being applied in a daily dose
of 0.1 to 400 mg/kg.
__________
]22[]12[
]1/[
PUMPING OR MIXING SYSTEM
USING A LEVITATING
MAGNETIC PUMPING OR
MIXING ELEMENT, RELATED
SYSTEM COMPONENTS, AND
RELATED METHODS
]11[
]/2[
12.01.2001
60/239187
]/1[ 09.10.2000
/1//21
1/62261666
Int. Cl.8 B01F 013/08, F16C 039/06
LEVTECH, INC., U.S.A.
ALEXANDRE N. TERENTIEV
WO/2002/031372
DR. MARK FRIEDMAN LTD.,
BEIT SAMUELOFF, 7 HAOMANIM
STREET
TEL AVIV
]12[
]/2[
]/1[
]//[
]//[
[57] A kit for assisting in the set-up of a
fluid pumping or mixing system (10)
including a superconducting element (20)
capable of reaching a transition
temperature during a field cooling process,
comprising: at least one pumping or
mixing element (14) including a levitation
magnet (38), and at least one charging
magnet (40) substantially corresponding in
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
233118
‫מערכת שאיבה או ערבוב המשתמש‬
‫ מרכיבי‬,‫בגורם שואב או מערבב מגנטי‬
‫ ושיטות קשורות‬,‫מערכת קשורים‬
]//[
US
US
,‫ד"ר מרק פרידמן ושות‬
‫ תל אביב‬,7 ‫בית שמואלוב רח' האומנים‬
size, shape, and magnetic field distribution
to the levitation magnet, whereby the
presence of the charging magnet adjacent
the superconducting element during the
field cooling process enables stable
levitation of the pumping or mixing
element, including when in a fluid-filled
vessel (16) positioned adjacent the
superconducting element.
360
___________
]22[]12[
]1/[
LAYER TRANSFER OF LOW
DEFECT SIGE USING AN ETCHBACK PROCESS
]11[
]/2[
]12[
]/2[
]//[
]//[
17.09.2001
692606
]/1[ 19.10.2000
Int. Cl.8 H01L 021/762
IBM CORPORATION, U.S.A.
WO/2002/033746
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[57] A method of preparing a relaxed
SiGe layer on an insulator and a SiGe/Si
heterostructure comprising the steps of:
361
233013
‫ בעלי‬,‫גרמניום‬-‫העברת שכבות סיליקון‬
‫ באמצעות תהליך של‬,‫איכות גבוהה‬
‫חריטהחוזרת‬
]//[
US
,‫מחלקת קניין רוחני מעבדות יבמ‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
forming a graded Si1-xGex epitaxial layer
on a first single crystalline semiconductor
substrate, forming a relaxed Sil-yGey
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
epitaxial layer over said graded Sil-xGex
layer, wherein y, the germanium content of
the relaxed Sil-xGex epitaxial layer, is equal
to or substantially equal to the value of x at
an upper suface of the graded Sil-xGex
epitaxial layer, smoothing the surface of
said relaxed Sil-xGey epitaxial layer to
provide a surface roughness in the range
from about 0.3 nm to about 1 nm root
mean square (RMS), selecting a structure
having an upper surface and comprising a
second substrate having a surface
roughness in the range from about 0.3 nm
to about 1 nm RMS and an intermediate
agent layer comprising a metal selected
from the group consisting of W, Co, Ti and
any other metal that can react with silicon
to form a metal silicide, and bonding said
smoothed surface of said relaxed Sil-yGey
epitaxial layer on said first substrate to the
upper surface of said structure including
said second substrate, said step of bonding
including the step of annealing to form
sufficiently strong bonds across the
bonding interface to form a single
mechanical structure, whereby during said
bonding said intermediate agent layer is
converted into a metal silicide which
includes germanium.
__________
]22[]12[
]1/[
CONVERTIBLE MULTIPURPOSE
MISSILE LAUNCHER
]11[
]/2[
]12[
]/2[
]//[
]//[
20.09.2002
960814
]/1[ 21.09.2001
Int. Cl.8 F41F 007/00
RAYTHEON COMPANY, U.S.A.
WO/2002/027598
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A convertible multipurpose missile
launcher (28), comprising: a launcher body
(32) having a top side (34), a bottom side
(36), a first lateral side (38), a second
lateral side (40), a forward end (42), and
an aft end (44); a support attachment (46)
on the top side of the launcher body and a
launch rail structure (48) on the launcher
body, the launch rail structure including a
first-middle launch rail (50) on the bottom
side of the launcher body and extending in
a longitudinal direction (52), the
longitudinal direction being defined as a
direction extending between the forward
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
231220
‫משגר טיל רב תכליתי הפיף‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
end and the aft end of the launcher body,
wherein the first-missile launch rail is
dimensioned for a first missile, and a
second-missile launch rail (56) on the
bottom side of the launcher body and
extending in the longitudinal direction,
wherein the second-missile launch rail is
dimensioned for a second missile different
from the first missile, and wherein the
second-missile launch rail includes a
stationary second-missile forward launch
rail segment (60), and a movable secondmissile aft launch rail segment (62), the
movable second-missile aft launch rail
362
segment being movable between a forward
position and an aft position, and wherein
the movable second-missile aft launch rail
segment may be locked in the forward
position when slid to the forward position
and locked in the aft position when slid to
the aft position.
__________
]22[]12[
]1/[
SYSTEM AND METHOD FOR
ADAPTIVE BROADCAST RADAR
SYSTEM
]11[
]/2[
]12[
]/2[
28.11.2001
60/253095
]/1[ 28.11.2000
Int. Cl.8 G01S 013/72
LOCKHEED MARTIN
CORPORATION, U.S.A.
ROBERT D. BUDIC
WO/2002/097467
SOROKER-AGMON,
14 SHENKAR STREET,
HERZLIYA PITUAH 46725
]/1[
]//[
]//[
[57] A method for generating a sensor
signal model for a received signal within
an adaptive broadcast radar system,
comprising: defining a clutter component
for said received signal at a receiver,
wherein said clutter component comprises
a direct path signal and a scattered signal;
defining a channel transfer function;
The applications for division
from this application have
not yet been published
231231
‫מערכת ושיטה למערכת רדאר בעלת‬
‫שידור מסתגל‬
]//[
US
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,14 ‫בית נולטון רחוב שנקר‬
generating a sampled version of said
received signal according to said channel
transfer function at a sample time;
determining a batch of data from said
sampled version for a sub-aperture of said
receiver at said sample time; and indexing
said batch of data into said sensor signal
model.
57400795719949
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
363
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
HIGH EFFICIENCY HEATER AND
STRIPPER
]11[
]/2[
27.11.2001
724001
]/1[ 28.11.2000
062/60///
1666/61662
062/6/10/
1/66/61662
062/262/1
6/66/61662
0//26/
2162661662
61///6
1162661662
Int. Cl.8 G02B 006/24
3SAE TECHNOLOGIES, INC., U.S.A.
WO/2002/044794
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.
P.O.B. 1426
TEL AVIV 61013
]12[
]/2[
]//[
]//[
[57] A system for stripping an optical
fiber having an outer coating, the system
including:
(a) a source of air (12);
(b) means (14) for generating one or more
air streams from said air source by
releasing compressed air from said air
source during relatively short periods of
time; and
(c) a heater (16) for heating said air
streams to a predetermined temperature
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
231231
‫מחמם ומקלף ביעילות גבוהה‬
]//[
US
US
US
US
US
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1409 .‫ד‬.‫ ת‬, :1 ‫רח' יבנה‬
sufficient to remove the outer coating from
the optical fiber, the heater including:
(i) a heat generating element (113) for
generating heat; and
(ii) a heat exchanger (112, 114, 116)
allowing heat from said heat generating
element to be transferred to an air stream
while maintaining said air stream isolated
from said heat source.
364
__________
]22[]12[
]1/[
COMPRESSOR UTILIZING
SHELL WITH LOW PRESSURE
SIDE MOTOR AND HIGH
PRESSURE SIDE OIL SUMP
]11[
]/2[
]12[
]/2[
28.11.2001
09/726606
]/1[ 01.12.2000
Int. Cl.8 F04B 035/04
BRISTOL COMPRESSORS, INC.,
U.S.A.
WO/2002/044562
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] A compressor system (10),
comprising: a housing (12); a partition
(36a) within the housing defining a first
chamber (14) and a second chamber (16); a
motor (24) disposed in the first chamber; a
compressor (18) disposed in the first
chamber operably connected to the motor;
an oil sump (48) disposed in the second
chamber; a first orifice in the housing
365
231211
‫מדחס המשתמש בקליפה בעלת מנוע צד‬
‫לחץ נמוך ועוקת שמן לחץ גבוה‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
communicating a suction tube (20) with
the first chamber, and a second orifice in
the housing communicating the second
chamber with a discharge tube (22),
wherein fluid in the first chamber is at
compressor suction pressure and fluid in
the second chamber is at compressor
discharge pressure.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
THERMOELECTRIC DEVICES
]11[
]/2[
]12[
]/2[
]//[
]//[
23.11.2001
731614
]/1[ 07.12.2000
Int. Cl.8 H01L 035/30
IBM CORPORATION, U.S.A.
WO/2002/047178
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[57] A thermoelectric device, comprising:
a planar electrical conductor (218); and a
thermoelement composed of a
thermoelectric material configured with a
plurality of tips (250) which are
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
231021
‫אלקטריים‬-‫התקנים תרמו‬
]//[
US
,‫מחלקת קניין רוחני מעבדות יבמ‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
electrically coupled to the electrical
conductor; wherein the tips are made to
have an effective tip radius (r) of less than
approximately 50 nanometers.
366
__________
]22[]12[
]1/[
THERMOELECTRIC SPOT
COOLERS FOR RF AND
MICROWAVE COMMUNICATION
INTEGRATED CIRCUITS
]11[
]/2[
]12[
]/2[
]//[
]//[
11.12.2001
734519
]/1[ 11.12.2000
Int. Cl.8 H01L 023/38
IBM CORPORATION, U.S.A.
WO/2002/049105
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
367
231012
‫מצננים תרמו–אלקטריים נקודתיים עבור‬
FR‫שבבי תקשורת בתדר מיקרוגל ו‬
]//[
US
,‫מחלקת קניין רוחני מעבדות יבמ‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
[57] An apparatus for cooling an element
of an integrated circuit (700), comprising:
a cold plate (762) thermally coupled to a
selected element (752) within the
integrated circuit through a path (708)
defined by at least one patterned integrated
circuit layer; a thermoelectric cooler (714)
thermally coupled to the cold plate; and a
hot plate (764) thermally coupled to the
thermoelectric cooler; wherein heat is
selectively removed from the selected
element within the integrated circuit
through the cold plate and transmitted to
the hot plate through the thermoelectric
cooler; and the hot plate is exposed at a
surface of the integrated circuit to dissipate
heat into the surrounding atmosphere.
__________
]22[]12[
]1/[
DISPENSER FOR HYGIENIC
PAPER PRODUCTS OR THE LIKE
]11[
]/2[
]12[
]/2[
15.12.2001
10062788.9
]/1[ 15.12.2000
Int. Cl.8 A47K 010/42, B65D 043/16
HAKLE-KIMBERLY
DEUTSCHLAND GMBH, GERMANY
WO/2002/055400
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
231602
‫מנפק עבור מוצרי נייר היגייניים או מוצרים‬
‫דומים‬
]//[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] Dispenser for towelettes or similat
items, in particular for moist toilet tissues,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
368
consisting of a container (1) open on one
side and of a closure (2) which can be
connected to the container via a latching
connection and consists of a frame (3) and
a lid (4) linked thereto, it being possible
for the frame to be put onto the container
in a releasable manner via a latching
connection and for the frame opening to be
closed by the lid in such a way that the lid
is releasably fastened to the frame via a
further latching connection, and the frame
and the lid in each case having sealing lips
(7, 8) which face one another and bear
tightly against one another in the closed
state of the lid, characterized in that a
recess (10) in the front region (9) of the
lid, and this recess, in the closed state of
the lid, comes into releasable engagement
with a corresponding recess (12) in the
encircling sealing lip on the frame and
leaves a deformable tactile region (11) of
the frame free.
__________
]22[]12[
369
231310
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
SYSTEM AND METHOD FOR
ELECTRICALLY INDUCED
BREAKDOWN OF
NANOSTRUCTURES
]11[
]/2[
]12[
]/2[
]//[
]//[
21.12.2001
753845
]/1[ 03.01.2001
Int. Cl.8 H01L 021/00
IBM CORPORATION, U.S.A.
WO/2002/054505
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[57] A method for forming a device
comprising the steps of: providing a
substrate; providing a plurality of
‫מערכת ושיטה להפרדה מושרית חשמלית‬
‫של מבנים זעירים‬
]//[
US
,‫מחלקת קניין רוחני מעבדות יבמ‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
nanotubes in contact with the substrate;
and selectively breaking a nanotube using
an electrical current.
__________
]22[]12[
]1/[
VEHICLE TRIP
DETERMINATION SYSTEM AND
METHOD
]11[
]/2[
28.01.2002
60/264498
]/1[ 26.01.2001
06210//1/
1066261662
Int. Cl.8 G07B 015/00
RAYTHEON COMPANY, U.S.A.
WO/2002/059838
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]12[
]/2[
]//[
]//[
[57] A method for determining a vehicle
trip on a roadway, the method comprising:
providing a plurality of vehicle detections
from a plurality of gateways; determining
a maximum travel time between
corresponding pairs of the plurality of
gateways;
correlating corresponding pairs of the
plurality of vehicle detections by
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
231183
‫מערכת ושיטה לקביעת נסיעה של כלי‬
‫רכב‬
]//[
US
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
determining that a travel time between
each of the gateways of each of the
corresponding pairs of detections is less
than a corresponding maximum travel
time; determining a plurality of chainable
detections; and determining the boundaries
of the trip.
370
__________
]22[]12[
]1/[
CONNECTOR COMPONENT FOR
MULTI-CORE OPTICAL FIBER,
FERRULE, AND METHOD FOR
MANUFACTURING THE SAME
]11[
]/2[
13.08.2001
2001-001947 ]/1[ 09.01.2001
1662-1/1/0/
/266/61662
Int. Cl.8 G02B 006/40
TAKAHIKO MUKOUDA, JAPAN
WO/2002/056079
DR. MARK FRIEDMAN LTD.,
BEIT SAMUELOFF, 7 HAOMANIM
STREET
TEL AVIV
]12[
]/2[
]//[
]//[
[57] A method of manufacturing a
connector, wherein thermal-spraying or
electroforming is applied, using a resin or
a metal, to a plurality of cylinder-shaped
ferrules, under the condition that
projections which are positioned opposite
each other of a positioning member are
231733
‫ טהעות‬,‫מרכיב מחבר עבור סיב אופטי‬
‫ ושיטה לייצורו‬,‫חיזוק‬
]//[
JP
JP
,‫ד"ר מרק פרידמן ושות‬
‫ תל אביב‬,7 ‫בית שמואלוב רח' האומנים‬
fitted and nipped to both ends of insertion
holes of the cylinder-shaped ferrules, so
that each ferrule is properly positioned and
the central axes are parallel to each other at
specified positions, so that said plurality of
cylinder-shaped ferrules are coated.
__________
371
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
231160
‫ – אמינובנזופיראן‬4 ‫נגזרות‬
]1/[
4 - AMINOBENZOPYRAN
DERIVATIVES
]11[
]/2[
]12[
]/2[
14.02.2002
2001-36293
]/1[ 14.02.2001
]//[ JP
Int. Cl.8 A61K 031/343, A61P 009/06, C07D 311/00, 311/74
NISSAN CHEMICAL INDUSTRIES
LTD., JAPAN
WO/2002/064581
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
41-45 ROTSHILD BLV
‫ תל אביב‬,41-4.‫שדרות רוטשילד‬
TEL AVIV 65784
]//[
]//[
[57] A benzopyran derivative of the formula
wherein,
R1 and R2 represent each independently a
hydrogen atom or a C1-6 alkyl group in
which said alkyl group may be optionally
substituted with a halogen atom, a
hydroxyl group or a C1-6 alkoxy group in
which said alkoxy group may be optionally
substituted with a fluorine atom,
R3 represents a hydroxyl group or a C1-6
alkylcarbonyloxy group,
R4 represents a hydrogen atom, or R3 and
R4 together form a bond,
R6 represents a hydrogen atom,
R7 represents a hydrogen atom or a C1-6
alkyl group,
X is absent, or represents C=O or SO2,
R8 represents a hydrogen atom or a C1-6
alkyl group in which said alkyl group may
be optionally substituted with a hydroxyl
group or a C1-6 alkoxy group, R9 represents
a hydrogen atom or a nitro group, when R9
represents a hydrogen atom,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
Y represents a C3-8 alkylene group or –
(CH2)m-CR11R12-(CH2)n-in which m and n
represent each independently 0, 1, 2, 3 or
4, and m+n is equal to or more than 2;
when m represents 0, R11 and R12 represent
each independently a C1-6 alkyl group, and
when m represents those other than 0, R11
and R12 represent each independently a C111
3 alkyl group or a hydroxyl group, or R
and R12 together form a oxygen atom, R5
represents a fluorine atom, a trifluromethyl
group, an amino group, a C1-6 alkylthio
group, a C1-6 alkylamino group, a di-C1-6
alkylamino group, a C1-6
alkylcarbonylamino group, a C1-6
alkylsulfonylamino group, an
aminocarbonyl group, a C1-6
alkylaminocarbonyl group, a di-C1-6
alkylaminocarbonyl group, a C1-6
alkylcarbonyl group, a C1-6 alkoxycarbonyl
group, a C1-6 alkoxycarbonylamino group,
an aminosulfonyl group, a C1-6
372
alkylsulfonyl group, a carboxyl group or a
benzoyl group in which said benzoyl group
may be optionally substituted with a C1-6
alkyl group, a C1-6 alkoxy group, a halogen
atom, a nitro group or a cyano group, and
when R9 represents a nitro group, Y
represents a C4-8 alkylene group, -(CH2)mCR11R12-(CH2)n-in which m, n, R11 and R12
are same as the above or –(CH2)o-O(CH2)p- in which o and p represent each
independently 2, 3 or 4, R5 represents a
hydrogen atom, a fluorine atom, a
trifluoromethyl group, a hydroxyl group, a
formamide group, an amino group, a C1-6
alkoxy group, a C3-8 cycloalkyl group, a
C1-6 alkylthio group, a C1-6 alkylamino
group, a di-C1-6 alkylamino group, a C1-6
alkylcarbonylamino group, a C1-6
alkylsulfonylamino group, an
aminocarbonyl group, a C1-6
alkylaminocarbonyl group, a di-C1-6
alkylaminocarbonyl group, a C1-6
alkylcarbonyl group, a C1-6 alkoxycarbonyl
group, a C1-6 alkoxycarbonylamino group,
an aminosulfonyl group, a C1-6
alkylsulfonyl group, a carboxyl group or a
benzoyl group in which said benzoyl group
may be optionally substituted with a C1-6
alkyl group, a C1-6 alkoxy group, a halogen
atom, a nitro group or a cyano group; or a
pharmaceutically acceptable salt thereof.
__________
]22[]12[
]1/[
ENERGY GENERATING SYSTEM
]11[
]/2[
]12[
]/2[
]//[
]//[
17.01.2002
0100141-1
]/1[ 17.01.2001
Int. Cl.8 F03B 003/12, 003/14, 017/06
WATER CROSSING, INC., SWEDEN
WO/2002/061273
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] System for generating energy,
primarily with the use of sea currents,
comprising a rotation body (4) having a
front inlet side and a rear outlet side, and at
least one transfer member (6) between the
inlet side and a generator, wherein said
rotation body has a conical and/or concave
section extending in a direction toward the
outlet side as well as a concially and/or
bulb shaped tapering portion extending
from a substantially cylindrical waist
portion towards the inlet side, wherein the
373
231110
‫מערכת מחוללת אנרגיה‬
]//[
SE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
waist portion is provided with turbine
blades (10) only along its circumference
that are adapted to maintain the rotation of
the rotation body, a free front end of which
is secured to the transfer member to
transfer a rotational movement to the
generator, and wherein an inner surface of
an outer wall (17) of the rotation body
exhibits blades (18) along its
circumference for the purpose of
eliminating friction generated by a fluid
(19) inside the rotation body.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
238022
‫התקן לתיקון סחיפת טמפרטורה עבור‬
‫ התקן בקרת לחץ והתקן בקרת‬,‫רגש לחץ‬
‫ספיקה מסוג חלץ‬
]1/[
APPARATUS FOR THE
CORRECTION OF
TEMPERATURE DRIFT FOR A
PRESSURE SENSOR, A
PRESSURE CONTROL
APPARATUS, AND A PRESSURETYPE FLOW RATE CONTROL
APPARATUS
]11[
]/2[
]12[
]/2[
22.11.2002
2001-399910 ]/1[ 28.12.2001
]//[
Int. Cl.8 G01D 003/08, G01L 009/00, 019/04
TADAHIRO OHMI, JAPAN
FUJIKIN INCORPORATED, JAPAN
TOKYO ELECTRON LTD, JAPAN
]//[
]//[
WO/2003/058187
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
374
[57] An apparatus for correcting
temperature drift for use in a pressure
sensor (10) for measuring the pressure of
fluid, said apparatus comprising a
temperature sensor (14) for measuring the
temperature of the fluid, a memory means
for storing both a relation between the
fluid temperature and zero point output
drift of the pressure sensor when the
pressure is zero, and a relation between the
fluid temperature and span output drift of
the pressure sensor at any given pressure,
and a temperature drift correcting means
provided with a span drift correcting
means for inputting an output voltage of
the pressure sensor by way of amplifiers
and an A/D converter, and a zero point
correcting means for outputting a reverse
voltage of a zero point drift voltage to the
offset terminal of the afore-mentioned
amplifier through an offset D/A converter,
which calculates the amount the output
drift of the pressure sensor from data in the
memory means when the fluid pressure
changes and negates the output drift of the
pressure sensor with said calculated
amount of the output drift, thereby
correcting the temperature drift, such that
even if the temperature of fluid changes,
the fluid pressure can be measured
accurately.
__________
]22[]12[
375
238168
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
5-[2-ALKOXY-5HALOSULPHONYL-PHENYL]-1,3(2,3-)DISUBSTITUTED-1,6-(2,6)DIHYDRO-7H-PYRAZOLO[4,3D]PYRIMIDIN-7-ONES
]11[
]/2[
10.04.1998
9708406.5
]/1[ 25.04.1997
0/21//66/
1166/6200/
0/1101/60
/66266200/
Int. Cl.8 C07D 487/04
DIVISION FROM 132276
PFIZER INC., U.S.A.
WO/1998/049166
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]12[
]01[
]/2[
]//[
]//[
–]‫–הלוסופוניל–פניל‬.–‫–אלקוקסי‬0[–.
–H7–‫–)דיהידרו‬9,0(–9,1 ‫–)די–מותמר‬:,0(:,1
‫–ונים‬7–‫] פירימידינ‬d– :,4[ ‫פיראזולו‬
]//[
GB
GB
GB
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A compound selected from the group
consisting of compounds of the formulae
wherein R1 is C1 to C3 alkyl substituted
with C3 to C6 cycloalkyl, CONR4R5 or a
N-linked heterocyclic group selected from
pyrazolyl, imidazolyl, triazolyl,
pyrrolidinyl, piperidinyl, morpholinyl and
4-R6-piperazinyl; (CH2)nHet or (CH2)nAr;
R2 is C1 to C6 alkyl; R3 is C1 to C6 alkyl
optionally substituted with C1-C4 alkoxy;
R4 and R5 are each independently selected
from H and C1 to C4 alkyl optionally
substituted with C1 to C4 alkoxy, or,
together with the nitrogen atom to which
they are attached, form a pyrrolidinyl,
piperidinyl, morpholinyl or 4-R6piperazinyl, group; R6 is C1 to C4 alkyl;
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
Het is a C-linked 6-membered heterocyclic
group containing one or two nitrogen
atoms, optionally in the form of its monoN-oxide, or a C-linked 5-membered
heterocyclic group containing from one to
four heteroatoms selected from nitrogen,
oxygen and sulphur, wherein either of said
heterocyclic groups is optionally
substituted with one or two substituents
selected from C1 to C4 alkyl optionally
substituted with C1 to C4 alkoxy, C1 to C4
alkoxy, halo and NH2; Ar is phenyl
optionally substituted with one or two
substituents selected from C1 to C4 alkyl,
C1 to C4 alkoxy, halo, CN, CONH2, NO2,
376
NH2, NHSO2 (C1 to C4 alkyl) and SO2NH2;
and n is 0 or 1.
__________
]22[]12[
]1/[
POLYMERISATION IN AQUEOUS
SUSPENSION OF VINYL
CHLORIDE
]11[
]/2[
]12[
]/2[
]//[
]//[
28.03.2002
01/04425
]/1[ 02.04.2001
Int. Cl.8 C08F 014/06
ATOFINA, FRANCE
WO/2002/079279
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] Process for aqueous suspension
polymerization of vinyl chloride alone or
in a mixture with less than 50% of another
vinyl monomer, characterized in that the
polymerization initiator system comprises
at least one compound selected from
dialkyl peroxydicarbonates, peroxy-tert-
238817
‫פילמור בתרחיף מימי של ויניל כלוריד‬
]//[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
alkanoates and diacyl peroxides, and in
that at least one short-stopper selected
from stable free radicals of nitroxide type
is used, introduced when the monomer
conversion by weight is between 60 and
90%.
__________
]22[]12[
]1/[
PROCESS FOR PRODUCING
AMMONIUM THIOSULFATE
]11[
]/2[
]12[
]/2[
08.03.2002
09/808618
]/1[ 14.03.2001
Int. Cl.8 B01D 053/14, C01B 017/64
MARK C. ANDERSON, U.S.A.
SIDNEY P. WHITE, U.S.A.
RONALD E. SHAFER, U.S.A.
]//[
]//[
WO/2002/072243
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
[57] A process for producing ammonium
thiosulfate comprising: (a) contacting a
feed gas mixture comprising hydrogen
377
238121
‫שיטה לייצור אמוניום תיוסולפט‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
sulfide and ammonia with an aqueous
absorbing stream comprising ammonium
sulfite and ammonium bisulfite in a first
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
reaction zone to produce an ammonium
thiosulfate-containing solution and a first
off-gas comprising hydrogen sulfide and
ammonia wherein conversion of sulfite
into thiosulfate is limited by varying the
aqueous absorbing stream to feed gas
mixture contact ratio (L/G ratio) in
response to an oxidation reduction
potential of the aqueous absorbing stream;
(b) contacting the first off-gas with water
to form an ammonium bisulfide-containing
solution and a second off-gas comprising
hydrogen sulfide;
(c) contacting the aqueous absorbing
stream with a sulfur dioxide-containing gas
is a second reaction zone to produce a
second reaction zone product comprising
ammonium sulfite and ammonium
bisulfite;
(d) combining at least a portion of the
second reaction zone product with the
ammonium thiosulfate-containing solution
to produce a combined solution, and
(e) recycling a first portion of the
combined stream back to at least the first
reaction zone and recovering ammonium
thiosulfate from a second portion of the
combined solution.
__________
]22[]12[
]1/[
ORGANIC OPEN CELL FOAM
]11[
]12[
]/2[
04.10.2001
Int. Cl.8 C08J 009/28
AMERICAN AEROGEL
CORPORATION, U.S.A.
WO/2002/074842
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
[57] An organic, small pore area material
comprising a monolithic aerogel, wherein
its smallest dimension is greater than about
3 inches; the average pore diameter is
238122
‫קצף אורגני עם תאים פתוחים‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
between about 55 nm and about 25 μm;
and said aerogel is substantially free of
cracks.
__________
]22[]12[
]1/[
METHOD AND DEVICE FOR
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
237201
‫שיטה והתקן לערבב גזים‬
378
MIXING GASES
]11[
]/2[
]12[
]/2[
]//[
]//[
20.01.2003
02/01207
]/1[ 01.02.2002
Int. Cl.8 B01D 015/04, B01F 003/02
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
(C.N.R.S), FRANCE
COMMISSARIAT A L'ENERGIE
ATOMIQUE, FRANCE
WO/2003/064016
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] A method of mixing, in dynamic
mode, a second gas in a first gas (4), in
which a stream of the second gas (6) is
introduced into a stream of the first gas,
said streams of gases having controlled
]//[
FR
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
flow rates (5, 8, 9) and said steams of the
first and second gases are mixed so as to
obtain a homogeneous mixture (10) of the
two gases that has a defined concentration
of the second gas.
__________
]22[]12[
379
237222
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
METHOD FOR THE
PREPARATION OF METAL
CARBENE COMPLEXES
]11[
]/2[
]12[
]/2[
15.04.2002
142610
]/1[ 16.04.2001
Int. Cl.8 C07F 015/00
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
WO/2002/083698
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
‫שיטה חדשה להכנת קומפלכסים של‬
‫קרבנים מתכתיים‬
]//[
IL
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] A process for preparing a metal carbene complex of the formula
wherein
M is a transition metal atom selected from
the group consisting of ruthenium,
rhodium, iron, cobalt, osmium and iridium;
L denotes neutral electron donor ligands
ligated to said metal, such groups being the
same or different;
X is an anionic ligand;
R1 and R2 are each independently selected
from the group consisting of hydrogen,
substituted or unsubstituted C1-C20 alkyl,
substituted or unsubstituted C2-C20
alkenyl, substituted or unsubstituted
cycloalkyl, substituted or unsubstituted
heterocycloalkyl, substituted or
unsubstituted aryl, substituted or
unsubsituted heteroaryl, substituted or
unsubstituted vinyl,
a is 2 or 3 and
b is 1 or 2,
such process comprising reacting a sulfur
ylide of the formula Ar2S=CR1R2 or its
precursor, wherein each Ar is
independently selected from aryl,
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
substituted aryl, and aryl or substituted aryl
bound to a polymeric unit, with an
appropriate metal complex comprising a
transition metal atom selected from the
group consisting of ruthenium, rhodium,
iron, cobalt, osmium and iridium, at least
two neutral ligands capable of forming
donor bonds with said metal and at least
one further organic or inorganic anionic
group which form a complex with said
metal, including dimers of such metal
complex, at a temperature between +80oC
and -80oC, in an inert solvent and under
inert atmosphere, to give the metal carbene
complex of formula (I).
380
Claimed as novel is the rhodium complex
of the formula
wherein R is alkyl or aryl, X is an amine
moiety and Y and Y' are independently
selected from H or alkyl.
__________
]22[]12[
]1/[
SOY PROTEIN CONCENTRATE
HAVING HIGH ISOFLAVONE
CONTENT AND PROCESS FOR
ITS MANUFACTURE
]11[
]/2[
]12[
]/2[
]//[
]//[
09.04.2002
60/282520
]/1[ 09.04.2001
Int. Cl.8 A23J 003/16
SOLAE, LLC, U.S.A.
WO/2002/080697
DR. SHLOMO COHEN & CO.,,
124 IBN GABIROL ST,
P.O.B. 11490,
TEL AVIV 62038
[57] A soy protein concentrate,
characterized by: a protein content of
between about 75.0 wt.% and about 85.0
wt. % of total dry matter; at least one of an
isoflavone content of at least about 2.0
237110
‫תרכיז חלבון סויה בעל תחולת איזופלבון‬
‫גבוהה והליך ליצורו‬
]//[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,1146/ .‫ד‬.‫ ת‬, 104 ‫אבן גבירול‬
mg/g of total dry matter and a
soyasapogenols content of at least about
2.0 mg/g of total dry matter; and a crude
fiber content of less than about 3.0 wt.% of
total dry matter.
__________
381
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]22[]12[
]1/[
MOTION DETECTION
APPARATUS EMPLOYING
MILLIMETER WAVE DETECTOR
]11[
]/2[
]12[
]/2[
]//[
]//[
01.04.2002
60/281209
]/1[ 03.04.2001
Int. Cl.8 G08B 013/18
VISONIC LTD.
WO/2002/082004
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
[57] Motion detection apparatus
comprising: a detector unit for detecting
motion of an object (120) and producing a
plurality of detection output signals,
including: at least one first detector (100)
including at least one sensing element
(112) operative to detect receipt of at least
first radiation in the millimeter wave range
having a wavelength between 0.05 mm and
10 mm; and at least first radiation input
optics (112) comprising an array of
multiple optical segments (102-108) for
focusing millimeter wave radiation from
first multiple spaced fields of view onto
said at least one first detector,
237182
‫התקן זיהוי תנועה המשתמש בגלאי גל‬
‫מילימטרי‬
]//[
US
‫ תל אביב‬,‫ויסוניק בע"מ‬
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
said at least one first detector (110)
generating a plurality of first output signals
(116) in response to receipt of said at least
first radiation resulting from motion of
said object between said first multiple
spaced fields of view; and a processor
(118) receiving said plurality of detection
output signals from said detector unit, said
plurality of detection output signals
including said plurality of first output
signals, said processor being operative to
process said plurality of detection output
signals according to predefined criteria and
to provide a motion detection output based
on said criteria.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
237112
382
]1/[
PESTICIDAL PREPARATIONS
COMPRISING COPOLYMERS
]11[
]/2[
]12[
]/2[
06.04.2002
10117993.6
]/1[ 10.04.2001
Int. Cl.8 A01N 025/30, C08G 065/00
CLARIANT PRODUKTE
(DEUTSCHLAND) GMBH,
GERMANY
WO/2002/089575
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]//[
]//[
[57] A pesticide preparation comprising
at least one copolymer obtainable by
copolymerization of
(a) glycerol
‫פולימרים‬-‫תכשירי הדברה המכילים כו‬
]//[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
(b) at leat one dicarboxylic acid and
(c) at least one monocarboxylic acid of the
formula
R1-COOH
where R1 is (C5-C29)-alkyl; (C7-C29)alkenyl; phenyl or naphthyl, wherein the
copolymers comprise 19.9 to 99% by
weight of component (a), 0.1 to 30% by
weight of component (b) and 0.9 to 80%
by weight component (c).
_____________
]22[]12[
383
237723
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
]1/[
AUTOMATIC AND GUIDED
SYSTEM FOR TRANSPORTING
PEOPLE, AND METHOD OF
CONTROLLING TRANSPORT
MODULES RUNNING IN SUCH A
SYSTEM
]11[
]/2[
]12[
]/2[
06.05.2002
01/07161
]/1[ 31.05.2001
Int. Cl.8 B60M 003/00, B61L 003/14
REGIE AUTONOME DES
TRANSPORTS PARISIENS, FRANCE
ALSTOM HOLDINGS, FRANCE
WO/2002/096737
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
[57] A system for automatic and guided
transport of people, the system comprising:
at least one running track having means for
guiding transport modules, each transport
module being constituted by a single selfpropelled vehicle or a self-propelled
vehicle associated with one or more other
transport vehicles; an electric power
supply system comprsing a sequence of
power supply blocks (31-35); electric selfpropelled transport modules (1, 2)
traveling individually along the running
track and fitted with means (3, 4) for
collecting electric power supplied by the
power supply blocks; and electric power
distribution means comprising switch
means (41-45) which supply said electric
power to the various power supply blocks
and which are controlled by a central
control unit (50) managing the progress of
the transport modules by causing the
various power supply blocks to be
powered or unpowered, the presence of a
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫מערכת אוטומטית מונחית להעברת‬
‫אנשים ושיטה לפקח על מודולי העברה‬
‫במערכת זו‬
]//[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
transport module on a power supply block
preventing power being applied to one or
more blocks situated behind the block that
is occupied so as to maintain a safety
distance between the various transport
modules traveling independently along the
track, the system being characterized in
that said transport modules are provided
with fixed onboard functions controlling
starting acceleration, cruising speed, and
deceleration, both while slowing down and
while braking, of the transport module,
said fixed onboard functions being
actuated as a function of the presence or
absence of a voltage on one or more
electric power supply conductors, said
transport modules moving automatically
along the track when the collector means
are electrically powered, and including
brake means that come into operation
when the collector means are no longer
powered with electricity.
384
__________
]22[]12[
]1/[
PANEL SEAL FOR AN AIR
HANDLING UNIT
]11[
]/2[
]12[
]/2[
]//[
]//[
11.07.2002
904672
]/1[ 13.07.2001
Int. Cl.8 F24F 013/20
CARRIER CORPORATION, U.S.A.
WO/2003/006889
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] In an air handling unit (10)
containing modular sections, each section
having a framework with perpendicularly
aligned rectangular shaped panel openings
(11) therein that are closed by close fitting
panels (12) that are latched into said panel
openings, apparatus for sealing said panels
in said panel openings that includes tubular
structural elements (20, 21, 23, 24)
mounted to form each panel opening so
that each panel opening shares a common
structural element (25) with an adjacent
perpendicularly aligned panel opening,
said common structural elements each
385
231122
‫פנל סוגר ליחידת טיפול באויר‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
containing a rail (30, 31) extending along
said element, a seal assembly (35)
mounted upon said rail that includes a rigid
elongated plate (37) having bulb seals (40,
41) mounted along opposing edges of said
plate so that the bulb seal extending along
one edge of the plate is capable of sealing
against a first panel contained in one of the
adjacent panel openings and the seal
extending along the other edge is capable
of sealing against a second panel contained
in the adjacent perpendicularly aligned
panel opening.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
THERMAL BARRIER FOR AIR
HANDLING UNIT (AHU)
CABINET
]11[
]/2[
11.07.2002
905234
]/1[ 13.07.2001
06/0/0
2/66/61662
Int. Cl.8 F24F 013/20, F25D 023/06
CARRIER CORPORATION, U.S.A.
WO/2003/006891
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
231121
‫מחסום תרמי עבור ארון של יחידת טיפול‬
‫באויר‬
]//[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
386
[57] A panel (12) for use in an air
handling duct (10) substantially defining
an interior space for conducting air along
an enclosed flow path, said panel
including: a peripheral wall having a top
edge and a bottom edge, said peripheral
wall including an upper channel opening to
the top edge of said wall and a lower
channel opening to the bottom edge of said
wall, said channel extending along
substantially the entire length of said wall,
said wall further including an upper groove
(90) opening to the top edge of said wall
and a lower groove (90) opening to the
bottom edge of said wall; a top cover (40)
and a bottom cover (41), each cover
having a periphery and an associated skirt
extending about the periphery thereof and
the skirt of the top cover being contained
within the upper channel of said wall and
the skirt of the bottom cover being
contained within the lower channel of said
wall to establish an enclosed cavity within
the panel; and a substantially L-shaped bar
(92), a first leg (94) of which is contained
within the lower groove of said wall, and a
second leg (96) of which possesses a
deformable bulbous section (98) adapted to
compressively, sealingly abut another
portion of the air handling duct such that
air is substantially prohibited from passing
between the interior space within said air
handling duct and the exterior of the air
handling duct.
__________
]22[]12[
]1/[
ROD AND CONNECTOR TOY
CONSTRUCTION SET
]11[
]/2[
]12[
]/2[
16.12.2002
60/367366
]/1[ 07.01.2002
Int. Cl.8 A63H 033/08
CONNECTOR SET LIMITED
PARTNERSHIP, U.S.A.
WO/2003/059481
WOLFF, BREGMAN AND GOLLER,
19B KEREN HAYESOD ST.
P.O.B. 1352,
JERUSALEM 91013
]//[
]//[
231106
‫מוט ומחבר למערכת משחק בניה‬
]//[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1:.0 .‫ד‬.‫ ת‬, '‫ב‬16 ‫רחוב קרן היסוד‬
[57] A rod and connector toy construction
387
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
set, especially for young children, which
comprises:
(a) a plurality of connector elements
comprising:
(i) a connector body (30) formed of a soft
and pliable plastic material and having
front and back sides and a peripheral edge;
(ii) said connector body having a rodengaging socket (41) therein extending
through said connector body from one of
said sides to the other of said sides and
defined by walls of said connector body;
(iii) said socket having spaced apart wall
portions forming a rod neck gripping
portion of a first predetermined width, with
one end thereof opening at the peripheral
edge of said connector body, and having a
rod end receiving portion adjoining an
opposite end of said rod neck gripping
portion, said rod end receiving portion
being of a second predetermined width
greater than said first predetermined width,
(iv) said rod neck gripping portion
defining a socket axis (42) positioned in a
plane between front and back sides of said
connector body and extending midway
between connector body socket walls
defining opposite sides of said rod neck
gripping portion,
(v) said socket wall portions having a
contour (35) along said socket axis to
enable gripping and confining of a rod
neck coaxially with said socket axis;
(b) a plurality of rod elements (45)
moulded of plastic material, each having a
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
rod axis, and comprising a body portion
(46), a rod neck (47) having one end
thereof adjoining said body portion, and a
rod end (48) adjoining said rod neck at an
end thereof opposite from said one end;
(i) said rod neck and said spaced apart wall
portions of said socket having
complementary contours to enable
retention of a rod element coaxially with
said socket axis;
(ii) said rod neck having a diameter less
than dimensions of said rod end transverse
to said rod axis and being of smaller size
than at least some elements of said body
portion;
(iii) a shoulder (103) being formed
between said rod end and said rod neck;
(iv) the diameter of said rod neck being
greater than said first predetermined width,
whereby said rod neck may be forced
laterally into said rod neck gripping
portion with a snap-in action and thereafter
gripped with said rod axis in coaxial
alignment with said socket axis;
(v) the transverse dimensions of said rod
end being greater than said first
predetermined width, whereby said
shoulder formed between said rod neck
and said rod end is engageable with
confronting surfaces at an inner end of said
rod neck gripping portion to resist axial
withdrawal of said rod from said rodengaging socket.
388
__________
]22[]12[
]1/[
SOLID COMPOSITIONS FOR
SELECTIVE ADSORPTION
FROM COMPLEX MIXTURES
]11[
]/2[
]12[
]/2[
]//[
]//[
12.08.2002
929621
]/1[ 14.08.2001
Int. Cl.8 B01J 020/28, 020/32
W.R. GRACE & CO. -CONN., U.S.A.
WO/2003/015915
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
389
212012
‫הרכבים מוצקים לספיחה סלקטיבית‬
‫מתערובות מורכבות‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
[57] A solid having reduced non-specific
binding of non-analyte component in a
complex mixture comprising inorganic
substance and moiety R10 covalently
bonded to a metal atom on at least one
surface of said inorganic substance,
wherein said inorganic substance is
inorganic oxide, and said R10 group
selected from the group consisting of –
CH2OH, -CH(OH)2, -CH(OH)CH3, CH2CH2OH, -C(OH)2CH3, -CH2CH(OH)2
and –CH(OH)CH2(OH).
__________
]22[]12[
]1/[
VACUUM ASSISTED TISSUE
TREATMENT SYSTEM
]11[
]/2[
]12[
]/2[
]//[
]//[
23.08.2002
939166
]/1[ 24.08.2001
Int. Cl.8 A61M 027/00
KCI LICENSING, INC., U.S.A.
WO/2003/018098
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A system (10) for stimulating the
healing of tissue, comprising: a porous pad
(11); an airtight dressing (13); a distal end
(16a) of a conduit connected to the
dressing; a canister (18) removably
connected to a proximal end (16b) of the
conduit; an electric pump (14) for applying
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
212632
‫מערכת לטיפול ברקמות באמצעות ואקום‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
negative pressure to a wound site (12); a
hydrophobic filter (20) positioned between
said canister and said electric pump; and
an odor vapor filter positioned between
said hydrophobic filter and said electric
pump.
390
5747041
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]22[]12[
]1/[
DEVICE FOR CONTROLLING
PROPULSIVE FLOW MIXTURE
FOR AIRCRAFT REACTOR
]11[
]/2[
]12[
]/2[
19.09.2002
01/12113
]/1[ 19.09.2001
Int. Cl.8 F02K 001/00, 001/28
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
(C.N.R.S), FRANCE
WO/2003/025377
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]//[
]//[
[57] Device for controlling the mix of
propulsion jets (8, 9) at the output of an
airplane jet engine, the device comprising
an exhaust nozzle, said propulsion jets
consisting of a hot primary jet coming
from the exhaust nozzle of said jet engine,
and a secondary flow that flows between
the outer wall of said exhaust nozzle and
the inner wall of said jet engine,
characterized in that the wall of said
391
212111
‫התקן לבקרת תערובת זרימת גזי דחף‬
‫במנוע של כלי טיס‬
]//[
FR
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
exhaust nozzle has a divergent trailing
edge (3) in order to generate the conditions
for said primary jet to separate close to an
existence limit value, and in that it
comprises means (4) for controlling said
primary jet, said controlling means making
it possible to control the shift of said
primary jet from a separated state to a
reattached state, and vice-versa.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
‫צינורות לחץ‬
]1/[
PRESSURE PIPES
]11[
]/2[
]12[
]/2[
06.11.2002
01127005.5
]/1[ 14.11.2001
Int. Cl.8 C08F 210/06
BOREALIS TECHNOLOGY OY,
FINLAND
WO/2003/042260
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
212180
[57] Pressure pipe with increased longterm pressure resistance comprised of a
polypropylene composition characterized
in that the polypropylene composition is
comprised of a propylene random
copolymer which comprises 73.0-99.0
]//[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
wt% of propylene and 1 to 20 wt% of one
or more C4-C8 α-olefins and/or up to 7.0
wt% of ethylene, where the propylene
random copolymer is at least partially
crystallized in the β-modification.
__________
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
392
]22[]12[
]1/[
SYSTEM FOR SEALING THE
SECONDARY FLOW AT THE
INLET TO A NOZZLE OF A
TURBOMACHINE HAVING A
POST-COMBUSTION CHAMBER
]11[
]/2[
]12[
]/2[
]//[
24.05.2004
03/06390
]/1[ 27.05.2003
Int. Cl.8 F02K 001/12
SNECMA MOTEURS, FRANCE
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] An aviation turbomachine
comprising, downstream from the turbine,
a post-combustion chamber (2) extended
by at least one nozzle (7), said chamber
being defined radially by a thermal
protection lining (3) disposed inside a
casing (4), said casing and said lining
together defining an annular channel (5) in
which, in operation, there flows a
secondary flow, an annular diaphragm (6)
secured to said casing being disposed at
the downstream end of said channel, said
nozzle comprising a plurality of flaps (8)
hinged to the upstream end of said casing,
each flap being fitted on its inside face
with a thermal protection plate (18) cooperating with said flap to define a passage
(11) for being fed with cooling air
393
211261
‫מערכת לאיטום זרימה משנית בכניסה‬
‫לנחיר של מכונת טורבו בעלת תא שלאחר‬
‫בעירה‬
]//[
FR
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,10900 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
delivered by said diaphragm, the
turbomachine being characterized by the
fact that the feed of cooling air to said
passages is provide by an annular duct
defined on the outside by a first flexible
annular gasket (30) retained, in operation,
pressed in sliding contact against the
downstream inside face of the casing and
against the upstream inside faces of the
flaps under urging from the pressure of the
secondary flow, and defined on the inside
by a second flexible annular gasket (40)
whose upstream end (40a) is fixed to the
radially inner zone of the diaphragm, and
whose downstream end (30c) is pressed in
sliding contact against the upstream inside
face of the protection plates.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
211102
‫תהליך הדפסה דיגיטלי ישיר של הזרקת דיו‬
‫בהנעה סילונית על קטע אריג רטוב‬
]1/[
PROCESS FOR DIRECT DIGITAL
INKJET PRINTING ONTO A
WET TEXTILE PIECE
]11[
]12[
]/2[
]//[
30.05.2004
Int. Cl.8 B41J 003/407, 015/04, D06B 011/00
KORNIT DIGITAL LTD.
‫ מושב מגשימים‬,‫קורנית דיגיטל בע"מ‬
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬166.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER 15TH FLOOR
,11 ‫ רחוב מנחם בגין‬1. ‫מגדל אילון קומה‬
11 MENACHEM BEGIN STREET
‫רמת גן‬
52521 RAMAT GAN
[57] A direct digital printing process
comprising digitally printing an inkjet ink
directly onto a wet textile piece (as defined
in the specification), said wet textile piece
being previously wetted with a wetting
composition which comprises a high to
low volatility solvent or a mixture of such
solvents.
__________
]22[]12[
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
211103
394
]1/[
MULTI-LAYER, WEATHERRESISTANT, COLOURED
PANEL
]11[
]/2[
05.12.2002
10160569.2
]/1[ 10.12.2001
26112/1/60
6162261661
Int. Cl.8 B32B 027/18, 027/20
BAYER MATERIALSCIENCE AG,
GERMANY
WO/2003/049940
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]12[
]/2[
]//[
]//[
[57] A multilayer product containing
(a) a layer A containing a base material
selected from the group comprising a
transparent thermoplastic material and a
lacquer and containing at least one UV
absorber,
(b) a layer B containing a transparent
thermoplastic material and containing at
least one colourant, and
‫לוח צבעוני רב שכבתי העמיד בשחיקה‬
]//[
DE
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
(c) a layer C containing a transparent
thermoplastic material, wherein the layer B
has a thickness of 1 to 500 μm, the layer A
is 0.01 to 10 times as thick as the layer B,
and the layer C is 20 to 10,000 times as
thick as the layer B.
__________
]22[]12[
]1/[
METHOD AND APPARATUS FOR
MANUFACTURING DECORATED
ICE CREAM CONFECTIONERY
ITEMS
]11[
]/2[
]12[
]/2[
03.02.2003
02076611.9
]/1[ 23.04.2002
Int. Cl.8 A23G 009/28
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2003/090549
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON STREET
P.O.B. 6451
TEL AVIV 61063
]//[
]//[
[57] Method of manufacturing an ice
cream dessert with built-in ice cream
confectionery decoration deposited by
395
210261
‫שיטה ומתקן ייצור פריטי ממתקי גלידה‬
‫מקושטים‬
]//[
EP
,‫ עו"פ‬,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.1 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
extrusion from at least one moving nozzle
with flattened end-piece with slot-shaped
nozzle outlet placed above a moving
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
support, characterized: in that an ice cream
composition is extruded continuously in
the form of ribbon(s) at a temperature of
below -6oC at the extrusion nozzle or
nozzles onto the moving support; in that
the nozzle or nozzles is or are secured to
an oscillating support given an oscillating
movement transversal to the moving
support; in that the nozzle furthest from the
moving support is placed in such a way
that the projection of the plane of the
nozzle outlet of the said nozzle onto a
plane parallel to the direction of travel of
the moving support and perpendicular to
the plane of the said moving support
makes, when viewed in the direction of
travel of the said support, an acute angle of
at least 45o with the projection of the
moving support onto the said plane; in that
the speed at which the ice cream
composition is extruded is greater than the
speed of travel of the moving support; and
in that the respective movements of the
nozzle or nozzles and of the moving
support are such that the ribbon deposited
under gravity has the shape of a gathered
frill folded over on itself, the folds of
which run alternately in one direction then
in the opposite direction.
__________
]22[]12[
]1/[
METHOD FOR THE
APPLICATION OF ANTIFOULING AGENTS
]11[
]12[
]/2[
11.04.2002
Int. Cl.8 C08F 002/00, 014/06
AKZO NOBEL N.V., THE
NETHERLANDS
WO/2003/085003
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
]//[
]//[
216611
‫שיטה לשימוש בגורמים נוגדי זיהום‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
[57] A method for applying an aqueous
solution to the internal walls of a reactor
for polymerizing vinyl chloride and/or
vinyl acetate, which aqueous solution
contains a salt of an anti-scaling agent
which comprises a product of condensation
of an aldehyde, a phenolic compound and
an aromatic carboxylic acid hydroxylated
at the aromatic nucleus, the method being
characterized in that the pH-value of this
aqueous solution is changed to a pH-value
of less than 5.
__________
]22[]12[
]1/[
PRINTER CONTROLLER FOR AN
INKJET PRINTER
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
216136
‫בקר מדפסת למדפסת הזרקת דיו‬
396
]11[
]/2[
]12[
]01[
]/2[
]//[
]//[
17.02.2000
PP 9960
]/1[ 23.04.1999
]//[ AU
Int. Cl.8 B41J 002/135, 002/14, 002/145
DIVISION FROM 146071
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/064679
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A printer controller (148) for an
inkjet printer, the controller including: a
processing means (138) for receiving
incoming data relating to a description of a
page to be printed, said descriptions
containing color data and black text data; a
memory means (152) in which the data are
stored; a rasterizing and compressing
397
means for rasterizing and compressing the
data, the compression of the color data and
the black text data being effected
separately from each other; and a printhead
controller (112) for receiving,
decompressing and processing said data
for printing via a printhead under control
of the printhead controller.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
DEVICE, METHOD, AND SYSTEM
FOR CONTROLLING FLUID
FLOW
]11[
]/2[
]12[
]/2[
]//[
05.01.2005
60/534590
]/1[ 06.01.2004
Int. Cl.8 F16K 001/00, 001/10, 031/122
THE BOC GROUP, INC., U.S.A.
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.BOX 4060,
TEL AVIV 61040
[57] A flow control device (1),
comprising: an inlet (9) for passing fluid
into the device; an outlet (7) for passing
fluid from the device; a fluid flow control
valve (2), wherein the fluid flow control
valve is configured to be actuated by
pneumatic pressure so as to adjust flow
rate of the fluid; a pneumatic pressure
controlling portion (5), wherein the device
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
211218
‫ שיטה ומערכת לשליטה בזרימת‬,‫התקן‬
‫נוזל‬
]//[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 01‫רחוב אחד העם‬
is configured so that the fluid flow control
valve is actuated by pneumatic pressure
supplied via the pneumatic pressure
controlling portion; a flow meter (3)
configured to measure flow rate of the
fluid; and a controller configured to
control the pneumatic pressure controlling
portion at least according to the flow rate
measured by the flow meter.
398
__________
]22[]12[
]1/[
PRINT ENGINE INCLUDING AN
AIR PUMP
]11[
]12[
]01[
]/2[
30.06.2000
Int. Cl.8 B41J 002/165
DIVISION FROM 153722
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/002345
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER
P.O.B 5352
BEER-SHEVA 84152
]//[
]//[
[57] A pump assembly (522) for a print
engine (500), the print engine having a
printhead (516) (not shown) employing an
arrangement for fluid cleaning of the
printhead, the pump assembly including: a
housing defining a fluid inlet (526) and a
fluid outlet (528); an impeller configured
for drawing fluid throught the inlet, and for
399
211812
‫מנוע הדפסה הכולל משאבת אוויר‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
ejecting the fluid through the outlet to
effect said fluid cleaning of the printhead;
and a drive means (530) for rotatably
driving the impeller, the drive means
further controlling feeding of print media
to the printhead for printing of an image on
the print media.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
]22[]12[
]1/[
PROPRIOCEPTIVE/KINESTHETIC
APPARATUS AND METHOD
]11[
]12[
]/2[
12.08.2003
Int. Cl.8 A63B 021/00
AVI ELBAZ
AMIT MOR
]//[
]//[
WO/2004/016321
DEKEL PATENTS LTD.,,
18 MENUHA VENAHALA ST,
REHOVOT 76209
[57] Footwear comprising: a support
member (12) having an upper surface (14)
attachable to a foot, and two bulbous
protubearances (22), each having a curved
outer contour, protruding from a lower
surface thereof, one of said protuberances
being positioned more posteriorly than the
other of said protuberances wherein said
protuberances are attached to a centerline
of said support member, said centerline
extending from a calcaneus support portion
of said support member to at least one of a
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
211182
‫התקן וחשיטה לפרופריוספציה‬
‫וקינסתטיקה‬
‫ דימונה‬,‫אבי אלבז‬
‫ רחובות‬,‫עמית מור‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,07 ‫ חדר‬10 ‫מנוחה ונחלה‬
metatarsals support portion and phalanges
support portion of said support member,
and wherein said protuberances are
attached to said support member on
opposite sides of a latitudinal midline of
said support member, said latitudinal
midline being halfway between a
calcaneus support portion and a phalanges
support portion of said support member,
wherein said protuberances provide
proprioceptive exercise to a wearer of the
footwear.
400
‫ לתקנות‬34 ‫פירוט זה נבחן בהתאם לתקנה‬
7994 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the
Patent Regulations, 5728 - 1968
__________
]22[]12[
]1/[
RESPIRATOR HEADPIECE AND
RELEASE MECHANISM
]11[
]/2[
]12[
]01[
]/2[
07.02.2000
255601
]/1[ 22.02.1999
Int. Cl.8 A62B 018/08
DIVISION FROM 138984
CABOT SAFETY INTERMEDIATE
CORPORATION, U.S.A.
WO/2000/050122
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT
]//[
]//[
[57] A quick release respirator
mechanism (2) comprising: a yoke (3)
attached to a respirator face mask (4), a
latch (7) attached to the yoke; at least one
401
281107
‫משאף ומנגנון שחרור‬
]//[
US
,,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
guide (34, 36) associated with the yoke; at
least one strap (20, 22) attached to the
latch, the at least one strap disposed within
the at least one guide.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
__________
‫פטנטים‬
‫‪PATENTS‬‬
‫פטנטים שניתנו‬
‫‪PATENTS GRANTED‬‬
‫‪2/0/6/‬‬
‫‪2//1/2‬‬
‫‪2/0211‬‬
‫‪2121//‬‬
‫‪21/1/0‬‬
‫‪2/10//‬‬
‫‪2///11‬‬
‫‪2//110‬‬
‫‪2////1‬‬
‫‪2/1/1/‬‬
‫‪2/0/1/‬‬
‫‪2//210‬‬
‫‪2/0/0/‬‬
‫‪21/260‬‬
‫‪21/0//‬‬
‫‪21///0‬‬
‫‪2//061‬‬
‫‪2/0610‬‬
‫‪2/2/1/‬‬
‫‪2/161/‬‬
‫‪202000‬‬
‫‪20//26‬‬
‫‪2/1/60‬‬
‫‪2//0/0‬‬
‫‪2/0602‬‬
‫‪2161//‬‬
‫‪21/002‬‬
‫‪2/10/1‬‬
‫‪2///1/‬‬
‫‪2//200‬‬
‫‪2///6/‬‬
‫‪2/1101‬‬
‫‪2/0//1‬‬
‫‪2///1/‬‬
‫‪2/01//‬‬
‫‪211001‬‬
‫‪21///0‬‬
‫‪210///‬‬
‫‪2///11‬‬
‫‪2//0//‬‬
‫‪2/26//‬‬
‫‪2/166/‬‬
‫‪202/1/‬‬
‫‪20/162‬‬
‫‪2/1210‬‬
‫‪2/////‬‬
‫‪2//060‬‬
‫‪21660/‬‬
‫‪26//60‬‬
‫‪2/1062‬‬
‫‪2/1000‬‬
‫‪2//61/‬‬
‫‪2//000‬‬
‫‪2/1200‬‬
‫‪2/062/‬‬
‫‪2///00‬‬
‫‪2/1026‬‬
‫‪2//011‬‬
‫‪21//11‬‬
‫‪21001/‬‬
‫‪21/100‬‬
‫‪2///02‬‬
‫‪2/602/‬‬
‫‪2/20/0‬‬
‫‪20222/‬‬
‫‪20////‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫‪2/20/6‬‬
‫‪2///11‬‬
‫‪2////2‬‬
‫‪2166/1‬‬
‫‪2111/0‬‬
‫‪2/1/0/‬‬
‫‪2/1/6/‬‬
‫‪2///1/‬‬
‫‪2//00/‬‬
‫‪2/12/2‬‬
‫‪2/1012‬‬
‫‪22//6/‬‬
‫‪2/1/60‬‬
‫‪2//0//‬‬
‫‪21/6/1‬‬
‫‪2110//‬‬
‫‪211/26‬‬
‫‪2/////‬‬
‫‪2/6///‬‬
‫‪2/2//0‬‬
‫‪202262‬‬
‫‪20///1‬‬
‫‪2/6/0/‬‬
‫‪2/////‬‬
‫‪2///60‬‬
‫‪2/0//2‬‬
‫‪2111/0‬‬
‫‪2/1//1‬‬
‫‪2/1///‬‬
‫‪2//0//‬‬
‫‪2//0/0‬‬
‫‪2/16//‬‬
‫‪2/1020‬‬
‫‪22/1/0‬‬
‫‪2/12/6‬‬
‫‪2////1‬‬
‫‪21/62/‬‬
‫‪211/00‬‬
‫‪211/1/‬‬
‫‪2//006‬‬
‫‪2/0012‬‬
‫‪2/2/06‬‬
‫‪20611/‬‬
‫‪20////‬‬
‫‪20/0//‬‬
‫‪210161‬‬
‫‪2//6/0‬‬
‫‪2//16/‬‬
‫‪2/0//2‬‬
‫‪2121/0‬‬
‫‪2/11/0‬‬
‫‪2/1///‬‬
‫‪2//0//‬‬
‫‪2//1//‬‬
‫‪2/161/‬‬
‫‪2/1100‬‬
‫‪221//1‬‬
‫‪2/1610‬‬
‫‪2//1//‬‬
‫‪21/0//‬‬
‫‪211/1/‬‬
‫‪21//60‬‬
‫‪2///11‬‬
‫‪2/0///‬‬
‫‪2/2//2‬‬
‫‪2/12/6‬‬
‫‪20/6//‬‬
‫‪2001/0‬‬
‫‪21///1‬‬
‫‪2/0010‬‬
‫‪2//102‬‬
‫‪2/0/21‬‬
‫‪212/11‬‬
‫‪21//00‬‬
‫‪2/1///‬‬
‫‪2//101‬‬
‫‪2//10/‬‬
‫‪2//02/‬‬
‫‪2/1112‬‬
‫‪///00‬‬
‫‪2//000‬‬
‫‪2//6/2‬‬
‫‪21/0/6‬‬
‫‪211201‬‬
‫‪21/262‬‬
‫‪2//0/1‬‬
‫‪2/0//0‬‬
‫‪2/2/11‬‬
‫‪2/1212‬‬
‫‪2011/1‬‬
‫‪20/1/0‬‬
‫‪221/06‬‬
‫‪2/0011‬‬
‫‪2//1//‬‬
‫‪2/0111‬‬
‫‪212101‬‬
‫‪21/11/‬‬
‫‪2/1///‬‬
‫‪2//110‬‬
‫‪2//106‬‬
‫‪2//06/‬‬
‫‪2/1///‬‬
‫‪2/01/0‬‬
‫‪2///10‬‬
‫‪2/0/22‬‬
‫‪21//02‬‬
‫‪211621‬‬
‫‪21////‬‬
‫‪2//0/6‬‬
‫‪2/01//‬‬
‫‪2/2/0/‬‬
‫‪2/160/‬‬
‫‪202/16‬‬
‫‪20//22‬‬
‫‪403‬‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪/0610‬‬
‫‪/0210‬‬
‫‪/0101‬‬
‫‪0/6/0‬‬
‫‪26//01‬‬
‫‪26/106‬‬
‫‪26/00/‬‬
‫‪26////‬‬
‫‪261///‬‬
‫‪22110/‬‬
‫‪2200/6‬‬
‫‪2166//‬‬
‫‪216260‬‬
‫‪216210‬‬
‫‪216161‬‬
‫‪2161/6‬‬
‫‪21//00‬‬
‫‪21/011‬‬
‫‪2112/2‬‬
‫‪211/06‬‬
‫‪211//0‬‬
‫‪211//0‬‬
‫‪2111//‬‬
‫‪2110/1‬‬
‫‪211///‬‬
‫‪211//0‬‬
‫‪2102//‬‬
‫‪21//1/‬‬
‫‪2/20/6‬‬
‫‪2//1//‬‬
‫‪2/1610‬‬
‫‪2/1001‬‬
‫‪2//0//‬‬
‫‪2///11‬‬
‫‪2/0610‬‬
‫‪2/6061‬‬
‫‪2/600/‬‬
‫‪2/210/‬‬
‫‪2/2/21‬‬
‫‪2/2//2‬‬
‫‪2/111/‬‬
‫‪2/1///‬‬
‫‪2//1//‬‬
‫‪404‬‬
‫‪/0610‬‬
‫‪/021/‬‬
‫‪/01//‬‬
‫‪/0/2/‬‬
‫‪26//11‬‬
‫‪26/1/1‬‬
‫‪26/011‬‬
‫‪26//10‬‬
‫‪261//0‬‬
‫‪22122/‬‬
‫‪2200/2‬‬
‫‪2166/0‬‬
‫‪21626/‬‬
‫‪216216‬‬
‫‪216201‬‬
‫‪2161//‬‬
‫‪211///‬‬
‫‪21/0//‬‬
‫‪2112/6‬‬
‫‪211/22‬‬
‫‪211/1/‬‬
‫‪211///‬‬
‫‪2111/1‬‬
‫‪2110/2‬‬
‫‪211//1‬‬
‫‪211///‬‬
‫‪21022/‬‬
‫‪21//00‬‬
‫‪2/2601‬‬
‫‪2//21/‬‬
‫‪2//1/1‬‬
‫‪2/1/10‬‬
‫‪2//06/‬‬
‫‪2///6/‬‬
‫‪2//016‬‬
‫‪2/6100‬‬
‫‪2/6006‬‬
‫‪2/2112‬‬
‫‪2/2/0/‬‬
‫‪2/2/10‬‬
‫‪2/1212‬‬
‫‪2/1///‬‬
‫‪2//106‬‬
‫‪/061/‬‬
‫‪/0212‬‬
‫‪/0116‬‬
‫‪/0//0‬‬
‫‪26//16‬‬
‫‪26/1/0‬‬
‫‪26/0//‬‬
‫‪26//2/‬‬
‫‪26//01‬‬
‫‪22/1/1‬‬
‫‪220010‬‬
‫‪2166//‬‬
‫‪216601‬‬
‫‪21622/‬‬
‫‪2162//‬‬
‫‪2161/0‬‬
‫‪2120//‬‬
‫‪21/0/0‬‬
‫‪211210‬‬
‫‪2111/0‬‬
‫‪211/20‬‬
‫‪211///‬‬
‫‪2111//‬‬
‫‪211021‬‬
‫‪211///‬‬
‫‪211/02‬‬
‫‪21100/‬‬
‫‪21/1//‬‬
‫‪2/600/‬‬
‫‪2/1/00‬‬
‫‪2///0/‬‬
‫‪2/100/‬‬
‫‪2//100‬‬
‫‪2//2/1‬‬
‫‪2//0//‬‬
‫‪2/616/‬‬
‫‪2/60//‬‬
‫‪2/21//‬‬
‫‪2/2///‬‬
‫‪2/210/‬‬
‫‪2/1610‬‬
‫‪2/1///‬‬
‫‪2//1/0‬‬
‫‪/0621‬‬
‫‪/0216‬‬
‫‪/0160‬‬
‫‪/0///‬‬
‫‪26//21‬‬
‫‪26/160‬‬
‫‪26/06/‬‬
‫‪26//2/‬‬
‫‪26//11‬‬
‫‪221/06‬‬
‫‪220022‬‬
‫‪216611‬‬
‫‪216606‬‬
‫‪216221‬‬
‫‪2162/0‬‬
‫‪21611/‬‬
‫‪212016‬‬
‫‪21//01‬‬
‫‪2112/0‬‬
‫‪2111/1‬‬
‫‪211/61‬‬
‫‪211/1/‬‬
‫‪21112/‬‬
‫‪211100‬‬
‫‪211/11‬‬
‫‪211/06‬‬
‫‪211/00‬‬
‫‪21/11/‬‬
‫‪2/61//‬‬
‫‪2/1/60‬‬
‫‪2///1/‬‬
‫‪2/1001‬‬
‫‪2///60‬‬
‫‪2//61/‬‬
‫‪2//021‬‬
‫‪2/6//0‬‬
‫‪2/6020‬‬
‫‪2/21/6‬‬
‫‪2/2/2/‬‬
‫‪2/2100‬‬
‫‪2/20/0‬‬
‫‪2/10/1‬‬
‫‪2//1//‬‬
‫‪/066/‬‬
‫‪/0220‬‬
‫‪/02/0‬‬
‫‪/0//1‬‬
‫‪26/160‬‬
‫‪26////‬‬
‫‪26/101‬‬
‫‪26/000‬‬
‫‪26//06‬‬
‫‪2600//‬‬
‫‪220/12‬‬
‫‪216626‬‬
‫‪2166/2‬‬
‫‪21622/‬‬
‫‪2162//‬‬
‫‪216116‬‬
‫‪212/0/‬‬
‫‪21//6/‬‬
‫‪2112/0‬‬
‫‪2111//‬‬
‫‪211/01‬‬
‫‪211//1‬‬
‫‪211//0‬‬
‫‪2111//‬‬
‫‪21100/‬‬
‫‪211/1/‬‬
‫‪211//0‬‬
‫‪21/220‬‬
‫‪2/6/10‬‬
‫‪2/106/‬‬
‫‪2//111‬‬
‫‪2/11//‬‬
‫‪2//6/2‬‬
‫‪2//0/1‬‬
‫‪2///21‬‬
‫‪2/610/‬‬
‫‪2/602/‬‬
‫‪2/21//‬‬
‫‪2/2/6/‬‬
‫‪2/21//‬‬
‫‪2/20/0‬‬
‫‪2/116/‬‬
‫‪2//2/1‬‬
‫‪//000‬‬
‫‪/022/‬‬
‫‪/020/‬‬
‫‪/0/1/‬‬
‫‪26/61/‬‬
‫‪26//01‬‬
‫‪26/1//‬‬
‫‪26/0//‬‬
‫‪26////‬‬
‫‪26/01/‬‬
‫‪220/10‬‬
‫‪21666/‬‬
‫‪21660/‬‬
‫‪21622/‬‬
‫‪216200‬‬
‫‪216121‬‬
‫‪212//0‬‬
‫‪21//1/‬‬
‫‪2116/2‬‬
‫‪2111//‬‬
‫‪211//2‬‬
‫‪211///‬‬
‫‪211//6‬‬
‫‪2111/0‬‬
‫‪21100/‬‬
‫‪211/1/‬‬
‫‪211/00‬‬
‫‪21/001‬‬
‫‪2/616/‬‬
‫‪2/1212‬‬
‫‪2///1/‬‬
‫‪2/1///‬‬
‫‪2/0/2/‬‬
‫‪2//011‬‬
‫‪2//00/‬‬
‫‪2/666/‬‬
‫‪2/6//1‬‬
‫‪2/2210‬‬
‫‪2/210/‬‬
‫‪2/2/0/‬‬
‫‪2/206/‬‬
‫‪2/1//1‬‬
‫‪2/1001‬‬
‫‪///0/‬‬
‫‪/026/‬‬
‫‪/0200‬‬
‫‪/0/2/‬‬
‫‪26/0/0‬‬
‫‪26///2‬‬
‫‪26/1/1‬‬
‫‪26/0/1‬‬
‫‪26///2‬‬
‫‪26/102‬‬
‫‪22////‬‬
‫‪216660‬‬
‫‪21661/‬‬
‫‪216226‬‬
‫‪2162/1‬‬
‫‪21616/‬‬
‫‪212///‬‬
‫‪21////‬‬
‫‪2116/1‬‬
‫‪21111/‬‬
‫‪211/00‬‬
‫‪211//1‬‬
‫‪211///‬‬
‫‪2111/1‬‬
‫‪2110/0‬‬
‫‪211/10‬‬
‫‪211//1‬‬
‫‪21/02/‬‬
‫‪21006/‬‬
‫‪2/1210‬‬
‫‪2///00‬‬
‫‪2/12/6‬‬
‫‪2/0//0‬‬
‫‪2///11‬‬
‫‪2//0//‬‬
‫‪2/0/01‬‬
‫‪2/6/61‬‬
‫‪2/22/0‬‬
‫‪2/2106‬‬
‫‪2/2/1/‬‬
‫‪2/2/01‬‬
‫‪2/1//1‬‬
‫‪2/1/01‬‬
‫‪////2‬‬
‫‪/06//‬‬
‫‪/02/1‬‬
‫‪/01/0‬‬
‫‪261010‬‬
‫‪26//10‬‬
‫‪26/1/1‬‬
‫‪26/0/6‬‬
‫‪26////‬‬
‫‪260001‬‬
‫‪22//1/‬‬
‫‪2200/1‬‬
‫‪216616‬‬
‫‪216260‬‬
‫‪2162//‬‬
‫‪21616/‬‬
‫‪212//1‬‬
‫‪21/20/‬‬
‫‪21/0//‬‬
‫‪2112//‬‬
‫‪211/0/‬‬
‫‪211//6‬‬
‫‪211///‬‬
‫‪2111//‬‬
‫‪2110/1‬‬
‫‪211/1/‬‬
‫‪211//2‬‬
‫‪21/262‬‬
‫‪21///1‬‬
‫‪2/2/01‬‬
‫‪2///16‬‬
‫‪2/1201‬‬
‫‪2/0211‬‬
‫‪2//011‬‬
‫‪2//1//‬‬
‫‪2/0/6/‬‬
‫‪2/6///‬‬
‫‪2/2661‬‬
‫‪2/21//‬‬
‫‪2/2/20‬‬
‫‪2/2/06‬‬
‫‪2/11/0‬‬
‫‪2/1/11‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫‪2//0//‬‬
‫‪2//216‬‬
‫‪2//0/0‬‬
‫‪2//02/‬‬
‫‪2/1200‬‬
‫‪2/1///‬‬
‫‪2/06/0‬‬
‫‪2/0/16‬‬
‫‪2//226‬‬
‫‪2//16/‬‬
‫‪2/0102‬‬
‫‪2166/0‬‬
‫‪21610/‬‬
‫‪2160//‬‬
‫‪216/0/‬‬
‫‪21260/‬‬
‫‪212101‬‬
‫‪211//6‬‬
‫‪21/0//‬‬
‫‪211610‬‬
‫‪21/110‬‬
‫‪21/2/1‬‬
‫‪206110‬‬
‫‪20/20/‬‬
‫‪2//101‬‬
‫‪2//6/1‬‬
‫‪2//1//‬‬
‫‪2///12‬‬
‫‪2/16//‬‬
‫‪2/1/16‬‬
‫‪2/06/0‬‬
‫‪2/01/0‬‬
‫‪2//6/0‬‬
‫‪2//1/2‬‬
‫‪2/0602‬‬
‫‪2/001/‬‬
‫‪216116‬‬
‫‪216011‬‬
‫‪216///‬‬
‫‪212621‬‬
‫‪2121/1‬‬
‫‪2111/0‬‬
‫‪21////‬‬
‫‪211621‬‬
‫‪21001/‬‬
‫‪21/2//‬‬
‫‪21001/‬‬
‫‪20////‬‬
‫‪2//1//‬‬
‫‪2//61/‬‬
‫‪2//11/‬‬
‫‪2///2/‬‬
‫‪2/16/2‬‬
‫‪2/1/20‬‬
‫‪2/0662‬‬
‫‪2/0116‬‬
‫‪2/000/‬‬
‫‪2//221‬‬
‫‪2//060‬‬
‫‪2/002/‬‬
‫‪2161//‬‬
‫‪21601/‬‬
‫‪216//6‬‬
‫‪212660‬‬
‫‪2121/0‬‬
‫‪2112/2‬‬
‫‪21/0/2‬‬
‫‪21///0‬‬
‫‪211/00‬‬
‫‪21/6/2‬‬
‫‪210110‬‬
‫‪2011/1‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫‪2//1//‬‬
‫‪2/////‬‬
‫‪2////1‬‬
‫‪2///06‬‬
‫‪2/16//‬‬
‫‪2/1/20‬‬
‫‪2/106/‬‬
‫‪2/012/‬‬
‫‪2/0002‬‬
‫‪2///1/‬‬
‫‪2////2‬‬
‫‪2/0//2‬‬
‫‪2161//‬‬
‫‪216022‬‬
‫‪216/12‬‬
‫‪2160//‬‬
‫‪2121//‬‬
‫‪21161/‬‬
‫‪21//1/‬‬
‫‪21/0/1‬‬
‫‪211//1‬‬
‫‪21/6//‬‬
‫‪2106//‬‬
‫‪202000‬‬
‫‪2//110‬‬
‫‪2////1‬‬
‫‪2///01‬‬
‫‪2////1‬‬
‫‪2/161/‬‬
‫‪2/1/60‬‬
‫‪2/1/60‬‬
‫‪2/0161‬‬
‫‪2/0010‬‬
‫‪2//016‬‬
‫‪2///20‬‬
‫‪2/0/21‬‬
‫‪2162//‬‬
‫‪216/00‬‬
‫‪216/11‬‬
‫‪216016‬‬
‫‪212116‬‬
‫‪212///‬‬
‫‪21/10/‬‬
‫‪21//11‬‬
‫‪211/10‬‬
‫‪21/0/0‬‬
‫‪21//1/‬‬
‫‪202262‬‬
‫‪2/6116‬‬
‫‪2///01‬‬
‫‪2///01‬‬
‫‪2//10/‬‬
‫‪2//010‬‬
‫‪2//000‬‬
‫‪2/1101‬‬
‫‪2/1100‬‬
‫‪2/0/1/‬‬
‫‪2/0011‬‬
‫‪2//12/‬‬
‫‪2///60‬‬
‫‪2/0001‬‬
‫‪21621/‬‬
‫‪216//1‬‬
‫‪216/2/‬‬
‫‪2160/0‬‬
‫‪212212‬‬
‫‪212/0/‬‬
‫‪21/160‬‬
‫‪21////‬‬
‫‪211/1/‬‬
‫‪21//0/‬‬
‫‪21////‬‬
‫‪206//6‬‬
‫‪2001/0‬‬
‫‪2////1‬‬
‫‪2///1/‬‬
‫‪2//102‬‬
‫‪2//0/0‬‬
‫‪2//012‬‬
‫‪2/11/1‬‬
‫‪2/11//‬‬
‫‪2/0//1‬‬
‫‪2/0/11‬‬
‫‪2/////‬‬
‫‪2//00/‬‬
‫‪2/00/1‬‬
‫‪216600‬‬
‫‪216/1/‬‬
‫‪216/2/‬‬
‫‪216//0‬‬
‫‪21226/‬‬
‫‪212/02‬‬
‫‪21/61/‬‬
‫‪21/161‬‬
‫‪21120/‬‬
‫‪21//6/‬‬
‫‪21/2//‬‬
‫‪20601/‬‬
‫‪20//22‬‬
‫‪2///0/‬‬
‫‪2///1/‬‬
‫‪2//20/‬‬
‫‪2//0/2‬‬
‫‪2//0//‬‬
‫‪2/1101‬‬
‫‪2/1112‬‬
‫‪2/0/1/‬‬
‫‪2/0/1/‬‬
‫‪2//11/‬‬
‫‪2//1//‬‬
‫‪2/0/62‬‬
‫‪2166/1‬‬
‫‪216/10‬‬
‫‪216/6/‬‬
‫‪216/2/‬‬
‫‪21260/‬‬
‫‪212/6/‬‬
‫‪211//2‬‬
‫‪21/6/1‬‬
‫‪211201‬‬
‫‪21///0‬‬
‫‪21/2//‬‬
‫‪20611/‬‬
‫‪20//26‬‬
‫‪405‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
/0/02
//662
//2/0
262///
261/2/
2611/6
261060
22//1/
22///0
22/01/
2110/2
211/01
21/26/
2/0/61
2/010/
212//1
/006/
//621
//210
262///
261//2
2611//
261026
22//01
22///0
22/011
211/11
211/00
21/212
2/0012
2/20/0
212///
/001/
//611
//200
261//0
261///
2611/2
261010
22//0/
22//11
22/01/
211/1/
21106/
21//6/
2//1/1
2/10/1
211012
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
/00/0
//601
//20/
261/12
261///
261100
2610/6
22//60
22//0/
22/00/
211/10
211060
21//0/
2///6/
2//0/6
2010/1
/0012
//60/
//2//
261/1/
261//0
2611/2
2610/0
22//21
22////
22/0/1
211/02
21101/
21/611
2///00
2/1100
/001/
//260
//2//
261/10
261//1
2611//
26101/
22//2/
22//0/
211/0/
211/21
2110/0
2///1/
2//162
2//200
/00/1
//22/
//1/0
261//6
261///
2611/1
26100/
22//11
22/061
211012
211//0
2110//
2//002
2//1/6
2//6/1
/0000
//220
262//1
261/66
26112/
261061
22//1/
22////
22/011
211011
211/00
2110/0
2/1110
2//1/0
2//21/
406
‫פטנטים שחודשו לעשרים שנה‬
‫‪PATENTS RENEWED FOR 20 YEARS‬‬
‫‪211/1/‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫‪21216/‬‬
‫‪2//1//‬‬
‫‪2//61/‬‬
‫‪22/010‬‬
‫‪00/00‬‬
‫‪407‬‬
‫פטנטים שפג תוקפם‬
‫‪PATENTS EXPIRED‬‬
‫‪/2160‬‬
‫‪/2/2/‬‬
‫‪/2/20‬‬
‫‪408‬‬
‫‪/2166‬‬
‫‪/2/21‬‬
‫‪/2/20‬‬
‫‪/22//‬‬
‫‪/2101‬‬
‫‪/2/0/‬‬
‫‪/22/1‬‬
‫‪/2106‬‬
‫‪/2//0‬‬
‫‪/221/‬‬
‫‪/21/6‬‬
‫‪/2//1‬‬
‫‪/2226‬‬
‫‪/2101‬‬
‫‪/2/1/‬‬
‫‪///00‬‬
‫‪/21//‬‬
‫‪/2/10‬‬
‫‪//1//‬‬
‫‪/2111‬‬
‫‪/2/21‬‬
‫‪0/1//‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
1697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
222///
/2200/
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
QUALCOMM INCORPORATED
Title of invention:
:‫שם האמצאה‬
‫ בין מגזרים בעלי בסיס משותף‬FFOKNAH ‫שיטה ומכשיר לביצוע‬
METHOD AND APPARATUS FOR PERFORMINGHANDOFF BETWEEN SECTORS
OF A COMMONBASE STATION
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬91 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1690
409
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
1697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
21/6/0
2121662
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
MEDSTENT INC.
:‫שם האמצאה‬
Title of invention:
‫סטנט הניתן להרחבה‬
EXPANDIBLE STENT
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫כל אדם רשאי להתנגד‬
‫לבקשה האמורה תוך‬
‫שלושה חודשים מתאריך‬
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
60 ‫ לחוק ובתקנה‬91 ‫בסעיף‬
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
1690
410
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
1697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
210600
262166/
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
NETBOT, INC.
Title of invention:
:‫שם האמצאה‬
‫שיטה ומערכת לגישה למידע ברשת‬
METHOD AND SYSTEM FOR NETWORK INFORMATION ACCESS
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬91 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1690
411
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
1697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
2/201/
/21662
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫ישראל אלון‬
ISRAEL ALON
:‫שם האמצאה‬
‫מנעול ומפתח על בסיס צבע‬
COLOR BASED LOCK AND KEY
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬91 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1690
Title of invention:
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
412
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
1697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
2/601/
212166/
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
HYDRODYNE R&D INC.
Title of invention:
:‫שם האמצאה‬
‫עיבוד מזון באמצעות גל הלם רציף עם החזר של גל הלם ומכשיר לכך‬
CONTINUOUS SHOCK WAVE FOOD PROCESSING WITH SHOCK WAVE
REFLECTION AND APPARATUS THEREFOR
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬91 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1690
413
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
221/22
222000
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
1697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.1690
414
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
415
22000/
122000
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
1697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.1690
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
2/1/2/
121661
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
1697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.1690
416
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי שם הבעלים‬
CHANGE OF NAME OF PROPRIETORS
No. of Patent:
Previous name:
:‫מס' פטנט‬
:‫השם הקודם‬
226//0
STRYKER TECHNOLOGIES CORPORATION
:‫השם החדש‬
New name:
HOWMEDICA OSTEONICS CORP.
‫שינוי בעלות‬
CHANGES IN PROPRIETORSHIP
No. of Patent:
Previous Proprietors:
226//0
HOWMEDICA INC.
New Proprietors:
HOWMEDICA OSTEONICS CORP.
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
:‫הבעלים החדשים‬
No. of Patent:
2211/6
Previous Proprietors:
INSTITUT STRAUMANN AG
New Proprietors:
STRAUMANN HOLDING AG
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
No. of Patent:
21//00
Previous Proprietors:
INSTITUT STRAUMANN AG
New Proprietors:
STRAUMANN HOLDING AG
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
417
:‫הבעלים החדשים‬
:‫הבעלים החדשים‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫תיקון טעות‬
Corrigendum
Journal 6121660 ‫יומן‬
P. 2010 Patent Application No. 144622
Correct name of applicant to –
1626 '‫ע‬
'‫בקשת פטנט מס‬
-‫תקן שם המבקשת ל‬
SOLVAY PHARMACEUTICALS GMBH
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
418
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
MX
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
MY
Malaysia
419
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
420
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
38989
23(02)
25.2.2004
‫סוג‬
‫חנוך ורונה‬
HANOCH VERONA
‫שרותים ניידים‬
Portable toilet
Class
39650
25(01)
6.9.2004
‫סוג‬
‫המדביק – ציפוי לבידים בפורניר‬
‫בע"מ‬
HAMADBIK IMPORT,
MARKETING & ADHESION
VENEERS LTD.
‫פרופיל‬
Profile
Class
39661
6(01)
8.9.2004
‫סוג‬
‫שני חי עיצובים בע"מ‬
SHANI HAY DESIGN LTD.
‫כורסה‬
Lounge
Class
39683
6(06)
20.9.2004
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫רגליים של ספה‬
Feet for couch
Class
KOL CHEN LTD. AND HAIM
AZOULAY
Profile
421
39687
25(01)
21.9.2004
‫סוג‬
‫כל חן בע"מ וחיים אזולאי‬
‫פרופיל‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
Class
39692, 39693, 39694,
39698, 39701, 39702,
39703, 39709
6(06)
21.9.2004
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫רגליים של ספה‬
Feet for couch
Class
39695, 39696, 39699,
39700
6(06)
21.9.2004
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫מסעד לספה‬
Support for couch
Class
39697
6(06)
21.9.2004
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫קושרת לספה‬
Link for couch
Class
39716
6(06)
21.9.2004
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
39725
6(06)
26.9.2004
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
Feet for couch
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫כפתור הפעלה למנגנון הרמה‬
)‫תאריך אמנה (ארצות הברית‬
Actuation button for a lifting
mechanism
Class
‫סוג‬
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫רגליים של ספה‬
422
Class
39850
25(01)
9.11.2004
‫סוג‬
‫יחזקאל טוינה‬
YEHESKEL TWINA
‫פרופיל‬
Profile
Class
40007
26(02)
16. 2.2003
‫סוג‬
MAG INSTRUMENT, INC
)‫תאריך אמנה (ארצות הברית‬
‫פנס‬
Flashlight
Class
40263
25(01)
7. 2.2005
‫סוג‬
‫כל חן בע"מ וחיים אזולאי וחיים‬
‫אזולאי‬
KOL CHEN LTD AND HAIM
AZOULAY
‫פרופיל‬
Profile
Class
40368
22(02)
24. 2.2005
AMNON SHILONI AND AMNON
MAOR
‫סוג‬
‫אמנון שילוני ואמנון מאור‬
‫אלה‬
Baton
Class
40391
7(02)
2.3.2005
‫סוג‬
‫שולי פרינטי‬
SHULI PARIENTI
‫סיר‬
Pot
Class
40406
22(02)
7.3.2005
AMNON SHILONI AND AMNON
MAOR
Brass knuckles
423
‫סוג‬
‫אמנון שילוני ואמנון מאור‬
‫אגרופן‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
40422
6(13)
8.3.2005
Class
‫סוג‬
‫אריגי עמר בע"מ‬-‫מנהטן‬
MANATTEN-ARIGE AMAR LTD.
‫מגבת‬
Towel
40502, 40503
8(06)
28. 3.2005
Class
‫סוג‬
UNION KNOPF GMBH
)‫תאריך אמנה (ארצות הברית‬
‫ידית‬
Handle
Class
40586, 40587
11(01)
10. 4.2005
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
)‫תכשיטאמנה (ארצות הברית‬
‫תאריך‬
Jewel
Class
40681, 40682, 40683,
40684, 40685
8(05)
19.4.2005
‫סוג‬
)‫שלמה (אזולאי‬-‫חנן בר‬
HANAN BAR-SHLOMO
(AZOULAY)
‫כלי עבודה‬
Work tool
Class
40688, 40689
7(01)
19.4.2005
‫סוג‬
VILLEROY & BOCH AG
Tableware set
Convention date (OHIM)
Class
27.10.2004
40770
10(07)
17.5.2005
‫מערכת כלי שולחן‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
MOVADO WATCH COMPANY S.A.
Watchcase
Convention date (U.S.A.)
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
19.11.2004
‫קופסת שעון‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
424
Class
40818
9(01)
30.5.2005
‫סוג‬
PARFUMS CHRISTIAN DIOR
‫בקבוקון לבושם‬
)‫(צרפת)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Flask for perfume
Convention date (France)
Class
2.12.2004
41274
24(02)
28.8.2005
‫סוג‬
FRESENIUS MEDICAL HOLDINGS, INC.
Peritoneal dialysis cycler
Convention date (U.S.A.)
Class
‫מחולל דיאליזה ציפקית‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫ריך אמנה‬
‫תאריך‬
‫תא‬
28.2.2005
41433
6(09)
2.10.2005
‫סוג‬
‫מיכל פירסט‬
MICHAL FIRST
‫כרית רחצה‬
Washing pad
Class
41480, 41482, 41483,
41484, 41485
6(06)
9.10.2005
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫מסעד גב לספה‬
Back support for couch
Class
41487, 41488, 41492,
41493
6(06)
9.10.2005
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
Support for couch
425
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫מסעד לספה‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
Class
41499, 41500
6(06)
9.10.2005
WIEDER THE EXPERTS ON BEDS
AND MATTRESSES LTD.
‫סוג‬
‫וידר המומחים למיטות ומזרונים‬
‫בע"מ‬
‫ארגז מצעים לספה‬
Linen box for a couch
Class
41564
9(07)
10.6.2003
‫סוג‬
‫ששון‬-‫עמית בן‬
AMIT BEN-SASSON
‫פקק למערכת שתיה‬
Stopper for drinking system
Class
41578
9(03)
6.11.2005
‫סוג‬
‫רול הדפסות בע"מ‬
ROL PRINT LTD.
‫מארז קלפים‬
Card package
Class
41688
20(01)
5.12.2005
‫סוג‬
COFFEE NATION LIMITED
Coffee vending machine
Convention date (OHIM)
‫מכונה לממכר קפה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
6.6.2005
Class
41729
11(01)
15.12.2005
‫סוג‬
K.P. SANGHVI & SONS
Diamond
Convention date (U.S.A.)
Class
24.6.2005
41824
28(03)
3.1.2006
‫יהלום‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
CALOR
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
426
Hair clipper
11.7.2005
Convention date (France)
42082
9(03)
26.2.2006
Class
‫מכונת תספורת‬
)‫(צרפת)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫עין גדי קוסמטיקס בע"מ‬
EIN GEDI COSMETICS LTD.
‫אריזה‬
Package
42207
25(01)
Class
‫סוג‬
21.3.2009
‫אקרשטיין תעשיות בע"מ‬
ACKERSTEIN INDUSTRIES LTD.
‫אריח לריצוף‬
Paving stone
42008, 43003
21 (01)
21. 3.2006
Class
‫סוג‬
SMART BABY TOYS
)‫אמנה (ארצות הברית‬
‫תאריךאופן‬
‫תלת‬
Tricycle
Class
42262
11(02)
3.4.2006
‫סוג‬
‫יצחק ברדע ועמוס ברדע‬
IZHAK BARDEA AND AMOS
BARDEA
‫טלית‬
Tallit
Class
42354
6(01)
23.4.2006
‫סוג‬
‫אריכא ובנין בע"מ‬.‫שחם י‬
SHAHAM Y. ARICHA AND SONS
LTD.
‫ספסל‬
Bench
Class
42358
23(01)
23.4.2006
TANA INDUSTRIES (1991) LTD.
Filter
427
‫סוג‬
‫) בע"מ‬1661( ‫חברת תנה תעשיות‬
‫מסנן‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
Class
42429
11(01)
4.5.2006
‫סוג‬
‫) שותפות‬166.( ‫גולד אנד האני‬
‫מוגבלת‬
GOLD & HONEY (1995) L.P.
‫ציר לעגיל‬
Joint for bar earing
Class
42544
15(09)
4.6.2006
‫סוג‬
‫ מפעלי מתכת בע"מ‬.‫א‬.‫ב‬.‫ש‬
S.B.A. METAL WORKS LTD.
‫כלי עבודה‬
Tool
Class
42547
20(01)
5.6.2006
‫סוג‬
SOCIETE DES PRODUITS NESTLE S.A.
Vending machine for drinks
Convention date (Switzerland)
8.3.2006
Class
42627
9(03)
19.6.2006
‫מכונה אוטומטית לממכר משקאות‬
)‫(שוויץ)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫) בע"מ‬166/( ‫ווק‬-‫פלסטו‬
PLASTO-VACK (1990) LTD.
‫מיכל‬
Container
Class
42629
25(01)
20.4.2004
‫סוג‬
‫איטונג בע"מ‬
YTONG LTD.
‫אבן ריצוף‬
Paving stone
Class
42639
11 (01)
22. 6.2006
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
428
)‫תכשיטאמנה (ארצות הברית‬
‫תאריך‬
Jewel
Class
42643, 42644, 42645
12(16)
22.6.2006
‫סוג‬
‫ אביזרי רכב בע"מ‬.‫ק‬.‫ט‬
T.C. AVISAREI RECHEV B.M.
‫משענת יד לרכב‬
Arm rest for car
42647
9(07)
25.6.2006
Class
‫סוג‬
‫מנטין פלסטיק בע"מ‬
MANTIN PLASTICS LTD.
‫פקק למיכל‬
Cap for container
42674
8(07)
4.7.2006
Class
‫סוג‬
‫פלמט רילאיינס בע"מ‬
PALMAT RELIANCE LTD.
‫קפיץ לסגר‬
Spring lock
Class
42693, 42694
11(01)
5.7.2006
‫סוג‬
‫פז חן תעשיות בע"מ‬
PAZ CHEN INDUSTRIES LTD.
‫כבל זהב‬
Gold cable
Class
42746
25(03)
17.7.2006
AVIV ZAGURI ADVERTISEMENT
LTD.
‫סוג‬
‫אביב זגורי פרסומאים בע"מ‬
‫תחנת אוטובוס מודולרית‬
Modular bus stop
Class
42794
8 (06)
23. 7.2006
‫סוג‬
SMILDO S.L.
Handle
429
‫ידית‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
42796, 42798
11 (01)
23. 7.2006
Class
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
42819, 42820, 42821,
42822
10(07)
27.7.2006
‫סוג‬
ZENITH INTERNATIONAL SA
Watch dial
Convention date (WIPO)
Class
13.2.2006
42912, 42913
25(01)
16.8.2006
‫לוח שעון‬
)‫(ארצות הברית‬
)‫האמנה (ויפו‬
‫תאריך אמנה‬
‫סוג‬
‫כל חן בע"מ וחיים אזולאי‬
KOL CHEN LTD AND HAIM
AZOULAY
‫פרופיל‬
Profile
Class
42954
25(01)
29.8.2006
‫סוג‬
‫קליל תעשיות בע"מ‬
KLIL INDUSTRIES LTD.
‫פרופיל‬
Profile
Class
43023
23(02)
6.9.2006
‫סוג‬
‫ יציקות בע"מ‬.‫מ‬.‫א‬.‫ר‬
R.A.M. CASTING LTD.
‫סבוניה‬
Soap tray
Class
43025
13(02)
6.9.2006
‫סוג‬
EVEREADY BATTERY COMPANY, INC.
Direct current power supply
Convention date (U.S.A.)
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
21.3.2006
‫ספק כוח לזרם ישר‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
430
Class
43041, 43043, 43048,
43049, 43051
11 (01)
10. 9.2006
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
43053, 43055, 43056,
43057, 43058
10(07)
11.9.2006
‫סוג‬
ZENITH INTERNATIONAL SA
‫לוח שעון‬
)‫(ארצות הברית‬
)‫האמנה (ויפו‬
‫תאריך אמנה‬
Watch dial
29.3.2006
Convention date (WIPO)
43087
23(04)
21.9.2006
Class
‫סוג‬
SARA LEE HOUSEHOLD AND BODY CARE NEDERLAND B.V.
‫מתקן לטיהור אוויר‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Air deodorizing apparatus
10.7.2006
Convention date (OHIM)
Class
43142, 43143, 43144
2(04)
27.9.2006
‫סוג‬
‫) בע"מ‬1664( ‫חברת אנטילופ‬
ANTELOPE YETZUR )200/(
‫סוליה‬
Sole
Class
MARK DONDE AND MICHA
YEMINI
Bicycle trailer
431
43179
12(11)
5.10.2006
‫סוג‬
‫מרק דונדה ומיכה ימיני‬
‫עגלה לאופניים‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
Class
43201, 43202
11 (01)
15. 10.2006
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
43204
26(05)
17.10.2006
DEL'ARTE AND ERAN LUTTVAK
‫סוג‬
‫דל ארטה וערן לוטבק‬
‫מנורה‬
Lamp
Class
43205
2 (04)
17.10.2006
TRAK SHOES INDUTRIES LTD.
Sole
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
‫סוג‬
‫טראק תעשיות נעליים בע"מ‬
‫סולייה‬
432
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪/1/1/‬‬
‫‪/022/‬‬
‫‪/016/‬‬
‫‪/0//1‬‬
‫‪//006‬‬
‫‪1//20‬‬
‫‪/06//‬‬
‫‪/020/‬‬
‫‪/0///‬‬
‫‪///16‬‬
‫‪1/0/0‬‬
‫‪/06/0‬‬
‫‪/02//‬‬
‫‪/01//‬‬
‫‪//1/0‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
‫‪1/0//‬‬
‫‪/06/1‬‬
‫‪/02/1‬‬
‫‪/0112‬‬
‫‪//0/0‬‬
‫‪1/102‬‬
‫‪/06//‬‬
‫‪/0212‬‬
‫‪/012/‬‬
‫‪/0/10‬‬
‫‪1/110‬‬
‫‪/10/0‬‬
‫‪/02/6‬‬
‫‪/012/‬‬
‫‪/0//0‬‬
‫‪1//10‬‬
‫‪/10//‬‬
‫‪/0210‬‬
‫‪/012/‬‬
‫‪/0///‬‬
‫‪1//1/‬‬
‫‪/11//‬‬
‫‪/0220‬‬
‫‪/0126‬‬
‫‪/0///‬‬
‫‪433‬‬
‫מדגמים שבוטלו‬
DESIGNS VOID
2////
2/0//
20661
10161
10111
/1/6/
/1/1/
/1//6
/1/1/
/1//1
/1/61
/1/2/
2/0//
2/006
20660
1016/
1011/
/1/26
/1/10
/1//0
///10
/1///
/1/60
/1/2/
2/010
2/00/
2062/
10126
1011/
/1/22
/1//6
/1/16
///06
/1//1
/1/6/
/1/21
2/002
2/00/
20621
10120
10110
/1/21
/1//2
/1/12
/////
/1//0
/1/6/
/1/20
2/0/1
20666
10/0/
1012/
101/2
/1/2/
/1///
/1/11
/////
/1///
/1/60
/1/2/
2/0//
20662
10//2
1012/
101//
/1/1/
/1//1
/1/11
/1//0
/1///
/1/26
/1/20
2/0/1
20661
10/00
10120
/1/61
/1/10
/1//0
/1/10
/1//6
/1/06
/1/22
/1/16
2/0/0
2066/
10162
10116
/1/60
/1/1/
/1//0
/1/1/
/1//2
/1/00
/1/21
/1/1/
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
434
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫‪ P.T.T.‬בע"מ ‪1.//.0‬‬
‫מתיתהו נוף ‪11/:97‬‬
‫אבי אלבז ‪199671‬‬
‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות‬
‫למחקר ופיתוח ‪147060‬‬
‫אופטיבייס בע"מ ‪1::09/‬‬
‫ניבה שפירא ‪100.41‬‬
‫נייס מערכות בע"מ ‪149:.0‬‬
‫דן ממטירים‪ ,‬אביזרי השקעה לחקלאות נוי‬
‫‪14::16‬‬
‫דניאל ברטל בע"מ ‪141016‬‬
‫סנדו פיטרו ‪11/:97‬‬
‫עמית בן ששון ‪1.4444‬‬
‫עמית מור ‪199671‬‬
‫פאור פייפר בע"מ ‪14.6/.‬‬
‫הנרי מ‪ .‬ישראל ‪1./110‬‬
‫ויסוניק בע"מ ‪1.007/‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪,10:01.‬‬
‫‪1.011/‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪10:./6‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪1./900‬‬
‫קולבר לייף סאיינס בע"מ ‪11/:97‬‬
‫קורנית דיגיטל בע"מ ‪1900:1‬‬
‫רפא"ל רשות לפיתוח אמצעי לחימה‬
‫בע"מ ‪1466:4 ,104969‬‬
‫רפא"ל רשות לפיתוח אמצעי לחימה‬
‫בע"מ ‪14..6:‬‬
‫מוסד הטכניון למחקר ופיתוח בע"מ‬
‫‪1:1.06‬‬
‫‪152951‬‬
‫‪AIRFLO EUROPE N.V. 139539‬‬
‫‪AKZO NOBEL N.V. 149424‬‬
‫‪AKZO NOBEL N.V. 164466‬‬
‫‪ALBEMARLE CORPORATION 139922‬‬
‫‪ALLIEDSIGNAL INC. 129073‬‬
‫‪ALSTOM HOLDINGS 158815‬‬
‫‪ALTANA PHARMA AG 144026‬‬
‫‪ALZA CORPORATION 147559‬‬
‫‪i‬‬
‫‪SAE TECHNOLOGIES, INC. 1561593‬‬
‫‪ABBOTT LABORATORIES 150490‬‬
‫‪ABIOGEN PHARMA S.P.A. 147222‬‬
‫‪ACTIVE BIOTECH AB 148782‬‬
‫‪ADC TELECOMMUNICATIONS, INC.‬‬
‫‪147844‬‬
‫‪ADVANCED MEDICINE RESEARCH‬‬
‫‪INSTITUTE 128941‬‬
‫‪AEG INFRAROT-MODULE GMBH‬‬
‫כ"ז באייר התשס"ז – ‪May 15, 2007‬‬
AMERICAN AEROGEL
CORPORATION 157910
AMGEN, INC. 136717
AMIT BEN-SASSON 154444
AMIT MOR 166971
ARKION LIFE SCIENCES 152186
ASTRAZENECA AB 136827
ASTRAZENECA AB 141324
ASTRAZENECA AB 148111
ATOFINA 157798
AVI ELBAZ 166971
BALLATAIRE INTERNATIONAL LLC.
148287
BASF CORPORATION 149773
BAXTER AKTIENGESELLSCHAFT
131171, 131346
BAYER AKTIENGESELLSCHAFT
153090
BAYER CROPSCIENCE GMBH 145925
BAYER MATERIALSCIENCE AG
162235
BEAMREACH NETWORKS, INC.
141464
BEECHAM PHARMACEUTICALS
(PTE) LIMITED 145580
BEL FUSE LTD. 138621, 142552
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY 147898
BIOSENSE, INC. 149645
BOEHRINGER INGELHEIM
(CANADA) LTD. 145375
BOREALIS TECHNOLOGY OY 161973
BRISTOL COMPRESSORS, INC.
156196
BRISTOL-MYERS SQUIBB
COMPANY 145280
BRN PHOENIX, INC. 141464
CABOT SAFETY INTERMEDIATE
CORPORATION 172238
CARRIER CORPORATION 159601,
159602
CENTER FOR THE APPLICATION OF
MOLECULAR BIOLOGY IN
ii
INTERNATIONAL AGRICULTURE
134700
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE
(C.N.R.S) 158039, 160696
CHIESI FARMACEUTICI S.P.A.
143294
CHUGAI SEIYAKU KABUSHIKI
KAISHA 129164
CIBA SPECIALTY CHEMICALS
HOLDING INC. 149527
CITRIX SYSTEMS, INC. 147754
CLARIANT PRODUKTE
(DEUTSCHLAND) GMBH 158290
COLBAR LIFESCIENCE LTD. 110367
COMMISSARIAT A L'ENERGIE
ATOMIQUE 158039
CONNECTOR SET LIMITED
PARTNERSHIP 159934
CORNELL RESEARCH
FOUNDATION, INC. 116119
CROSSJECT 151120
CYTOKINETICS, INC. 149164
DAN MAMTIRIM 143319
DANIEL BARTAL LTD. 141219
DAVID JOSHUA SILVER 128950
DELAVAL HOLDING AB 145605
DENTSU INC. 135448
DIAMOND INNOVATIONS, INC.
148287, 154390
DIDIER LAPEYRE 140059
ESTILL MEDICAL
TECHNOLOGIES,INCORPORATED
141980
ETHYPHARM 147212
EURO-CELTIQUE S.A. 136804
F. HOFFMANN-LA ROCHE AG 143119
FLEX PRODUCTS, INC. 143076
FMC CORPORATION 149063
FUJIKIN INCORPORATED 157311
GE HEALTHCARE LIMITED 143927
GENENTECH, INC. 134968
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
GLAXO GROUP LIMITED 138353
GLAXO WELLCOME SPA 140062
GRUNENTHAL GMBH 148407
GRUPPO LEPETIT S.P.A. 127155
HAKLE-KIMBERLY DEUTSCHLAND
GMBH 156431
HENDRIK CORPORAAL 148699
HENRY M. ISRAEL 150112
HITACHI HIGH-TECHNOLOGIES
CORPORATION 154504
IBM CORPORATION 155395, 156319,
156321, 156523
IDEC PHARMACEUTICALS
CORPORATION 145112
IMMUNEX CORPORATION 127363
INDIAN INSTITUTE OF
TECHNOLOGY 148356
INTEL CORPORATION 148356
INTRALUMINAL THERAPEUTICS,
INC. 150960
INTRINSIC THERAPEUTICS, INC.
148121
JACK G. BITTERLY, 154033
KCI LICENSING, INC. 145629, 160450
KINETIC CONCEPTS, INC. 145629
KORNIT DIGITAL LTD. 162231
LAVIPHARM LABORATORIES, INC.
140475
LEVTECH, INC. 155267
LG LIFE SCIENCES LTD. 137828
LOCKHEED MARTIN CORPORATION
156156
LTS LOHMANN THERAPIESYSTEME AG 134787, 140667, 140670
LTS LOHMANN THERAPIESYSTEME AG 140744, 140745
MARK C. ANDERSON 157906
MARS, INCORPORATED 145814
MATITYAHU NOFF 110367
MATSUSHITA ELECTRIC
INDUSTRIAL CO., LTD. 137058
MERCK SHARP & DOHME LTD
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
139946
MERZ PHARMA GMBH & CO. KGAA
146974
MGI S.A.S. 137514
MINNESOTA MINING AND
MANUFACTURING COMPANY
148318
MORPHOCHEM AG 132518
N.V. ORGANON 149424
NDS LIMITED 135184
NEKTAR THERAPEUTICS 149085
NETWORK EQUIPMENT
TECHNOLOGIES, INC. 146765, 146767
NICE SYSTEMS LTD. 146352
NISSAN CHEMICAL INDUSTRIES
LTD. 156943
NIVA SHAPIRA 128541
NOKIA CORPORATION 146048
NOVARTIS AG 143093
NOVARTIS AG 146578, 153703
NOVO NORDISK A/S 148609
NUTRITION 21 134163
OLIN CORPORATION 154056
OPTIBASE LTD. 133260
OPTIBASE US, INC. 133260
ORION CORPORATION 140032
OXY VINYLS LP 149332
P.T.T. LTD. 150052
PERFECT CIRCLE PAINTBALL, INC.
145097
Perfect Circle Projectiles, LLC 145097
PFIZER INC. 157647
PHANOS TECHNOLOGIES, INC.
130842
PHARMACIA & UPJOHN S.P.A 141645
PHARMASOLUTIONS, INC. 143580
POWER PAPER LTD. 145905
PPG INDUSTRIES OHIO, INC. 152174
QUALCOMM INCORPORATED
140564, 144258, 147577
RAFAEL ARMAMENT
DEVELOPMENT AUTHORITY LTD.
145593
iii
RAFAEL-ARMAMENT
DEVELOPMENT AUTHORITY LTD.
124696, 149934
RANBAXY LABORATORIES
LIMITED 144274
RAYTHEON COMPANY 151258
RAYTHEON COMPANY 156013,
156675
RECKITT BENCKISER HEALTHCARE
(UK) LIMITED 149580
REGENTS OF THE UNIVERSITY OF
CALIFORNIA 137964
REGIE AUTONOME DES
TRANSPORTS PARISIENS 158815
RHEINMETALL W & M GMBH 148248
RIETER PERFOJET 150139
ROBOTIC VISION SYSTEMS, INC.
150832
RONALD E. SHAFER 157906
RUFUS M. HOLLOWAY JR. 144701
RUTGERS Chemicals AG 148761
SANDU PITRU 110367
SANIMAT DIFFUSION S.A. 137514
SANOFI-AVENTIS DEUTSCHLAND
GMBH 146372
SANOFI-AVENTIS DEUTSCHLAND
GMBH 148870
SAP AG 148037
SCHERING AG 150082
SCHERING AKTIENGESELLSCHAFT
154974, 154975, 154976
SCHOTT AG 154708
SCHOTT GLAS 154708
SEMBIOSYS GENETICS INC. 132259
SEMINIS VEGETABLE SEEDS, INC.
116119
SENSORMATIC ELECTRONICS
CORPORATION 154961
SHERWOOD PARTNERS, INC. 141464
SIDNEY P. WHITE 157906
SIEMENS AKTIENGESELLSCHAFT
149861
SILVERBROOK RESEARCH PTY.
LTD. 146673, 164954, 166721
SILVERBROOK RESEARCH PTY.
iv
LTD. 149952
SKYEPHARMA INC. 140899
SNECMA MOTEURS 162142
SOCIETE DES PRODUITS NESTLE
S.A. 163146
SOLAE, LLC 158263
SOLVAY PHARMACEUTICALS B.V.
148218
STEVEN E. BITTERLY, 154033
SYMRISE GMBH & CO. KG 148761
SYNT:EM S.A. 143012
TADAHIRO OHMI 153153, 153156
TADAHIRO OHMI 157311
TAKAHIKO MUKOUDA 156855
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
131589
TELEFONAKTIEBOLAGET LM
ERICSSON
(PUBL) 147142, 147513
TETRONICS LIMITED 152119
THE BOC GROUP, INC. 166167
THE UNIVERSITY COURT OF THE
UNIVERSITY OF GLASGOW 128578
THERAVANCE, INC. 149289
TIAX LLC 150925
TIBOTEC N.V. 145970
TOKYO ELECTRON LIMITED 153153,
153156
TOKYO ELECTRON LTD 157311
TRANSKARYOTIC THERAPIES, INC.
107822
TRIFLO MEDICAL, INC. 140059
TURBOCARE, INC. 146687
TVC COMMUNICATIONS, L.L.C.
145847
TVC INTERNATIONAL HOLDING,
INC. 145847
UNILEVER PLC 146356, 154878
UNITED STATES GYPSUM
COMPANY 150465
UNIVERSITEIT GENT 145970
UNIVERSITY OF FLORIDA 143234
UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION 150490
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
VACUUMSCHMELZE GMBH 154961
VASOGEN IRELAND LIMITED 148636
VIASAT, INC. 148207
VIRATA LIMITED 135907
VISONIC LTD. 158270
W.R. GRACE & CO. -CONN. 160321
WATER CROSSING, INC. 156993
WEARAIR OXYGEN INC. 154244
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. 123815,
158110
YIFAT GURION OFER 141219
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
150628
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM 123509
ZAMBON GROUP S.P.A. 146032
ZAVITAN SEMICONDUCTORS INC.
150784
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
v
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01G – 144701
B01J – 148287, 154390, 160321
A01J – 145605
B05B – 143319
A01H – 149773, 150925, 152186
B32B – 162235
A23G – 146356, 163146
A23J – 158263
B41J – 149952, 150382, 164954,
166721
A23K – 128541
B60N – 154444
A61B – 137514, 149645
B61L – 158815
A61F – 140059, 141980, 145629,
148121, 150112
B65D – 147222, 154878, 156431
C03B – 154708
A61K – 123509, 130842, 131346,
134163, 136804, 140667,
140670, 140745, 140899,
143012, 143093, 143234,
143294, 143580, 145112,
145580, 146578, 146974,
147212, 147559, 149085,
149580, 150628, 154975,
154976
A61J – 143119
A61M – 140475, 148609, 148636,
150960, 151120, 160450
C07C – 132518, 137964, 139922,
140744, 146032, 146372,
148111, 148407, 148761,
148870, 149527, 154974
C07D – 134787, 136717, 136827,
137828, 139946, 140032,
140062, 141324, 144026,
145375, 145814, 147898,
148218, 148318, 148782,
149063, 149164, 149289,
156943, 157457
A62B – 172238
C07F – 145280, 145925, 150490,
158110
A63B – 141219, 166971
C07H – 144274
A63H – 159934
C07J – 149424, 150082, 153703
B01D – 139539, 154033, 154244,
157906, 158039
C07K– 110367, 123815, 127155,
128941, 134968
B01F – 155267
C08F – 149332, 152174, 157798,
vi
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
161973, 164466
G01R – 143927
C08G – 158290
G01S – 156156
C08J – 150465, 157910
G02B – 128950, 156159, 156855
C09D – 153090
C12N– 107822, 127363, 128578,
129164, 131171, 132259,
134700, 138353
G03F – 154504
G06F – 135448, 146048, 147754,
147844
C12P – 141645
G06K –145905, 146673
C23C– 143076
G07B – 156675
D04H – 150139
G08B – 158270
D06B – 162231
G08G – 151258
E04C – 148699
F02K – 160696, 162142
H01L – 150784, 153153, 153156,
156319, 156321, 156523
F03B – 156993
H01R – 138621, 142552
F04B – 156196
H01T – 124696
F15D – 131589
H02G – 145847
F16J –146687
H02H – 149861
F16K – 166167
H03F – 140564
F24F – 159601
H04B – 144258, 147792, 148207
F25B – 152951
H04H – 135184
F25D – 159602
H04J – 137058
F41F – 156013
H04L – 141464, 147513, 148037
F42B – 145097, 148248, 154056
H04N – 148356
G01C – 145593, 149934
H04Q– 135907, 147142, 147577
G01D – 157311
H05H – 152119
G01N – 145970, 154961
May 15, 2007 – ‫כ"ז באייר התשס"ז‬
vii
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER